Metabolite,´úÐ»Îï,P_value,FDR,VIP_pred_OPLS-DA,VIP_PLS-DA,FC(KA/HA),Log2FC(KA/HA),Significant,Regulate,"KEGG Compound ID","KEGG Compound First Category","KEGG Compound Second Category","KEGG Pathway ID","KEGG Pathway Description","KEGG Pathway First Category","KEGG Pathway Second Category","Library ID","HMDB Superclass","HMDB Class","HMDB Subclass","CAS ID",M/Z,"Retention time",Adducts,Formula,"Fragmentation Score","Theoretical Fragmentation Score","Metab ID",ID,Mode,KA1,KA10,KA11,KA12,KA6,KA8,HA12,HA14,HA16,HA3,HA4,HA6,ka_mean,ka_SD,ha_mean,ha_SD
L-Isoleucine,L-ÒìÁÁ°±Ëá,2.334E-5,0.01412,1.7178,1.7783,0.6266,-0.6744,yes,down,C00407,Peptides,"Amino acids",map01100;map04978;map00280;map00290;map01210;map02010;map01230;map04974;map00970;map05230,"Metabolic pathways;Mineral absorption;Valine, leucine and isoleucine degradation;Valine, leucine and isoleucine biosynthesis;2-Oxocarboxylic acid metabolism;ABC transporters;Biosynthesis of amino acids;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer","Metabolism;Organismal Systems;Metabolism;Metabolism;Metabolism;Environmental Information Processing;Metabolism;Organismal Systems;Genetic Information Processing;Human Diseases","Global and overview maps;Digestive system;Amino acid metabolism;Amino acid metabolism;Global and overview maps;Membrane transport;Global and overview maps;Digestive system;Translation;Cancer: overview",HMDB0000172;PW_C000112;HMDB0000557;MJDBOTE0001077,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1509-34-8;73-32-5,132.101717008,0.886083333333,M+H,C6H13NO2,68.4,0,metab_552,pos_1515,pos,7988000,10730000,7636000,10710000,9164000,10170000,15040000,15330000,16260000,12860000,16120000,14410000,,,,
"PG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))",-,7.723E-5,0.007354,1.7037,1.5983,0.2649,-1.9165,yes,down,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",LMGP04010838;PW_C063057;HMDB0116603,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,865.502945786,7.17096666667,M+Na-2H,C48H77O10P,0,34.8,metab_6594,neg_1224,neg,159600,124700,729800,274200,341800,1024000,2161000,1505000,1368000,1574000,1596000,1818000,,,,
L-Hexanoylcarnitine,"L -¼ºõ£»ùÈâ¼î",0.0001085,0.01563,1.7036,1.5997,1.9911,0.9936,yes,up,-,-,-,-,-,-,-,HMDB0000756,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",22671-29-0,260.185142184,4.52751666667,M+H,C13H25NO4,90.6,0,metab_892,pos_1827,pos,907100,1065000,1125000,1217000,982900,1110000,437500,470100,655200,321800,777200,556600,,,,
Butyryl-L-carnitine,"¶¡õ£- L -Èâ¼î",0.0002193,0.01632,1.6985,1.5766,1.9185,0.94,yes,up,C02862,-,-,-,-,-,-,HMDB0002013,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",25576-40-3,232.153953706,2.72931666667,M+H,C11H21NO4,57.3,0,metab_5006,pos_5914,pos,2533000,2211000,1618000,1900000,2185000,2411000,1097000,929800,1032000,744900,1380000,1515000,,,,
"(9S,10E,12S,13S)-9,12,13-Trihydroxyoctadec-10-enoylcarnitine","£¨9S£¬10E£¬12S£¬13S£©-9,12,13-ÈýôÇ»ùÊ®°ËÍé»ù-10-Ï©õ£»ùÈâ¼î",0.0001275,0.01563,1.6979,1.7019,0.3406,-1.5538,yes,down,-,-,-,-,-,-,-,HMDB0241532,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,456.33107174,6.19298333333,M+H-H2O,C25H47NO7,0,47.7,metab_1332,pos_2241,pos,315800,240900,465800,284300,369300,661500,1077000,1402000,1454000,850800,1084000,996700,,,,
"1,3-Butadiene",3-¶¡¶þÏ©,5.147E-5,0.01412,1.697,1.7496,0.6408,-0.6421,yes,down,C16450,-,-,-,-,-,-,HMDB0041792,Hydrocarbons,"Unsaturated hydrocarbons",Olefins,106-99-0,72.0812674713,0.743166666667,M+NH4,C4H6,0,42.9,metab_5363,pos_6253,pos,440700,602600,459500,545100,526300,581700,814500,839600,926900,689600,873200,781000,,,,
"Alpha-Terpineol formate",-,0.000508,0.02466,1.6953,1.5194,1.1894,0.2502,yes,up,-,-,-,-,-,-,-,HMDB0032050,"Lipids and lipid-like molecules","Prenol lipids",Monoterpenoids,2153-26-6,200.16422391,6.02478333333,M+NH4,C11H18O2,0,31.8,metab_4318,pos_5283,pos,1457000,1511000,1416000,1486000,1529000,1491000,1221000,1281000,1226000,1168000,1403000,1175000,,,,
"Pantothenic Acid",·ºËá,0.0005388,0.02562,1.695,1.5938,2.5674,1.3603,yes,up,C00864,"Vitamins and cofactors",Vitamins,map01100;map01240;map00770;map00410;map04977,"Metabolic pathways;Biosynthesis of cofactors;Pantothenate and CoA biosynthesis;beta-Alanine metabolism;Vitamin digestion and absorption","Metabolism;Metabolism;Metabolism;Metabolism;Organismal Systems","Global and overview maps;Global and overview maps;Metabolism of cofactors and vitamins;Metabolism of other amino acids;Digestive system",PW_C000136;HMDB0000210;HMDB0250782;MJDBOTE0000845,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",79-83-4,220.117605238,2.73731666667,"M+H-H2O, M+Na, M+H, M+H-2H2O",C9H17NO5,77.8,0,metab_223,pos_12,pos,6535000,8710000,5051000,7215000,6779000,4774000,2042000,2136000,3699000,2297000,2658000,2388000,,,,
Octanoylcarnitine,ÐÁõ£Èâ¼î,0.0009332,0.02992,1.6826,1.5841,1.8484,0.8863,yes,up,C02838,-,-,-,-,-,-,LMFA07070095;HMDB0000791,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",25243-95-2,310.200603254,5.9521,M+Na,C15H29NO4,0,53.8,metab_1149,pos_2059,pos,778300,1140000,807600,787500,870200,700700,447500,435900,432000,389600,547700,497600,,,,
4-Chloro-L-phenylalanine,"4 -ÂÈ- L -±½±û°±Ëá",0.0002555,0.01817,1.6817,1.5033,1.4837,0.5692,yes,up,-,-,-,-,-,-,-,HMDB0244605,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,241.073372665,4.03145,M+ACN+H,C9H10ClNO2,0,70.4,metab_4827,pos_5747,pos,5580000,5148000,4712000,5705000,6427000,6104000,3710000,4388000,3028000,3792000,4218000,3565000,,,,
L-Octanoylcarnitine,"L -ÐÁõ£»ùÈâ¼î",0.0001841,0.01615,1.6635,1.5516,1.8773,0.9087,yes,up,C02838,-,-,-,-,-,-,LMFA07070002;HMDB0000791,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",25243-95-2,288.216337053,5.9761,M+H,C15H29NO4,86.9,0,metab_4342,pos_5305,pos,410200,541300,550400,572900,471700,538900,213400,248300,327900,188000,400400,265200,,,,
Histamine,×é°·,0.0003513,0.02086,1.6606,1.4942,4.8909,2.2901,yes,up,C00388,"Peptides;Hormones and transmitters;Hormones and transmitters","Amines;Other hormones;Neurotransmitters",map01100;map05310;map04664;map04750;map00340;map04971;map04974;map04080;map04721,"Metabolic pathways;Asthma;Fc epsilon RI signaling pathway;Inflammatory mediator regulation of TRP channels;Histidine metabolism;Gastric acid secretion;Protein digestion and absorption;Neuroactive ligand-receptor interaction;Synaptic vesicle cycle","Metabolism;Human Diseases;Organismal Systems;Organismal Systems;Metabolism;Organismal Systems;Organismal Systems;Environmental Information Processing;Organismal Systems","Global and overview maps;Immune disease;Immune system;Sensory system;Amino acid metabolism;Digestive system;Digestive system;Signaling molecules and interaction;Nervous system",HMDB0000870;PW_C000693;MJDBOTE0000422,"Organic nitrogen compounds","Organonitrogen compounds",Amines,51-45-6,112.087054813,0.602133333333,M+H,C5H9N3,76.1,0,metab_312,pos_1282,pos,56800,39170,21090,46030,39170,45090,1180,21140,12890,1755,12750,858.8,,,,
Nornicotine,È¥¼×ÑÌ¼î,0.0006199,0.0275,1.6505,1.4964,1.7734,0.8265,yes,up,C06524,-,-,-,-,-,-,PW_C000880;HMDB0001126,"Organoheterocyclic compounds","Pyridines and derivatives",Pyrrolidinylpyridines,494-97-3,314.231846338,6.08076666667,2M+NH4,C9H12N2,0,40.6,metab_4266,pos_5233,pos,1055000,1248000,1166000,953900,1251000,1220000,471100,612300,671100,444400,987200,700800,,,,
1-Phenylbiguanide,1-±½»ùË«ËõëÒ,0.002207,0.04352,1.6476,1.6599,4.2363,2.0828,yes,up,-,-,-,-,-,-,-,HMDB0256437,"Organic nitrogen compounds","Organonitrogen compounds",Guanidines,-,160.096625815,2.6973,M+H-H2O,C8H11N5,0,42.1,metab_5015,pos_5922,pos,1573000,1784000,1277000,1003000,655700,1129000,337900,264900,308700,310300,240000,290400,,,,
"3-Hydroxyanthranilic acid",3-ôÇ»ù-2-°±»ù±½¼×Ëá,0.001148,0.033,1.6376,1.4867,0.532,-0.9105,yes,down,C00632,-,-,map01100;map00380;map01240,"Metabolic pathways;Tryptophan metabolism;Biosynthesis of cofactors",Metabolism;Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism;Global and overview maps",HMDB0001476;PW_C001137,Benzenoids,"Benzene and substituted derivatives","Benzoic acids and derivatives",548-93-6,154.04961934,1.91188333333,M+H,C7H7NO3,92.4,0,metab_5125,pos_6023,pos,2368000,2256000,3444000,1054000,1784000,3001000,4780000,3892000,4343000,4252000,4108000,4766000,,,,
Betaine,Ìð²Ë¼î,0.0002231,0.01632,1.6374,1.6049,0.5272,-0.9236,yes,down,C00719,-,-,map01100;map02010;map00260,"Metabolic pathways;ABC transporters;Glycine, serine and threonine metabolism","Metabolism;Environmental Information Processing;Metabolism","Global and overview maps;Membrane transport;Amino acid metabolism",HMDB0000043;PW_C000030;MJDBTMA0000064,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",6915-17-9;107-43-7,118.086316101,0.704516666667,M+H,C5H11NO2,64.7,0,metab_5415,pos_6304,pos,9737000,10840000,7554000,6965000,9082000,11520000,20060000,19150000,17970000,12580000,16310000,19600000,,,,
Serotonin,5-ôÇÉ«°·,0.0009113,0.02992,1.6174,1.4898,5.6079,2.4875,yes,up,C00780,"Peptides;Hormones and transmitters",Amines;Neurotransmitters,map01100;map05207;map04750;map04540;map04976;map04024;map04080;map04726;map04742;map00380;map04721,"Metabolic pathways;Chemical carcinogenesis - receptor activation;Inflammatory mediator regulation of TRP channels;Gap junction;Bile secretion;cAMP signaling pathway;Neuroactive ligand-receptor interaction;Serotonergic synapse;Taste transduction;Tryptophan metabolism;Synaptic vesicle cycle","Metabolism;Human Diseases;Organismal Systems;Cellular Processes;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Organismal Systems;Metabolism;Organismal Systems","Global and overview maps;Cancer: overview;Sensory system;Cellular community - eukaryotes;Digestive system;Signal transduction;Signaling molecules and interaction;Nervous system;Sensory system;Amino acid metabolism;Nervous system",PW_C000178;HMDB0000259;MJDBSJD0000073,"Organoheterocyclic compounds","Indoles and derivatives","Tryptamines and derivatives",50-67-9,218.128557211,2.70531666667,M+ACN+H,C10H12N2O,88.1,0,metab_717,pos_1668,pos,75710,78200,128900,155000,117900,180500,4424,51580,22180,2999,45820,4275,,,,
5-Methyl-1H-Benzotriazole,5-¼×»ù±½²¢Èýßò,0.0003309,0.02045,1.6172,1.4826,1.1969,0.2593,yes,up,-,-,-,-,-,-,-,-,-,-,-,-,134.071164423,6.03278333333,M+H,C7H7N3,91.6,0,metab_4308,pos_5273,pos,366100,370400,359100,413100,360200,367200,309600,313900,297500,303000,348600,296000,,,,
"LysoPI(20:4(5Z,8Z,11Z,14Z)/0:0)",-,0.0003598,0.01423,1.6152,1.521,0.5245,-0.931,yes,down,-,-,-,-,-,-,-,HMDB0061690,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoinositols,1246430-04-5,619.288798129,7.53103333333,M-H,C29H49O12P,0,87.7,metab_6886,neg_1488,neg,177000,94990,204900,192200,121300,154300,232400,334300,300400,338000,246800,349000,,,,
Falcarindiol,¸£¶û¿¨Ï©È²¶þ´¼,0.001033,0.03086,1.6103,1.5714,0.3897,-1.3596,yes,down,C08449,-,-,-,-,-,-,LMFA05000658;HMDB0244257;HMDB0033941,"Lipids and lipid-like molecules","Fatty Acyls","Fatty alcohols",55297-87-5,538.385854033,7.75028333333,2M+NH4,C17H24O2,0,51.5,metab_2647,pos_3585,pos,445900,202300,466600,247000,108500,66710,544900,807500,768700,521900,721700,580200,,,,
Tetrahydrodipicolinate,"2,3,4,5-ËÄÇâßÁà¤-2,6-¶þ¼×Ëá",0.001525,0.03719,1.604,1.4455,0.5161,-0.9543,yes,down,C03972,-,-,map01100;map01230,"Metabolic pathways;Biosynthesis of amino acids",Metabolism;Metabolism,"Global and overview maps;Global and overview maps",HMDB0012289,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",4226-22-6,154.049696132,0.846383333333,M+H-H2O,C7H9NO4,0,55.7,metab_533,pos_1499,pos,1891000,1663000,2869000,753200,1273000,2329000,3738000,3278000,3158000,3707000,3047000,3953000,,,,
Melatonin,ÍÊºÚ¼¤ËØ,0.003397,0.0531,1.6033,1.5729,93.5111,6.5471,yes,up,C01598,"Hormones and transmitters","Other hormones",map01100;map04713;map04080;map00380,"Metabolic pathways;Circadian entrainment;Neuroactive ligand-receptor interaction;Tryptophan metabolism","Metabolism;Organismal Systems;Environmental Information Processing;Metabolism","Global and overview maps;Environmental adaptation;Signaling molecules and interaction;Amino acid metabolism",PW_C001074;HMDB0001389;MJDBZSJ0000127,"Organoheterocyclic compounds","Indoles and derivatives",Indoles,73-31-4,233.127985963,4.7402,M+H,C13H16N2O2,42.2,0,metab_905,pos_1839,pos,106200,42530,112200,136400,59250,175000,600.1,443.7,568.2,564.4,3961,613,,,,
"1,2,3-Benzotriazole","1£¬2£¬3 -±½²¢Èýßò",0.0002787,0.01927,1.6011,1.5285,0.684,-0.5479,yes,down,-,-,-,-,-,-,-,-,-,-,-,-,120.056592045,2.55261666667,"M+H-H2O, M+H",C6H5N3,40.3,0,metab_2348,pos_329,pos,88310,113500,77820,95120,97360,106100,164900,133900,123700,139000,131700,152400,,,,
P-Aminophenazone,-,0.0004077,0.02148,1.6011,1.5089,0.6779,-0.5609,yes,down,-,-,-,-,-,-,-,HMDB0256031,"Organoheterocyclic compounds",Diazanaphthalenes,Benzodiazines,-,250.038153729,2.53661666667,M+K,C12H9N3O,0,35.8,metab_5053,pos_5958,pos,288800,331800,237300,256100,268000,301900,503700,397500,381800,391900,372900,435700,,,,
Biguanide,Ë«ËõëÒ,0.0008928,0.02992,1.5994,1.5915,1.114,0.1557,yes,up,C07672,-,-,-,-,-,-,HMDB0249203,"Organic nitrogen compounds","Organonitrogen compounds",Guanidines,56-03-1,84.0670287018,7.82211666667,M+H-H2O,C2H7N5,0,42.1,metab_2449,pos_3393,pos,107500,103300,98830,103400,100700,109200,93840,88000,91820,91140,94480,99820,,,,
3-Pyridinecarboxaldehyde,3-ßÁà¤¼×È©,0.0004882,0.02416,1.5929,1.4648,0.8487,-0.2367,yes,down,C07327,-,-,-,-,-,-,HMDB0245978,"Organoheterocyclic compounds","Pyridines and derivatives","Pyridine carboxaldehydes",500-22-1,108.0445648,1.91188333333,M+H,C6H5NO,0,48.6,metab_5129,pos_6027,pos,596900,591100,623700,540600,577500,654900,738500,664100,693700,687300,692600,747500,,,,
L-Erythrulose,L-³àÞºÍªÌÇ,0.0015,0.02505,1.5926,1.4735,1.4587,0.5447,yes,up,C02045,Carbohydrates,Monosaccharides,-,-,-,-,HMDB0006293,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",533-50-6,119.033941534,0.714166666667,M-H,C4H8O4,30.1,0,metab_7781,neg_2313,neg,1088000,1446000,1154000,1076000,1473000,1241000,724500,919200,927100,859000,939100,756400,,,,
Glycerophosphocholine,¸ÊÓÍÁ×Ëáµ¨¼î,0.001137,0.033,1.5834,1.6235,0.613,-0.706,yes,down,C00670,-,-,map00565;map00564;map05231,"Ether lipid metabolism;Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Metabolism;Human Diseases","Lipid metabolism;Lipid metabolism;Cancer: overview",HMDB0008359;PW_C000059;HMDB0008094;HMDB0008718;HMDB0008784;HMDB0008556;HMDB0008062;HMDB0008194;HMDB0008456;HMDB0008458;HMDB0011222;HMDB0008027;HMDB0008685;HMDB0011225;HMDB0007928;HMDB0008357;HMDB0008588;HMDB0008652;HMDB0007930;HMDB0008360;HMDB0008162;HMDB0008523;HMDB0008424;HMDB0008488;HMDB0007962;HMDB0008721;HMDB0008061;HMDB0007994;HMDB0000086;HMDB0008327;HMDB0008554;HMDB0008653;HMDB0007929;HMDB0008093;HMDB0011227;HMDB0008325;HMDB0008422;HMDB0008787;HMDB0008159;HMDB0007896;HMDB0008030;HMDB0007997;HMDB0008227;HMDB0008589;HMDB0008258;HMDB0008491;HMDB0008620;HMDB0011223;HMDB0007996;HMDB0011221;HMDB0008228;HMDB0008390;HMDB0008687;HMDB0008587;HMDB0008785;HMDB0008226;HMDB0008586;HMDB0008063;HMDB0008326;HMDB0008193;HMDB0008392;HMDB0008820;HMDB0008555;HMDB0008293;HMDB0008719;HMDB0008060;HMDB0008127;HMDB0007995;HMDB0008455;HMDB0008225;HMDB0011224;HMDB0008291;HMDB0008753;HMDB0008457;HMDB0008654;HMDB0008489;HMDB0008521;HMDB0008358;HMDB0011228;HMDB0007895;HMDB0008425;HMDB0008294;HMDB0008622;HMDB0008261;HMDB0008817;HMDB0008160;HMDB0007931;HMDB0008096;HMDB0011290;HMDB0008557;HMDB0008423;HMDB0008095;HMDB0008720;HMDB0008818;HMDB0011226;HMDB0008621;HMDB0008195;HMDB0008619;HMDB0008128;HMDB0008260;HMDB0008391;HMDB0007963;HMDB0008292;HMDB0008819;HMDB0008524;HMDB0008490;HMDB0008393;HMDB0008161;HMDB0008786;HMDB0008259;MJDBOTE0000471,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,28319-77-9,258.109548363,0.886083333333,M+H,C8H20NO6P,77.1,0,metab_554,pos_1517,pos,481400,273800,373100,390700,305200,373200,583700,778100,497700,619200,572600,533000,,,,
12(S)-HETrE,12£¨S£©-ºÕÌØ¶û,0.001753,0.03994,1.5824,1.4257,1.1393,0.1881,yes,up,-,-,-,-,-,-,-,HMDB0062747,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,-,345.237442783,6.0001,M+Na,C20H34O3,0,78.8,metab_1179,pos_2086,pos,1477000,1453000,1363000,1462000,1464000,1469000,1263000,1265000,1272000,1254000,1413000,1160000,,,,
"8,8-Dimethoxy-2,6-dimethyl-2-octanol","8£¬8 -¶þ¼×Ñõ»ù- 2£¬6 -¶þ¼×»ù- 2 -ÐÁ´¼",0.0009642,0.0302,1.582,1.4446,1.5056,0.5903,yes,up,-,-,-,-,-,-,-,HMDB0040219,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",141-92-4,282.203456442,6.04078333333,M+ACN+Na,C12H26O3,0,32.2,metab_1208,pos_2113,pos,130400,163300,170400,172500,158700,163800,115700,118800,95760,82510,139700,84550,,,,
"2,4-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one","2,4-¶þôÇ»ù-2H-1,4-±½²¢¶ñàº-3£¨4H£©-Íª",0.003619,0.05444,1.5774,1.4294,0.1235,-3.0174,yes,down,C15770,-,-,-,-,-,-,HMDB0033733,"Organoheterocyclic compounds",Benzoxazines,Benzoxazinones,17359-54-5,199.071048688,2.72131666667,M+NH4,C8H7NO4,0,43.9,metab_5007,pos_5915,pos,13190,2842,31790,2347,2356,20380,134000,44410,139400,108400,44550,119600,,,,
"Kinetensin 4-7","¼¤¶¯ËØ4 ~ 7",0.002918,0.03442,1.5704,1.4506,2.2346,1.16,yes,up,-,-,-,-,-,-,-,HMDB0012986,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",138482-56-1,592.265458759,6.40991666667,M+Na-2H,C26H37N9O6,0,65.9,metab_7159,neg_1737,neg,977000,845200,846900,886500,1106000,905500,177400,435800,305700,751700,672400,148200,,,,
Pro-Pro-Pro,¾Û×óÐý¸¬°±Ëá,0.00178,0.03994,1.5629,1.4171,0.4986,-1.004,yes,down,-,-,-,-,-,-,-,HMDB0256689,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,310.175416109,2.63333333333,M+H,C15H23N3O4,0,77.6,metab_692,pos_1645,pos,103100,111200,142200,73370,77110,129400,233000,169100,278500,198000,149400,248600,,,,
SM(d18:0/16:1(9Z)),-,0.001452,0.03684,1.5618,1.4226,1.9581,0.9695,yes,up,C00550,Lipids,Phospholipids,map00600;map01100;map04071;map04217,"Sphingolipid metabolism;Metabolic pathways;Sphingolipid signaling pathway;Necroptosis","Metabolism;Metabolism;Environmental Information Processing;Cellular Processes","Lipid metabolism;Global and overview maps;Signal transduction;Cell growth and death",HMDB0013464,"Lipids and lipid-like molecules",Sphingolipids,Phosphosphingolipids,-,725.55544236,7.617,"M+Na, M+ACN+H",C39H79N2O6P,0,82.5,metab_6135,pos_819,pos,714500,680300,613400,1093000,881100,899600,337300,316400,365600,470500,627600,375500,,,,
N1-Methyl-2-pyridone-5-carboxamide,"N1 -¼×»ù- 2 -ßÁà¤Íª- 5 -¼×õ£°·",0.003181,0.05213,1.5575,1.4009,0.5553,-0.8487,yes,down,C05842,-,-,map01100;map00760,"Metabolic pathways;Nicotinate and nicotinamide metabolism",Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins",PW_C002086;HMDB0004193,"Organoheterocyclic compounds","Pyridines and derivatives","Pyridinecarboxylic acids and derivatives",701-44-0,153.065654344,1.91188333333,"M+H, M+Na",C7H8N2O2,0,52.2,metab_2272,pos_320,pos,8995000,8621000,14570000,4253000,6438000,11670000,18240000,14740000,16280000,16060000,14790000,18120000,,,,
3-Cyanoalanine,3-Çè»ù±û°±Ëá,0.004455,0.05933,1.5569,1.4161,0.5118,-0.9663,yes,down,C02512,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0060245;HMDB0245844,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",6232-19-5,156.076588681,0.649766666667,M+ACN+H,C4H6N2O2,0,32.4,metab_5532,pos_6413,pos,440600,466000,494600,380000,401000,503700,1200000,567900,1018000,846300,727600,888600,,,,
"PA(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))",-,0.004849,0.04359,1.5568,1.4495,0.1648,-2.6012,yes,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",PW_C063986;HMDB0115601,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,817.502811074,7.3682,M+FA-H,C45H73O8P,0,34,metab_6606,neg_1235,neg,797500,494400,1873000,605700,843100,1461000,9936000,3243000,5245000,5916000,3771000,8722000,,,,
N1-Methyl-4-pyridone-3-carboxamide,"N1 -¼×»ù- 4 -ßÁà¤Íª- 3 -¼×õ£°·",0.002906,0.04874,1.5562,1.3925,0.5237,-0.9332,yes,down,C05843,-,-,map01100;map00760,"Metabolic pathways;Nicotinate and nicotinamide metabolism",Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins",HMDB0004194;PW_C002087,"Organoheterocyclic compounds","Pyridines and derivatives","Pyridinecarboxylic acids and derivatives",769-49-3,153.065644648,0.846383333333,M+H,C7H8N2O2,0,63.1,metab_532,pos_1498,pos,7709000,6843000,12960000,3182000,5024000,9313000,15810000,13040000,13150000,15450000,12370000,16180000,,,,
FAHFA(18:0/13-O-16:0),-,0.001718,0.03994,1.544,1.3985,2.8253,1.4984,yes,up,-,-,-,-,-,-,-,LMFA07090048;HMDB0112153,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,556.529028256,6.82985,M+NH4,C34H66O4,0,65.3,metab_1834,pos_2739,pos,457700,396900,198600,257500,394100,333100,81760,76970,47440,222000,220800,72480,,,,
"PA(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))",PA£¨22:6£¨4Z£¬7Z£¬10Z£¬13Z£¬16Z£¬19Z£©/22:4£¨7Z£¬10Z£¬13Z£¬16Z£©£©,0.00526,0.04572,1.5434,1.4386,0.1308,-2.9346,yes,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",PW_C062848;HMDB0115422;LMGP10010844,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,841.50235734,7.26493333333,M+FA-H,C47H73O8P,0,48.2,metab_6946,neg_1542,neg,157900,80600,594200,142000,164100,469900,3270000,1001000,1825000,1907000,1181000,3108000,,,,
"Riesling acetal",-,0.001207,0.02352,1.5393,1.456,0.3522,-1.5055,yes,down,-,-,-,-,-,-,-,HMDB0037562,"Organoheterocyclic compounds",Tetrahydrofurans,"Not Available",-,271.154839842,6.06311666667,M+FA-H,C13H22O3,0,67.8,metab_8985,neg_958,neg,35410,46750,82740,6595,41270,49660,113300,120200,152900,97590,84670,176800,,,,
"Valganciclovir, (S)-",çÓ¸üÎôÂåÎ¤£¨S£©-,0.007347,0.07362,1.5385,1.3839,0.0366,-4.772,yes,down,-,-,-,-,-,-,-,HMDB0259748,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,372.201035798,3.68913333333,M+NH4,C14H22N6O5,0,46.8,metab_832,pos_1773,pos,2265,2254,52510,2154,2210,3277,360600,71990,378400,484200,121500,351300,,,,
Triethanolamine,ÈýÒÒ´¼°·,0.004941,0.0614,1.5329,1.4082,1.1713,0.2281,yes,up,C06771,-,-,map00564,"Glycerophospholipid metabolism",Metabolism,"Lipid metabolism",HMDB0032538,"Organic nitrogen compounds","Organonitrogen compounds",Amines,102-71-6,150.112312677,6.0081,M+H,C6H15NO3,81.9,0,metab_1181,pos_2088,pos,317600,317300,318700,330000,315700,324900,252100,280300,270400,275600,316800,247700,,,,
"Taurocholic Acid",Å£»Çµ¨Ëá,0.008828,0.08001,1.5324,1.4034,5.9523,2.5734,yes,up,C05122,Steroids,"24-Carbon atoms",map01100;map04979;map04976;map00120;map00430,"Metabolic pathways;Cholesterol metabolism;Bile secretion;Primary bile acid biosynthesis;Taurine and hypotaurine metabolism","Metabolism;Organismal Systems;Organismal Systems;Metabolism;Metabolism","Global and overview maps;Digestive system;Digestive system;Lipid metabolism;Metabolism of other amino acids",LMST05040001;PW_C000025;HMDB0000036;MJDBOTE0000483,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",81-24-3,480.277021705,6.01676666667,M+H-2H2O,C26H45NO7S,82,0,metab_1188,pos_2095,pos,2398000,4927000,1755000,2162000,4272000,1567000,424600,326800,599500,621800,622200,274900,,,,
"PE(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.001721,0.02669,1.5287,1.4374,0.3778,-1.4043,yes,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",PW_C005093;HMDB0009045,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,788.52330999,7.49966666667,M-H,C45H76NO8P,0,65.7,metab_6916,neg_1515,neg,136300,199500,379300,118900,237700,421700,892700,369500,601500,563500,723300,802700,,,,
Mifepristone,Ã×·ÇË¾Íª,0.006571,0.06968,1.5271,1.3706,0.3552,-1.4933,yes,down,C07652,-,-,-,-,-,-,HMDB0014972;MJDBOTE0001512,"Lipids and lipid-like molecules","Steroids and steroid derivatives",Oxosteroids,84371-65-3,471.30001804,6.29546666667,M+ACN+H,C29H35NO2,0,38.5,metab_3969,pos_4934,pos,108400,204100,157200,236500,155900,229400,608700,320800,601500,795300,333700,412800,,,,
5-Hydroxyoctanoylcarnitine,"5 -ôÇ»ùÐÁõ£Èâ¼î",0.004563,0.06029,1.5229,1.6016,1.477,0.5627,yes,up,-,-,-,-,-,-,-,HMDB0241694,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,286.200613763,5.6322,M+H-H2O,C15H29NO5,0,47.8,metab_4697,pos_5629,pos,171900,185200,187900,138900,138600,216300,133000,115100,110500,102900,108200,133300,,,,
"(6R,8Z)-6-Hydroxy-3-oxotetradecenoic acid",£¨6R£¬8Z£©-6-ôÇ»ù-3-Ñõ´úÊ®ÁùÌ¼Ï©Ëá,0.005281,0.04572,1.5219,1.4196,0.429,-1.221,yes,down,-,-,-,-,-,-,-,HMDB0062363,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,255.159780671,6.20003333333,"M-H, M+Na-2H",C14H24O4,0,71.2,metab_7902,neg_243,neg,93790,84810,105100,63550,80270,117700,209200,234600,264000,135900,134100,293000,,,,
Lubiprostone,Â³±ÈÇ°ÁÐÍª,0.002711,0.0467,1.5206,1.3631,1.2052,0.2693,yes,up,C13707,-,-,-,-,-,-,HMDB0015180,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,333963-40-9;136790-76-6,391.229176393,6.03278333333,"M+H, M+Na",C20H32F2O5,0,42.3,metab_3553,pos_454,pos,2613000,2724000,2518000,2705000,2957000,2872000,2217000,2309000,2251000,2184000,2665000,1971000,,,,
Fibrin,ÏËÎ¬µ°°×,0.005585,0.06481,1.5191,1.3791,0.4727,-1.081,yes,down,C00290,-,-,map05171;map04371;map04610,"Coronavirus disease - COVID-19;Apelin signaling pathway;Complement and coagulation cascades","Human Diseases;Environmental Information Processing;Organismal Systems","Infectious disease: viral;Signal transduction;Immune system",HMDB0252249,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",9001-31-4,110.071444396,0.649766666667,M+H-2H2O,C5H11N3O2,0,46.1,metab_5534,pos_6415,pos,52030,56770,60390,38460,39080,54800,152500,65810,127200,106300,82440,103600,,,,
Niacinamide,ÑÌõ£°·,0.005245,0.06274,1.5189,1.4029,0.3639,-1.4584,yes,down,C00153,"Vitamins and cofactors",Vitamins,map01100;map00760;map04977;map01240,"Metabolic pathways;Nicotinate and nicotinamide metabolism;Vitamin digestion and absorption;Biosynthesis of cofactors","Metabolism;Metabolism;Organismal Systems;Metabolism","Global and overview maps;Metabolism of cofactors and vitamins;Digestive system;Global and overview maps",PW_C001086;HMDB0001406,"Organoheterocyclic compounds","Pyridines and derivatives","Pyridinecarboxylic acids and derivatives",98-92-0,123.055299661,0.806533333333,M+H,C6H6N2O,71.2,0,metab_5283,pos_6171,pos,801200,933700,673400,1136000,767800,677300,2283000,1983000,1994000,1945000,1679000,3824000,,,,
"N-formimidoyl-glutamic acid",-,0.003355,0.05309,1.5178,1.3749,0.4725,-1.0816,yes,down,C00439,-,-,map01100;map00340,"Metabolic pathways;Histidine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0255140;HMDB0000854,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",816-90-0,139.050017734,0.998466666667,M+H-2H2O,C6H10N2O4,0,43.4,metab_575,pos_1538,pos,273400,216300,365400,201900,167200,312800,598100,320100,458400,540100,575400,760800,,,,
"Eugenyl glucoside",¶¡×ÓÏã»ùÌÇÜÕ,0.005886,0.06603,1.5175,1.376,0.1251,-2.9988,yes,down,-,-,-,-,-,-,-,HMDB0302740,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,327.142234461,3.68111666667,"M+H-H2O, M+H, M+Na",C16H22O7,0,53.1,metab_6060,pos_75,pos,39670,29890,275600,5701,13700,77820,752600,205200,825400,797700,228900,727900,,,,
Venlafaxine,ÎÄÀ­·¨ÐÁ,0.002692,0.04655,1.5159,1.3404,1.1675,0.2234,yes,up,C07187,-,-,-,-,-,-,PW_C002364;HMDB0005016,Benzenoids,"Phenol ethers",Anisoles,93413-69-5,341.221613622,6.01676666667,M+ACN+Na,C17H27NO2,0,46.4,metab_1187,pos_2094,pos,412900,425100,387800,363200,433300,416100,332400,362000,350800,327500,389600,326600,,,,
LysoPE(P-18:1(9Z)/0:0),-,0.003621,0.03654,1.5128,1.4343,0.3892,-1.3614,yes,down,-,-,-,-,-,-,-,HMDB0240599,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,1425046-04-3,462.298752639,6.67931666667,M-H,C23H46NO6P,0,67.4,metab_7084,neg_1669,neg,783100,432400,1008000,697800,480500,634200,1451000,1387000,2259000,2569000,1380000,1321000,,,,
"Phaseoloside D",²Ë¶¹ÔíÜÕD,0.009896,0.08354,1.5116,1.4778,0.0377,-4.7293,yes,down,C08967,-,-,-,-,-,-,HMDB0303708;HMDB0039410,"Lipids and lipid-like molecules","Prenol lipids","Terpene glycosides",30937-16-7,702.332048312,4.66291666667,M+H+Na,C65H104O31,0,59.3,metab_901,pos_1835,pos,42460,621.2,14910,593.6,609.2,85990,737100,527100,283300,1245000,823100,240500,,,,
"PG(18:1(11Z)/18:2(9Z,12Z))",-,0.008086,0.05705,1.5104,1.4072,0.0753,-3.7312,yes,down,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",PW_C006628;HMDB0010620,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,793.5028643,7.42911666667,M+Na-2H,C42H77O10P,0,51,metab_6609,neg_1238,neg,490300,92800,868200,191000,190700,357900,8477000,2067000,4001000,4885000,2365000,7316000,,,,
"Ethyl beta-D-fructofuranoside","ÒÒ»ù¦Â - D -ß»à«¹ûÌÇÜÕ",0.003818,0.05576,1.508,1.3747,0.7426,-0.4293,yes,down,-,-,-,-,-,-,-,HMDB0303035,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,226.128109531,0.418266666667,M+NH4,C8H16O6,0,34.7,metab_5907,pos_6760,pos,1379000,1368000,1661000,1263000,1472000,1390000,2249000,1558000,1829000,2048000,1711000,2096000,,,,
DL-Glutamate,DL-¹È°±Ëá,0.004988,0.06141,1.5061,1.3618,0.5786,-0.7894,yes,down,C00302,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0060475,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,192.024046185,0.6731,"M+2Na-H, M+ACN+Na",C5H9NO4,0,30.9,metab_108,pos_1096,pos,190300,177500,195400,132000,133700,151500,395100,222700,279600,307900,215300,273800,,,,
2-Hydroxypyridine,2-ôÇ»ùßÁà¤,0.009357,0.08259,1.5053,1.356,0.1624,-2.6224,yes,down,C02502,-,-,-,-,-,-,HMDB0013751,"Organoheterocyclic compounds","Pyridines and derivatives",Hydropyridines,142-08-5,137.070811118,0.665266666667,M+ACN+H,C5H5NO,0,46.7,metab_5480,pos_6365,pos,48960,63550,104900,76870,58480,59690,686400,137200,559600,555300,233000,367800,,,,
"Alpha-Terpineol propanoate",-,0.006106,0.06672,1.5038,1.3326,1.2291,0.2976,yes,up,-,-,-,-,-,-,-,HMDB0032052,"Lipids and lipid-like molecules","Prenol lipids",Monoterpenoids,80-27-3,243.19512231,6.02478333333,M+CH3OH+H,C13H22O2,0,32.2,metab_1191,pos_2098,pos,112300,125100,112900,121200,124600,121400,103700,109800,91250,79150,111000,89000,,,,
P-Coumaraldehyde,"P -Ïã¶¹È©",0.001732,0.03994,1.503,1.4085,0.7249,-0.4641,yes,down,C05608,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0040986,"Phenylpropanoids and polyketides",Cinnamaldehydes,"Not Available",2538-87-6;20711-53-9,166.086049616,2.55261666667,"M+H-H2O, M+NH4",C9H8O2,0,46.6,metab_2340,pos_328,pos,19890000,24180000,17190000,19960000,19700000,21290000,33550000,25730000,25270000,26970000,25540000,31540000,,,,
Bisdethiobis(methylthio)gliotoxin,¶þÁò´úË«£¨¼×Áò»ù£©½ºÖÊ¶¾ËØ,0.003478,0.03623,1.5027,1.3987,1.1834,0.2429,yes,up,-,-,-,-,-,-,-,HMDB0249258,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,401.087307651,6.04741666667,M+FA-H,C15H20N2O4S2,0,81.2,metab_8983,neg_956,neg,274200,309100,255900,271900,314800,293500,235500,250600,242400,247700,256700,219700,,,,
Deoxyuridine,ÍÑÑõÄòÜÕ,0.003498,0.03623,1.4992,1.4068,1.6929,0.7595,yes,up,C00526,"Nucleic acids",Nucleosides,map00240;map01100;map02010,"Pyrimidine metabolism;Metabolic pathways;ABC transporters","Metabolism;Metabolism;Environmental Information Processing","Nucleotide metabolism;Global and overview maps;Membrane transport",HMDB0245528;HMDB0000012;PW_C000007;MJDBOTE0000510,"Nucleosides, nucleotides, and analogues","Pyrimidine nucleosides","Pyrimidine 2''-deoxyribonucleosides",951-78-0,273.072436451,1.93113333333,"M-H, M+Cl, M+FA-H",C9H12N2O5,36.6,0,metab_8418,neg_43,neg,150700,161200,159600,163600,131400,125800,58600,127200,88750,76050,123200,53250,,,,
"N-Linoleoyl Histidine","N -ÑÇÓÍõ£×é°±Ëá",0.01174,0.08354,1.4966,1.3487,7.3558,2.8789,yes,up,-,-,-,-,-,-,-,HMDB0241977,"Not Available","Not Available","Not Available",-,462.266319498,6.15315,M+2Na-H,C24H39N3O3,0,60.7,metab_1290,pos_2196,pos,1154000,2550000,720400,1568000,2663000,757900,193200,156300,322300,219700,289300,98900,,,,
"Linoelaidic acid",·´ÑÇÓÍËá,0.002992,0.03481,1.4939,1.3741,0.6431,-0.6369,yes,down,C01595,Lipids,"Fatty acids",map01100;map00591;map01040,"Metabolic pathways;Linoleic acid metabolism;Biosynthesis of unsaturated fatty acids",Metabolism;Metabolism;Metabolism,"Global and overview maps;Lipid metabolism;Lipid metabolism",HMDB0247706;LMFA01030123;HMDB0000673;HMDB0006270,"Lipids and lipid-like molecules","Fatty Acyls","Lineolic acids and derivatives",506-21-8;60-33-3,559.472911319,7.25693333333,2M-H,C18H32O2,0,33,metab_6947,neg_1543,neg,203600,172500,296700,294100,182700,259400,449100,309800,415700,315600,315600,385100,,,,
5-Hydroxyindoleacetylglycine,"5 -ôÇ»ùßÅßáÒÒõ£¸Ê°±Ëá",0.005936,0.04845,1.4865,1.4081,0.3308,-1.596,yes,down,C05832,-,-,map00380,"Tryptophan metabolism",Metabolism,"Amino acid metabolism",HMDB0004185,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,293.077606942,3.61406666667,M+FA-H,C12H12N2O4,0,42.1,metab_8791,neg_781,neg,116400,168300,177100,71700,111300,204000,451500,243300,425100,458800,288700,699100,,,,
N(6)-Methyllysine,N£¨6£©-¼×»ùÀµ°±Ëá,0.007995,0.07557,1.4833,1.3663,0.1459,-2.7769,yes,down,C02728,-,-,-,-,-,-,HMDB0002038,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1188-07-4,193.154479119,0.6731,M+CH3OH+H,C7H16N2O2,0,46.1,metab_5465,pos_6351,pos,67330,93060,257200,47790,16110,91090,880800,316700,950500,568400,228700,980100,,,,
PE(PGJ2/20:0),-,0.006045,0.06663,1.4807,1.3242,1.6461,0.7191,yes,up,-,-,-,-,-,-,-,HMDB0261851,"Not Available","Not Available","Not Available",-,848.537047764,7.65663333333,M+Na,C45H80NO10P,0,46.4,metab_2715,pos_3660,pos,16580000,27240000,21850000,23460000,32580000,28410000,15010000,12400000,12330000,12950000,20830000,17680000,,,,
"4'-Hydroxyfenoprofen glucuronide","4 ' -ôÇ»ù·ÒÂå·ÒÆÏÌÑÌÇÈ©ËáÜÕ",0.0104,0.06441,1.4759,1.4687,57.6952,5.8504,yes,up,-,-,-,-,-,-,-,HMDB0060772,Benzenoids,"Benzene and substituted derivatives",Diphenylethers,-,433.113487761,5.94051666667,"M-H, M+Na-2H",C21H22O10,0,56.3,metab_7624,neg_216,neg,442600,293000,684400,70440,427300,857800,29310,1790,8811,4313,1840,2039,,,,
S-Allylcysteine,S-Ï©±û»ù°ëë×°±Ëá,0.005194,0.06257,1.4734,1.3029,0.2606,-1.9401,yes,down,C16759,-,-,-,-,-,-,HMDB0034323,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",21593-77-1,345.092079854,1.7119,2M+Na,C6H11NO2S,0,45.8,metab_5167,pos_6061,pos,61400,29590,177800,1535,9647,64810,261600,94030,297800,321800,152800,194900,,,,
Milrinone,-,0.002199,0.04352,1.4726,1.38,0.724,-0.4659,yes,down,C07224,-,-,-,-,-,-,HMDB0014380,"Organoheterocyclic compounds","Pyridines and derivatives","Bipyridines and oligopyridines",78415-72-2,250.038178888,2.07991666667,M+K,C12H9N3O,0,30.9,metab_5090,pos_5993,pos,200400,250300,167700,197200,209500,212000,335900,254800,245100,299300,259000,314800,,,,
1-Oleoylglycerophosphoserine,"1 -ÓÍõ£¸ÊÓÍÁ×Ëáõ¥",0.004046,0.0394,1.4717,1.3673,2.1668,1.1156,yes,up,-,-,-,-,-,-,-,HMDB0061694,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoserines,-,544.266234323,6.4819,M+Na-2H,C24H46NO9P,0,63,metab_7137,neg_1717,neg,509800,407300,379300,396800,341000,296700,63990,309700,112500,268600,254400,66660,,,,
"N-Methylglutamic acid","N -¼×»ù¹È°±Ëá",0.004628,0.06062,1.4687,1.3006,0.4672,-1.0979,yes,down,C01046,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0062660,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",35989-16-3,184.057752381,0.782666666667,"M+Na, M+2Na-H, M+H",C6H11NO4,35.3,0,metab_984,pos_191,pos,521200,414500,1084000,337500,320800,589800,1432000,916900,1524000,1331000,759900,1029000,,,,
"(4,6-Dimethylpyrimidin-5-yl)-[4-[4-[2-[2-methoxy-4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone","£¨4,6-¶þ¼×»ùà×à¤-5-»ù£©-[4-[4-[2-[2-¼×Ñõ»ù-4-£¨Èý·ú¼×»ù£©±½»ù]ÒÒ»ù]-3-¼×»ùßßàº-1-»ù]-4-¼×»ùßßà¤-1-»ù]¼×Íª",0.008271,0.05763,1.4686,1.3597,1.9615,0.972,yes,up,-,-,-,-,-,-,-,HMDB0257760,Benzenoids,"Benzene and substituted derivatives",Trifluoromethylbenzenes,-,568.265834248,6.44096666667,M+Cl,C28H38F3N5O2,0,31.2,metab_7152,neg_1730,neg,633300,493200,557600,515800,496900,576500,111900,362500,185900,445100,454400,108700,,,,
Taurine,Å£»ÇËá,0.003572,0.03634,1.4636,1.3665,0.6069,-0.7205,yes,down,C00245,-,-,map01100;map00920;map00430;map02010;map00120;map04080,"Metabolic pathways;Sulfur metabolism;Taurine and hypotaurine metabolism;ABC transporters;Primary bile acid biosynthesis;Neuroactive ligand-receptor interaction","Metabolism;Metabolism;Metabolism;Environmental Information Processing;Metabolism;Environmental Information Processing","Global and overview maps;Energy metabolism;Metabolism of other amino acids;Membrane transport;Lipid metabolism;Signaling molecules and interaction",PW_C000171;HMDB0000251;MJDBOTE0000787,"Organic acids and derivatives","Organic sulfonic acids and derivatives","Organosulfonic acids and derivatives",107-35-7,124.006351744,0.6444,M-H,C2H7NO3S,90.8,0,metab_7953,neg_2476,neg,2493000,5690000,4306000,4112000,4462000,4784000,8479000,5748000,8622000,6684000,5272000,7784000,,,,
Homodolichosterone,¸ßÈý¼âÉ¼õ¥Íª,0.01277,0.08354,1.4631,1.3168,0.0247,-5.3393,yes,down,-,-,-,-,-,-,-,HMDB0034079,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Stigmastanes and derivatives",85797-14-4,521.319269977,3.48473333333,M+2Na-H,C29H48O5,0,54.3,metab_4879,pos_5796,pos,677,371.9,2478,2121,1726,24910,366500,79680,108900,410800,168300,173000,,,,
Loliolide,ºÚÂó²ÝÄÚõ¥,0.006816,0.05294,1.4629,1.3807,0.2451,-2.0286,yes,down,-,-,-,-,-,-,-,HMDB0302428,"Organoheterocyclic compounds",Benzofurans,"Not Available",-,241.107689611,5.87513333333,M+FA-H,C11H16O3,0,39.9,metab_7376,neg_1935,neg,19790,12310,29030,670.4,13530,21500,52150,57840,112400,37120,46550,89060,,,,
Dinoterb,ÌØÀÖ·Ó,0.005831,0.04808,1.4613,1.3754,1.4471,0.5332,yes,up,C18671,-,-,-,-,-,-,-,-,-,-,1420-07-1,239.06683912,6.34248333333,M-H,C10H12N2O5,52.2,0,metab_7178,neg_1755,neg,27980,43310,28440,32090,33880,38800,22310,21810,22010,21010,26420,27720,,,,
"Kainic acid",-,0.005264,0.04572,1.4543,1.369,1.38,0.4647,yes,up,C12819,-,-,-,-,-,-,HMDB0253757,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",487-79-6,194.081460747,6.27278333333,M-H2O-H,C10H15NO4,0,42.6,metab_7196,neg_1771,neg,4979000,6974000,4695000,5579000,6540000,6226000,4449000,3632000,3874000,3917000,4638000,4846000,,,,
"N-Linoleoyl Leucine","N -ÑÇÓÍõ£ÁÁ°±Ëá",0.008532,0.05821,1.4497,1.4358,0.278,-1.8468,yes,down,-,-,-,-,-,-,-,HMDB0241979,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,392.316756692,6.67931666667,M-H,C24H43NO3,0,34.7,metab_7088,neg_1672,neg,245100,87380,283700,203900,189100,142700,335800,956000,804400,1053000,621500,373000,,,,
"(3S,7E,9S)-9-Hydroxy-4,7-megastigmadien-3-one 9-glucoside","£¨3S£¬7E£¬9S£©-9-ôÇ»ù-4,7-¾Þ¶¹¶þÏ©-3-Íª9-ÆÏÌÑÌÇÜÕ",0.005106,0.04498,1.4495,1.386,0.3803,-1.3948,yes,down,-,-,-,-,-,-,-,HMDB0036822,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acyl glycosides",-,415.196975651,6.06311666667,M+FA-H,C19H30O7,0,41,metab_8986,neg_959,neg,328300,198300,351400,78280,174900,225000,618600,388900,659000,597500,371100,930700,,,,
Pectin,¹û½º,0.005976,0.04856,1.4493,1.3917,0.3983,-1.3281,yes,down,C08348,-,-,-,-,-,-,HMDB0242608;HMDB0003402,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",9000-69-5,193.03462403,0.675266666667,M-H,C6H10O7,0,46.1,metab_9044,neg_2368,neg,168300,149800,277900,89910,121000,179000,510100,216800,463600,508700,246300,529400,,,,
"2-Acetamido-2,6-dideoxygalactose","2 -ÒÒõ£°±»ù- 2£¬6 -¶þÍÑÑõ°ëÈéÌÇ",0.0094,0.08259,1.4485,1.3467,0.3965,-1.3346,yes,down,-,-,-,-,-,-,-,HMDB0259683,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,188.091464081,2.68931666667,"M+H-H2O, M+K, M+Na",C8H15NO5,0,40.2,metab_5950,pos_68,pos,300300,231300,437600,226600,235100,309500,988600,420900,901600,626600,433700,1018000,,,,
"Tetradecanedioic acid",Ê®ËÄÌ¼¶þÔªËá,0.003508,0.03623,1.4475,1.3693,0.5059,-0.9831,yes,down,C11002,-,-,-,-,-,-,HMDB0000872;LMFA01170018,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",821-38-5,257.175442025,6.0788,M-H,C14H26O4,71,0,metab_8994,neg_966,neg,271800,337700,479800,179800,373400,559700,623900,785000,814500,496500,627400,1005000,,,,
1-Arachidonoylglycerol,"1 -»¨ÉúËÄÏ©õ£¸ÊÓÍ",0.01191,0.08354,1.4466,1.3393,0.0449,-4.4771,yes,down,C13857,-,-,-,-,-,-,LMGL01010032;HMDB0011578;HMDB0243830,"Lipids and lipid-like molecules",Glycerolipids,Monoradylglycerols,124511-15-5,361.27287689,7.70341666667,M+H-H2O,C23H38O4,0,34,metab_2689,pos_3632,pos,21790,7920,20420,7568,7767,8166,483200,75810,181200,290700,155800,451100,,,,
O-Acetylserine,"O -ÒÒõ£Ë¿°±Ëá",0.009939,0.08354,1.4466,1.3269,0.4396,-1.1857,yes,down,C00979,-,-,map01100;map00920;map00270;map01200;map01230;map04122,"Metabolic pathways;Sulfur metabolism;Cysteine and methionine metabolism;Carbon metabolism;Biosynthesis of amino acids;Sulfur relay system","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Genetic Information Processing","Global and overview maps;Energy metabolism;Amino acid metabolism;Global and overview maps;Global and overview maps;Folding, sorting and degradation",HMDB0003011,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",5147-00-2,189.086690731,0.966466666667,M+ACN+H,C5H9NO4,0,50.2,metab_5210,pos_6101,pos,419200,354400,451700,222000,297600,414200,1194000,427300,1025000,877900,547700,838800,,,,
"Ricinoleic acid",-,0.005619,0.06504,1.4463,1.4773,1.2835,0.3601,yes,up,C08365,-,-,-,-,-,-,HMDB0034297;LMFA02000184,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",141-22-0,263.236412864,0.434266666667,M+H-2H2O,C18H34O3,0,73.6,metab_5902,pos_6756,pos,677700,646500,542200,756900,696400,736500,553800,482200,520800,543900,425800,633600,,,,
L-Threonine,L-ËÕ°±Ëá,0.006476,0.06896,1.4455,1.5247,1.0856,0.1185,yes,up,C00188,Peptides,"Amino acids",map01100;map04978;map00970;map00290;map02010;map00860;map01230;map04974;map00260,"Metabolic pathways;Mineral absorption;Aminoacyl-tRNA biosynthesis;Valine, leucine and isoleucine biosynthesis;ABC transporters;Porphyrin and chlorophyll metabolism;Biosynthesis of amino acids;Protein digestion and absorption;Glycine, serine and threonine metabolism","Metabolism;Organismal Systems;Genetic Information Processing;Metabolism;Environmental Information Processing;Metabolism;Metabolism;Organismal Systems;Metabolism","Global and overview maps;Digestive system;Translation;Amino acid metabolism;Membrane transport;Metabolism of cofactors and vitamins;Global and overview maps;Digestive system;Amino acid metabolism",HMDB0000167;PW_C000109;MJDBOTE0000464,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",72-19-5,84.0448078925,0.33825,M+H-2H2O,C4H9NO3,66.9,0,metab_5913,pos_6766,pos,425500,448000,437900,434300,462000,479100,428300,389600,421100,416000,399500,420800,,,,
2-Oxazolidinone,fßòßø-2-Íª,0.004189,0.03989,1.4442,1.3514,0.5479,-0.868,yes,down,C06695,Antibiotics,Others,-,-,-,-,HMDB0245282,"Organoheterocyclic compounds",Azolines,Oxazolines,497-25-6,123.981046306,0.6444,M+K-2H,C3H5NO2,0,64.9,metab_7954,neg_2477,neg,65720,201300,139200,120200,152400,147800,311100,202600,311800,232000,170200,281400,,,,
KOBUSONE,-,0.00737,0.07362,1.4417,1.332,0.3842,-1.3801,yes,down,C16983,-,-,-,-,-,-,HMDB0036790,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",24173-71-5,223.168917684,6.11325,M+H,C14H22O2,49.4,0,metab_4238,pos_5206,pos,53910,55170,79940,19370,56310,64440,146700,90770,138900,127900,111300,241200,,,,
"PS(20:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))",-,0.0079,0.07552,1.4413,1.2851,3.9331,1.9757,yes,up,-,-,-,-,-,-,-,HMDB0282117,"Not Available","Not Available","Not Available",-,916.524587465,7.617,M+2Na-H,C46H82NO12P,0,60.7,metab_2308,pos_3241,pos,451500,1065000,1028000,1067000,2060000,1239000,158000,197900,103200,286500,851200,160700,,,,
Diminazene,ÖØµª±½ëß,0.009558,0.08333,1.4392,1.2586,2.5614,1.3569,yes,up,C18388,-,-,-,-,-,-,HMDB0251412,Benzenoids,"Benzene and substituted derivatives",Phenylhydrazines,536-71-0,585.269892068,6.04878333333,2M+Na,C14H15N7,0,41.3,metab_4288,pos_5254,pos,920000,1412000,359600,763500,1046000,1154000,189400,641300,399400,221100,583600,173100,,,,
"Actinidic acid",â¨ºïÌÒËá,0.0128,0.08354,1.4377,1.343,0.1202,-3.0565,yes,down,-,-,-,-,-,-,-,LMPR0106180010;HMDB0037963,"Lipids and lipid-like molecules","Prenol lipids",Triterpenoids,341971-45-7,550.350768405,5.82483333333,M+ACN+Na,C30H46O5,0,38.6,metab_4623,pos_5562,pos,37120,40810,84610,30210,25040,46220,639700,147200,344000,402600,117100,546200,,,,
LysoPC(P-18:0/0:0),-,0.01299,0.08354,1.4369,1.2846,0.3125,-1.6781,yes,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0013122,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,530.35722843,7.66461666667,M+Na,C26H54NO6P,0,79.6,metab_2712,pos_3657,pos,207300,61190,221700,96990,87660,201100,479600,428600,319300,887300,320200,368000,,,,
"17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one",17-N£¬N-¶þÒÒ»ù°±»ù¼×õ£»ù-4-¼×»ù-4-µªÔÓÐÛçÞÍé-3-Íª,0.006644,0.06987,1.4367,1.2587,1.464,0.5499,yes,up,-,-,-,-,-,-,-,HMDB0246483,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Androstane steroids",-,430.345891258,6.35111666667,M+ACN+H,C24H40N2O2,0,45.7,metab_3887,pos_4851,pos,246100,299600,218100,247400,328400,305700,192200,186200,130600,179900,268000,166800,,,,
C75,3-ôÈ»ù-4-ÐÁ»ù-2-ÑÇ¼×»ù¶¡ÄÚõ¥,0.01037,0.06441,1.4355,1.3572,0.4335,-1.2059,yes,down,-,-,-,-,-,-,-,-,-,-,-,-,253.144154711,6.17698333333,"M-H, M+Na-2H",C14H22O4,71.2,0,metab_7839,neg_237,neg,129100,143200,185200,104800,167200,159600,315600,262300,437700,218400,279300,538100,,,,
"3-Oxododecanoic acid","3 -Ñõ´úÊ®¶þÍéËá",0.006701,0.07018,1.4349,1.2887,1.2277,0.296,yes,up,C02367,-,-,-,-,-,-,PW_C006734;HMDB0010727,"Organic acids and derivatives","Keto acids and derivatives","Medium-chain keto acids and derivatives",-,237.145398073,6.20866666667,M+Na,C12H22O3,0,38.1,metab_4103,pos_5071,pos,407100,412500,384900,391100,466600,438300,325300,343600,335600,316900,422500,293000,,,,
Kaempferol,É½èÍ·Ó,0.005764,0.06523,1.434,1.4529,2.8284,1.5,yes,up,C05903,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0005801;HMDB0032008;LMPK12110003;MJDBOTE0000798,"Phenylpropanoids and polyketides",Flavonoids,Flavones,80714-53-0;520-18-3,304.083584696,3.50075,M+NH4,C15H10O6,0,57.5,metab_6339,pos_5794,pos,300200,295200,308300,131200,155600,165600,72040,111000,147900,50550,63970,34170,,,,
"Estradiol cypionate",-,0.01121,0.08354,1.4329,1.2488,0.4302,-1.2169,yes,down,C14640,-,-,-,-,-,-,HMDB0251962,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroid esters",313-06-4,438.297160058,6.84573333333,M+ACN+H,C26H36O3,0,36.7,metab_3311,pos_4292,pos,203600,105700,240400,153600,51960,168900,331500,221300,404900,600400,298600,291500,,,,
Cer(d18:0/14:0),-,0.004291,0.05889,1.4328,1.3384,1.6673,0.7375,yes,up,-,-,-,-,-,-,-,LMSP02020016;HMDB0011759,"Lipids and lipid-like molecules",Sphingolipids,Ceramides,-,512.502954653,6.87766666667,M+H,C32H65NO3,0,33.8,metab_1874,pos_2781,pos,2210000,1840000,1263000,1606000,1713000,1652000,913400,815200,818200,1634000,1205000,783500,,,,
"Suberic Acid",ÐÁ¶þËá,0.007598,0.05539,1.4317,1.3569,0.633,-0.6597,yes,down,C08278,"Organic acids","Carboxylic acids",-,-,-,-,HMDB0000893;LMFA01170001;MJDBOTE0000630,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",505-48-6,173.081054464,5.40723333333,M-H,C8H14O4,62,0,metab_7396,neg_1954,neg,135500,139300,170500,113300,116300,141800,216700,213500,216000,227400,134100,282300,,,,
Aglepristone,-,0.01638,0.08354,1.4312,1.2857,0.4299,-1.2179,yes,down,-,-,-,-,-,-,-,HMDB0248061,"Lipids and lipid-like molecules","Steroids and steroid derivatives",Oxosteroids,-,464.312925912,6.86965,"M+CH3OH+H, 2M+NH4",C29H37NO2,0,47.3,metab_5873,pos_673,pos,56320,73510,63150,62610,50500,44740,123500,61770,165900,220000,140600,104200,,,,
Piperidines,ßßà¤Àà,0.007456,0.07362,1.4253,1.2877,1.2536,0.3261,yes,up,-,-,-,-,-,-,-,HMDB0302905,"Organoheterocyclic compounds",Piperidines,"Not Available",-,329.192378105,6.19298333333,2M+H,C6H14NO4+,0,32.6,metab_4135,pos_5100,pos,431300,429000,402200,384200,483200,432700,310400,365300,317100,315100,434100,302000,,,,
Vomifoliol,´ßÍÂÒ¶´¼,0.009593,0.06166,1.4241,1.3448,0.3984,-1.3277,yes,down,C04166,-,-,-,-,-,-,HMDB0303570,"Lipids and lipid-like molecules","Prenol lipids",Sesquiterpenoids,-,269.13901185,6.03956666667,M+FA-H,C13H20O3,0,54.1,metab_7311,neg_1875,neg,47910,55000,63590,21870,48930,50300,94780,130400,198700,70490,95010,132200,,,,
Amantadine,½ð¸ÕÍé°·,0.01668,0.08354,1.4189,1.3552,0.5182,-0.9484,yes,down,C06818,-,-,-,-,-,-,HMDB0015051;HMDB0005000;HMDB0245807,"Organic nitrogen compounds","Organonitrogen compounds",Amines,768-94-5;79794-75-5,193.169695147,0.08225,M+ACN+H,C10H17N,0,31.2,metab_194,pos_1173,pos,17990,18660,19410,15560,15730,17930,28060,44910,48020,37350,19300,25580,,,,
Boc-phepsi(CH(OH)CH2)phe-val-phe-morpholine,Boc-phepsi£¨CH£¨OH£©CH2£©phe-val-pheÂðßø,0.01504,0.07467,1.4165,1.3281,0.0142,-6.138,yes,down,-,-,-,-,-,-,-,HMDB0249334,"Organic acids and derivatives",Peptidomimetics,"Hybrid peptides",-,749.39526082,4.04291666667,M+Na-2H,C42H56N4O7,0,30.3,metab_7469,neg_2019,neg,10740,6229,6504,6360,6529,74910,2427000,451200,633200,2347000,904900,1048000,,,,
Wyerone,²Ï¶¹Íª,0.01959,0.08495,1.412,1.3596,14.8822,3.8955,yes,up,C08465,-,-,-,-,-,-,HMDB0030947,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",20079-30-5,259.095989464,5.91215,M+H,C15H14O4,0,62.6,metab_1109,pos_2022,pos,24580,17080,26600,1256,28550,53540,1894,1382,1793,1781,1404,1935,,,,
"PA(18:1(9Z)/20:3(5Z,8Z,11Z))",-,0.01709,0.08123,1.4119,1.3078,0.0414,-4.5942,yes,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",PW_C062351;HMDB0114933,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,769.502823146,7.49183333333,M+FA-H,C41H73O8P,0,46,metab_6919,neg_1518,neg,153400,15490,22200,48220,67260,36840,2839000,572000,1041000,1085000,573400,2192000,,,,
9(S)-HpOTrE,-,0.01454,0.0739,1.4118,1.3057,0.5549,-0.8497,yes,down,C16321,-,-,map00592,"alpha-Linolenic acid metabolism",Metabolism,"Lipid metabolism",-,-,-,-,111004-08-1,309.206860761,6.31315,M-H,C18H30O4,70.8,0,metab_7182,neg_1759,neg,34370,40260,38070,41720,34240,50340,73230,98080,83700,42240,49000,84480,,,,
"Resolvin D1",ÏûÍËËØD1,0.01452,0.08354,1.4089,1.3211,0.1321,-2.9203,yes,down,C18178,-,-,-,-,-,-,LMFA04030011;HMDB0003733,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,770.481565882,5.86808333333,2M+NH4,C22H32O5,0,35.9,metab_1057,pos_1976,pos,23920,44180,178300,55100,48560,58670,766100,208700,388000,622200,186700,922800,,,,
"Filipin II",·ÆÀûÆ½¢ò,0.01441,0.08354,1.4088,1.3264,0.169,-2.5649,yes,down,-,-,-,-,-,-,-,HMDB0252258;HMDB0242297,"Phenylpropanoids and polyketides","Macrolides and analogues","Not Available",-,652.411025253,5.86808333333,2M+3H2O+2H,C35H58O10,0,74.9,metab_4524,pos_5472,pos,135800,212100,436400,128900,139300,238200,1940000,495400,1043000,1419000,534200,2207000,,,,
Armillarin,-,0.007859,0.07528,1.4078,1.2676,1.7667,0.8211,yes,up,-,-,-,-,-,-,-,HMDB0039380,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",83329-14-0,437.192709806,7.79026666667,"M+Na, M+K",C24H30O6,0,69.4,metab_6221,pos_899,pos,144400,144400,102400,216400,202800,166700,89340,136200,91390,93130,95130,47720,,,,
Adenine,ÏÙàÑßÊ,0.008592,0.079,1.4061,1.2637,1.2665,0.3408,yes,up,C00147,"Nucleic acids",Bases,map01100;map00230,"Metabolic pathways;Purine metabolism",Metabolism;Metabolism,"Global and overview maps;Nucleotide metabolism",HMDB0000034;PW_C000024;MJDBOTE0000759,"Organoheterocyclic compounds",Imidazopyrimidines,"Purines and purine derivatives",73-24-5,177.088042488,6.20088333333,M+ACN+H,C5H5N5,0,52.4,metab_4120,pos_5088,pos,986700,1109000,900700,1062000,1282000,1122000,784200,901300,838700,803700,1039000,735100,,,,
"Lamivudine sulfoxide",À­Ã×·ò¶¨ÑÇí¿,0.01175,0.06729,1.4029,1.3118,1.1145,0.1564,yes,up,-,-,-,-,-,-,-,HMDB0060599;PW_C040661,"Nucleosides, nucleotides, and analogues","Nucleoside and nucleotide analogues","Not Available",-,266.019870669,3.73071666667,"M-H, M+Na-2H",C8H11N3O4S,0,39.1,metab_7250,neg_182,neg,611400,650700,527700,615400,597500,599600,521400,531200,549000,527300,547300,556100,,,,
"L-Glutamic Acid",L-¹È°±Ëá,0.01236,0.06808,1.4011,1.3333,0.6445,-0.6337,yes,down,C00025,"Peptides;Hormones and transmitters","Amino acids;Neurotransmitters",map01240;map01200;map00330;map00220;map00250;map04072;map04216;map00630;map00430;map04964;map02010;map00860;map04080;map05016;map05017;map05014;map04727;map04742;map04723;map05031;map04721;map04720;map01100;map00480;map04540;map01210;map00340;map00524;map01230;map04068;map05034;map04724;map05030;map00650;map00910;map04974;map04713;map00970;map05230;map05033;map04730;map05022,"Biosynthesis of cofactors;Carbon metabolism;Arginine and proline metabolism;Arginine biosynthesis;Alanine, aspartate and glutamate metabolism;Phospholipase D signaling pathway;Ferroptosis;Glyoxylate and dicarboxylate metabolism;Taurine and hypotaurine metabolism;Proximal tubule bicarbonate reclamation;ABC transporters;Porphyrin and chlorophyll metabolism;Neuroactive ligand-receptor interaction;Huntington disease;Spinocerebellar ataxia;Amyotrophic lateral sclerosis;GABAergic synapse;Taste transduction;Retrograde endocannabinoid signaling;Amphetamine addiction;Synaptic vesicle cycle;Long-term potentiation;Metabolic pathways;Glutathione metabolism;Gap junction;2-Oxocarboxylic acid metabolism;Histidine metabolism;Neomycin, kanamycin and gentamicin biosynthesis;Biosynthesis of amino acids;FoxO signaling pathway;Alcoholism;Glutamatergic synapse;Cocaine addiction;Butanoate metabolism;Nitrogen metabolism;Protein digestion and absorption;Circadian entrainment;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;Nicotine addiction;Long-term depression;Pathways of neurodegeneration - multiple diseases","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Environmental Information Processing;Cellular Processes;Metabolism;Metabolism;Organismal Systems;Environmental Information Processing;Metabolism;Environmental Information Processing;Human Diseases;Human Diseases;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Metabolism;Metabolism;Cellular Processes;Metabolism;Metabolism;Metabolism;Metabolism;Environmental Information Processing;Human Diseases;Organismal Systems;Human Diseases;Metabolism;Metabolism;Organismal Systems;Organismal Systems;Genetic Information Processing;Human Diseases;Human Diseases;Organismal Systems;Human Diseases","Global and overview maps;Global and overview maps;Amino acid metabolism;Amino acid metabolism;Amino acid metabolism;Signal transduction;Cell growth and death;Carbohydrate metabolism;Metabolism of other amino acids;Excretory system;Membrane transport;Metabolism of cofactors and vitamins;Signaling molecules and interaction;Neurodegenerative disease;Neurodegenerative disease;Neurodegenerative disease;Nervous system;Sensory system;Nervous system;Substance dependence;Nervous system;Nervous system;Global and overview maps;Metabolism of other amino acids;Cellular community - eukaryotes;Global and overview maps;Amino acid metabolism;Biosynthesis of other secondary metabolites;Global and overview maps;Signal transduction;Substance dependence;Nervous system;Substance dependence;Carbohydrate metabolism;Energy metabolism;Digestive system;Environmental adaptation;Translation;Cancer: overview;Substance dependence;Nervous system;Neurodegenerative disease",HMDB0000148;HMDB0060475;PW_C000095;HMDB0003339;MJDBOTE0000649,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",6893-26-1;56-86-0,146.044920242,0.7064,M-H,C5H9NO4,78.7,0,metab_9040,neg_573,neg,225600,250900,265400,218700,183300,243400,471300,248200,381800,378500,269600,403100,,,,
L-Palmitoylcarnitine,"L -×Øéµõ£¿¨Äá¶¡",0.009779,0.06205,1.3984,1.3343,0.4663,-1.1007,yes,down,C02990,-,-,map01212;map00071,"Fatty acid metabolism;Fatty acid degradation",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0240774;LMFA07070004;HMDB0000222;LMFA07070079;PW_C000147,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",2364-67-2,436.282822208,6.67931666667,M+K-2H,C23H45NO4,0,35.8,metab_6479,neg_1120,neg,1963000,1188000,2288000,1610000,1224000,1720000,3202000,2447000,3931000,5791000,3330000,2740000,,,,
Hydroxybutyrylglycine,-,0.01379,0.07189,1.3955,1.3437,0.3027,-1.724,yes,down,-,-,-,-,-,-,-,HMDB0094716,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,182.044998759,0.862233333333,M+Na-2H,C6H11NO4,0,39.3,metab_7663,neg_2196,neg,81530,50490,120100,48770,56210,100100,277500,122400,386500,278300,96620,349200,,,,
N6-Methyl-2'-deoxyadenosine,"N6 -¼×»ù- 2 ' -ÍÑÑõÏÙÜÕ",0.008772,0.07964,1.3889,1.2667,1.1802,0.239,yes,up,C03795,-,-,-,-,-,-,HMDB0255300,"Nucleosides, nucleotides, and analogues","Purine nucleosides","Purine 2''-deoxyribonucleosides",2002-35-9,283.150700725,6.03278333333,M+NH4,C11H15N5O3,0,36.6,metab_4303,pos_5269,pos,1777000,1780000,1627000,1795000,2033000,1834000,1492000,1573000,1468000,1501000,1818000,1340000,,,,
Deltaline,µÂËüÁé,0.01019,0.08354,1.3888,1.2491,1.8364,0.8769,yes,up,C08679,-,-,-,-,-,-,HMDB0250984,"Lipids and lipid-like molecules","Prenol lipids",Diterpenoids,6836-11-9,472.26876934,6.28761666667,M+H-2H2O,C27H41NO8,0,88.2,metab_1417,pos_2330,pos,1924000,2510000,1927000,2880000,3939000,2917000,1304000,1994000,1408000,1150000,2168000,743500,,,,
"PG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z))",-,0.0066,0.05209,1.3869,1.4315,0.3304,-1.5977,yes,down,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",PW_C063032;HMDB0116578,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,817.502985112,6.83641666667,M+Na-2H,C44H77O10P,0,33,metab_7002,neg_1593,neg,1691000,413100,175900,679100,355400,335600,2119000,2958000,1315000,1533000,2027000,1093000,,,,
"Heptanoic acid",¸ýËá,0.009707,0.08349,1.3849,1.2583,0.308,-1.699,yes,down,C17714,"Organic acids","Carboxylic acids",-,-,-,-,HMDB0304376;HMDB0000666;LMFA01010007,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",111-14-8,175.07116121,0.696666666667,"M+NH4, M+2Na-H",C7H14O2,0,30.5,metab_126,pos_1111,pos,46920,45280,155900,22760,12810,99380,139700,287100,289400,154900,88770,284100,,,,
Propylene,±ûÏ©,0.007335,0.07362,1.3838,1.3084,1.2309,0.2997,yes,up,C11505,-,-,-,-,-,-,HMDB0256839,Hydrocarbons,"Unsaturated hydrocarbons","Unsaturated aliphatic hydrocarbons",115-07-1,102.127914665,7.56158333333,2M+NH4,C3H6,0,40.5,metab_2773,pos_3732,pos,14070000,12140000,11140000,11010000,13100000,13050000,9720000,9252000,9346000,12390000,10400000,9451000,,,,
N-arachidonylethanolamine,-,0.01195,0.06753,1.3832,1.4091,0.3072,-1.7027,yes,down,C11695,-,-,map04080;map04723;map04714;map04750,"Neuroactive ligand-receptor interaction;Retrograde endocannabinoid signaling;Thermogenesis;Inflammatory mediator regulation of TRP channels","Environmental Information Processing;Organismal Systems;Organismal Systems;Organismal Systems","Signaling molecules and interaction;Nervous system;Environmental adaptation;Sensory system",HMDB0004080;HMDB0255084,"Organic nitrogen compounds","Organonitrogen compounds",Amines,94421-68-8,378.300912008,6.67931666667,M+FA-H,C22H39NO,0,35.8,metab_7089,neg_1673,neg,113400,30620,97120,60700,72450,62300,80880,312900,283000,349700,265400,129400,,,,
"2-Aminohexanedioic Acid","2 -°±»ù¼º¶þËá",0.007443,0.05506,1.3804,1.3346,0.4029,-1.3115,yes,down,C00956,-,-,map01100;map01210;map00310;map01230,"Metabolic pathways;2-Oxocarboxylic acid metabolism;Lysine degradation;Biosynthesis of amino acids",Metabolism;Metabolism;Metabolism;Metabolism,"Global and overview maps;Global and overview maps;Amino acid metabolism;Global and overview maps",HMDB0302754;HMDB0000510,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1118-90-7,160.060588158,0.79995,"M-H, M+Cl",C6H11NO4,38.2,0,metab_6766,neg_138,neg,364900,265600,778200,173200,209100,390600,1177000,635800,1319000,1024000,561500,696700,,,,
"4-methoxy-3-(sulfooxy)benzoic acid",4-¼×Ñõ»ù-3-£¨»Çõ£»ù£©±½¼×Ëá,0.01536,0.07567,1.38,1.3347,0.1327,-2.9138,yes,down,-,-,-,-,-,-,-,HMDB0140929,Benzenoids,"Benzene and substituted derivatives","Benzoic acids and derivatives",-,246.99126635,3.36971666667,M-H,C8H8O7S,0,36,metab_7548,neg_2091,neg,22350,1085,53400,1107,1137,18680,184500,35580,201900,125900,31180,158000,,,,
Octadec-9-enal,"Ê®°ËÌ¼- 9 -Ï©È©",0.009225,0.06004,1.3773,1.2887,2.073,1.0517,yes,up,-,-,-,-,-,-,-,HMDB0250283,"Lipids and lipid-like molecules","Fatty Acyls","Fatty aldehydes",-,311.258883511,6.72636666667,M+FA-H,C18H34O,0,35.8,metab_7051,neg_1639,neg,166500,72220,128300,128700,131100,72270,23130,70010,67730,56710,85550,34090,,,,
"PA(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.01966,0.08523,1.3767,1.2973,0.0463,-4.4328,yes,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",LMGP10010040;PW_C062361;HMDB0114943,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,791.487598884,7.29413333333,M+FA-H,C43H71O8P,0,35,metab_6602,neg_1231,neg,232.6,11180,48480,5240,11970,22810,637800,51950,324400,423600,102300,615500,,,,
Nylidrin,ÜÐ±û·Ó°·,0.01811,0.08354,1.3761,1.3101,0.1565,-2.6758,yes,down,-,-,-,-,-,-,-,HMDB0255826,Benzenoids,"Benzene and substituted derivatives",Phenylpropanes,-,599.378619834,5.88313333333,2M+H,C19H25NO2,0,36.2,metab_4486,pos_5438,pos,49320,71850,174300,37130,44120,67290,761500,134700,425300,585800,152800,776200,,,,
"3-hydroxy-3-(3-hydroxyphenyl)propanoic acid-O-sulphate",3-ôÇ»ù-3-£¨3-ôÇ»ù±½»ù£©±ûËá-O-ÁòËáÑÎ,0.01143,0.06681,1.3743,1.3406,0.1959,-2.3518,yes,down,-,-,-,-,-,-,-,HMDB0059967,"Organic acids and derivatives","Hydroxy acids and derivatives","Beta hydroxy acids and derivatives",-,261.007045739,3.31026666667,"M-H, M+Na-2H",C9H10O7S,0,49.2,metab_7106,neg_169,neg,135600,67580,512800,8345,27780,169100,1112000,250300,1116000,1029000,266000,927600,,,,
"Taurallocholic acid",-,0.02596,0.09242,1.3741,1.2259,25.5929,4.6777,yes,up,-,-,-,-,-,-,-,LMST05040016;HMDB0000922,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",59005-70-8,533.324644992,6.14518333333,"M+H-H2O, M+2Na-H, M+H, M+NH4",C26H45NO7S,0,33.9,metab_752,pos_17,pos,604600,2022000,366200,877900,2000000,345500,33880,38600,48520,20750,94810,6339,,,,
"PG(18:1(9Z)/18:2(9Z,12Z))",-,0.008524,0.05821,1.3719,1.412,0.3598,-1.4747,yes,down,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",LMGP04010960;PW_C006643;HMDB0010635,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,793.50300568,6.20693333333,M+Na-2H,C42H77O10P,0,35.2,metab_7229,neg_1800,neg,1877000,438200,46330,830600,371100,162900,2015000,2150000,1187000,1797000,1993000,1217000,,,,
"LysoPE(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)",-,0.01581,0.07699,1.3701,1.2873,1.7819,0.8334,yes,up,-,-,-,-,-,-,-,HMDB0011519,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,498.262349716,6.37583333333,M-H,C25H42NO7P,0,46.7,metab_7168,neg_1745,neg,208100,162800,210200,199500,181500,194700,41290,182400,96570,122100,163400,43600,,,,
"4-Pyridoxic Acid","4 -ßÁ¶ßËá",0.01833,0.08354,1.3673,1.2712,0.4109,-1.2831,yes,down,C00847,-,-,map01100;map00750,"Metabolic pathways;Vitamin B6 metabolism",Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins",PW_C000011;HMDB0000017,"Organoheterocyclic compounds","Pyridines and derivatives","Pyridinecarboxylic acids and derivatives",82-82-6,184.060255196,1.93588333333,M+H,C8H9NO4,93.8,0,metab_5116,pos_6015,pos,92160,58340,110500,64270,63430,94190,220400,100300,295200,203800,92620,263000,,,,
D-Galactosamine,D-°±»ù°ëÈéÌÇ,0.007121,0.07276,1.3658,1.26,0.9023,-0.1483,yes,down,C02262,Carbohydrates,Monosaccharides,map01100;map00052,"Metabolic pathways;Galactose metabolism",Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism",;MJDBOTE0000404,-,-,-,7535-00-4,180.086366671,0.506266666667,M+H,C6H13NO5,80.9,0,metab_5885,pos_6740,pos,223700,217200,226300,209000,234900,246400,256600,237100,240700,270000,246500,253700,,,,
Suberylglycine,ÐÁ¶þõ£¸Ê°±Ëá,0.01938,0.08471,1.3653,1.2565,0.2735,-1.8704,yes,down,-,-,-,-,-,-,-,HMDB0000953,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",60317-54-6,214.107044445,2.73731666667,"M+H-H2O, M+H, M+Na",C10H17NO5,0,31.1,metab_6005,pos_70,pos,291400,165800,534600,159000,158500,231000,1307000,293700,1539000,1109000,379400,1003000,,,,
Styrene,±½ÒÒÏ©,0.0118,0.08354,1.3618,1.2265,1.6681,0.7382,yes,up,C07083,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0034240,Benzenoids,"Benzene and substituted derivatives",Styrenes,100-42-5,105.070054934,6.29546666667,M+H,C8H8,70.4,0,metab_6344,pos_2336,pos,102200,121400,94920,158600,182100,140300,74940,114800,90190,60590,93070,45870,,,,
2-Amino-6-methoxypurine,"2 -°±»ù- 6 -¼×Ñõ»ùàÑßÊ",0.01256,0.08354,1.3602,1.2416,1.2019,0.2653,yes,up,-,-,-,-,-,-,-,HMDB0245002,"Organoheterocyclic compounds",Imidazopyrimidines,"Purines and purine derivatives",-,207.098585456,6.20088333333,M+ACN+H,C6H7N5O,0,62.3,metab_4119,pos_5087,pos,561800,573000,508400,541500,634400,581200,440400,474900,471700,445300,587500,408900,,,,
"Dodecatrienoic acid",-,0.01096,0.08354,1.3596,1.2469,1.2285,0.2969,yes,up,-,-,-,-,-,-,-,HMDB0302622,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,212.164182896,6.07278333333,M+NH4,C12H18O2,0,37.6,metab_4275,pos_5242,pos,105700,120200,111700,128700,136800,129600,93160,110200,95980,87830,120900,88260,,,,
"PC(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))",-,0.02269,0.0913,1.3594,1.2672,0.0231,-5.436,yes,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004070;HMDB0008021;LMGP01011497,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,844.522175358,7.42125,M+K-2H,C46H82NO8P,0,53.6,metab_6939,neg_1536,neg,7287,4553,43480,4648,5888,15860,1195000,135400,380500,581400,220800,1028000,,,,
O-(11-Carboxyundecanoyl)carnitine,O-£¨11-ôÈ»ùÊ®Ò»Íéõ£»ù£©Èâ¼î,0.008399,0.07775,1.3575,1.4842,0.4086,-1.2912,yes,down,-,-,-,-,-,-,-,HMDB0240775;LMFA07070083,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,785.456366683,6.88568333333,2M+K,C19H35NO6,0,65.2,metab_1884,pos_2792,pos,18540,18450,23030,124300,74320,70680,182600,142100,150000,101900,160100,69330,,,,
"Ethyl Glucuronide",ÒÒ»ùÆÏÌÑÌÇÈ©ËáÜÕ,0.01645,0.07922,1.357,1.3473,2.3819,1.2521,yes,up,-,-,-,-,-,-,-,HMDB0010325,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",17685-04-0,221.066046266,0.792283333333,M-H,C8H14O7,62.9,0,metab_7692,neg_2226,neg,306800,318600,241800,203700,261800,257900,61340,74580,317200,143600,57680,13690,,,,
PG(18:1(11Z)/18:1(11Z)),-,0.01794,0.08275,1.3558,1.4086,0.4872,-1.0374,yes,down,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0010618;PW_C006626,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,773.533280537,7.39771666667,"M-H, M+FA-H",C42H79O10P,0,56.1,metab_8281,neg_306,neg,1340000,966500,649500,1041000,1038000,785000,2748000,2750000,1457000,1150000,2460000,1384000,,,,
"PA(18:2(9Z,12Z)/20:1(11Z))",-,0.0126,0.06808,1.3553,1.4396,0.3585,-1.48,yes,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",HMDB0114959;LMGP10010355;PW_C062377,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,771.51828949,6.84488333333,M+FA-H,C41H75O8P,0,80.3,metab_6560,neg_1194,neg,24570000,9873000,4743000,11970000,9916000,7339000,38370000,52260000,20700000,21790000,39440000,18230000,,,,
"Dihomo-alpha-linolenic acid","¶þ¸ß- ¦Á -ÑÇÂéËá",0.01076,0.08354,1.3534,1.6301,0.6309,-0.6645,yes,down,C16522,-,-,map01040,"Biosynthesis of unsaturated fatty acids",Metabolism,"Lipid metabolism",HMDB0060039,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",17046-59-2,339.288746846,6.90968333333,M+CH3OH+H,C20H34O2,0,36.8,metab_1897,pos_2808,pos,890000,447100,618400,537000,723500,588700,970500,1393000,890500,840400,1169000,768300,,,,
Myo-Inositol,¼¡-¼¡´¼,0.02245,0.0913,1.3525,1.2799,0.4285,-1.2226,yes,down,C00137,Carbohydrates,Monosaccharides,map01100;map00562;map02010;map00053;map00052;map04070,"Metabolic pathways;Inositol phosphate metabolism;ABC transporters;Ascorbate and aldarate metabolism;Galactose metabolism;Phosphatidylinositol signaling system","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Metabolism;Environmental Information Processing","Global and overview maps;Carbohydrate metabolism;Membrane transport;Carbohydrate metabolism;Carbohydrate metabolism;Signal transduction",HMDB0000211;PW_C000137;MJDBOTE0000341,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",87-89-8,215.032142183,0.667433333333,M+Cl,C6H12O6,36.9,0,metab_8529,neg_531,neg,12980000,12480000,15270000,10480000,14210000,14380000,49870000,18800000,35140000,35930000,12530000,33950000,,,,
(2E)-Hexenedioylcarnitine,£¨2E£©-¼º¶þõ£»ùÈâ¼î,0.01562,0.08354,1.3519,1.2397,0.2872,-1.7999,yes,down,-,-,-,-,-,-,-,LMFA07070013;HMDB0240749,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,252.120215485,4.78203333333,M+H-2H2O,C13H21NO6,0,42.2,metab_907,pos_1840,pos,15660,11410,51170,5630,9327,25550,64270,13190,103500,79670,50210,102600,,,,
"Lyso-PAF C-16",-,0.0157,0.08354,1.3496,1.1793,0.6323,-0.6613,yes,down,-,-,-,-,-,-,-,-,-,-,-,-,482.359602103,7.70341666667,M+H,C24H52NO6P,50.6,0,metab_2688,pos_3631,pos,4484000,3027000,5529000,3073000,3068000,4645000,6209000,5238000,6330000,9253000,4811000,5837000,,,,
"Equol 4'-O-glucuronide","´ÆÂí·Ó4 ' - O -ÆÏÌÑÌÇÈ©ËáÜÕ",0.02544,0.09452,1.3495,1.2578,0.0687,-3.8635,yes,down,-,-,-,-,-,-,-,HMDB0041731,"Phenylpropanoids and polyketides",Flavonoids,Flavans,-,417.118637095,5.77851666667,M-H,C21H22O9,0,61.5,metab_7384,neg_1942,neg,6296,6408,6691,8849,6717,6567,178800,72540,161100,33540,6182,152900,,,,
Phenol,±½·Ó,0.00634,0.06817,1.3488,1.2661,0.8104,-0.3033,yes,down,C00146,-,-,map01100;map04974;map00350;map05208,"Metabolic pathways;Protein digestion and absorption;Tyrosine metabolism;Chemical carcinogenesis - reactive oxygen species","Metabolism;Organismal Systems;Metabolism;Human Diseases","Global and overview maps;Digestive system;Amino acid metabolism;Cancer: overview",PW_C000153;HMDB0013674;HMDB0000228,Benzenoids,Phenols,"Benzenetriols and derivatives",108-95-2;87-66-1,95.0494468067,2.53661666667,M+H,C6H6O,39.9,0,metab_6343,pos_5959,pos,86000,102100,74730,78330,77190,84920,121300,99100,102400,96210,94720,107600,,,,
7alpha-Hydroxycholesterol,"7 ¦Á -ôÇ»ùµ¨¹Ì´¼",0.008852,0.05836,1.3476,1.2755,1.7726,0.8259,yes,up,C03594,-,-,map01100;map00120,"Metabolic pathways;Primary bile acid biosynthesis",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0001496,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Cholestane steroids",566-26-7,447.347717653,6.73421666667,M+FA-H,C27H46O2,0,63.2,metab_7046,neg_1634,neg,547900,330300,307500,488600,330500,351900,142500,299400,192200,286800,287500,121200,,,,
"Solutol HS 15",¾ÛÒÒ¶þ´¼Ó²Ö¬Ëáõ¥15,0.02422,0.09035,1.347,1.1783,1.3853,0.4702,yes,up,C11317,-,-,-,-,-,-,HMDB0258368,"Lipids and lipid-like molecules","Fatty Acyls","Fatty alcohols",61909-81-7,362.325610508,6.20866666667,M+NH4,C20H40O4,0,60.5,metab_4099,pos_5068,pos,17350000,17850000,15420000,18090000,27360000,20640000,14620000,14160000,13610000,14320000,15800000,11730000,,,,
N4-Acetylcytidine,"N4 -ÒÒõ£°ûÜÕ",0.01466,0.08354,1.3459,1.1941,0.5866,-0.7696,yes,down,C22293,-,-,-,-,-,-,HMDB0005923,"Nucleosides, nucleotides, and analogues","Pyrimidine nucleosides","Not Available",3768-18-1,308.084625346,2.66531666667,"M+Na, M+K, M+H",C11H15N3O6,0,49,metab_6027,pos_72,pos,109600,148000,183300,101500,71440,107600,208900,146900,299100,229500,150900,194100,,,,
"7-imidazo[1,2-a]pyridin-6-Ylisoquinolin-1-Amine","7 -ßäßò»ù- [ 1 , 2-a]ßÁà¤- 6 -Òìà­ßø- 1 -°·",0.01447,0.08354,1.3434,1.2159,0.4552,-1.1354,yes,down,-,-,-,-,-,-,-,-,-,-,-,-,278.141675757,4.56751666667,M+NH4,C16H12N4,90.2,0,metab_898,pos_1832,pos,63360,27300,119100,11580,20730,62430,125400,85530,141900,126900,65490,124000,,,,
Netilmicin,ÄÎÌæÃ¹ËØ,0.0147,0.08354,1.3392,1.29,0.5161,-0.9543,yes,down,C07657,-,-,-,-,-,-,PW_C009396;HMDB0015090,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",56391-56-1,489.313415034,4.98248333333,2M+3H2O+2H,C21H41N5O7,0,68.7,metab_4756,pos_5682,pos,164600,202400,252500,118200,105000,139400,435200,197300,302900,330900,201700,435500,,,,
"Taurohyocholic Acid",Å£»ÇÖíµ¨Ëá,0.03192,0.1023,1.3384,1.1979,17.8293,4.1562,yes,up,C15516,-,-,-,-,-,-,HMDB0011637;LMST05040010;MJDBDZS0000018,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",117997-17-8,538.280283567,6.01676666667,"M+H-H2O, M+H, M+Na, M+2Na-H",C26H45NO7S,39.5,0,metab_972,pos_19,pos,1137000,2677000,352000,634300,2169000,455200,76910,61880,124000,65390,71040,17080,,,,
Phenacetyl-carnitine,±½ÒÒõ£»ù-Èâ¼î,0.01819,0.08354,1.3366,1.2574,0.4132,-1.2751,yes,down,-,-,-,-,-,-,-,HMDB0242104,"Organic nitrogen compounds","Organonitrogen compounds","Quaternary ammonium salts",-,298.186661239,0.602133333333,M+NH4,C15H22NO4+,0,38,metab_318,pos_1288,pos,70930,59830,141200,43430,41160,85730,254400,69700,220800,232900,99230,193700,,,,
"2,5-Heptadien-1-ol","2£¬5 -¸ý¶þÏ©- 1 -´¼",0.02305,0.09144,1.3359,1.2312,1.9415,0.9572,yes,up,-,-,-,-,-,-,-,HMDB0040339,"Lipids and lipid-like molecules","Fatty Acyls","Fatty alcohols",62237-90-5,157.086075713,6.10233333333,M+FA-H,C7H12O,0,36.9,metab_7286,neg_1852,neg,41710,71920,31370,27190,41540,39090,21230,20210,17630,30960,21270,18910,,,,
"Dihydroorotic Acid",¶þÇâÈéÇåËá,0.00917,0.08207,1.3299,1.6203,0.7034,-0.5076,yes,down,C00337,-,-,map00240;map01100;map01240,"Pyrimidine metabolism;Metabolic pathways;Biosynthesis of cofactors",Metabolism;Metabolism;Metabolism,"Nucleotide metabolism;Global and overview maps;Global and overview maps",HMDB0000528;MJDBOTE0000601,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",155-54-4,176.065665494,0.830433333333,M+NH4,C5H6N2O4,56.5,0,metab_5264,pos_6151,pos,146100,177400,137200,251400,208200,199200,245200,302100,310100,210400,294800,229400,,,,
"PG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))",-,0.01625,0.08354,1.3293,1.2903,0.5177,-0.9498,yes,down,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0116602;PW_C063056,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,423.274030253,4.8051,M+2H,C48H77O10P,0,39.2,metab_908,pos_1841,pos,89920,111300,152300,63220,69070,88210,244000,107300,185900,206900,112600,252200,,,,
Zeranol,ÓñÃ×³àÃ¹´¼,0.01704,0.08354,1.3292,1.2641,0.4733,-1.0792,yes,down,C14752,-,-,-,-,-,-,HMDB0041824;HMDB0032702,"Phenylpropanoids and polyketides","Macrolides and analogues","Not Available",36455-72-8;26538-44-3,367.149230051,2.6013,M+2Na-H,C18H26O5,0,34.8,metab_6345,pos_5952,pos,124800,181800,240500,89890,76590,137800,361800,158200,393000,364700,153200,367900,,,,
3-Methylcrotonylglycine,2-(3-¼×»ù¶¡-2-Ï©õ£°±»ù)ÒÒËá,0.01175,0.06729,1.3291,1.2729,0.5865,-0.7698,yes,down,C20828,-,-,-,-,-,-,HMDB0000459,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",33008-07-0,156.065654829,3.62975,M-H,C7H11NO3,51.3,0,metab_7521,neg_2066,neg,95550,54610,120500,66680,63180,97070,166200,91930,194600,111600,131600,152400,,,,
Malonylcarnitine,±û¶þõ£Èâ¼î,0.01616,0.08354,1.329,1.1942,0.3476,-1.5245,yes,down,-,-,-,-,-,-,-,LMFA07070080;HMDB0002095;LMFA07070093,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",910825-21-7,248.112361926,2.78535,"M+H, M+Na",C10H17NO6,0,43.3,metab_2414,pos_336,pos,77480,18140,132800,15960,25660,35920,167600,75610,250800,155300,79330,151300,,,,
"L-2,3-Dihydrodipicolinate","L - 2£¬3 -¶þÇâ¶þÒìÑÌËáõ¥",0.01342,0.07086,1.3285,1.2455,1.0709,0.0988,yes,up,C03340,-,-,-,-,-,-,HMDB0303995;HMDB0012247,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",16052-12-3,168.029319098,6.02388333333,M-H,C7H7NO4,0,32.1,metab_8971,neg_945,neg,204300,224200,205800,207500,223900,211900,192500,189800,200100,205800,196900,207300,,,,
Amastatin,-,0.03313,0.1044,1.3277,1.1809,16.5928,4.0525,yes,up,C01552,-,-,-,-,-,-,HMDB0248277,"Organic acids and derivatives",Peptidomimetics,"Hybrid peptides",67655-94-1;69400-55-1,538.280243098,6.14518333333,M+ACN+Na,C21H38N4O8,0,51.5,metab_1281,pos_2187,pos,247500,778900,90550,403400,799600,105500,27080,17630,36090,22740,17920,24690,,,,
4-Hydroxyphenylacetaldehyde,"4 -ôÇ»ù±½ÒÒÈ©",0.01331,0.07039,1.3272,1.2821,0.5955,-0.7478,yes,down,C03765,-,-,map01100;map00350,"Metabolic pathways;Tyrosine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0003767,Benzenoids,"Benzene and substituted derivatives",Phenylacetaldehydes,7339-87-9,181.049761141,3.75328333333,"M-H, M+FA-H",C8H8O2,0,37.2,metab_7261,neg_183,neg,614400,631500,759300,389800,460700,656200,877200,838300,1444000,848700,726500,1162000,,,,
Porphobilinogen,µ¨É«ËØÔ­,0.01689,0.08354,1.3264,1.2271,0.5273,-0.9233,yes,down,C00931,-,-,map01100;map00860;map01240,"Metabolic pathways;Porphyrin and chlorophyll metabolism;Biosynthesis of cofactors",Metabolism;Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins;Global and overview maps",PW_C000166;HMDB0000245,"Organic nitrogen compounds","Organonitrogen compounds",Amines,487-90-1,227.102194979,2.67331666667,M+H,C10H14N2O4,0,36.2,metab_5028,pos_5934,pos,168700,139700,212300,77050,78340,118600,292000,152100,344400,305900,147000,266100,,,,
Ectoine,ÒÀ¿Ë¶àÒò,0.0183,0.08343,1.3236,1.2751,0.4272,-1.227,yes,down,C06231,-,-,map01100;map00260,"Metabolic pathways;Glycine, serine and threonine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0240650;MJDBOTE0001351,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",96702-03-3,187.071664606,0.714166666667,M+FA-H,C6H10N2O2,0,31.1,metab_7772,neg_2304,neg,162700,158900,244300,67960,127400,193400,592800,176700,471200,423800,229100,341000,,,,
"Dihydrocaffeic acid 3-sulfate","¶þÇâ¿§·ÈËá3 -ÁòËáÑÎ",0.02043,0.08667,1.323,1.298,0.2113,-2.2426,yes,down,-,-,-,-,-,-,-,HMDB0041721,"Organic acids and derivatives","Organic sulfuric acids and derivatives",Arylsulfates,-,261.007066893,3.59246666667,M-H,C9H10O7S,0,55,metab_8788,neg_779,neg,158500,68450,311300,33560,25910,179700,808100,171700,1051000,635200,187800,825500,,,,
"8-Hydroxyquinoline-5-sulfonic acid",8£­ôÇ»ùà­ßø£­5£­»ÇËá,0.02051,0.08687,1.3214,1.2976,0.2167,-2.2062,yes,down,-,-,-,-,-,-,-,HMDB0247444,"Organoheterocyclic compounds","Quinolines and derivatives",Hydroxyquinolines,-,270.007476823,3.59246666667,M+FA-H,C9H7NO4S,0,46.2,metab_7524,neg_2069,neg,34640,9681,66600,9885,10150,22590,176000,30880,180800,122300,34850,163700,,,,
"PA(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))",-,0.01094,0.06572,1.3193,1.395,0.3891,-1.3618,yes,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",HMDB0115331;LMGP10010799;PW_C062754,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,793.502979165,6.82073333333,M+FA-H,C43H73O8P,0,40,metab_7019,neg_1608,neg,5614000,1600000,507400,2357000,1737000,1181000,6376000,8653000,4032000,4762000,6375000,3200000,,,,
"PA(18:0/18:2(9Z,12Z))",-,0.01622,0.0784,1.3184,1.4307,0.2642,-1.9203,yes,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",HMDB0007861;PW_C003911;LMGP10010036,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,745.503037784,6.83641666667,M+FA-H,C39H73O8P,0,73.5,metab_7004,neg_1595,neg,523100,170900,21990,170400,133800,79420,824000,1224000,353600,472200,947700,341700,,,,
"PG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))",-,0.0122,0.06802,1.3161,1.3753,0.4894,-1.0309,yes,down,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0116610;PW_C063065;LMGP04010631,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,795.517915595,6.82073333333,"M-H, M+FA-H",C44H77O10P,0,73.7,metab_8264,neg_291,neg,13250000,5401000,2030000,7235000,4154000,3806000,13710000,16280000,9697000,11700000,13540000,8371000,,,,
"12-Hydroxydodecanoic acid",12-ôÇ»ùÊ®¶þËá,0.01753,0.08354,1.3154,1.272,0.3769,-1.4077,yes,down,C08317,-,-,-,-,-,-,HMDB0002059;HMDB0304547,"Organic acids and derivatives","Hydroxy acids and derivatives","Medium-chain hydroxy acids and derivatives",505-95-3,261.143856362,1.88788333333,M+2Na-H,C12H24O3,0,58.4,metab_5147,pos_6043,pos,122900,162900,297000,53720,77350,189300,620400,168100,473800,372500,221300,539900,,,,
N-Nitrosomethylethylamine,"N -ÑÇÏõ»ù¼×»ùÒÒ°·",0.02323,0.08873,1.3135,1.2847,1.7324,0.7928,yes,up,C19281,-,-,-,-,-,-,-,-,-,-,10595-95-6,121.096535727,0.696666666667,M+CH3OH+H,C3H8N2O,75.9,0,metab_414,pos_1382,pos,70880,125700,79800,45390,78470,97780,62330,31590,57870,34190,57190,44300,,,,
Calcidiol,¹Ç»¯¶þ´¼,0.01142,0.06681,1.3123,1.2458,1.8197,0.8637,yes,up,C01561,-,-,map01100;map04928;map00100;map05152,"Metabolic pathways;Parathyroid hormone synthesis, secretion and action;Steroid biosynthesis;Tuberculosis","Metabolism;Organismal Systems;Metabolism;Human Diseases","Global and overview maps;Endocrine system;Lipid metabolism;Infectious disease: bacterial",HMDB0003550,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Vitamin D and derivatives",19356-17-3,445.332026083,6.68715,M+FA-H,C27H44O2,0,49.9,metab_7079,neg_1664,neg,319000,184200,179700,314200,206300,207200,66030,170100,110500,181500,175200,71880,,,,
"3,5,6-Trihydroxy-5-(hydroxymethyl)-2-methoxy-2-cyclohexen-1-one","3,5,6-ÈýôÇ»ù-5-£¨ôÇ¼×»ù£©-2-¼×Ñõ»ù-2-»·¼ºÏ©-1-Íª",0.02359,0.08921,1.3103,1.2209,0.1842,-2.4407,yes,down,-,-,-,-,-,-,-,HMDB0041031,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",76663-30-4,246.096721867,2.76135,"M+Na, M+ACN+H, M+ACN+Na",C8H12O6,0,60.5,metab_5993,pos_69,pos,150100,56080,244100,40400,72880,133500,605600,521700,688300,426900,186100,1357000,,,,
"Parylene C",¾Û¶Ô¶þ¼×±½C,0.03142,0.1045,1.3097,1.2198,0.2654,-1.9138,yes,down,-,-,-,-,-,-,-,HMDB0256138,Benzenoids,"Not Available","Not Available",-,321.043320299,5.86281666667,M+FA-H,C16H14Cl2,0,76.4,metab_7379,neg_1938,neg,18280,18600,19420,31160,19500,19060,90370,148700,71930,19780,33530,110700,,,,
"PG(18:0/18:2(9Z,12Z))",-,0.01292,0.06905,1.3092,1.4,0.3861,-1.373,yes,down,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",LMGP04010982;HMDB0010605;PW_C006613,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,795.518143483,6.71068333333,"M+Na-2H, M+FA-H",C42H79O10P,0,56.1,metab_8252,neg_280,neg,16740000,6325000,2207000,7331000,4674000,3844000,21130000,27650000,11340000,14000000,22240000,10100000,,,,
Hydroxypropionylcarnitine,ôÇ»ù±ûõ£Èâ¼î,0.02575,0.0923,1.3055,1.1597,0.3305,-1.5973,yes,down,-,-,-,-,-,-,-,HMDB0013125;LMFA07070074,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,234.133194791,2.80135,M+H,C10H19NO5,0,31.8,metab_729,pos_1679,pos,20490,11010,41390,10250,8534,15910,58360,22570,101000,68640,28800,46090,,,,
"6-Ethylchenodeoxycholic acid","6 -ÒÒ»ù¶ìÈ¥Ñõµ¨Ëá",0.01149,0.06685,1.3051,1.2439,2.053,1.0377,yes,up,C15636,-,-,-,-,-,-,HMDB0247056,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",459789-99-2,419.316333688,6.67931666667,M-H,C26H44O4,0,75.7,metab_7087,neg_1671,neg,155900,102100,86660,178300,96870,105100,24640,77390,49790,91790,89300,20110,,,,
"Ascorbic Acid",¿¹»µÑªËá,0.02539,0.09452,1.3016,1.2329,0.1103,-3.1805,yes,down,C01041,-,-,map01100;map00053,"Metabolic pathways;Ascorbate and aldarate metabolism",Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism",PW_C000031;HMDB0000044;MJDBOTE0001568,"Organoheterocyclic compounds",Dihydrofurans,Furanones,50-81-7,175.023938423,0.714166666667,"M-H, M+Cl, 2M-H",C6H8O6,67.1,0,metab_9033,neg_27,neg,1074000,393600,455900,126500,435800,1586000,5810000,1950000,13850000,7514000,5021000,2789000,,,,
"9,12,13-TriHOME",ÝåËá,0.02365,0.09185,1.301,1.1943,0.6435,-0.636,yes,down,C14833,-,-,map00591,"Linoleic acid metabolism",Metabolism,"Lipid metabolism",HMDB0004708;LMFA02000014,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,311.222494919,6.37583333333,M-H2O-H,C18H34O5,0,55,metab_7170,neg_1747,neg,120600,148300,144600,186400,143800,202000,233600,333400,297900,175100,162900,266300,,,,
"LysoPE(18:3(9Z,12Z,15Z)/0:0)",-,0.01136,0.08354,1.3005,1.2157,2.7508,1.4599,yes,up,-,-,-,-,-,-,-,HMDB0011509,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,476.276595316,6.51805,M+H,C23H42NO7P,0,76.4,metab_3707,pos_4687,pos,273100,115200,164400,181800,161400,132800,4511,149000,13700,67580,133700,5366,,,,
(12Z)-10-Hydroxyoctadecenoylcarnitine,£¨12Z£©-10-ôÇ»ùÊ®°ËÏ©õ£»ùÈâ¼î,0.01628,0.08354,1.3003,1.3618,0.652,-0.6171,yes,down,-,-,-,-,-,-,-,HMDB0241535,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,424.341512997,6.36713333333,M+H-H2O,C25H47NO5,0,43.7,metab_1486,pos_2397,pos,2520000,2188000,4102000,2065000,2675000,3528000,3129000,5627000,5364000,3579000,4549000,3941000,,,,
"Deca-2,5,8-trienedioylcarnitine","¹ï- 2£¬5£¬8 -ÈýÏ©¶þõ£»ùÈâ¼î",0.01708,0.08354,1.2968,1.2452,0.5302,-0.9154,yes,down,-,-,-,-,-,-,-,HMDB0241128,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,340.1747727,3.89813333333,M+H,C17H25NO6,0,60,metab_4840,pos_5759,pos,1062000,1496000,1709000,454900,964700,903400,2465000,1123000,2519000,2404000,1292000,2625000,,,,
1-Methylguanosine,1-¼×»ùÄñÜÕ,0.01878,0.08387,1.2965,1.1447,0.7195,-0.4749,yes,down,C04545,-,-,-,-,-,-,HMDB0001563,"Nucleosides, nucleotides, and analogues","Purine nucleosides","Not Available",2140-65-0,298.113919059,2.63333333333,M+H,C11H15N5O5,91.4,0,metab_5046,pos_5950,pos,110100,97690,139100,101000,84160,140300,157500,130600,211800,160500,135200,139300,,,,
Idremcinal,-,0.02352,0.08908,1.2953,1.1911,1.1832,0.2427,yes,up,-,-,-,-,-,-,-,HMDB0253381,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,776.51334749,6.33508333333,M+CH3OH+H,C39H69NO12,0,52.5,metab_3907,pos_4872,pos,1872000,1770000,1812000,1678000,1953000,1842000,1408000,1254000,1662000,1448000,1879000,1581000,,,,
L-Histidine,L-×é°±Ëá,0.02309,0.09144,1.2942,1.2055,0.7484,-0.4181,yes,down,C00135,Peptides,"Amino acids",map01100;map00340;map02010;map04974;map01230;map00970;map05230;map00410,"Metabolic pathways;Histidine metabolism;ABC transporters;Protein digestion and absorption;Biosynthesis of amino acids;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer;beta-Alanine metabolism","Metabolism;Metabolism;Environmental Information Processing;Organismal Systems;Metabolism;Genetic Information Processing;Human Diseases;Metabolism","Global and overview maps;Amino acid metabolism;Membrane transport;Digestive system;Global and overview maps;Translation;Cancer: overview;Metabolism of other amino acids",HMDB0000177;PW_C000116;MJDBOTE0000427,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",71-00-1,154.061279405,0.6289,M-H,C6H9N3O2,77.4,0,metab_7990,neg_2511,neg,410100,515500,409500,456400,499300,510300,787400,476300,677400,522600,565000,713800,,,,
"LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.02498,0.09134,1.2926,1.2512,1.676,0.745,yes,up,-,-,-,-,-,-,-,HMDB0011496,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,526.292157043,6.54216666667,"M+H-H2O, M+Na, M+H",C27H44NO7P,0,76.9,metab_557,pos_152,pos,32310000,27940000,29760000,31810000,34630000,30680000,7346000,27140000,15320000,22900000,30750000,8190000,,,,
Castanospermine,ËÚÊ÷¾«°·(ÔÝ¶¨Ãû),0.0261,0.09265,1.29,1.2269,0.4647,-1.1056,yes,down,C02256,-,-,-,-,-,-,HMDB0249700,"Organoheterocyclic compounds",Indolizidines,"Not Available",79831-76-8,190.107071203,3.00923333333,M+H,C8H15NO4,34.3,0,metab_757,pos_1703,pos,72950,44650,86510,44200,43900,64090,215000,66260,147600,125300,73890,138700,,,,
Salmeterol,É³ÃÀÌØÂÞ,0.01265,0.08354,1.2893,1.1887,0.7048,-0.5047,yes,down,C07241,-,-,-,-,-,-,HMDB0015073,Benzenoids,"Benzene and substituted derivatives","Benzyl alcohols",89365-50-4,872.580038599,6.62236666667,2M+ACN+H,C25H37NO4,0,57,metab_1668,pos_2567,pos,65850,103200,124400,78350,98670,115200,161900,105800,134400,115800,146700,166200,,,,
"N-Palmitoyl Isoleucine","N -×Øéµõ£ÒìÁÁ°±Ëá",0.02178,0.0899,1.2835,1.2819,0.4459,-1.1652,yes,down,-,-,-,-,-,-,-,HMDB0241927;LMFA08020112,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,368.3165034,6.74991666667,M-H,C22H43NO3,0,71.6,metab_6518,neg_1156,neg,854300,325900,928100,911600,708400,611400,765900,1950000,2087000,2427000,1667000,833300,,,,
"PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.02178,0.08726,1.2831,1.137,0.3782,-1.4028,yes,down,-,-,-,-,-,-,-,HMDB0011394;LMGP02030005,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,206059-98-5,793.585967183,7.3548,M+NH4,C45H78NO7P,0,47.1,metab_2183,pos_3107,pos,75010,29010,62170,725.8,16090,16910,88310,68400,73990,158400,42940,96550,,,,
4-Propylphenol,4-±û»ù±½·Ó,0.02248,0.08843,1.2829,1.1641,1.5878,0.667,yes,up,C14311,-,-,-,-,-,-,HMDB0032625,Benzenoids,"Benzene and substituted derivatives",Phenylpropanes,645-56-7,119.085543717,6.29546666667,M+H-H2O,C9H12O,0,53,metab_3976,pos_4941,pos,4469000,5077000,4119000,6793000,8364000,6336000,3384000,5156000,4030000,3105000,4274000,2192000,,,,
Yohimbine,Óýºà±ö,0.0258,0.09503,1.2815,1.2256,0.1896,-2.399,yes,down,C09256,-,-,-,-,-,-,HMDB0015464,"Alkaloids and derivatives","Yohimbine alkaloids","Not Available",146-48-5,375.165604631,5.96115,M+Na-2H,C21H26N2O3,0,42.2,metab_8949,neg_924,neg,5345,3044,25910,1262,21190,16340,63280,10960,76800,47300,51950,135200,,,,
Butylisopropylamine,¶¡»ùÒì±û°·,0.01742,0.08354,1.2802,1.1818,1.3539,0.4371,yes,up,-,-,-,-,-,-,-,-,-,-,-,-,116.143425974,7.56158333333,M+H,C7H17N,74.2,0,metab_2274,pos_3201,pos,694700,510300,466900,490700,617800,671900,377000,386300,368100,583700,449800,385200,,,,
"LysoPE(18:2(9Z,12Z)/0:0)",-,0.01454,0.08354,1.2796,1.206,1.9085,0.9324,yes,up,-,-,-,-,-,-,-,HMDB0011507,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,85046-18-0,478.292063089,6.63035,"M+H, M+Na",C23H44NO7P,0,83.2,metab_5997,pos_693,pos,15750000,10130000,12030000,11190000,11700000,8584000,2319000,10560000,3783000,7779000,9588000,2320000,,,,
Methylisopelletierine,¼×»ùÒìÊ¯ÁñÆ¤¼î,0.03116,0.1042,1.2791,1.1781,1.6401,0.7138,yes,up,C06184,-,-,-,-,-,-,HMDB0030326,"Organoheterocyclic compounds",Piperidines,"Not Available",-,200.128468696,6.0788,M+FA-H,C9H17NO,0,46.2,metab_7296,neg_1861,neg,254400,520800,251900,263100,297400,312300,159900,176600,183600,208400,242800,187100,,,,
"Fenofibric acid",-,0.03216,0.106,1.2768,1.2001,4.0497,2.0178,yes,up,C07586,-,-,-,-,-,-,HMDB0252207;HMDB0250346;HMDB0015173,Benzenoids,"Benzene and substituted derivatives",Benzophenones,49562-28-9,353.033278947,5.93266666667,M+Cl,C17H15ClO4,0,61.1,metab_7352,neg_1913,neg,85170,19670,18790,36310,70260,97600,13130,12480,14140,14140,12830,14220,,,,
"3-Hydroxy-Hexanoyl-DL-Homoserine Lactone","3 -ôÇ»ù-¼ºõ£»ù- Dl -¸ßË¿°±ËáÄÚõ¥",0.02302,0.08859,1.2763,1.2299,0.4877,-1.0359,yes,down,-,-,-,-,-,-,-,-,-,-,-,-,216.122731146,4.42265,"M+H, M+Na",C10H17NO4,42.1,0,metab_2902,pos_386,pos,372600,207200,460000,211400,229600,417400,790300,283000,632300,657200,495100,1035000,,,,
"PA(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))",-,0.01916,0.08422,1.2728,1.3475,0.3248,-1.6224,yes,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",LMGP10010815;HMDB0115343;PW_C062767,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,845.533139998,6.68715,M+FA-H,C47H77O8P,0,35.7,metab_6491,neg_1131,neg,2278000,687500,191800,790300,372400,512600,3309000,4108000,1377000,1724000,3164000,1200000,,,,
"N-Oleoyl Leucine","N -ÓÍõ£ÁÁ°±Ëá",0.02377,0.0919,1.2714,1.2504,0.4243,-1.2368,yes,down,-,-,-,-,-,-,-,HMDB0241962;LMFA08020116,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,394.33216555,6.81288333333,M-H,C24H45NO3,75.3,0,metab_7028,neg_1617,neg,474700,174400,609600,563400,396700,359900,477400,1288000,1352000,1536000,932300,493700,,,,
"N-Docosahexaenoyl Glutamine","N -¶þÊ®¶þÌ¼ÁùÏ©õ£¹È°±õ£°·",0.0234,0.09156,1.2709,1.2329,2.0744,1.0527,yes,up,-,-,-,-,-,-,-,HMDB0242012;LMFA08020129,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,501.299941131,6.36045,M+FA-H,C27H40N2O4,0,42.4,metab_7174,neg_1750,neg,175300,344900,143000,408900,207500,327000,122100,119200,120000,140200,94890,178100,,,,
"PE(16:0/20:3(8Z,11Z,14Z))",-,0.02484,0.09379,1.2701,1.1902,0.6025,-0.731,yes,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0008936;PW_C004984;LMGP02011222,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,762.507765914,7.49183333333,"M-H, M+Na-2H",C41H76NO8P,0,67.8,metab_8292,neg_316,neg,783100,1279000,1395000,1098000,1210000,1555000,2903000,1106000,1596000,1905000,2259000,2379000,,,,
"Uric Acid",ÄòËá,0.01454,0.0739,1.2684,1.2365,1.6149,0.6914,yes,up,C00366,-,-,map01100;map04976;map00230,"Metabolic pathways;Bile secretion;Purine metabolism","Metabolism;Organismal Systems;Metabolism","Global and overview maps;Digestive system;Nucleotide metabolism",HMDB0000289;PW_C000195;MJDBOTE0001097,"Organoheterocyclic compounds",Imidazopyrimidines,"Purines and purine derivatives",69-93-2,167.020125659,1.2347,M-H,C5H4N4O3,79.6,0,metab_8705,neg_703,neg,1137000,1342000,1785000,2190000,1271000,1471000,925000,696700,961500,874900,1450000,787400,,,,
Taurohyocholate,Å£»Çµ¨Ëá,0.04413,0.1248,1.2678,1.1365,16.1584,4.0142,yes,up,C15516,-,-,-,-,-,-,HMDB0011637;LMST05040010,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",117997-17-8,533.324807039,6.01676666667,M+NH4,C26H45NO7S,0,88.1,metab_4321,pos_5286,pos,315600,799600,85970,152300,529000,101000,25010,26390,50770,3571,12060,4960,,,,
"Cis-4-Hydroxycyclohexylacetic acid",-,0.02731,0.09814,1.2668,1.2548,0.189,-2.4035,yes,down,-,-,-,-,-,-,-,HMDB0000451,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",68592-22-3,203.091747735,4.49073333333,M+FA-H,C8H14O3,0,37.4,metab_7452,neg_2003,neg,24240,16180,72950,970.6,10030,26700,146500,21220,231500,136400,44170,219200,,,,
Oleoyl-L-Carnitine,"ÓÍõ£- L -Èâ¼î",0.02287,0.08846,1.2666,1.2692,0.6368,-0.6511,yes,down,-,-,-,-,-,-,-,HMDB0005065,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",38677-66-6,426.357173728,6.45396666667,M+H,C25H47NO4,52.5,0,metab_3770,pos_4744,pos,4218000,3065000,7864000,4974000,4356000,6563000,5703000,10980000,10210000,7551000,7332000,6964000,,,,
3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carbaldehyde,3¦Â-ôÇ»ù-4¦Â-¼×»ù-5¦Á-µ¨¹Ì´¼-7-Ï©-4¦Á-¼×È©,0.01749,0.0822,1.2661,1.2042,1.6283,0.7034,yes,up,C11509,-,-,-,-,-,-,HMDB0304158;LMST01010204,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Cholestane steroids",-,473.363319438,6.74991666667,M+FA-H,C29H48O2,0,54,metab_6520,neg_1158,neg,399800,229700,239200,343400,223300,235900,123800,233700,158600,201500,206000,102900,,,,
LysoPE(P-18:0/0:0),-,0.0186,0.08352,1.265,1.2143,0.5282,-0.9208,yes,down,-,-,-,-,-,-,-,HMDB0240598,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,174062-73-8,464.314058795,6.83641666667,M-H,C23H48NO6P,0,74,metab_6547,neg_1182,neg,1159000,615100,1104000,591100,590600,931900,1520000,1024000,1542000,2604000,1488000,1270000,,,,
PE(22:6/0:0),-,0.02694,0.09748,1.2643,1.1835,1.4874,0.5728,yes,up,-,-,-,-,-,-,-,-,-,-,-,-,524.277742215,6.40991666667,M-H,C27H44NO7P,88.4,0,metab_6418,neg_1063,neg,34490000,32370000,39310000,39870000,43990000,36480000,11930000,32470000,26790000,32660000,34260000,14150000,,,,
5-Hydroxylysine,"5 -ôÇ»ùÀµ°±Ëá",0.02405,0.08993,1.2642,1.2225,0.4131,-1.2754,yes,down,C16741,-,-,map01100;map00310,"Metabolic pathways;Lysine degradation",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0000450;HMDB0245508,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1190-94-9,204.133952887,1.66388333333,M+ACN+H,C6H14N2O3,0,42.2,metab_5170,pos_6064,pos,1392000,1488000,3831000,622000,604500,1851000,5545000,1752000,5122000,4994000,1791000,4483000,,,,
2-Aminopurine,2-°±»ùàÑßÊ,0.01675,0.08354,1.2609,1.1909,1.5104,0.5949,yes,up,-,-,-,-,-,-,-,HMDB0245025,"Organoheterocyclic compounds",Imidazopyrimidines,"Purines and purine derivatives",-,177.088045641,7.7269,M+ACN+H,C5H5N5,0,45.4,metab_2666,pos_3606,pos,730700,526100,439300,473200,535500,528800,318300,311600,259600,574900,399500,277100,,,,
PE(14:0/PGF1alpha),-,0.01639,0.08354,1.2596,1.1747,1.4474,0.5335,yes,up,-,-,-,-,-,-,-,HMDB0260666,"Not Available","Not Available","Not Available",-,808.467120965,6.41003333333,M+2Na-H,C39H74NO11P,0,37.7,metab_1512,pos_2420,pos,120500,113400,110300,162000,88400,110400,64180,97000,106200,58920,82910,77940,,,,
Carboxyphosphamide,ôÈ»ùÁ×õ£°·,0.02884,0.0967,1.2595,1.1369,2.1674,1.116,yes,up,C07646,-,-,map00982,"Drug metabolism - cytochrome P450",Metabolism,"Xenobiotics biodegradation and metabolism",PW_C040481;HMDB0060449,"Organic nitrogen compounds","Organonitrogen compounds","Nitrogen mustard compounds",22788-18-7,315.003197177,0.790616666667,M+Na,C7H15Cl2N2O4P,0,32.5,metab_5293,pos_6183,pos,285400,341500,175100,588700,324400,234600,104000,202900,82330,120900,214300,175200,,,,
S-Allylmercaptocysteine,S-Ï©±û»ùÛÏ»ù°ëë×°±Ëá,0.02499,0.09406,1.2588,1.2563,0.2685,-1.897,yes,down,-,-,-,-,-,-,-,HMDB0302210,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,238.020774929,1.93898333333,M+FA-H,C6H11NO2S2,0,31.8,metab_8732,neg_728,neg,22480,11350,61560,4026,4134,30090,137200,18080,116300,96200,31670,98030,,,,
L-Phenylalanine,L-±½±û°±Ëá,0.02767,0.09534,1.2581,1.098,1.3149,0.395,yes,up,C00079,Peptides,"Amino acids",map01100;map04978;map01210;map02010;map01230;map00360;map04974;map00970;map00400;map05230,"Metabolic pathways;Mineral absorption;2-Oxocarboxylic acid metabolism;ABC transporters;Biosynthesis of amino acids;Phenylalanine metabolism;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer","Metabolism;Organismal Systems;Metabolism;Environmental Information Processing;Metabolism;Metabolism;Organismal Systems;Genetic Information Processing;Metabolism;Human Diseases","Global and overview maps;Digestive system;Global and overview maps;Membrane transport;Global and overview maps;Amino acid metabolism;Digestive system;Translation;Amino acid metabolism;Cancer: overview",PW_C000104;HMDB0250791;HMDB0000159;MJDBAA00000196,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",63-91-2,207.112353415,3.18185,M+ACN+H,C9H11NO2,74.6,0,metab_4922,pos_5836,pos,801900,778900,592300,857100,1028000,897300,640800,754500,410200,611000,707200,645200,,,,
N-Acetyl-D-phenylalanine,"N -ÒÒõ£»ù- D -±½±û°±Ëá",0.0141,0.07253,1.2571,1.2175,0.7053,-0.5037,yes,down,C05620,-,-,map01100;map00360,"Metabolic pathways;Phenylalanine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",-,-,-,-,10172-89-1,206.081541323,5.26851666667,M-H,C11H13NO3,52.8,0,metab_8897,neg_878,neg,224600,295500,273700,145200,216200,264700,370600,247200,429500,332700,320600,313100,,,,
"N-Methyl-L-Glutamic Acid","N -¼×»ù- L -¹È°±Ëá",0.02261,0.08846,1.2533,1.1535,0.7087,-0.4968,yes,down,C01046,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0062660,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",35989-16-3,144.065348801,2.21593333333,M+H-H2O,C6H11NO4,57,0,metab_666,pos_1621,pos,726500,526400,945600,535200,561400,772300,1160000,775600,1201000,881600,755900,965600,,,,
"3-Isopropenylpentanedioic acid","3 -Òì±ûÏ©»ùÎì¶þËá",0.02571,0.09496,1.2523,1.2202,0.2796,-1.8386,yes,down,-,-,-,-,-,-,-,HMDB0032352,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",6839-75-4,389.14499003,5.88696666667,2M+FA-H,C8H12O4,0,43.4,metab_8926,neg_903,neg,10340,10530,52570,10750,14360,26070,69010,13810,117100,60840,56230,128700,,,,
"Heptadecanoyl carnitine",Ê®ÆßÍéõ£Èâ¼î,0.02,0.08571,1.2522,1.2065,0.4135,-1.274,yes,down,-,-,-,-,-,-,-,HMDB0006210;LMFA07070067,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",106182-29-0,450.298939283,6.73421666667,M+K-2H,C24H47NO4,0,37.7,metab_6514,neg_1152,neg,92790,34850,117600,39540,41460,60360,108300,140500,179400,281100,128400,97330,,,,
2-Hydroxyethanesulfonate,"2 -ôÇ»ùÒÒ»ÇËáÑÎ",0.02457,0.09379,1.2522,1.2598,0.4688,-1.093,yes,down,C05123,-,-,map01100;map00430,"Metabolic pathways;Taurine and hypotaurine metabolism",Metabolism;Metabolism,"Global and overview maps;Metabolism of other amino acids",HMDB0003903,"Organic acids and derivatives","Organic sulfonic acids and derivatives","Organosulfonic acids and derivatives",107-36-8,124.990374646,0.667433333333,M-H,C2H6O4S,0,52.6,metab_8525,neg_528,neg,217200,287900,418400,152800,165400,199900,702000,252300,705500,610700,243000,562000,,,,
Indan-1-ol,1-Üá´¼,0.02812,0.09568,1.252,1.1398,1.5553,0.6372,yes,up,C01710,-,-,-,-,-,-,HMDB0059601,Benzenoids,Indanes,"Not Available",-,135.080286466,6.29546666667,"M+H-H2O, M+H",C9H10O,0,40.2,metab_6248,pos_922,pos,1265000,1400000,1117000,1875000,2352000,1771000,984300,1434000,1124000,904100,1220000,619700,,,,
M-Xylene,-,0.026,0.09247,1.251,1.1568,1.6299,0.7048,yes,up,C07208,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0059810,Benzenoids,"Benzene and substituted derivatives",Xylenes,108-38-3,107.085699102,6.28761666667,M+H,C8H10,92.5,0,metab_3991,pos_4957,pos,128000,152400,125900,204400,257900,196300,92550,162600,108500,89780,138600,61670,,,,
"2,6-Diamino-5-hydroxyhexanoic acid","2£¬6 -¶þ°±»ù- 5 -ôÇ»ù¼ºËá",0.02673,0.09386,1.2474,1.1534,0.5045,-0.9871,yes,down,C16741,-,-,map01100;map00310,"Metabolic pathways;Lysine degradation",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0000450;HMDB0245508,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1190-94-9,204.133981144,1.89588333333,M+ACN+H,C6H14N2O3,0,53.2,metab_5144,pos_6040,pos,680800,683100,1625000,423700,394800,811900,1827000,828300,2275000,1755000,964800,1508000,,,,
Lauryldiethanolamine,ÔÂ¹ð»ù¶þÒÒ´¼°·,0.03386,0.1055,1.2472,1.087,1.3812,0.4659,yes,up,-,-,-,-,-,-,-,-,-,-,-,-,274.273423379,6.2243,"M+H-H2O, M+H",C16H35NO2,69.1,0,metab_6273,pos_946,pos,28490000,31560000,27970000,29540000,48370000,36040000,30160000,23120000,21090000,23330000,28700000,19820000,,,,
D-Glucamine,"D -°±»ùÆÏÌÑÌÇ",0.02753,0.09501,1.2462,1.4185,1.5366,0.6197,yes,up,-,-,-,-,-,-,-,HMDB0246693,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,146.0809703,1.91188333333,M+H-2H2O,C6H15NO5,0,55.7,metab_5127,pos_6025,pos,494300,388400,674900,341600,383100,610600,316300,284500,394400,308600,282700,296200,,,,
Glycylglycylglycine,¸Ê°±õ£¸Ê°±õ£¸Ê°±Ëá,0.02941,0.09794,1.2428,1.0858,0.8063,-0.3106,yes,down,-,-,-,-,-,-,-,HMDB0029419,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",556-33-2,154.060879341,2.67331666667,M+H-2H2O,C6H11N3O4,0,38.6,metab_703,pos_1655,pos,57500,61340,75480,56140,46190,64790,72710,71170,91770,78840,71920,61840,,,,
2-Pyrrolidinone,2-ßÁ¿©ÍéÍª,0.02916,0.09722,1.2411,1.4111,1.4519,0.5379,yes,up,C11118,-,-,-,-,-,-,HMDB0002039,"Organoheterocyclic compounds",Pyrrolidines,Pyrrolidones,616-45-5,86.0604321201,1.91188333333,M+H,C4H7NO,57.1,0,metab_626,pos_1585,pos,416000,353700,561300,304100,333200,523900,290400,256700,346600,276200,270300,276200,,,,
LysoPC(20:1(11Z)/0:0),-,0.03235,0.103,1.2399,1.0855,0.6024,-0.7312,yes,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010391,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,550.38573562,7.68765,M+H,C28H56NO7P,0,89.8,metab_2341,pos_3280,pos,4048000,2136000,4427000,1676000,2203000,2917000,3596000,4840000,5109000,7608000,3933000,3811000,,,,
"(2S,3S,4S,5R)-3,4,5-Trihydroxy-6-sulfooxyoxane-2-carboxylic acid","£¨2S£¬3S£¬4S£¬5R£©-3,4,5-ÈýôÇ»ù-6-»Ç»ùÑõÍé-2-ôÈËá",0.03686,0.115,1.2388,1.2066,0.2779,-1.8474,yes,down,-,-,-,-,-,-,-,HMDB0258086,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,254.981231477,0.7064,M-H2O-H,C6H10O10S,0,61.8,metab_7785,neg_2317,neg,4201000,2436000,6472000,1250000,1522000,3697000,22690000,3976000,13780000,9867000,3725000,16410000,,,,
PE(18:3/0:0),-,0.02291,0.09144,1.2373,1.1586,1.6545,0.7264,yes,up,-,-,-,-,-,-,-,-,-,-,-,-,474.262044094,6.4045,M-H,C23H42NO7P,94,0,metab_6417,neg_1062,neg,368800,222100,350600,322900,326700,224400,82210,291200,152000,246000,233400,92690,,,,
"L-Hexahydro-3-imino-1,2,4-oxadiazepine-3-carboxylic acid","L-ÁùÇâ-3-ÑÇ°±»ù-1,2,4-¶ñ¶þµªÔÓ-3-ôÈËá",0.02343,0.09156,1.2368,1.221,0.2841,-1.8155,yes,down,-,-,-,-,-,-,-,HMDB0030402,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",21539-44-6,363.129344431,5.27638333333,2M+FA-H,C5H9N3O3,0,39.6,metab_8898,neg_879,neg,31920,17980,137300,14130,40140,33780,165600,12980,242100,163600,126000,259100,,,,
Ergocornine,Âó½Ç¿ÂÄþ¼î,0.04465,0.1241,1.2359,1.1398,18.4637,4.2066,yes,up,C09162,-,-,-,-,-,-,HMDB0251906,"Alkaloids and derivatives","Ergoline and derivatives","Lysergic acids and derivatives",564-36-3,582.271599271,6.00036666667,M+Na-2H,C31H39N5O5,0,64,metab_8969,neg_942,neg,76970,254900,30050,47380,171000,41280,13140,1552,9230,2660,4397,2681,,,,
Cinnamaldehyde,Èâ¹ðÈ©,0.03001,0.09905,1.2351,1.1381,1.6718,0.7414,yes,up,C00903,-,-,map01100;map04750,"Metabolic pathways;Inflammatory mediator regulation of TRP channels","Metabolism;Organismal Systems","Global and overview maps;Sensory system",HMDB0245299;HMDB0258628;HMDB0003441;MJDBOTE0001083,"Phenylpropanoids and polyketides",Cinnamaldehydes,"Not Available",104-55-2,133.064445439,6.27965,"M+H-H2O, M+H",C9H8O,73.1,0,metab_4201,pos_517,pos,175400,189500,145200,265200,343000,242100,120400,205400,142900,107900,166500,70230,,,,
"2',3'-Dideoxy-3'-fluorouridine","2 '£¬3 ' - Dideoxy-3 ' -·úëåÜÕ",0.04079,0.1183,1.2327,1.1509,0.2623,-1.9307,yes,down,-,-,-,-,-,-,-,HMDB0245543,"Nucleosides, nucleotides, and analogues","Pyrimidine nucleosides","Pyrimidine 2'',3''-dideoxyribonucleosides",-,263.102088565,3.82218333333,M+CH3OH+H,C9H11FN2O4,0,50.7,metab_4849,pos_5767,pos,39720,17950,71230,13230,10300,27160,189000,23090,192900,154500,34390,90800,,,,
DG(TXB2/i-14:0/0:0),-,0.03551,0.1081,1.2318,1.2187,0.1859,-2.4274,yes,down,-,-,-,-,-,-,-,HMDB0298802,"Not Available","Not Available","Not Available",-,693.436734778,5.94411666667,M+K,C37H66O9,0,36.1,metab_4371,pos_5332,pos,27250,48470,215700,55150,43740,93970,656900,174300,354900,395500,106900,917100,,,,
"Ginkgoic acid",°×¹ûËá,0.03009,0.103,1.2317,1.1562,1.3631,0.4469,yes,up,C10794,-,-,-,-,-,-,HMDB0033897,Benzenoids,"Benzene and substituted derivatives","Benzoic acids and derivatives",22910-60-7,327.232513862,6.41933333333,M-H2O-H,C22H34O3,0,46.1,metab_7156,neg_1734,neg,326700,346900,380200,403600,434400,392500,150000,348200,292000,347300,333100,205200,,,,
"(+)-cis-5,6-Dihydro-5-hydroxy-4-methoxy-6-(2-phenylethyl)-2H-pyran-2-one","£¨+£©-Ë³Ê½-5,6-¶þÇâ-5-ôÇ»ù-4-¼×Ñõ»ù-6-£¨2-±½ÒÒ»ù£©-2H-ßÁà«-2-Íª",0.03216,0.1027,1.2303,1.1223,1.5433,0.626,yes,up,-,-,-,-,-,-,-,HMDB0029575,"Phenylpropanoids and polyketides",Kavalactones,"Not Available",52247-81-1,281.137788173,6.29546666667,M+CH3OH+H,C14H16O4,0,61.1,metab_3972,pos_4938,pos,2667000,2973000,2456000,4145000,5113000,3732000,2127000,3056000,2489000,1961000,2654000,1373000,,,,
"16-Hydroxyhexadecanoic acid","16 -ôÇ»ùÊ®ÁùÍéËá",0.02097,0.08795,1.2301,1.1627,1.3945,0.4797,yes,up,C18218,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0006294,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",506-13-8,271.227578574,6.67931666667,M-H,C16H32O3,0,68.1,metab_6473,neg_1114,neg,1589000,949900,1215000,1431000,1119000,1246000,588100,1079000,789000,939800,1216000,801000,,,,
"9,10,13-TriHOME","11Ê®°ËÌ¼Ï©Ëá£¬9,10,13-ÈýôÇ»ù-",0.02935,0.102,1.2299,1.1678,0.3731,-1.4224,yes,down,C14835,-,-,map00591,"Linoleic acid metabolism",Metabolism,"Lipid metabolism",HMDB0004710,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",29907-57-1,329.232942343,6.16128333333,M-H,C18H34O5,0,68.3,metab_9023,neg_993,neg,85560,213300,200700,87890,62470,106700,169900,427700,269800,416100,146800,597600,,,,
Nivalenol,¹ÏÎ®Á­¾ú´¼,0.03504,0.1073,1.2286,1.1205,1.6128,0.6896,yes,up,C06080,-,-,-,-,-,-,HMDB0004304,"Lipids and lipid-like molecules","Prenol lipids",Sesquiterpenoids,23282-20-4,295.117050589,6.28761666667,M+H-H2O,C15H20O7,0,42.1,metab_3990,pos_4956,pos,515500,622900,486200,894400,1092000,815500,414400,601600,471900,379300,591000,286200,,,,
"Trans-4-Aminocyclohexanecarboxylic acid",-,0.03078,0.1004,1.2254,1.294,1.0467,0.0658,yes,up,-,-,-,-,-,-,-,HMDB0246355,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,108.080911579,7.83811666667,M+H-2H2O,C7H13NO2,0,49.4,metab_2538,pos_3476,pos,359200,333600,337300,332800,354200,355000,343300,325900,324000,334700,320300,332100,,,,
Nitrosobenzene,ÑÇÏõ»ù±½,0.02863,0.1004,1.2248,1.1524,1.0771,0.1072,yes,up,C06876,-,-,-,-,-,-,HMDB0255658,Benzenoids,"Benzene and substituted derivatives","Not Available",586-96-9,152.0343362,6.08663333333,M+FA-H,C6H5NO,0,49.1,metab_7292,neg_1858,neg,152900,172100,162500,160500,178900,171000,149900,148600,153100,153300,158000,163600,,,,
Embelin,ËáÌÙ×Ó·Ó,0.01944,0.08498,1.2192,1.218,1.1944,0.2563,yes,up,C10342,-,-,-,-,-,-,HMDB0251767;LMPK15050006,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",550-24-3,293.175529864,6.2438,M-H,C17H26O4,0,45.3,metab_6377,neg_1026,neg,287900,369300,336000,367800,388700,391800,314500,264600,310200,266300,288300,348900,,,,
"N-Acetylglucosamine 6-sulfate","N -ÒÒõ£°±»ùÆÏÌÑÌÇ- 6 -»ÇËá",0.03348,0.1083,1.2187,1.2318,0.4618,-1.1147,yes,down,C04132,-,-,-,-,-,-,HMDB0000814,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",10356-99-7,300.039183799,0.690783333333,M-H,C8H15NO9S,0,51.5,metab_8561,neg_561,neg,104500,117800,165400,70360,63600,94670,301900,96380,331600,271900,99820,232900,,,,
"6-Hydroxydodeca-8,10-dienoylcarnitine","6 -ôÇ»ùÊ®¶þÌ¼- 8£¬10 -¶þÏ©õ£»ùÈâ¼î",0.0323,0.1029,1.2159,1.1628,1.4829,0.5684,yes,up,-,-,-,-,-,-,-,HMDB0241251,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,338.231734771,6.07278333333,"M+H-H2O, M+H",C19H33NO5,0,59.1,metab_3604,pos_459,pos,114500,246800,192600,142800,161000,155700,97230,118300,154200,101200,117500,95280,,,,
Hydroxyphenylacetylglycine,ôÇ»ù±½ÒÒõ£»ù¸Ê°±Ëá,0.03525,0.1078,1.215,1.0938,0.6196,-0.6906,yes,down,C05596,-,-,map00350,"Tyrosine metabolism",Metabolism,"Amino acid metabolism",HMDB0000735,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",28116-23-6,251.102136576,4.159,"M+H-2H2O, M+ACN+H, M+ACN+Na",C10H11NO4,0,55,metab_6081,pos_77,pos,417000,539100,450400,252400,404200,476500,677600,432600,1062000,798700,556700,570900,,,,
Isoquinoline,Òìà­ßø,0.04265,0.1217,1.2098,1.1916,0.5872,-0.7681,yes,down,C06323,-,-,-,-,-,-,HMDB0034244,"Organoheterocyclic compounds","Isoquinolines and derivatives","Not Available",119-65-3,130.065063476,4.43933333333,M+H,C9H7N,40.7,0,metab_4796,pos_5719,pos,197900,145100,190400,157100,163000,201000,424800,147900,378100,323800,174900,345500,,,,
Hymenoxon,Ä¤ÖÊ¾ÕÄÚõ¥,0.04587,0.126,1.2092,1.1644,0.2886,-1.7929,yes,down,C09482,-,-,-,-,-,-,HMDB0253305,"Organoheterocyclic compounds",Oxanes,"Not Available",57377-32-9,281.139101117,6.04741666667,M-H,C15H22O5,0,54.9,metab_7308,neg_1872,neg,49530,45080,82160,28090,54380,81890,300300,112000,259200,100900,40900,368700,,,,
"N-Linoleoyl Phenylalanine","N -ÑÇÓÍõ£»ù±½±û°±Ëá",0.02789,0.09848,1.203,1.2143,0.44,-1.1844,yes,down,-,-,-,-,-,-,-,HMDB0241982,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,426.30111748,6.67931666667,M-H,C27H41NO3,0,32,metab_6477,neg_1119,neg,701400,188000,527100,327600,365700,285000,426800,1137000,908200,1557000,868400,545200,,,,
Oligomycin,¹ÑÃ¹ËØ,0.03452,0.1069,1.2029,1.0715,1.8593,0.8948,yes,up,-,-,-,-,-,-,-,HMDB0255952,"Phenylpropanoids and polyketides","Macrolides and analogues","Not Available",-,755.501479935,6.46001666667,M+H-2H2O,C45H74O11,0,41.3,metab_1542,pos_2449,pos,172100,100600,69980,76860,82720,143300,73160,72290,26520,55720,89110,30450,,,,
D-Citrulline,"D -¹Ï°±Ëá",0.0305,0.1,1.1999,1.0735,0.6932,-0.5287,yes,down,-,-,-,-,-,-,-,HMDB0250742,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,176.102758626,0.68885,M+H,C6H13N3O3,0,31.6,metab_406,pos_1374,pos,243800,219500,304100,132000,191400,289400,323800,270100,475200,338000,274800,309300,,,,
Etiracetam,ÒÒÀ­Î÷Ì¹,0.04331,0.1232,1.1997,1.0632,2.0407,1.0291,yes,up,C07841,-,-,-,-,-,-,HMDB0252105;HMDB0015333,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",102767-28-2,171.112718575,1.87191666667,M+H,C8H14N2O2,0,54.8,metab_5151,pos_6047,pos,41960,22030,15310,35780,58520,45900,24240,19020,4164,8622,16060,35470,,,,
Creatine,¼¡Ëá,0.03691,0.111,1.1995,1.2491,1.2702,0.3451,yes,up,C00300,-,-,map01100;map00330;map00260,"Metabolic pathways;Arginine and proline metabolism;Glycine, serine and threonine metabolism",Metabolism;Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism;Amino acid metabolism",PW_C000046;HMDB0000064;MJDBOTE0000560,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",57-00-1,132.076654365,0.696666666667,M+H,C4H9N3O2,94.2,0,metab_415,pos_1383,pos,16130000,20310000,14430000,12150000,14680000,14830000,12810000,11540000,15190000,10570000,10240000,12490000,,,,
"Glutarate semialdehyde",Îì¶þËá°ëÈ©,0.04188,0.1201,1.1995,1.1478,0.6323,-0.6613,yes,down,C03273,-,-,map01100;map00310,"Metabolic pathways;Lysine degradation",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0012233,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",5746-02-1,158.080984328,2.6813,M+ACN+H,C5H8O3,0,42.8,metab_5026,pos_5932,pos,649000,528800,847000,515300,542100,633200,1314000,626900,1382000,934600,621800,996400,,,,
D-Galactose,D-°ëÈéÌÇ,0.04961,0.1323,1.1948,1.1468,0.568,-0.816,yes,down,C00124,Carbohydrates,Monosaccharides,map01100;map04973;map04978;map00052,"Metabolic pathways;Carbohydrate digestion and absorption;Mineral absorption;Galactose metabolism","Metabolism;Organismal Systems;Organismal Systems;Metabolism","Global and overview maps;Digestive system;Digestive system;Carbohydrate metabolism",PW_C000093;HMDB0250761;HMDB0000143;HMDB0003449;MJDBOTE0001042,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",7296-64-2;59-23-4;59-23-4;10257-28-0;3646-73-9,225.061022739,0.636666666667,M+FA-H,C6H12O6,44.9,0,metab_9035,neg_2488,neg,1539000,1518000,1648000,1544000,1962000,1615000,4436000,1815000,3305000,3342000,1160000,3248000,,,,
N6-Threonylcarbamoyladenosine,6-ËÕ°±õ£°±»ù¼×õ£ÏÙÜÕËá,0.03481,0.1072,1.1945,1.1446,0.4915,-1.0247,yes,down,-,-,-,-,-,-,-,-,-,-,-,-,413.140666586,3.30018333333,M+H,C15H20N6O8,80.8,0,metab_4899,pos_5813,pos,83130,77480,193000,37900,53480,89730,200900,100600,284700,182700,94970,223600,,,,
4-Chlorobenzaldehyde,¶ÔÂÈ±½¼×È©,0.04051,0.1182,1.1913,1.1961,1.0661,0.0923,yes,up,C06648,-,-,-,-,-,-,HMDB0246392,Benzenoids,"Benzene and substituted derivatives","Benzoyl derivatives",104-88-1,141.009925627,3.18185,M+H,C7H5ClO,0,32.8,metab_4924,pos_5838,pos,862900,885100,861600,847100,936100,957000,875300,786800,880000,817100,826100,832400,,,,
"4-Hydroxy-2-oxoglutaric acid","4 -ôÇ»ù- 2-ÍªÎì¶þËá",0.03242,0.1062,1.1902,1.1664,0.2272,-2.138,yes,down,C01127,-,-,map01100;map00630,"Metabolic pathways;Glyoxylate and dicarboxylate metabolism",Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism",HMDB0002070;PW_C001391,"Organic acids and derivatives","Keto acids and derivatives","Gamma-keto acids and derivatives",1187-99-1,142.997628554,0.7298,M-H2O-H,C5H6O6,0,48.6,metab_8593,neg_595,neg,50370,10250,1085,2044,10770,30600,48920,30270,158800,81790,109000,33830,,,,
1-O-Hexadecyl-sn-glycero-3-phosphocholine,"1 - O -Ê®ÁùÍé»ù- sn -¸ÊÓÍ-3 -Á×Ëáµ¨¼î",0.04788,0.131,1.19,1.028,0.6009,-0.7348,yes,down,C13903,-,-,-,-,-,-,HMDB0243890,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,504.341554228,7.67991666667,M+Na,C24H52NO6P,0,64.4,metab_2703,pos_3649,pos,1049000,573000,1029000,538600,575900,809400,1102000,1027000,1244000,2204000,954000,1082000,,,,
"Polyglycerol esters of fatty acids",Ö¬·¾Ëá¾Û¸ÊÓÍõ¥,0.04861,0.1323,1.1865,1.0546,1.4547,0.5407,yes,up,-,-,-,-,-,-,-,HMDB0303271,"Lipids and lipid-like molecules",Glycerolipids,Diradylglycerols,-,450.376980633,6.20088333333,M+NH4,C24H48O6,0,56.8,metab_1343,pos_2252,pos,383100,290200,269400,395600,591200,404400,258400,309300,304000,291100,181000,260400,,,,
"PC(18:3(9Z,12Z,15Z)/18:0)",-,0.03125,0.1012,1.1851,1.5347,0.6495,-0.6226,yes,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004249;HMDB0008201;LMGP01011682,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,828.550007562,7.67211666667,"M+NH4, M+2Na-H",C44H82NO8P,0,88.5,metab_6148,pos_831,pos,21210000,18780000,13420000,28110000,22890000,15350000,30910000,31050000,33620000,19440000,44920000,24440000,,,,
Epinephrine,ÉöÉÏÏÙËØ,0.03523,0.1119,1.1834,1.1898,0.4098,-1.287,yes,down,C00788,"Hormones and transmitters;Hormones and transmitters","Other hormones;Neurotransmitters",map01100;map05207;map04261;map04080;map04024;map04923;map04924;map00350,"Metabolic pathways;Chemical carcinogenesis - receptor activation;Adrenergic signaling in cardiomyocytes;Neuroactive ligand-receptor interaction;cAMP signaling pathway;Regulation of lipolysis in adipocytes;Renin secretion;Tyrosine metabolism","Metabolism;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Organismal Systems;Metabolism","Global and overview maps;Cancer: overview;Circulatory system;Signaling molecules and interaction;Signal transduction;Endocrine system;Endocrine system;Amino acid metabolism",PW_C000048;HMDB0000068;MJDBOTE0000810,Benzenoids,Phenols,Benzenediols,51-43-4,228.087118023,3.76111666667,M+FA-H,C9H13NO3,0,49,metab_8815,neg_802,neg,439900,178900,328500,92310,182200,197700,735000,142700,871200,691600,281800,741600,,,,
PE(18:2/0:0),-,0.03674,0.1149,1.1822,1.0986,1.6134,0.6901,yes,up,-,-,-,-,-,-,-,-,-,-,-,-,476.277760501,6.4819,M-H,C23H44NO7P,95.2,0,metab_7138,neg_1718,neg,21690000,15070000,19010000,17140000,16310000,11950000,4264000,16210000,8131000,14920000,14380000,4798000,,,,
"Methylprednisolone acetate",¼×»ùÆÃÄáËÉÁú´×Ëáõ¥,0.03904,0.1157,1.1799,1.1092,1.4312,0.5172,yes,up,C08179,-,-,-,-,-,-,HMDB0014998;HMDB0254661,"Lipids and lipid-like molecules","Steroids and steroid derivatives",Hydroxysteroids,53-36-1;50-24-8,458.252933888,6.29546666667,M+ACN+H,C24H32O6,0,59.9,metab_6341,pos_4935,pos,5398000,6412000,5230000,8126000,9748000,7782000,4671000,6730000,5226000,4120000,5981000,3103000,,,,
Fludrocortisone,·úÇâ¿ÉµÄËÉ,0.04632,0.1283,1.1783,1.1572,0.2866,-1.8029,yes,down,C07004,-,-,-,-,-,-,HMDB0014825;LMST02030103,"Lipids and lipid-like molecules","Steroids and steroid derivatives",Hydroxysteroids,127-31-1,345.187612719,5.72531666667,M+H-2H2O,C21H29FO5,0,81.9,metab_4668,pos_5602,pos,11390,19280,22860,15830,4320,12320,102200,25020,31740,39200,21480,80330,,,,
"Imidazolepropionic acid",ßäßò±ûËá,0.04135,0.1192,1.178,1.02,0.6164,-0.6981,yes,down,C20522,-,-,map00340,"Histidine metabolism",Metabolism,"Amino acid metabolism",HMDB0002271,"Organoheterocyclic compounds",Azoles,Imidazoles,1074-59-5,141.065648399,0.71195,M+H,C6H8N2O2,0,54,metab_5398,pos_6287,pos,456900,493600,869600,283200,265500,479800,676900,754200,1189000,795900,591900,613700,,,,
"Glucaric acid",ÆÏÌÇ¶þËá,0.04224,0.1208,1.1779,1.1003,0.4698,-1.0899,yes,down,C00818,-,-,map01100;map00053,"Metabolic pathways;Ascorbate and aldarate metabolism",Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism",HMDB0000663;LMFA01170108,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",87-73-0,252.072202911,2.81736666667,M+ACN+H,C6H10O8,0,36.5,metab_4992,pos_5901,pos,47020,42240,114500,25930,23330,45180,109200,60610,178300,125600,46520,114300,,,,
Cnidilide,´¨ÜºÄÚõ¥A,0.02964,0.1023,1.175,1.1141,1.1183,0.1613,yes,up,C16937,-,-,-,-,-,-,HMDB0302259,"Organoheterocyclic compounds",Isobenzofurans,"Not Available",3674-03-1,239.128403851,6.23595,M+FA-H,C12H18O2,0,42.7,metab_6373,neg_1022,neg,60120,64320,61300,65610,73160,68140,60870,49330,59130,58680,62420,60670,,,,
"N-Palmitoyl Valine","N -×Øéµõ£çÓ°±Ëá",0.0388,0.1174,1.1746,1.245,0.5219,-0.9382,yes,down,-,-,-,-,-,-,-,HMDB0241935;LMFA08020120,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,354.300963048,6.71851666667,M-H,C21H41NO3,0,55.9,metab_7054,neg_1641,neg,484900,227700,524200,521000,447300,371400,310600,1052000,997000,1105000,1026000,446900,,,,
"Isocitric Acid",ÒìÄûÃÊËá,0.04453,0.1241,1.1711,1.1203,0.1334,-2.9062,yes,down,C00311,"Organic acids","Carboxylic acids",map01100;map00630;map01240;map01210;map01200;map01230;map04922;map00020;map05230,"Metabolic pathways;Glyoxylate and dicarboxylate metabolism;Biosynthesis of cofactors;2-Oxocarboxylic acid metabolism;Carbon metabolism;Biosynthesis of amino acids;Glucagon signaling pathway;Citrate cycle (TCA cycle);Central carbon metabolism in cancer","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Organismal Systems;Metabolism;Human Diseases","Global and overview maps;Carbohydrate metabolism;Global and overview maps;Global and overview maps;Global and overview maps;Global and overview maps;Endocrine system;Carbohydrate metabolism;Cancer: overview",HMDB0033717;HMDB0304324;PW_C000125;HMDB0000193;HMDB0001874,"Organic acids and derivatives","Carboxylic acids and derivatives","Tricarboxylic acids and derivatives",6061-97-8;30810-51-6;320-77-4,226.995793865,0.714166666667,M+Cl,C6H8O7,58.1,0,metab_9039,neg_586,neg,214700,26080,20690,20230,20770,122300,341600,171000,1302000,635300,557900,175700,,,,
Diglyceride,¸ÊÓÍ¶þõ¥,0.04335,0.1226,1.1705,1.1733,0.3108,-1.6859,yes,down,C03199,-,-,-,-,-,-,HMDB0093154;HMDB0056322;HMDB0007708;HMDB0093917;HMDB0094050;HMDB0093315;HMDB0056068;HMDB0094420;HMDB0056213;HMDB0094249;HMDB0007485;HMDB0093184;HMDB0093625;HMDB0007589;HMDB0094473;HMDB0056028;HMDB0055994;HMDB0007295;HMDB0056038;HMDB0007270;HMDB0056315;HMDB0007218;HMDB0056176;HMDB0093810;HMDB0094247;HMDB0093028;HMDB0007565;HMDB0094606;HMDB0007390;HMDB0094395;HMDB0094100;HMDB0094448;HMDB0056205;HMDB0007291;HMDB0094372;HMDB0094138;HMDB0056354;HMDB0007535;HMDB0056278;HMDB0093985;HMDB0056013;HMDB0007364;HMDB0093069;HMDB0093858;HMDB0093617;HMDB0007071;HMDB0094011;HMDB0093221;HMDB0007469;HMDB0093436;HMDB0007368;HMDB0056011;HMDB0094135;HMDB0093532;HMDB0007723;HMDB0007151;HMDB0093313;HMDB0093155;HMDB0056067;HMDB0007023;HMDB0093848;HMDB0007184;HMDB0007067;HMDB0007353;HMDB0094432;HMDB0093806;HMDB0056105;HMDB0093675;HMDB0056103;HMDB0007418;HMDB0094462;HMDB0094304;HMDB0094035;HMDB0007013;HMDB0007583;HMDB0007848;HMDB0093882;HMDB0094043;HMDB0056046;HMDB0055982;HMDB0093744;HMDB0055972;HMDB0094081;HMDB0116384;HMDB0093116;HMDB0093817;HMDB0056224;HMDB0007380;HMDB0007285;HMDB0056135;HMDB0007519;HMDB0094091;HMDB0007664;HMDB0055962;HMDB0093096;HMDB0094547;HMDB0094286;HMDB0093349;HMDB0093344;HMDB0094545;HMDB0093201;HMDB0116425;HMDB0055961;HMDB0056237;HMDB0094300;HMDB0094222;HMDB0094012;HMDB0056052;HMDB0093003;HMDB0056260;HMDB0007642;HMDB0093337;HMDB0093899;HMDB0093374;HMDB0094366;HMDB0093621;HMDB0094031;HMDB0056070;HMDB0007474;HMDB0007681;HMDB0007103;HMDB0056235;HMDB0093382;HMDB0007707;HMDB0094141;HMDB0056164;HMDB0093238;HMDB0007464;HMDB0056261;HMDB0093977;HMDB0007586;HMDB0094588;HMDB0007453;HMDB0094339;HMDB0007484;HMDB0094122;HMDB0094248;HMDB0093642;HMDB0251280;HMDB0007791;HMDB0093085;HMDB0007245;HMDB0093218;HMDB0007214;HMDB0093636;HMDB0094491;HMDB0093331;HMDB0093432;HMDB0093246;HMDB0007375;HMDB0007629;HMDB0007126;HMDB0094555;HMDB0094139;HMDB0007648;HMDB0094131;HMDB0007402;HMDB0007091;HMDB0094014;HMDB0094540;HMDB0007384;HMDB0093414;HMDB0094633;HMDB0093546;HMDB0056096;HMDB0093944;HMDB0093448;HMDB0094355;HMDB0093569;HMDB0094446;HMDB0007371;HMDB0056254;HMDB0093352;HMDB0093258;HMDB0007417;HMDB0094183;HMDB0094421;HMDB0094205;HMDB0056284;HMDB0093981;HMDB0007110;HMDB0093149;HMDB0094550;HMDB0093514;HMDB0093999;HMDB0007771;HMDB0007520;HMDB0093568;HMDB0094311;HMDB0094456;HMDB0093554;HMDB0007276;HMDB0094341;HMDB0093208;HMDB0093961;HMDB0093207;HMDB0094415;HMDB0116401;HMDB0007433;HMDB0093934;HMDB0093067;HMDB0007150;HMDB0056086;HMDB0056039;HMDB0007377;HMDB0007651;HMDB0093404;HMDB0007502;HMDB0093494;HMDB0007381;HMDB0094048;HMDB0093339;HMDB0007345;HMDB0093045;HMDB0094065;HMDB0007204;HMDB0094330;HMDB0007658;HMDB0093644;HMDB0094488;HMDB0007158;HMDB0092936;HMDB0093082;HMDB0056182;HMDB0056288;HMDB0093870;HMDB0094532;HMDB0007498;HMDB0094026;HMDB0007362;HMDB0007598;HMDB0093092;HMDB0093759;HMDB0093394;HMDB0007278;HMDB0007759;HMDB0007601;HMDB0056062;HMDB0093674;HMDB0093304;HMDB0056215;HMDB0093262;HMDB0093169;HMDB0094604;HMDB0007161;HMDB0007534;HMDB0007769;HMDB0007373;HMDB0007262;HMDB0093267;HMDB0093716;HMDB0092948;HMDB0093272;HMDB0007619;HMDB0093764;HMDB0007591;HMDB0007634;HMDB0007116;HMDB0094257;HMDB0093187;HMDB0007152;HMDB0056152;HMDB0007391;HMDB0094146;HMDB0093815;HMDB0056359;HMDB0093372;HMDB0094537;HMDB0056076;HMDB0007185;HMDB0094096;HMDB0007697;HMDB0007224;HMDB0007099;HMDB0007119;HMDB0007542;HMDB0094484;HMDB0056337;HMDB0093880;HMDB0094464;HMDB0116444;HMDB0094255;HMDB0055995;HMDB0094264;HMDB0007617;HMDB0093685;HMDB0094218;HMDB0007189;HMDB0007085;HMDB0007673;HMDB0056117;HMDB0056083;HMDB0056005;HMDB0055957;HMDB0093638;HMDB0094124;HMDB0007641;HMDB0007778;HMDB0093316;HMDB0094303;HMDB0094099;HMDB0094058;HMDB0094526;HMDB0094379;HMDB0094103;HMDB0007316;HMDB0094045;HMDB0056283;HMDB0093493;HMDB0093245;HMDB0094228;HMDB0094177;HMDB0093837;HMDB0092987;HMDB0007237;HMDB0007636;HMDB0056212;HMDB0007228;HMDB0056353;HMDB0094627;HMDB0093916;HMDB0007105;HMDB0093172;HMDB0007683;HMDB0056382;HMDB0007284;HMDB0007330;HMDB0094111;HMDB0093371;HMDB0094283;HMDB0093134;HMDB0094209;HMDB0093656;HMDB0007656;HMDB0094315;HMDB0093975;HMDB0093095;HMDB0116417;HMDB0094047;HMDB0093865;HMDB0056037;HMDB0094039;HMDB0092974;HMDB0093288;HMDB0094403;HMDB0093093;HMDB0007446;HMDB0007466;HMDB0055988;HMDB0056223;HMDB0056336;HMDB0007396;HMDB0093684;HMDB0007187;HMDB0007153;HMDB0093193;HMDB0056049;HMDB0007231;HMDB0093903;HMDB0094180;HMDB0116418;HMDB0007309;HMDB0093923;HMDB0007366;HMDB0093227;HMDB0094543;HMDB0094237;HMDB0055978;HMDB0093441;HMDB0056144;HMDB0007831;HMDB0093754;HMDB0094373;HMDB0116431;HMDB0093119;HMDB0093962;HMDB0007490;HMDB0094271;HMDB0094276;HMDB0093583;HMDB0094147;HMDB0094085;HMDB0007351;HMDB0093351;HMDB0007501;HMDB0093519;HMDB0007011;HMDB0093156;HMDB0093798;HMDB0094452;HMDB0093176;HMDB0093336;HMDB0093385;HMDB0092981;HMDB0007618;HMDB0093927;HMDB0093722;HMDB0093456;HMDB0093056;HMDB0116408;HMDB0093627;HMDB0094461;HMDB0093584;HMDB0056345;HMDB0055958;HMDB0056031;HMDB0007209;HMDB0094199;HMDB0092988;HMDB0092958;HMDB0056147;HMDB0007693;HMDB0007028;HMDB0093014;HMDB0093589;HMDB0116395;HMDB0007537;HMDB0092986;HMDB0093226;HMDB0092965;HMDB0007843;HMDB0007341;HMDB0093168;HMDB0093805;HMDB0094105;HMDB0056314;HMDB0093641;HMDB0056138;HMDB0093023;HMDB0007487;HMDB0093224;HMDB0007667;HMDB0094052;HMDB0093159;HMDB0094106;HMDB0093042;HMDB0007039;HMDB0056263;HMDB0007437;HMDB0093347;HMDB0093926;HMDB0093729;HMDB0093579;HMDB0007513;HMDB0094216;HMDB0094049;HMDB0093706;HMDB0056367;HMDB0007521;HMDB0007182;HMDB0007121;HMDB0056059;HMDB0092942;HMDB0092941;HMDB0007575;HMDB0094580;HMDB0093395;HMDB0093254;HMDB0116386;HMDB0007783;HMDB0094349;HMDB0094192;HMDB0094348;HMDB0116430;HMDB0056137;HMDB0007816;HMDB0093771;HMDB0093777;HMDB0007293;HMDB0007825;HMDB0116400;HMDB0093761;HMDB0094148;HMDB0056160;HMDB0055954;HMDB0093117;HMDB0116380;HMDB0007089;HMDB0093991;HMDB0093965;HMDB0093143;HMDB0093443;HMDB0116439;HMDB0007647;HMDB0094465;HMDB0007026;HMDB0093932;HMDB0055965;HMDB0007086;HMDB0056193;HMDB0007141;HMDB0093219;HMDB0007439;HMDB0092907;HMDB0092951;HMDB0093332;HMDB0094576;HMDB0056313;HMDB0056277;HMDB0094159;HMDB0056079;HMDB0094337;HMDB0056380;HMDB0007431;HMDB0007157;HMDB0093723;HMDB0093523;HMDB0056051;HMDB0093310;HMDB0094639;HMDB0116413;HMDB0094110;HMDB0093455;HMDB0007650;HMDB0094392;HMDB0094541;HMDB0007462;HMDB0007062;HMDB0055959;HMDB0094188;HMDB0007346;HMDB0094214;HMDB0092918;HMDB0056338;HMDB0056126;HMDB0007678;HMDB0093857;HMDB0007252;HMDB0007627;HMDB0093031;HMDB0093521;HMDB0055966;HMDB0093284;HMDB0056082;HMDB0094538;HMDB0093271;HMDB0093995;HMDB0056346;HMDB0056055;HMDB0094407;HMDB0094641;HMDB0093694;HMDB0056030;HMDB0093012;HMDB0093683;HMDB0092928;HMDB0094331;HMDB0092969;HMDB0093699;HMDB0093380;HMDB0092957;HMDB0092984;HMDB0007756;HMDB0007571;HMDB0007019;HMDB0056125;HMDB0093578;HMDB0007809;HMDB0094567;HMDB0056307;HMDB0056297;HMDB0007620;HMDB0056304;HMDB0056032;HMDB0094429;HMDB0093705;HMDB0093475;HMDB0094608;HMDB0094376;HMDB0061538;HMDB0007635;HMDB0093731;HMDB0093296;HMDB0007587;HMDB0116390;HMDB0007705;HMDB0094614;HMDB0093321;HMDB0007178;HMDB0093558;HMDB0093491;HMDB0056232;HMDB0093211;HMDB0093663;HMDB0092979;HMDB0007837;HMDB0056253;HMDB0056351;HMDB0056017;HMDB0094352;HMDB0094034;HMDB0093362;HMDB0093633;HMDB0093005;HMDB0093831;HMDB0007365;HMDB0093956;HMDB0007687;HMDB0116370;HMDB0007660;HMDB0055970;HMDB0007045;HMDB0094554;HMDB0055960;HMDB0116435;HMDB0094519;HMDB0007815;HMDB0093256;HMDB0093420;HMDB0007500;HMDB0056206;HMDB0116373;HMDB0007458;HMDB0093889;HMDB0007344;HMDB0093282;HMDB0093696;HMDB0007662;HMDB0094634;HMDB0093138;HMDB0056279;HMDB0093087;HMDB0093825;HMDB0007562;HMDB0093652;HMDB0093571;HMDB0092938;HMDB0092982;HMDB0056081;HMDB0007574;HMDB0093126;HMDB0007230;HMDB0092992;HMDB0007315;HMDB0007720;HMDB0094312;HMDB0007213;HMDB0056275;HMDB0094117;HMDB0093185;HMDB0007328;HMDB0007386;HMDB0116438;HMDB0056199;HMDB0093976;HMDB0056233;HMDB0007305;HMDB0094288;HMDB0007558;HMDB0093596;HMDB0094299;HMDB0093689;HMDB0093897;HMDB0094324;HMDB0007146;HMDB0093021;HMDB0093538;HMDB0093540;HMDB0007095;HMDB0056352;HMDB0093763;HMDB0007385;HMDB0056185;HMDB0094640;HMDB0007261;HMDB0007065;HMDB0007142;HMDB0093626;HMDB0093556;HMDB0093195;HMDB0007323;HMDB0093250;HMDB0093333;HMDB0056290;HMDB0093998;HMDB0007631;HMDB0093123;HMDB0007179;HMDB0093259;HMDB0093348;HMDB0094440;HMDB0007129;HMDB0094198;HMDB0093177;HMDB0094166;HMDB0093972;HMDB0093077;HMDB0007734;HMDB0093398;HMDB0056019;HMDB0094272;HMDB0093484;HMDB0093276;HMDB0056325;HMDB0007363;HMDB0094593;HMDB0094414;HMDB0007059;HMDB0007425;HMDB0056369;HMDB0007197;HMDB0093846;HMDB0056256;HMDB0094467;HMDB0094152;HMDB0093306;HMDB0007168;HMDB0007255;HMDB0056104;HMDB0092959;HMDB0093403;HMDB0007171;HMDB0093334;HMDB0093280;HMDB0056264;HMDB0007120;HMDB0007614;HMDB0094309;HMDB0007244;HMDB0056289;HMDB0007838;HMDB0056094;HMDB0093323;HMDB0094224;HMDB0007022;HMDB0093017;HMDB0056211;HMDB0094497;HMDB0094594;HMDB0007256;HMDB0093690;HMDB0093620;HMDB0093745;HMDB0094118;HMDB0094322;HMDB0056317;HMDB0007302;HMDB0094158;HMDB0007139;HMDB0094430;HMDB0093129;HMDB0007679;HMDB0007200;HMDB0007421;HMDB0094434;HMDB0007488;HMDB0056010;HMDB0007155;HMDB0094265;HMDB0007367;HMDB0094444;HMDB0093914;HMDB0056187;HMDB0093821;HMDB0092916;HMDB0094619;HMDB0093984;HMDB0093669;HMDB0007057;HMDB0007661;HMDB0007163;HMDB0007254;HMDB0093285;HMDB0056162;HMDB0093861;HMDB0007249;HMDB0007788;HMDB0093688;HMDB0007338;HMDB0007383;HMDB0093289;HMDB0093847;HMDB0007845;HMDB0093125;HMDB0007046;HMDB0093943;HMDB0093111;HMDB0056001;HMDB0007058;HMDB0094084;HMDB0094234;HMDB0056115;HMDB0094449;HMDB0116434;HMDB0094029;HMDB0093736;HMDB0094190;HMDB0093708;HMDB0093878;HMDB0093057;HMDB0094227;HMDB0007127;HMDB0007147;HMDB0007128;HMDB0116447;HMDB0094546;HMDB0094508;HMDB0007556;HMDB0094261;HMDB0007677;HMDB0093442;HMDB0093939;HMDB0093113;HMDB0094172;HMDB0094356;HMDB0093505;HMDB0007049;HMDB0007715;HMDB0093989;HMDB0093340;HMDB0093292;HMDB0007444;HMDB0093522;HMDB0093425;HMDB0007300;HMDB0093951;HMDB0007361;HMDB0007643;HMDB0007360;HMDB0007203;HMDB0007538;HMDB0094079;HMDB0094454;HMDB0092991;HMDB0056026;HMDB0094476;HMDB0007746;HMDB0007258;HMDB0007308;HMDB0093516;HMDB0093354;HMDB0093841;HMDB0094294;HMDB0056173;HMDB0094194;HMDB0093037;HMDB0094133;HMDB0007569;HMDB0007628;HMDB0094232;HMDB0007429;HMDB0094334;HMDB0093428;HMDB0093444;HMDB0093471;HMDB0007357;HMDB0092980;HMDB0093020;HMDB0094522;HMDB0116415;HMDB0007547;HMDB0094559;HMDB0094297;HMDB0007327;HMDB0094410;HMDB0007265;HMDB0007190;HMDB0093434;HMDB0007590;HMDB0093228;HMDB0007482;HMDB0007608;HMDB0056249;HMDB0056063;HMDB0007050;HMDB0007241;HMDB0007064;HMDB0094494;HMDB0093535;HMDB0093733;HMDB0094636;HMDB0007459;HMDB0094611;HMDB0007670;HMDB0007510;HMDB0093366;HMDB0093543;HMDB0094451;HMDB0094426;HMDB0007042;HMDB0094327;HMDB0007242;HMDB0007140;HMDB0094343;HMDB0056143;HMDB0056243;HMDB0007082;HMDB0056060;HMDB0007104;HMDB0094433;HMDB0092971;HMDB0056123;HMDB0094089;HMDB0007835;HMDB0094230;HMDB0093317;HMDB0093838;HMDB0007304;HMDB0007743;HMDB0116372;HMDB0092955;HMDB0093728;HMDB0093419;HMDB0093791;HMDB0093616;HMDB0007416;HMDB0007009;HMDB0093724;HMDB0007584;HMDB0093649;HMDB0007654;HMDB0093290;HMDB0094062;HMDB0094436;HMDB0094175;HMDB0094295;HMDB0007585;HMDB0055969;HMDB0093658;HMDB0007639;HMDB0093377;HMDB0007738;HMDB0007411;HMDB0093651;HMDB0007376;HMDB0056360;HMDB0007826;HMDB0093677;HMDB0093618;HMDB0007690;HMDB0007518;HMDB0056129;HMDB0116429;HMDB0094242;HMDB0093954;HMDB0056166;HMDB0094381;HMDB0093707;HMDB0093486;HMDB0007079;HMDB0092939;HMDB0094193;HMDB0092905;HMDB0007198;HMDB0007523;HMDB0093875;HMDB0093753;HMDB0093030;HMDB0093130;HMDB0094511;HMDB0094321;HMDB0056204;HMDB0056246;HMDB0007130;HMDB0093950;HMDB0093278;HMDB0007596;HMDB0007812;HMDB0056383;HMDB0094061;HMDB0055990;HMDB0094383;HMDB0007795;HMDB0007659;HMDB0093039;HMDB0056364;HMDB0007288;HMDB0094129;HMDB0007597;HMDB0093585;HMDB0093548;HMDB0056298;HMDB0093607;HMDB0094189;HMDB0094018;HMDB0092935;HMDB0093474;HMDB0094040;HMDB0094134;HMDB0093319;HMDB0093450;HMDB0056344;HMDB0007124;HMDB0094083;HMDB0094621;HMDB0007420;HMDB0116411;HMDB0093635;HMDB0094575;HMDB0094024;HMDB0094590;HMDB0093104;HMDB0007037;HMDB0007526;HMDB0093389;HMDB0093993;HMDB0007070;HMDB0007550;HMDB0056323;HMDB0007714;HMDB0093980;HMDB0007593;HMDB0092983;HMDB0094196;HMDB0007014;HMDB0007640;HMDB0056366;HMDB0007609;HMDB0093426;HMDB0093053;HMDB0116446;HMDB0094485;HMDB0093318;HMDB0007175;HMDB0055985;HMDB0056208;HMDB0093488;HMDB0056319;HMDB0094412;HMDB0093446;HMDB0094592;HMDB0094578;HMDB0093949;HMDB0094364;HMDB0093255;HMDB0093751;HMDB0007389;HMDB0094438;HMDB0056015;HMDB0093918;HMDB0007846;HMDB0093358;HMDB0093743;HMDB0093049;HMDB0007131;HMDB0007162;HMDB0056150;HMDB0093608;HMDB0093888;HMDB0093614;HMDB0093891;HMDB0056108;HMDB0093643;HMDB0094557;HMDB0093742;HMDB0093181;HMDB0007440;HMDB0093019;HMDB0007798;HMDB0094273;HMDB0094154;HMDB0092920;HMDB0092932;HMDB0094005;HMDB0094503;HMDB0007695;HMDB0055977;HMDB0094507;HMDB0056374;HMDB0007096;HMDB0093811;HMDB0007471;HMDB0093386;HMDB0055984;HMDB0094098;HMDB0007621;HMDB0007087;HMDB0093859;HMDB0056282;HMDB0092931;HMDB0007436;HMDB0093553;HMDB0007577;HMDB0093298;HMDB0007027;HMDB0007333;HMDB0007711;HMDB0056050;HMDB0093881;HMDB0094104;HMDB0116432;HMDB0093236;HMDB0056016;HMDB0092922;HMDB0093822;HMDB0007275;HMDB0007624;HMDB0056181;HMDB0007564;HMDB0007098;HMDB0007758;HMDB0093421;HMDB0007229;HMDB0093148;HMDB0093025;HMDB0093986;HMDB0007633;HMDB0093305;HMDB0007533;HMDB0093268;HMDB0093047;HMDB0116403;HMDB0093591;HMDB0094424;HMDB0007443;HMDB0093078;HMDB0093440;HMDB0056250;HMDB0094022;HMDB0056306;HMDB0094335;HMDB0007413;HMDB0056156;HMDB0093217;HMDB0007800;HMDB0093302;HMDB0093235;HMDB0007762;HMDB0093555;HMDB0093144;HMDB0007274;HMDB0056258;HMDB0092970;HMDB0094524;HMDB0056141;HMDB0094136;HMDB0007349;HMDB0056112;HMDB0092902;HMDB0007166;HMDB0093931;HMDB0007266;HMDB0094064;HMDB0094527;HMDB0056027;HMDB0007382;HMDB0094418;HMDB0094459;HMDB0007406;HMDB0007321;HMDB0056151;HMDB0093713;HMDB0093468;HMDB0093871;HMDB0093248;HMDB0007603;HMDB0116448;HMDB0094342;HMDB0056299;HMDB0007470;HMDB0093755;HMDB0056066;HMDB0094113;HMDB0056311;HMDB0093437;HMDB0007554;HMDB0007726;HMDB0094256;HMDB0093963;HMDB0056231;HMDB0116402;HMDB0093946;HMDB0094087;HMDB0094259;HMDB0056048;HMDB0007192;HMDB0093274;HMDB0007223;HMDB0093127;HMDB0094466;HMDB0007541;HMDB0094270;HMDB0093356;HMDB0007663;HMDB0056004;HMDB0094441;HMDB0007314;HMDB0056065;HMDB0007528;HMDB0092985;HMDB0007827;HMDB0056085;HMDB0056381;HMDB0056239;HMDB0055971;HMDB0093832;HMDB0094220;HMDB0094499;HMDB0094025;HMDB0007452;HMDB0007303;HMDB0094391;HMDB0093915;HMDB0094510;HMDB0092963;HMDB0093922;HMDB0092954;HMDB0094570;HMDB0094080;HMDB0093534;HMDB0094624;HMDB0094292;HMDB0093512;HMDB0007760;HMDB0093299;HMDB0056198;HMDB0093772;HMDB0093959;HMDB0007434;HMDB0007671;HMDB0007546;HMDB0094474;HMDB0007745;HMDB0007021;HMDB0093894;HMDB0093365;HMDB0055991;HMDB0093462;HMDB0093032;HMDB0093892;HMDB0056132;HMDB0007311;HMDB0056349;HMDB0007313;HMDB0094144;HMDB0094318;HMDB0094202;HMDB0093447;HMDB0007461;HMDB0056003;HMDB0056058;HMDB0007685;HMDB0007497;HMDB0094404;HMDB0093717;HMDB0007432;HMDB0007741;HMDB0093834;HMDB0093862;HMDB0007559;HMDB0093594;HMDB0094353;HMDB0093407;HMDB0094325;HMDB0094003;HMDB0007793;HMDB0094455;HMDB0007473;HMDB0056074;HMDB0056088;HMDB0007460;HMDB0056025;HMDB0092940;HMDB0007717;HMDB0056300;HMDB0007419;HMDB0007201;HMDB0093854;HMDB0094077;HMDB0094290;HMDB0094178;HMDB0007494;HMDB0094607;HMDB0094362;HMDB0007133;HMDB0093756;HMDB0094254;HMDB0007069;HMDB0093406;HMDB0007719;HMDB0056308;HMDB0093439;HMDB0093188;HMDB0094262;HMDB0056113;HMDB0007579;HMDB0094552;HMDB0094184;HMDB0007215;HMDB0055996;HMDB0094204;HMDB0094346;HMDB0007450;HMDB0007320;HMDB0007072;HMDB0093629;HMDB0055981;HMDB0093422;HMDB0007701;HMDB0056268;HMDB0094586;HMDB0094354;HMDB0094296;HMDB0056269;HMDB0056178;HMDB0093152;HMDB0093173;HMDB0094518;HMDB0094269;HMDB0007754;HMDB0056292;HMDB0093898;HMDB0056154;HMDB0093046;HMDB0092997;HMDB0093112;HMDB0093118;HMDB0094057;HMDB0055998;HMDB0093230;HMDB0093320;HMDB0007706;HMDB0093472;HMDB0094569;HMDB0094566;HMDB0007552;HMDB0093151;HMDB0094302;HMDB0093065;HMDB0094536;HMDB0007602;HMDB0094447;HMDB0094320;HMDB0093454;HMDB0093011;HMDB0093515;HMDB0093244;HMDB0055992;HMDB0007354;HMDB0116371;HMDB0094584;HMDB0093869;HMDB0094581;HMDB0056229;HMDB0056002;HMDB0094468;HMDB0007792;HMDB0010338;HMDB0093263;HMDB0093183;HMDB0093509;HMDB0093799;HMDB0056370;HMDB0093427;HMDB0007032;HMDB0093001;HMDB0007522;HMDB0007814;HMDB0007731;HMDB0094046;HMDB0094054;HMDB0056361;HMDB0092911;HMDB0007340;HMDB0093623;HMDB0056357;HMDB0116412;HMDB0093937;HMDB0093565;HMDB0094601;HMDB0093970;HMDB0056200;HMDB0093900;HMDB0007818;HMDB0007592;HMDB0094370;HMDB0092919;HMDB0094469;HMDB0094345;HMDB0093639;HMDB0056238;HMDB0093265;HMDB0007455;HMDB0055986;HMDB0094217;HMDB0093575;HMDB0055975;HMDB0056273;HMDB0007336;HMDB0007447;HMDB0056318;HMDB0093359;HMDB0056189;HMDB0007830;HMDB0094568;HMDB0094207;HMDB0056324;HMDB0094501;HMDB0093353;HMDB0007560;HMDB0116387;HMDB0094487;HMDB0094101;HMDB0094574;HMDB0094126;HMDB0007729;HMDB0093795;HMDB0094458;HMDB0093270;HMDB0093953;HMDB0093750;HMDB0093453;HMDB0056128;HMDB0094350;HMDB0093602;HMDB0093545;HMDB0056092;HMDB0093632;HMDB0007847;HMDB0116393;HMDB0094416;HMDB0007008;HMDB0093530;HMDB0007174;HMDB0093083;HMDB0007317;HMDB0056330;HMDB0093909;HMDB0007545;HMDB0007563;HMDB0093973;HMDB0056347;HMDB0007680;HMDB0094245;HMDB0116428;HMDB0094506;HMDB0093393;HMDB0093687;HMDB0093830;HMDB0093938;HMDB0093234;HMDB0092990;HMDB0093203;HMDB0093052;HMDB0007839;HMDB0007035;HMDB0094521;HMDB0056071;HMDB0056148;HMDB0007736;HMDB0056240;HMDB0093853;HMDB0093423;HMDB0093499;HMDB0007581;HMDB0007312;HMDB0056228;HMDB0056195;HMDB0093297;HMDB0094427;HMDB0007359;HMDB0094562;HMDB0093459;HMDB0093879;HMDB0093209;HMDB0093401;HMDB0093628;HMDB0007424;HMDB0093162;HMDB0007638;HMDB0093312;HMDB0056183;HMDB0094475;HMDB0093845;HMDB0094549;HMDB0093430;HMDB0094365;HMDB0007210;HMDB0056295;HMDB0093485;HMDB0007207;HMDB0092908;HMDB0056000;HMDB0093101;HMDB0093167;HMDB0093820;HMDB0007040;HMDB0116440;HMDB0094571;HMDB0007355;HMDB0093120;HMDB0094393;HMDB0093537;HMDB0007696;HMDB0094515;HMDB0093072;HMDB0093062;HMDB0007401;HMDB0094140;HMDB0007787;HMDB0007136;HMDB0094500;HMDB0056285;HMDB0094284;HMDB0007704;HMDB0094252;HMDB0093342;HMDB0093328;HMDB0093544;HMDB0116433;HMDB0093725;HMDB0094638;HMDB0094070;HMDB0056136;HMDB0093712;HMDB0094596;HMDB0094308;HMDB0093599;HMDB0094563;HMDB0007700;HMDB0092956;HMDB0007306;HMDB0094589;HMDB0093071;HMDB0056332;HMDB0007799;HMDB0094009;HMDB0007777;HMDB0007194;HMDB0007730;HMDB0094157;HMDB0093198;HMDB0094513;HMDB0056362;HMDB0056262;HMDB0093465;HMDB0007509;HMDB0094603;HMDB0056305;HMDB0094274;HMDB0007267;HMDB0093247;HMDB0093737;HMDB0007625;HMDB0094357;HMDB0093812;HMDB0094435;HMDB0056270;HMDB0094579;HMDB0093739;HMDB0093700;HMDB0116437;HMDB0093670;HMDB0007238;HMDB0056280;HMDB0056174;HMDB0093560;HMDB0056047;HMDB0007260;HMDB0094523;HMDB0116368;HMDB0094600;HMDB0094042;HMDB0094417;HMDB0094013;HMDB0093141;HMDB0093823;HMDB0094174;HMDB0056044;HMDB0093070;HMDB0007029;HMDB0094329;HMDB0056372;HMDB0094360;HMDB0007279;HMDB0092915;HMDB0094409;HMDB0093978;HMDB0007287;HMDB0093301;HMDB0093330;HMDB0056210;HMDB0094182;HMDB0007108;HMDB0116414;HMDB0093718;HMDB0093842;HMDB0094496;HMDB0093002;HMDB0094059;HMDB0093734;HMDB0092960;HMDB0094051;HMDB0007269;HMDB0007232;HMDB0093240;HMDB0007481;HMDB0007465;HMDB0116375;HMDB0007544;HMDB0007457;HMDB0093033;HMDB0093782;HMDB0094125;HMDB0055974;HMDB0094078;HMDB0092993;HMDB0056220;HMDB0094251;HMDB0093668;HMDB0056121;HMDB0007834;HMDB0093063;HMDB0007399;HMDB0093189;HMDB0093637;HMDB0093345;HMDB0094332;HMDB0093249;HMDB0093460;HMDB0094359;HMDB0007132;HMDB0093215;HMDB0007076;HMDB0007408;HMDB0093955;HMDB0093856;HMDB0094056;HMDB0093408;HMDB0007548;HMDB0007250;HMDB0056245;HMDB0092952;HMDB0093789;HMDB0093370;HMDB0007727;HMDB0093679;HMDB0056257;HMDB0094086;HMDB0093059;HMDB0007248;HMDB0056255;HMDB0007097;HMDB0007337;HMDB0094313;HMDB0093133;HMDB0093355;HMDB0094402;HMDB0093948;HMDB0007322;HMDB0094213;HMDB0056244;HMDB0093400;HMDB0056158;HMDB0007217;HMDB0056078;HMDB0094591;HMDB0093180;HMDB0056101;HMDB0093747;HMDB0093483;HMDB0093390;HMDB0093952;HMDB0094445;HMDB0007770;HMDB0056350;HMDB0094073;HMDB0056194;HMDB0093925;HMDB0007540;HMDB0093424;HMDB0093476;HMDB0007247;HMDB0094481;HMDB0056378;HMDB0007525;HMDB0007183;HMDB0007445;HMDB0007607;HMDB0094535;HMDB0007486;HMDB0094490;HMDB0056029;HMDB0092962;HMDB0007024;HMDB0094531;HMDB0094250;HMDB0093582;HMDB0007733;HMDB0116399;HMDB0093692;HMDB0007148;HMDB0056159;HMDB0093992;HMDB0093378;HMDB0094017;HMDB0056111;HMDB0094602;HMDB0007718;HMDB0007824;HMDB0056020;HMDB0007281;HMDB0093912;HMDB0093982;HMDB0093105;HMDB0094628;HMDB0093783;HMDB0056165;HMDB0007117;HMDB0093969;HMDB0007290;HMDB0007480;HMDB0093018;HMDB0056375;HMDB0055973;HMDB0007282;HMDB0092906;HMDB0094145;HMDB0094431;HMDB0093574;HMDB0056248;HMDB0093308;HMDB0094082;HMDB0093252;HMDB0056130;HMDB0056236;HMDB0007053;HMDB0094551;HMDB0093029;HMDB0093153;HMDB0094396;HMDB0007015;HMDB0007296;HMDB0056116;HMDB0093489;HMDB0007073;HMDB0007491;HMDB0007529;HMDB0056157;HMDB0116423;HMDB0007595;HMDB0094483;HMDB0093171;HMDB0093698;HMDB0116374;HMDB0093161;HMDB0094027;HMDB0007074;HMDB0007774;HMDB0056225;HMDB0007264;HMDB0093041;HMDB0007813;HMDB0094306;HMDB0093788;HMDB0007767;HMDB0094280;HMDB0092961;HMDB0094397;HMDB0093906;HMDB0093809;HMDB0093335;HMDB0007610;HMDB0093818;HMDB0007031;HMDB0093269;HMDB0007702;HMDB0007684;HMDB0093326;HMDB0056293;HMDB0094371;HMDB0007030;HMDB0007747;HMDB0116424;HMDB0007280;HMDB0007682;HMDB0093790;HMDB0093590;HMDB0092967;HMDB0093606;HMDB0007699;HMDB0094291;HMDB0093212;HMDB0093559;HMDB0094323;HMDB0007332;HMDB0093740;HMDB0093605;HMDB0056321;HMDB0007492;HMDB0094514;HMDB0093940;HMDB0093887;HMDB0093502;HMDB0093088;HMDB0093506;HMDB0093766;HMDB0007226;HMDB0007622;HMDB0093361;HMDB0093801;HMDB0094599;HMDB0092934;HMDB0093281;HMDB0093884;HMDB0093314;HMDB0092976;HMDB0093784;HMDB0007259;HMDB0093529;HMDB0007138;HMDB0094517;HMDB0007512;HMDB0094623;HMDB0007347;HMDB0056342;HMDB0007820;HMDB0093178;HMDB0056007;HMDB0094625;HMDB0094004;HMDB0092909;HMDB0094137;HMDB0093160;HMDB0007181;HMDB0094127;HMDB0094385;HMDB0094361;HMDB0094423;HMDB0093338;HMDB0007508;HMDB0007582;HMDB0007227;HMDB0007806;HMDB0007811;HMDB0007169;HMDB0093287;HMDB0007415;HMDB0094310;HMDB0092947;HMDB0007712;HMDB0092996;HMDB0007772;HMDB0093839;HMDB0093043;HMDB0007761;HMDB0094516;HMDB0093094;HMDB0056334;HMDB0093901;HMDB0007078;HMDB0094453;HMDB0007515;HMDB0007551;HMDB0093964;HMDB0094187;HMDB0093202;HMDB0094155;HMDB0116389;HMDB0056216;HMDB0093945;HMDB0056042;HMDB0093714;HMDB0007423;HMDB0093634;HMDB0093191;HMDB0007388;HMDB0093990;HMDB0093872;HMDB0093957;HMDB0093266;HMDB0056057;HMDB0093852;HMDB0092926;HMDB0094201;HMDB0094336;HMDB0056089;HMDB0094006;HMDB0007319;HMDB0056099;HMDB0094577;HMDB0093936;HMDB0056110;HMDB0093758;HMDB0094573;HMDB0094390;HMDB0093697;HMDB0007271;HMDB0056155;HMDB0092978;HMDB0093363;HMDB0056219;HMDB0093024;HMDB0094389;HMDB0116436;HMDB0093850;HMDB0093242;HMDB0093539;HMDB0093058;HMDB0007755;HMDB0007454;HMDB0093466;HMDB0056163;HMDB0093461;HMDB0094564;HMDB0094529;HMDB0093194;HMDB0007668;HMDB0094151;HMDB0093200;HMDB0093044;HMDB0056291;HMDB0055953;HMDB0093415;HMDB0093930;HMDB0007637;HMDB0093929;HMDB0092930;HMDB0093611;HMDB0055952;HMDB0056287;HMDB0007092;HMDB0055968;HMDB0007807;HMDB0007516;HMDB0094132;HMDB0093124;HMDB0093210;HMDB0094115;HMDB0093145;HMDB0056149;HMDB0093402;HMDB0093563;HMDB0094301;HMDB0094074;HMDB0007789;HMDB0056171;HMDB0093678;HMDB0093417;HMDB0007686;HMDB0094512;HMDB0094504;HMDB0093793;HMDB0056023;HMDB0007212;HMDB0093016;HMDB0093849;HMDB0093935;HMDB0007623;HMDB0094000;HMDB0094635;HMDB0093098;HMDB0093050;HMDB0093653;HMDB0093206;HMDB0093551;HMDB0007066;HMDB0094520;HMDB0056139;HMDB0093381;HMDB0094278;HMDB0094015;HMDB0093409;HMDB0093060;HMDB0092921;HMDB0094595;HMDB0056186;HMDB0056377;HMDB0007407;HMDB0093947;HMDB0094225;HMDB0093619;HMDB0094408;HMDB0007387;HMDB0056376;HMDB0093084;HMDB0055993;HMDB0056091;HMDB0093036;HMDB0007507;HMDB0007240;HMDB0056201;HMDB0093588;HMDB0093229;HMDB0094344;HMDB0093467;HMDB0093035;HMDB0094258;HMDB0094162;HMDB0093110;HMDB0093988;HMDB0093416;HMDB0056045;HMDB0093533;HMDB0093397;HMDB0093686;HMDB0093186;HMDB0007426;HMDB0093007;HMDB0093375;HMDB0007615;HMDB0007744;HMDB0093913;HMDB0093492;HMDB0093508;HMDB0116397;HMDB0094231;HMDB0093561;HMDB0007196;HMDB0007781;HMDB0093222;HMDB0007202;HMDB0093054;HMDB0056118;HMDB0093792;HMDB0094405;HMDB0007612;HMDB0093388;HMDB0094212;HMDB0116392;HMDB0007438;HMDB0056109;HMDB0094279;HMDB0094289;HMDB0056184;HMDB0007352;HMDB0116369;HMDB0007118;HMDB0093711;HMDB0093836;HMDB0056093;HMDB0094268;HMDB0093662;HMDB0093076;HMDB0094386;HMDB0056153;HMDB0094275;HMDB0056272;HMDB0094443;HMDB0093895;HMDB0094539;HMDB0093960;HMDB0056358;HMDB0007527;HMDB0094572;HMDB0094142;HMDB0007665;HMDB0007219;HMDB0007154;HMDB0094307;HMDB0055956;HMDB0093572;HMDB0116388;HMDB0007041;HMDB0093667;HMDB0093942;HMDB0093580;HMDB0007776;HMDB0007728;HMDB0007422;HMDB0093967;HMDB0093814;HMDB0007055;HMDB0094489;HMDB0094002;HMDB0093510;HMDB0007310;HMDB0056276;HMDB0093863;HMDB0094008;HMDB0093646;HMDB0094450;HMDB0007489;HMDB0094170;HMDB0093691;HMDB0007246;HMDB0094001;HMDB0093715;HMDB0093279;HMDB0093726;HMDB0094411;HMDB0056230;HMDB0093974;HMDB0007803;HMDB0007752;HMDB0056145;HMDB0007626;HMDB0092929;HMDB0093833;HMDB0092910;HMDB0031011;HMDB0094637;HMDB0094374;HMDB0056167;HMDB0093325;HMDB0007325;HMDB0094492;HMDB0116416;HMDB0056355;HMDB0092901;HMDB0007539;HMDB0093006;HMDB0007763;HMDB0093451;HMDB0094544;HMDB0007611;HMDB0056265;HMDB0007077;HMDB0093470;HMDB0093410;HMDB0056056;HMDB0007111;HMDB0093080;HMDB0093064;HMDB0007286;HMDB0093760;HMDB0093115;HMDB0007653;HMDB0093364;HMDB0093458;HMDB0007786;HMDB0093802;HMDB0007199;HMDB0094317;HMDB0056214;HMDB0094093;HMDB0007414;HMDB0056188;HMDB0094558;HMDB0007143;HMDB0093819;HMDB0007145;HMDB0007272;HMDB0093741;HMDB0093511;HMDB0094630;HMDB0007172;HMDB0116426;HMDB0116407;HMDB0094470;HMDB0093622;HMDB0093357;HMDB0094479;HMDB0094165;HMDB0056226;HMDB0007034;HMDB0007553;HMDB0056316;HMDB0092927;HMDB0093650;HMDB0116422;HMDB0056310;HMDB0093507;HMDB0007709;HMDB0056127;HMDB0094033;HMDB0093979;HMDB0093748;HMDB0007193;HMDB0094556;HMDB0093824;HMDB0094528;HMDB0007833;HMDB0093174;HMDB0092968;HMDB0093786;HMDB0093223;HMDB0093996;HMDB0007403;HMDB0007020;HMDB0094632;HMDB0093576;HMDB0093593;HMDB0007106;HMDB0094233;HMDB0093732;HMDB0092900;HMDB0056087;HMDB0094398;HMDB0055963;HMDB0056172;HMDB0094032;HMDB0007779;HMDB0056034;HMDB0007114;HMDB0056041;HMDB0094609;HMDB0056197;HMDB0093233;HMDB0093000;HMDB0007123;HMDB0007836;HMDB0007652;HMDB0093504;HMDB0093720;HMDB0093102;HMDB0093158;HMDB0093768;HMDB0116404;HMDB0116420;HMDB0007277;HMDB0093971;HMDB0007358;HMDB0094163;HMDB0056124;HMDB0093987;HMDB0093615;HMDB0093100;HMDB0007292;HMDB0055976;HMDB0093048;HMDB0093391;HMDB0007221;HMDB0094367;HMDB0093295;HMDB0093396;HMDB0007061;HMDB0056168;HMDB0007397;HMDB0007326;HMDB0093781;HMDB0093600;HMDB0093873;HMDB0094368;HMDB0007225;HMDB0007797;HMDB0093829;HMDB0007841;HMDB0007599;HMDB0093251;HMDB0056343;HMDB0007739;HMDB0056180;HMDB0094610;HMDB0007467;HMDB0093182;HMDB0093164;HMDB0093190;HMDB0094622;HMDB0092917;HMDB0093027;HMDB0093549;HMDB0093604;HMDB0093905;HMDB0007134;HMDB0094038;HMDB0094153;HMDB0056335;HMDB0093702;HMDB0093303;HMDB0093570;HMDB0094036;HMDB0007370;HMDB0093079;HMDB0007675;HMDB0094340;HMDB0116427;HMDB0007273;HMDB0093738;HMDB0056267;HMDB0056363;HMDB0007052;HMDB0093586;HMDB0056035;HMDB0007208;HMDB0007378;HMDB0056146;HMDB0056018;HMDB0007742;HMDB0116419;HMDB0094351;HMDB0056036;HMDB0093640;HMDB0094457;HMDB0093654;HMDB0094422;HMDB0007038;HMDB0093855;HMDB0116406;HMDB0007646;HMDB0093587;HMDB0093433;HMDB0007655;HMDB0094285;HMDB0007688;HMDB0094530;HMDB0093368;HMDB0093140;HMDB0007100;HMDB0093645;HMDB0093139;HMDB0007033;HMDB0093136;HMDB0056271;HMDB0093322;HMDB0116445;HMDB0094243;HMDB0007828;HMDB0094240;HMDB0116377;HMDB0094509;HMDB0007016;HMDB0093928;HMDB0093099;HMDB0056202;HMDB0093867;HMDB0007477;HMDB0093524;HMDB0093061;HMDB0093609;HMDB0093307;HMDB0093921;HMDB0093775;HMDB0094116;HMDB0055980;HMDB0094102;HMDB0093746;HMDB0093527;HMDB0094400;HMDB0094041;HMDB0093309;HMDB0094305;HMDB0007113;HMDB0007505;HMDB0094413;HMDB0094088;HMDB0007409;HMDB0007394;HMDB0007823;HMDB0056120;HMDB0007356;HMDB0007472;HMDB0093860;HMDB0007689;HMDB0093757;HMDB0092943;HMDB0093557;HMDB0093807;HMDB0007666;HMDB0093573;HMDB0094617;HMDB0094377;HMDB0093013;HMDB0093469;HMDB0007299;HMDB0093232;HMDB0056379;HMDB0092913;HMDB0056084;HMDB0093431;HMDB0094629;HMDB0094226;HMDB0093213;HMDB0094053;HMDB0093199;HMDB0093089;HMDB0007644;HMDB0094037;HMDB0093513;HMDB0093128;HMDB0094094;HMDB0007722;HMDB0093601;HMDB0056221;HMDB0056327;HMDB0007233;HMDB0056133;HMDB0094338;HMDB0007165;HMDB0056247;HMDB0093730;HMDB0056119;HMDB0007220;HMDB0094267;HMDB0094533;HMDB0094112;HMDB0007048;HMDB0094071;HMDB0092925;HMDB0094375;HMDB0094281;HMDB0116382;HMDB0094287;HMDB0093672;HMDB0056177;HMDB0094235;HMDB0094021;HMDB0007751;HMDB0093412;HMDB0007125;HMDB0056386;HMDB0056170;HMDB0007576;HMDB0093449;HMDB0007243;HMDB0092914;HMDB0007112;HMDB0007804;HMDB0093877;HMDB0007191;HMDB0007753;HMDB0094388;HMDB0056102;HMDB0056365;HMDB0094019;HMDB0093196;HMDB0094561;HMDB0093277;HMDB0093496;HMDB0007479;HMDB0093369;HMDB0093577;HMDB0007805;HMDB0007725;HMDB0093536;HMDB0007606;HMDB0007517;HMDB0093893;HMDB0056340;HMDB0093735;HMDB0093911;HMDB0007504;HMDB0007156;HMDB0094613;HMDB0093418;HMDB0007819;HMDB0056301;HMDB0007017;HMDB0056022;HMDB0007495;HMDB0007506;HMDB0056142;HMDB0093610;HMDB0007081;HMDB0093840;HMDB0116381;HMDB0007810;HMDB0094480;HMDB0007289;HMDB0056090;HMDB0093051;HMDB0094072;HMDB0116398;HMDB0007324;HMDB0056331;HMDB0093463;HMDB0007476;HMDB0007297;HMDB0056014;HMDB0094092;HMDB0093498;HMDB0093661;HMDB0093908;HMDB0007532;HMDB0093966;HMDB0093473;HMDB0093542;HMDB0056217;HMDB0007060;HMDB0056098;HMDB0093399;HMDB0093015;HMDB0007222;HMDB0007530;HMDB0116391;HMDB0094620;HMDB0093630;HMDB0094525;HMDB0007047;HMDB0094384;HMDB0056191;HMDB0116385;HMDB0094471;HMDB0007802;HMDB0093179;HMDB0007257;HMDB0093253;HMDB0056190;HMDB0056303;HMDB0007724;HMDB0007782;HMDB0093844;HMDB0092966;HMDB0007435;HMDB0094587;HMDB0056161;HMDB0007235;HMDB0093346;HMDB0094472;HMDB0093497;HMDB0007339;HMDB0093477;HMDB0093038;HMDB0093165;HMDB0055999;HMDB0093197;HMDB0094565;HMDB0092944;HMDB0093828;HMDB0093780;HMDB0093517;HMDB0007331;HMDB0093405;HMDB0055967;HMDB0056222;HMDB0092949;HMDB0094173;HMDB0007137;HMDB0093360;HMDB0056040;HMDB0007283;HMDB0093566;HMDB0007588;HMDB0007122;HMDB0093770;HMDB0007102;HMDB0093487;HMDB0094181;HMDB0056329;HMDB0093526;HMDB0007084;HMDB0093531;HMDB0094219;HMDB0094406;HMDB0007268;HMDB0093214;HMDB0055983;HMDB0116449;HMDB0056309;HMDB0093261;HMDB0094378;HMDB0007578;HMDB0056122;HMDB0116376;HMDB0092950;HMDB0094394;HMDB0007780;HMDB0093175;HMDB0116405;HMDB0093239;HMDB0056373;HMDB0007400;HMDB0094030;HMDB0007056;HMDB0007294;HMDB0056384;HMDB0094618;HMDB0055964;HMDB0093562;HMDB0094542;HMDB0094437;HMDB0092933;HMDB0007348;HMDB0094007;HMDB0056296;HMDB0093541;HMDB0007109;HMDB0093631;HMDB0093886;HMDB0007672;HMDB0093864;HMDB0093073;HMDB0094369;HMDB0094401;HMDB0116379;HMDB0093595;HMDB0007536;HMDB0093710;HMDB0056131;HMDB0007740;HMDB0007430;HMDB0093941;HMDB0007186;HMDB0055987;HMDB0093933;HMDB0007566;HMDB0056241;HMDB0056053;HMDB0007766;HMDB0093681;HMDB0007483;HMDB0007524;HMDB0092975;HMDB0094097;HMDB0093293;HMDB0007765;HMDB0093034;HMDB0094195;HMDB0093264;HMDB0093787;HMDB0094114;HMDB0007036;HMDB0007236;HMDB0093204;HMDB0094095;HMDB0094171;HMDB0093010;HMDB0094598;HMDB0056073;HMDB0056326;HMDB0093567;HMDB0094069;HMDB0056368;HMDB0094109;HMDB0094023;HMDB0093163;HMDB0093300;HMDB0093479;HMDB0007496;HMDB0056140;HMDB0093457;HMDB0007692;HMDB0007785;HMDB0007051;HMDB0093673;HMDB0094143;HMDB0093778;HMDB0007475;HMDB0007160;HMDB0007567;HMDB0093324;HMDB0094631;HMDB0094548;HMDB0007404;HMDB0056192;HMDB0007075;HMDB0093481;HMDB0094358;HMDB0094075;HMDB0093147;HMDB0116409;HMDB0007374;HMDB0093808;HMDB0094236;HMDB0093225;HMDB0007372;HMDB0094191;HMDB0093329;HMDB0056251;HMDB0007493;HMDB0093813;HMDB0094068;HMDB0094156;HMDB0007676;HMDB0094238;HMDB0007750;HMDB0094016;HMDB0007605;HMDB0093528;HMDB0093665;HMDB0094585;HMDB0094560;HMDB0094534;HMDB0093752;HMDB0093367;HMDB0093564;HMDB0007594;HMDB0093008;HMDB0092937;HMDB0007468;HMDB0093157;HMDB0007555;HMDB0007657;HMDB0007757;HMDB0093376;HMDB0093170;HMDB0007511;HMDB0093009;HMDB0093066;HMDB0094108;HMDB0056339;HMDB0093682;HMDB0092946;HMDB0007205;HMDB0093709;HMDB0092998;HMDB0093343;HMDB0056203;HMDB0092972;HMDB0007842;HMDB0056266;HMDB0093603;HMDB0093260;HMDB0007716;HMDB0007449;HMDB0093237;HMDB0093086;HMDB0007674;HMDB0007298;HMDB0093294;HMDB0007808;HMDB0007441;HMDB0094298;HMDB0007176;HMDB0007054;HMDB0094263;HMDB0116394;HMDB0007216;HMDB0056106;HMDB0093804;HMDB0056114;HMDB0007088;HMDB0007018;HMDB0093106;HMDB0094478;HMDB0093676;HMDB0056054;HMDB0007395;HMDB0007107;HMDB0094164;HMDB0094246;HMDB0092989;HMDB0094582;HMDB0094316;HMDB0094314;HMDB0007568;HMDB0007335;HMDB0093205;HMDB0094060;HMDB0094477;HMDB0093655;HMDB0092903;HMDB0093671;HMDB0094382;HMDB0007301;HMDB0093547;HMDB0092924;HMDB0092923;HMDB0007773;HMDB0007448;HMDB0093769;HMDB0094615;HMDB0007342;HMDB0007427;HMDB0007817;HMDB0093091;HMDB0007451;HMDB0094090;HMDB0056281;HMDB0007164;HMDB0093022;HMDB0093776;HMDB0240593;HMDB0093097;HMDB0093341;HMDB0093896;HMDB0092953;HMDB0093550;HMDB0056341;HMDB0093968;HMDB0093445;HMDB0007398;HMDB0093919;HMDB0094266;HMDB0007094;HMDB0056371;HMDB0007710;HMDB0093122;HMDB0092999;HMDB0094239;HMDB0093055;HMDB0093291;HMDB0093680;HMDB0093090;HMDB0094363;HMDB0094169;HMDB0055979;HMDB0093904;HMDB0094123;HMDB0094428;HMDB0007768;HMDB0007600;HMDB0056356;HMDB0056259;HMDB0007632;HMDB0094347;HMDB0007012;HMDB0094161;HMDB0093997;HMDB0007211;HMDB0056333;HMDB0007713;HMDB0093478;HMDB0094208;HMDB0056286;HMDB0092973;HMDB0007334;HMDB0007572;HMDB0093387;HMDB0092912;HMDB0094067;HMDB0094616;HMDB0093719;HMDB0093693;HMDB0007790;HMDB0093983;HMDB0007775;HMDB0056294;HMDB0094605;HMDB0093883;HMDB0093107;HMDB0007543;HMDB0007573;HMDB0093794;HMDB0094076;HMDB0007043;HMDB0093464;HMDB0093598;HMDB0094210;HMDB0007698;HMDB0007503;HMDB0093613;HMDB0007844;HMDB0093851;HMDB0007393;HMDB0093435;HMDB0007115;HMDB0094399;HMDB0093068;HMDB0007083;HMDB0094442;HMDB0093797;HMDB0007669;HMDB0007167;HMDB0094179;HMDB0007801;HMDB0055997;HMDB0094495;HMDB0094186;HMDB0093243;HMDB0093885;HMDB0056033;HMDB0007177;HMDB0093040;HMDB0094200;HMDB0007239;HMDB0093525;HMDB0007748;HMDB0007630;HMDB0092964;HMDB0093004;HMDB0007764;HMDB0007170;HMDB0093135;HMDB0007068;HMDB0007206;HMDB0116378;HMDB0093327;HMDB0093275;HMDB0094206;HMDB0093727;HMDB0094119;HMDB0092904;HMDB0007749;HMDB0093166;HMDB0093703;HMDB0007645;HMDB0056320;HMDB0007410;HMDB0094215;HMDB0093273;HMDB0094203;HMDB0093503;HMDB0007253;HMDB0007549;HMDB0093495;HMDB0007735;HMDB0094028;HMDB0094185;HMDB0056209;HMDB0093994;HMDB0007093;HMDB0093103;HMDB0093647;HMDB0007144;HMDB0056218;HMDB0093150;HMDB0093659;HMDB0093383;HMDB0007604;HMDB0093081;HMDB0093109;HMDB0007784;HMDB0094277;HMDB0056024;HMDB0093660;HMDB0093581;HMDB0007796;HMDB0094241;HMDB0007428;HMDB0094333;HMDB0056227;HMDB0007822;HMDB0056179;HMDB0007580;HMDB0094425;HMDB0094229;HMDB0093826;HMDB0093657;HMDB0094168;HMDB0093241;HMDB0094463;HMDB0007721;HMDB0055955;HMDB0093785;HMDB0094626;HMDB0093429;HMDB0093835;HMDB0007369;HMDB0093350;HMDB0056077;HMDB0094211;HMDB0056064;HMDB0007442;HMDB0056100;HMDB0093612;HMDB0007392;HMDB0094223;HMDB0094439;HMDB0056274;HMDB0056021;HMDB0093920;HMDB0093816;HMDB0093413;HMDB0093216;HMDB0094063;HMDB0094120;HMDB0056012;HMDB0094020;HMDB0007737;HMDB0093026;HMDB0007318;HMDB0007343;HMDB0093874;HMDB0093868;HMDB0093592;HMDB0093131;HMDB0056006;HMDB0094505;HMDB0093108;HMDB0093597;HMDB0093902;HMDB0094121;HMDB0093520;HMDB0056134;HMDB0007135;HMDB0094293;HMDB0092995;HMDB0007329;HMDB0056075;HMDB0093779;HMDB0093827;HMDB0056312;HMDB0094460;HMDB0094260;HMDB0093146;HMDB0092945;HMDB0116396;HMDB0007379;HMDB0094128;HMDB0056175;HMDB0007832;HMDB0055989;HMDB0093438;HMDB0056107;HMDB0056061;HMDB0007570;HMDB0094176;HMDB0093132;HMDB0116443;HMDB0093762;HMDB0094055;HMDB0007616;HMDB0116442;HMDB0093311;HMDB0094221;HMDB0093286;HMDB0093800;HMDB0007090;HMDB0094419;HMDB0056207;HMDB0007251;HMDB0056043;HMDB0056234;HMDB0094486;HMDB0093924;HMDB0093958;HMDB0056252;HMDB0056169;HMDB0093843;HMDB0093075;HMDB0092977;HMDB0093373;HMDB0056095;HMDB0007840;HMDB0094493;HMDB0094010;HMDB0007703;HMDB0093749;HMDB0007531;HMDB0094319;HMDB0093910;HMDB0007412;HMDB0056080;HMDB0094553;HMDB0007694;HMDB0007829;HMDB0116383;HMDB0056242;HMDB0093664;HMDB0093666;HMDB0007456;HMDB0093796;HMDB0007180;HMDB0007234;HMDB0094066;HMDB0093866;HMDB0056097;HMDB0093876;HMDB0007195;HMDB0093452;HMDB0093137;HMDB0007561;HMDB0007173;HMDB0116421;HMDB0056072;HMDB0094150;HMDB0056385;HMDB0007463;HMDB0056328;HMDB0093501;HMDB0093121;HMDB0094583;HMDB0094253;HMDB0093890;HMDB0093552;HMDB0007649;HMDB0094244;HMDB0093283;HMDB0007063;HMDB0056302;HMDB0093624;HMDB0007025;HMDB0056348;HMDB0093704;HMDB0094612;HMDB0093648;HMDB0093384;HMDB0094380;HMDB0007794;HMDB0007691;HMDB0094282;HMDB0116441;HMDB0116410;HMDB0093518;HMDB0007010;HMDB0007149;HMDB0093500;HMDB0093392;HMDB0093767;HMDB0093220;HMDB0007613;HMDB0094597;HMDB0093192;HMDB0094167;HMDB0007478;HMDB0056196;HMDB0094482;HMDB0007821;HMDB0007188;HMDB0092994;HMDB0093482;HMDB0094498;HMDB0093074;HMDB0093721;HMDB0093231;HMDB0007514;HMDB0094149;HMDB0007101;HMDB0093257;HMDB0007405;HMDB0007557;HMDB0056069;HMDB0093695;HMDB0093773;HMDB0007732;HMDB0094107;HMDB0094387;HMDB0094197;HMDB0056008;HMDB0007044;HMDB0007499;HMDB0007307;HMDB0094044;HMDB0093480;HMDB0007263;HMDB0007159;HMDB0093774;HMDB0094502;HMDB0007080;HMDB0093379;HMDB0093490;HMDB0093701;HMDB0007350,"Lipids and lipid-like molecules",Glycerolipids,Diradylglycerols,51621-26-2;29541-66-0;127809-08-9;257891-89-7;91125-76-7;502-52-3,351.056451108,0.97145,2M-H,C6H8O6,0,90.3,metab_9036,neg_692,neg,12410,4395,23130,3937,4042,8223,56210,3618,34050,36490,12970,37250,,,,
"LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0)",-,0.0379,0.1131,1.1696,1.1424,1.6653,0.7358,yes,up,-,-,-,-,-,-,-,HMDB0011518,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,502.292003276,6.59835,"M+H, M+Na, M+H-H2O",C25H44NO7P,0,62.8,metab_598,pos_156,pos,23470000,15450000,20990000,17970000,19970000,20960000,4650000,17600000,8179000,14970000,21040000,4897000,,,,
"Guanidoacetic acid",ëÒ»ùÒÒËá,0.04284,0.122,1.1693,1.1552,0.3195,-1.6461,yes,down,C00581,-,-,map01100;map00330;map00260,"Metabolic pathways;Arginine and proline metabolism;Glycine, serine and threonine metabolism",Metabolism;Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism;Amino acid metabolism",PW_C000083;HMDB0000128,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",352-97-6,233.102511167,3.71506666667,"M+FA-H, 2M-H",C3H7N3O2,0,30.8,metab_7239,neg_181,neg,226400,284100,583700,92650,352600,374900,704100,227800,1643000,1048000,570800,1798000,,,,
"(Z)-5-[(2R,3S,4S)-4-Hydroxy-2-[(E)-3-hydroxyoct-1-enyl]oxan-3-yl]pent-3-enoic acid","£¨Z£© -5-[£¨2R£¬3S£¬4S£©-4-ôÇ»ù-2-[£¨E£©-3-ôÇ»ùÐÁ-1-Ï©»ù]Ñõ´ú-3-»ù]Îì-3-Ï©Ëá",0.03728,0.1154,1.169,1.1655,0.3146,-1.6684,yes,down,-,-,-,-,-,-,-,HMDB0244345,"Organic acids and derivatives","Hydroxy acids and derivatives","Medium-chain hydroxy acids and derivatives",-,371.207029906,6.23595,M+FA-H,C18H30O5,0,55.1,metab_7211,neg_1785,neg,54740,109200,127400,10950,261700,250000,374000,107000,297600,369400,584900,855500,,,,
Terpestacin,ÌØÅåË¹ËþÐÁ,0.04657,0.1287,1.1681,1.1992,1.5649,0.6461,yes,up,-,-,-,-,-,-,-,-,-,-,-,-,385.272990377,6.54216666667,M+H-H2O,C25H38O4,54.2,0,metab_3676,pos_4658,pos,1780000,1509000,1569000,1757000,1918000,1736000,490900,1668000,877500,1269000,1798000,458900,,,,
"Shikimic Acid",Ã§²ÝËá,0.05908,0.1468,1.1589,1.0866,0.0706,-3.8242,no,down,C00493,-,-,map01100;map00400;map01230;map01240,"Metabolic pathways;Phenylalanine, tyrosine and tryptophan biosynthesis;Biosynthesis of amino acids;Biosynthesis of cofactors",Metabolism;Metabolism;Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism;Global and overview maps;Global and overview maps",HMDB0003070;MJDBOTE0000801,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",138-59-0,155.034001481,1.93113333333,"M-H2O-H, M-H",C7H10O5,56.3,0,metab_7052,neg_164,neg,34670,17720,37480,3049,14850,47850,254300,777500,232500,90990,31790,817200,,,,
Capsidiol,½·¶þ´¼,0.05632,0.1458,1.1587,1.0656,0.343,-1.5437,no,down,C09627,-,-,-,-,-,-,HMDB0002352;LMPR0103250002,"Lipids and lipid-like molecules","Prenol lipids",Sesquiterpenoids,37208-05-2,536.370193293,7.38658333333,2M+ACN+Na,C15H24O2,0,85.6,metab_2197,pos_3120,pos,123400,15120,142100,14870,29780,12490,50310,201300,151100,345600,138000,98470,,,,
"9,10-Dihydroxystearic acid","9,10-¶þôÇ»ùÓ²Ö¬Ëá",0.04089,0.1199,1.1543,1.0901,1.3143,0.3943,yes,up,C19622,-,-,-,-,-,-,HMDB0303981;LMFA02000142;HMDB0302281,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",120-87-6,297.2431071,6.67931666667,M-H2O-H,C18H36O4,0,50.5,metab_9032,neg_1676,neg,1162000,850900,894000,1119000,949900,969900,464200,860800,802400,949600,913600,533500,,,,
Suprofen,ÊæÂå·Ò,0.06108,0.1538,1.1524,1.1198,0.1068,-3.227,no,down,C07320,-,-,-,-,-,-,HMDB0015008;PW_C009324,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",40828-46-4,261.057506486,0.75105,M+H,C14H12O3S,0,41.8,metab_466,pos_1431,pos,74200,79.08,90.56,75.56,77.54,25300,80470,35860,408000,172000,202100,36270,,,,
"4alpha-hydroxymethyl,4beta,14alpha-dimethyl-9beta,19-cyclo-5alpha-ergost-24(241)-en-3beta-ol",4alpha-ôÇ¼×»ù£¬4beta£¬14alpha-¶þ¼×»ù-9beta£¬19-»·-5alpha-ergost-24£¨241£©-en-3beta-ol,0.03449,0.1103,1.1521,1.1036,1.3893,0.4744,yes,up,-,-,-,-,-,-,-,HMDB0304199,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Cycloartanols and derivatives",-,501.394742401,6.85273333333,M+FA-H,C31H52O2,0,78.2,metab_6986,neg_1579,neg,440400,311900,285700,402100,278000,303500,164100,307500,209000,284200,310800,179300,,,,
Medrysone,¼×ôÇËÉ,0.04382,0.1235,1.1509,1.1175,0.6547,-0.6111,yes,down,C14643,-,-,-,-,-,-,HMDB0014398;MJDBOTE0000317,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Pregnane steroids",2668-66-8,343.227381093,6.37583333333,M-H,C22H32O3,0,37,metab_7169,neg_1746,neg,397500,471900,309800,450200,328900,477100,528400,407000,497200,717700,612800,956900,,,,
D-Gulose,"D -¹ÅÂåÌÇ",0.05721,0.1473,1.1501,1.1415,0.6055,-0.7238,no,down,C06465,Carbohydrates,Monosaccharides,-,-,-,-,HMDB0250761,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",4205-23-6,225.034192765,0.665266666667,M+2Na-H,C6H12O6,0,34.8,metab_6336,pos_1358,pos,227300,191300,203200,177100,220800,197600,499100,241100,375000,402900,125700,366700,,,,
O-methoxycatechol-O-sulphate,"O -¼×Ñõ»ù¶ù²è·Ó- O -ÁòËáõ¥",0.03546,0.1121,1.1465,1.2083,0.3395,-1.5585,yes,down,-,-,-,-,-,-,-,HMDB0060013,"Organic acids and derivatives","Organic sulfuric acids and derivatives",Arylsulfates,-,249.00707085,0.714166666667,M+FA-H,C7H8O5S,0,44.2,metab_7763,neg_2296,neg,63270,36580,243100,15350,14400,60800,264800,104100,361900,266200,65600,214100,,,,
Ser-Tyr,-,0.04097,0.1199,1.1461,1.1101,0.6644,-0.5899,yes,down,-,-,-,-,-,-,-,HMDB0029051;HMDB0258243,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",21435-27-8,249.087614493,4.70681666667,M-H2O-H,C12H16N2O5,0,46.5,metab_7436,neg_1990,neg,65310,91170,75950,50270,83530,90200,128500,77750,170600,125100,85410,99940,,,,
Acetyl-DL-Leucine,"ÒÒõ£- Dl -ÁÁ°±Ëá",0.04287,0.122,1.145,1.1005,0.6834,-0.5492,yes,down,C02710,-,-,-,-,-,-,HMDB0011756,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1188-21-2,172.097013848,5.05406666667,M-H,C8H15NO3,72.6,0,metab_8891,neg_872,neg,138600,171800,168600,123500,172800,194700,285800,123800,267000,279900,282300,180600,,,,
"5-(4-Carboxybutylperoxy)pentanoic acid",5-£¨4-ôÈ»ù¶¡»ù¹ýÑõ»ù£©ÎìËá,0.05742,0.1476,1.1435,1.0786,0.1555,-2.685,no,down,-,-,-,-,-,-,-,HMDB0260291,"Organic acids and derivatives","Carboxylic acids and derivatives","Dicarboxylic acids and derivatives",-,257.099025807,3.08025,M+Na,C10H18O6,0,32,metab_4951,pos_5865,pos,21260,1003,148300,958.8,4236,21210,127700,20480,449200,230100,50960,388000,,,,
"Sorbic Acid",É½ÀæËá,0.06342,0.1521,1.1429,1.0795,0.106,-3.2379,no,down,-,-,-,-,-,-,-,HMDB0029581;LMFA01030100;HMDB0256823;MJDBOTE0000472,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",110-44-1,111.044076439,1.93113333333,M-H,C6H8O2,44.7,0,metab_7598,neg_2136,neg,4602,3128,6054,1320,3373,8552,28920,99100,27100,10290,6093,83520,,,,
N-Methyl-L-Proline,"N -¼×»ù- L -¸¬°±Ëá",0.03937,0.1161,1.1396,1.0842,0.7581,-0.3995,yes,down,C22223,-,-,-,-,-,-,HMDB0094696,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",475-11-6,147.112606843,0.586233333333,M+NH4,C6H11NO2,44.4,0,metab_5800,pos_6662,pos,451400,528400,357100,454800,419100,429900,795700,463800,587400,500100,497600,638200,,,,
"(3-Aminopropyl)(n-butyl)phosphinic acid",£¨3-°±±û»ù£©£¨Õý¶¡»ù£©ì¢Ëá,0.04812,0.1314,1.1394,1.1635,1.0529,0.0744,yes,up,-,-,-,-,-,-,-,HMDB0249860,"Organophosphorus compounds","Not Available","Not Available",-,202.09663122,3.22081666667,M+Na,C7H18NO2P,0,40.3,metab_783,pos_1729,pos,1692000,1638000,1694000,1736000,1702000,1812000,1746000,1601000,1570000,1542000,1631000,1665000,,,,
"3-Hydroxynona-4,7-dienoylcarnitine","3 -ôÇ»ùÈÉ- 4£¬7 -¶þÏ©õ£»ùÈâ¼î",0.04418,0.1248,1.138,1.0757,0.5283,-0.9206,yes,down,-,-,-,-,-,-,-,HMDB0241769,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,346.22168019,5.07961666667,M+CH3OH+H,C16H27NO5,0,31.2,metab_4750,pos_5677,pos,90020,100700,194500,57280,120300,130800,212200,121900,308800,135400,182500,351800,,,,
"N-Acetyl-L-Glutamic Acid","N -ÒÒõ£- L -¹È°±Ëá",0.06636,0.155,1.1378,1.0637,0.1647,-2.6021,no,down,C00624,-,-,map01100;map01210;map00220;map01230,"Metabolic pathways;2-Oxocarboxylic acid metabolism;Arginine biosynthesis;Biosynthesis of amino acids",Metabolism;Metabolism;Metabolism;Metabolism,"Global and overview maps;Global and overview maps;Amino acid metabolism;Global and overview maps",HMDB0001138;MJDBOTE0000638,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1188-37-0,188.055649065,0.815583333333,M-H,C7H11NO5,69.5,0,metab_8646,neg_649,neg,25690,50980,44210,31810,22690,26620,481500,48560,97370,165700,65950,367200,,,,
"Senkyunolide N",-,0.02845,0.1001,1.1353,1.1543,0.9201,-0.1201,yes,down,-,-,-,-,-,-,-,HMDB0302272,"Organoheterocyclic compounds",Isobenzofurans,"Not Available",-,207.102031476,6.16128333333,M-H2O-H,C12H18O4,0,44.1,metab_9022,neg_991,neg,52950,54210,54630,48440,57060,50370,54220,57750,60350,53240,59270,60410,,,,
"5-Hydroxypentanoic acid",5-ôÇÎìËá,0.0398,0.1186,1.134,1.083,1.2061,0.2703,yes,up,C02804,-,-,-,-,-,-,HMDB0061927,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",13392-69-3,117.054637437,3.53163333333,M-H,C5H10O3,0,33.7,metab_8780,neg_771,neg,2706000,2481000,2278000,2782000,2229000,2446000,1549000,2649000,2201000,1904000,2106000,1965000,,,,
"11-Dehydro-2,3-dinor-txb2","11-ÍÑÇâ-2,3-¶þ´¼-TXB2",0.06243,0.1513,1.127,1.0419,3.5122,1.8124,no,up,-,-,-,-,-,-,-,HMDB0244346;LMFA03030013,"Organic acids and derivatives","Hydroxy acids and derivatives","Medium-chain hydroxy acids and derivatives",-,321.167882488,6.3311,M-H2O-H,C18H28O6,0,55.9,metab_6399,neg_1046,neg,27420,43280,38700,5971,102900,91580,4318,4104,6912,20370,33880,18610,,,,
"LysoPC(20:2(11Z,14Z)/0:0)",-,0.07088,0.1698,1.1268,1.0522,0.575,-0.7984,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010392,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,548.370169144,7.13953333333,M+H,C28H54NO7P,0,77.7,metab_3025,pos_3988,pos,1802000,804300,1863000,1183000,800700,1090000,1454000,2492000,2015000,3925000,2024000,1204000,,,,
"3,4-Dimethyl-5-pentyl-2-furanpropanoic acid","3£¬4 -¶þ¼×»ù- 5 -Îì»ù- 2 -ß»à«±ûËá",0.04395,0.1236,1.1262,1.1096,0.4159,-1.2657,yes,down,-,-,-,-,-,-,-,HMDB0112083,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",116627-39-5,283.154761284,6.118,M+FA-H,C14H22O3,0,42.9,metab_7278,neg_1845,neg,39850,46370,67650,8037,95500,88210,94100,76750,142000,88710,154800,274700,,,,
Doqualast,-,0.06019,0.148,1.1254,1.2441,34.2582,5.0984,no,up,-,-,-,-,-,-,-,HMDB0251585,"Organoheterocyclic compounds",Pyridopyrimidines,"Not Available",-,275.022849509,4.02818333333,M+Cl,C13H8N2O3,0,51.6,metab_7472,neg_2021,neg,49380,12510,142100,30440,5914,143400,738.8,677.9,767.8,768.2,697,7551,,,,
"Tulathromycin A",ÍÁÀ­Ã¹ËØA,0.04686,0.1274,1.1249,1.249,0.8266,-0.2747,yes,down,C21788,-,-,-,-,-,-,HMDB0259324,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",217500-96-4,850.561080419,7.49183333333,"M+Na-2H, M+FA-H",C41H79N3O12,0,75.3,metab_8287,neg_311,neg,44310000,36160000,28400000,48410000,38260000,37220000,49510000,47760000,46800000,38510000,54350000,44670000,,,,
"Alpha-Aminobutyric acid",-,0.05062,0.1364,1.1248,1.3504,1.2897,0.367,no,up,C02356,-,-,map01100;map00270,"Metabolic pathways;Cysteine and methionine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0245013;HMDB0000650;HMDB0000452,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1492-24-6;2623-91-8,86.0604374229,0.917966666667,M+H-H2O,C4H9NO2,0,48.1,metab_6335,pos_1522,pos,540500,455900,686400,402400,441700,630200,415500,382400,467600,409100,374100,399700,,,,
"PC(18:2(9Z,12Z)/14:0)",-,0.05562,0.1446,1.1237,1.0539,0.1245,-3.0058,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004178;LMGP01011616;HMDB0008130,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,730.536989317,6.25598333333,M+H,C40H76NO8P,0,43.7,metab_4032,pos_4996,pos,174200,172400,330200,204400,945400,312100,1916000,3255000,4344000,252200,613300,6803000,,,,
"8(R)-Hydroperoxylinoleic acid",8£¨R£©-Çâ¹ýÑõÑÇÓÍËá,0.05457,0.1405,1.1233,1.0528,0.639,-0.6461,no,down,C14831,-,-,map00591,"Linoleic acid metabolism",Metabolism,"Lipid metabolism",HMDB0004706,"Lipids and lipid-like molecules","Fatty Acyls","Lineolic acids and derivatives",143343-95-7,311.222450751,6.2438,M-H,C18H32O4,0,49.9,metab_7208,neg_1782,neg,81780,67900,86370,72750,63620,108000,82030,145100,154100,97230,83630,189700,,,,
Aspartame,Ìì¶¬Ìð¾«,0.05965,0.1474,1.122,1.0607,1.8899,0.9183,no,up,C11045,-,-,map04742,"Taste transduction","Organismal Systems","Sensory system",HMDB0001894;MJDBOTE0001640,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",22839-47-0,293.114123761,4.13028333333,M-H,C14H18N2O5,0,43.9,metab_7465,neg_2015,neg,269000,466300,100400,335300,244300,181500,116500,145300,147500,97080,198600,140000,,,,
"Formiminoglutamic acid",ÑÇ°·¼×»ù¹È°±Ëá,0.04104,0.1199,1.1215,1.1578,0.5722,-0.8054,yes,down,C00439,-,-,map01100;map00340,"Metabolic pathways;Histidine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0255140;HMDB0000854;PW_C000680,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",816-90-0,173.055894223,0.714166666667,M-H,C6H10N2O4,0,31.4,metab_7774,neg_2306,neg,144800,128500,183100,23660,106000,125200,304400,144400,247600,204000,101200,241200,,,,
"Cucurbic acid",Î÷ºùÂ«Ëá,0.04999,0.1351,1.12,1.068,1.2825,0.359,yes,up,C08482,-,-,-,-,-,-,HMDB0029388,"Lipids and lipid-like molecules","Fatty Acyls","Lineolic acids and derivatives",58240-50-9,245.174318005,6.17711666667,M+CH3OH+H,C12H20O3,0,51.9,metab_4155,pos_5121,pos,83620,89510,73330,90160,72050,77560,72110,76190,59820,55870,80280,34890,,,,
Asparaginyl-Proline,ÃÅ¶¬õ£°·-¸¬°±Ëá,0.06347,0.1577,1.115,0.9577,0.619,-0.692,no,down,-,-,-,-,-,-,-,HMDB0028739,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,212.102725878,0.71195,M+H-H2O,C9H15N3O4,0,46.9,metab_431,pos_1399,pos,250500,215300,351400,104600,134400,188700,317400,291300,413000,534300,222400,232900,,,,
"N-(2-Hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl)acetamide","N-£¨2-ôÇ»ù-3,3,3-Èý·ú±û»ù£©-2-£¨2-Ïõ»ù-1-ßäßò»ù£©ÒÒõ£°·",0.07298,0.1734,1.1063,1.064,0.1404,-2.8324,no,down,-,-,-,-,-,-,-,HMDB0258458,"Organic 1,3-dipolar compounds","Allyl-type 1,3-dipolar organic compounds","Organic nitro compounds",-,247.041963876,0.71195,M+H-2H2O,C8H9F3N4O4,0,39.4,metab_434,pos_1400,pos,238200,22260,4077,3402,3491,81740,220300,104200,1122000,487200,498300,82850,,,,
"Camphorsulfonic Acid",ÕÁ»ÇËá,0.06276,0.1565,1.1053,0.9876,0.5203,-0.9426,no,down,-,-,-,-,-,-,-,HMDB0243496,"Lipids and lipid-like molecules","Prenol lipids",Monoterpenoids,-,250.110182033,3.13533333333,M+NH4,C10H16O4S,63.2,0,metab_772,pos_1718,pos,206300,101800,280700,19640,39900,119200,224500,125900,353200,366100,183900,221000,,,,
Sphinganine,¶þÇâ(Éñ¾­)ÇÊ°±´¼,0.06155,0.1545,1.1042,1.1185,1.6038,0.6815,no,up,C00836,-,-,map00600;map01100;map04071,"Sphingolipid metabolism;Metabolic pathways;Sphingolipid signaling pathway","Metabolism;Metabolism;Environmental Information Processing","Lipid metabolism;Global and overview maps;Signal transduction",LMSP01020001;PW_C000184;HMDB0242634;HMDB0000269,"Organic nitrogen compounds","Organonitrogen compounds",Amines,764-22-7,302.3047736,6.3033,M+H,C18H39NO2,80.1,0,metab_1431,pos_2347,pos,662500,625100,451100,370200,713600,710800,717600,199200,129300,446100,402000,308900,,,,
16-a-Hydroxypregnenolone,"16 - ¦Á -ôÇ»ùÔÐÏ©´¼Íª",0.06352,0.1521,1.1034,1.0321,0.4501,-1.1517,no,down,C06390,-,-,-,-,-,-,HMDB0000315,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Pregnane steroids",520-88-7,377.23292788,6.20693333333,M+FA-H,C21H32O3,0,75,metab_6357,neg_1008,neg,32410,25860,47870,48840,17260,32950,22740,108400,136300,44040,53740,90800,,,,
"PC(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))",-,0.04809,0.1314,1.1029,1.3456,0.6991,-0.5164,yes,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008024;LMGP01012141;PW_C004073,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,806.567307743,7.71138333333,M+H,C46H80NO8P,0,90.4,metab_2674,pos_3619,pos,87670000,121700000,94540000,153600000,111200000,113100000,180300000,177800000,179000000,79280000,209800000,148900000,,,,
1-Methyladenosine,1-¼×»ùÏÙÜÕ,0.06288,0.1565,1.1026,1.1578,0.7669,-0.3829,no,down,C02494,-,-,-,-,-,-,HMDB0003331;HMDB0243935,"Nucleosides, nucleotides, and analogues","Purine nucleosides","Not Available",15763-06-1,282.118964037,1.36788333333,M+H,C11H15N5O4,49.4,0,metab_592,pos_1554,pos,82830,70350,95980,92660,71410,87400,132300,71530,116300,111800,85000,136100,,,,
"Phthalic anhydride",ÁÚ±½¶þ¼×Ëáôû,0.06162,0.1546,1.1024,1.136,0.5382,-0.8938,no,down,-,-,-,-,-,-,-,HMDB0256501,"Organoheterocyclic compounds",Benzofurans,Benzofuranones,-,190.049569296,3.47673333333,"M+Na, M+ACN+H",C8H4O3,0,42.8,metab_2686,pos_363,pos,134400,86570,130300,64230,74670,110000,231200,79670,276200,161700,93830,272000,,,,
L-Proline,L-¸¬°±Ëá,0.05264,0.1402,1.1018,1.0077,0.8599,-0.2178,no,down,C00148,Peptides,"Amino acids",map01100;map04978;map02010;map00330;map01230;map04974;map00970;map05230,"Metabolic pathways;Mineral absorption;ABC transporters;Arginine and proline metabolism;Biosynthesis of amino acids;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;Central carbon metabolism in cancer","Metabolism;Organismal Systems;Environmental Information Processing;Metabolism;Metabolism;Organismal Systems;Genetic Information Processing;Human Diseases","Global and overview maps;Digestive system;Membrane transport;Amino acid metabolism;Global and overview maps;Digestive system;Translation;Cancer: overview",PW_C000106;HMDB0000162;HMDB0251528;MJDBOTE0000527,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",147-85-3,116.070698189,0.704516666667,"M+H, M+2Na-H",C5H9NO2,79,0,metab_132,pos_1117,pos,1997000,2149000,1783000,2202000,1881000,2099000,2552000,1891000,2813000,2311000,2241000,2281000,,,,
"Dodecanedioic Acid",Ê®¶þÌ¼¶þÔªËá,0.05017,0.133,1.0994,1.0114,0.7254,-0.4632,no,down,C16308,-,-,map00592,"alpha-Linolenic acid metabolism",Metabolism,"Lipid metabolism",LMFA01170009;HMDB0000623;HMDB0000933;MJDBOTE0000650,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",693-23-2;6402-36-4,229.143954564,6.16128333333,M-H,C12H22O4,84.9,0,metab_9037,neg_992,neg,50160,57160,52990,43400,42900,86000,75900,95540,92720,59690,54810,79820,,,,
N-Choloylglycine,"N -µ¨õ£¸Ê°±Ëá",0.06538,0.1546,1.095,1.0207,1.4394,0.5255,no,up,C01921,Steroids,"24-Carbon atoms",map01100;map04979;map04976;map00120,"Metabolic pathways;Cholesterol metabolism;Bile secretion;Primary bile acid biosynthesis","Metabolism;Organismal Systems;Organismal Systems;Metabolism","Global and overview maps;Digestive system;Digestive system;Lipid metabolism",HMDB0255104;HMDB0000148;HMDB0000138,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",475-31-0;56-86-0,500.277931028,6.4464,M+Cl,C26H43NO6,0,63.8,metab_9043,neg_1071,neg,27380000,19700000,29630000,23950000,24830000,25450000,7964000,23070000,15320000,23380000,26200000,8946000,,,,
Forodesine,"7-[(2S,3S,4R,5R)-3,4-¶þôÇ»ù-5-(ôÇ¼×»ù)-2-ßÁ¿©Íé»ù]-3,5-¶þÇâ-4H-ßÁ¿©²¢[3,2-D]à×à¤-4-Íª",0.06137,0.1543,1.0948,1.1038,0.4777,-1.0658,no,down,-,-,-,-,-,-,-,HMDB0252454,"Organoheterocyclic compounds",Pyrrolopyrimidines,"Not Available",-,308.13460882,2.76135,M+ACN+H,C11H14N4O4,0,41.1,metab_723,pos_1673,pos,90510,55420,136300,44360,47730,100200,208200,59550,267800,115400,94380,248200,,,,
Chymostatin,-,0.03688,0.111,1.0912,1.3207,1.4604,0.5464,yes,up,C11308,-,-,-,-,-,-,HMDB0242696,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Vitamin D and derivatives",9076-44-2,608.322259314,7.75825,"M+H, M+Na",C31H41N7O6,0,33.6,metab_6173,pos_855,pos,1622000,1284000,1932000,1050000,1434000,1401000,939000,818200,966200,1698000,748100,804000,,,,
"Methylisocitric acid",¼×»ùÒìÄûÃÊËá,0.05652,0.1425,1.0912,1.0543,0.2012,-2.3133,no,down,C04593,-,-,map01100;map00640,"Metabolic pathways;Propanoate metabolism",Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism",HMDB0006471,"Organic acids and derivatives","Carboxylic acids and derivatives","Tricarboxylic acids and derivatives",-,241.011642732,0.792283333333,M+Cl,C7H10O7,0,41.5,metab_7694,neg_2228,neg,158000,32080,1825,1785,15880,83430,149000,73510,577900,296400,289900,70360,,,,
Cinobufagin,»ªó¸ËÖ¶¾»ù,0.07429,0.1755,1.0907,0.9834,1.7213,0.7835,no,up,C16931,Steroids,"24-Carbon atoms",-,-,-,-,LMST01130032;HMDB0250266,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroid lactones",470-37-1,460.268501306,6.28761666667,M+NH4,C26H34O6,0,56.5,metab_1415,pos_2329,pos,24450000,31910000,24150000,26060000,64330000,40280000,19510000,26350000,21470000,15810000,30850000,8702000,,,,
"Imidazolone A",ßäßòßøÍªA,0.05174,0.1385,1.0895,0.9906,0.9083,-0.1388,no,down,-,-,-,-,-,-,-,HMDB0253421,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,360.18950794,2.78535,M+ACN+H,C12H22N4O6,0,34.2,metab_726,pos_1676,pos,171000,179400,197500,175000,180700,213800,211000,188600,226300,205300,197500,201600,,,,
"S-Phenylmercapturic acid",±½ÛÏ»ùÄòËá,0.07459,0.1756,1.0893,1.4855,0.2573,-1.9585,no,down,-,-,-,-,-,-,-,HMDB0042011,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",4775-80-8,222.05806155,5.8113,M+H-H2O,C11H13NO3S,0,65.7,metab_1012,pos_1935,pos,45060,16580,21520,69150,17620,42040,56720,350700,143100,75470,137300,60680,,,,
Aspartyl-L-proline,"ÌìÃÅ¶¬°±Ëá- L -¸¬°±Ëá",0.06874,0.1663,1.0871,1.0393,0.3989,-1.3259,no,down,-,-,-,-,-,-,-,HMDB0002335,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",42155-95-3,195.076256578,3.8595,M+H-2H2O,C9H14N2O5,0,63.9,metab_845,pos_1785,pos,9123,6559,41490,3660,3071,8998,49780,11390,36540,47200,15440,22390,,,,
"SM(d16:2(4E,8Z)/6 keto-PGF1alpha)",-,0.05345,0.1414,1.0835,1.0476,0.4317,-1.2119,no,down,-,-,-,-,-,-,-,HMDB0290310,"Not Available","Not Available","Not Available",-,831.482783482,6.84573333333,M+2Na-H,C41H75N2O10P,0,51,metab_3309,pos_4290,pos,18790,21820,71020,29810,18330,95460,114000,30480,157800,64770,70480,153700,,,,
"PC(16:0/18:3(9Z,12Z,15Z))",-,0.06879,0.1664,1.0795,0.9523,1.7118,0.7755,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004024;LMGP01010601;HMDB0007975,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,778.534638757,6.89368333333,M+Na,C42H78NO8P,0,89.1,metab_1887,pos_2798,pos,217100,1294000,983000,796300,965300,1209000,505900,521300,371700,374000,950600,468400,,,,
"3-(naphthalen-1-ylmethyl)-1h-pyrazolo[3,4-d]pyrimidin-4-Amine","3-£¨ÝÁ-1-»ù¼×»ù£©-1h-ßÁßò²¢[3,4-d]à×à¤-4-°·",0.07203,0.172,1.0741,0.9872,0.5863,-0.7703,no,down,-,-,-,-,-,-,-,-,-,-,-,-,276.125874614,4.143,M+H,C16H13N5,34.9,0,metab_4815,pos_5736,pos,485100,301700,579700,121400,181000,313200,540900,312600,801300,849700,362700,513500,,,,
Lauroylcarnitine,ÔÂ¹ðõ£Èâ¼î,0.04461,0.1257,1.0738,1.0076,1.6012,0.6792,yes,up,-,-,-,-,-,-,-,LMFA07070090;HMDB0002250,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",25518-54-1,344.278768388,6.24016666667,M+H,C19H37NO4,84.1,0,metab_4064,pos_5028,pos,1515000,1786000,3112000,3130000,2284000,2604000,960800,1604000,2272000,858400,2376000,938100,,,,
"Traumatic Acid",ÓúÉËËá,0.06263,0.1513,1.0701,1.0457,0.5564,-0.8458,no,down,C16308,-,-,map00592,"alpha-Linolenic acid metabolism",Metabolism,"Lipid metabolism",HMDB0000933;LMFA01170002,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",6402-36-4,227.128304307,6.11016666667,"M-H, M+Na-2H",C12H20O4,67.1,0,metab_7778,neg_231,neg,107300,98690,146300,51620,138400,108500,158200,143500,267100,113300,148900,339200,,,,
Allylisopropylacetamide,Ï©±û»ùÒì±ûÒÒõ£°·,0.05187,0.1359,1.0691,1.0133,1.3248,0.4058,no,up,-,-,-,-,-,-,-,HMDB0248168,"Lipids and lipid-like molecules","Fatty Acyls","Fatty amides",-,186.112753375,5.96115,M+FA-H,C8H15NO,0,35.7,metab_8948,neg_923,neg,71690,46610,61370,80140,65480,65010,42280,30930,48370,43080,67070,62880,,,,
N-Dodecylsarcosinate,"N -Ê®¶þÍé»ù¼¡°±Ëáõ¥",0.07807,0.1805,1.068,0.9125,1.4175,0.5033,no,up,-,-,-,-,-,-,-,HMDB0255129,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,290.268294594,6.23228333333,M+CH3OH+H,C15H31NO2,0,57.5,metab_4074,pos_5039,pos,216700,299200,266600,272100,480800,344800,294700,232100,155900,143100,299800,200700,,,,
"20-Hydroxyeicosatetraenoic acid",20-ôÇ¶þÊ®ÍéËÄÏ©Ëá,0.07401,0.175,1.0636,0.9546,0.7576,-0.4005,no,down,C14748,-,-,map00590;map01100;map04270,"Arachidonic acid metabolism;Metabolic pathways;Vascular smooth muscle contraction","Metabolism;Metabolism;Organismal Systems","Lipid metabolism;Global and overview maps;Circulatory system",PW_C002614;HMDB0005998,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",79551-86-3,303.231307299,6.54216666667,M+H-H2O,C20H32O3,0,66,metab_1596,pos_2499,pos,37830,60600,53310,63400,44450,48910,61800,62040,46900,98220,66420,71860,,,,
"N-Stearoyl Isoleucine",-,0.06259,0.1513,1.0634,1.0884,0.5425,-0.8823,no,down,-,-,-,-,-,-,-,HMDB0241944,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,396.34783097,6.92216666667,M-H,C24H47NO3,0,52.3,metab_6570,neg_1202,neg,63180,26120,93980,87300,58520,51430,54250,159300,141100,172100,128600,46160,,,,
N-Acetyl-L-Alanine,"N -ÒÒõ£- L -±û°±Ëá",0.05563,0.1415,1.061,1.1008,0.7979,-0.3257,no,down,-,-,-,-,-,-,-,HMDB0000766;HMDB0255053,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",97-69-8,130.049933832,0.8234,M-H,C5H9NO3,63.7,0,metab_8649,neg_651,neg,163600,163300,217000,130800,161800,207900,268500,164800,234500,229400,182700,229200,,,,
"2-Hydroxystearic acid",2-ôÇ»ùÓ²Ö¬Ëá,0.06471,0.1535,1.0554,0.993,1.2636,0.3375,no,up,C03045,-,-,-,-,-,-,HMDB0062549;HMDB0242145,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",26531-80-6,299.258781917,6.81288333333,M-H,C18H36O3,0,58.6,metab_7029,neg_1618,neg,728300,446900,657800,608800,577600,590400,330500,484700,484800,652600,527000,376800,,,,
"Androstane-3,17-diol dipropionate","ÐÛçÞÍé- 3£¬17 -¶þ´¼¶þ±ûËáõ¥",0.05849,0.1491,1.0475,1.2046,0.7613,-0.3935,no,down,C14624,-,-,-,-,-,-,HMDB0249623,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroid esters",4350-14-5,422.325603954,6.3113,"M+NH4, 2M+K, M+ACN+H",C25H40O4,0,49.9,metab_401,pos_137,pos,495600,410600,672500,377800,743600,663800,595600,837900,886300,584100,822100,692100,,,,
"Metabolite M6",´úÐ»ÎïM6,0.07025,0.1613,1.0471,1.0336,0.429,-1.221,no,down,-,-,-,-,-,-,-,HMDB0061034,Benzenoids,Indanes,"Not Available",-,557.287748586,6.59523333333,M+Cl,C30H42N4O4,0,45.2,metab_6461,neg_1103,neg,131800,41520,186500,108500,108100,199400,166500,308200,214400,660200,261700,197400,,,,
PG(a-13:0/i-22:0),-,0.07053,0.1694,1.0417,1.1455,1.8338,0.8748,no,up,C00344,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0116652;PW_C076270,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,797.587970679,7.02138333333,M+CH3OH+H,C41H81O10P,0,36.1,metab_3136,pos_4113,pos,200100,247400,172100,181100,142400,74070,109200,134100,23500,45920,32740,209000,,,,
"PI(20:4(5Z,8Z,11Z,14Z)/0:0)",-,0.06146,0.15,1.0414,1.0397,0.7268,-0.4604,no,down,-,-,-,-,-,-,-,HMDB0061690;LMGP06050006;HMDB0256523,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoinositols,1246430-04-5,619.288791858,6.50158333333,M-H,C29H49O12P,0,56.4,metab_6437,neg_1081,neg,2631000,1516000,2186000,2520000,1568000,2048000,1986000,2967000,2477000,4228000,2842000,2656000,,,,
"3-Methyl-2-Oxovaleric Acid","3 -¼×»ù- 2 -ÑõÎìËá",0.06401,0.1528,1.0406,1.0356,1.193,0.2546,no,up,C00671,"Organic acids","Carboxylic acids",map01100;map01210;map00280;map01230;map00290,"Metabolic pathways;2-Oxocarboxylic acid metabolism;Valine, leucine and isoleucine degradation;Biosynthesis of amino acids;Valine, leucine and isoleucine biosynthesis",Metabolism;Metabolism;Metabolism;Metabolism;Metabolism,"Global and overview maps;Global and overview maps;Amino acid metabolism;Global and overview maps;Amino acid metabolism",HMDB0000491;PW_C000373,"Organic acids and derivatives","Keto acids and derivatives","Short-chain keto acids and derivatives",24809-08-3;1460-34-0,129.054667455,3.87795,M-H,C6H10O3,86.5,0,metab_9030,neg_811,neg,642500,828100,544400,751600,800900,775100,539100,614000,681900,497800,716400,590100,,,,
Allantoin,ÄòÄÒËØ,0.06337,0.1521,1.0374,1.1162,0.7088,-0.4965,no,down,C01551,-,-,-,-,-,-,HMDB0000462;MJDBOTE0001088,"Organoheterocyclic compounds",Azoles,Imidazoles,97-59-6,157.035794385,0.698583333333,"M-H, M+Cl",C4H6N4O3,69.4,0,metab_8328,neg_349,neg,2334000,2823000,4632000,1762000,1716000,2770000,3800000,3269000,4662000,4279000,2857000,3757000,,,,
L-Norleucine,"L -ÕýÁÁ°±Ëá",0.0792,0.1822,1.037,1.0511,1.3597,0.4433,no,up,C01933,-,-,-,-,-,-,HMDB0001645,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",327-57-1,173.128252625,2.85748333333,M+ACN+H,C6H13NO2,0,44,metab_4986,pos_5897,pos,427100,469300,357500,609400,658100,594900,345800,593300,257500,324400,466400,304700,,,,
Hydroxyvalerylglycine,-,0.08409,0.1906,1.0333,0.9942,0.6825,-0.5511,no,down,-,-,-,-,-,-,-,HMDB0094717,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,217.117885942,0.886083333333,M+ACN+H,C7H13NO4,0,41.4,metab_5233,pos_6122,pos,112100,81470,121800,57480,42880,70290,128100,70170,172900,137400,86630,117100,,,,
"15H-11,12-EETA",-,0.08049,0.1844,1.031,1.0231,0.3559,-1.4905,no,down,C14781,-,-,map00590;map01100,"Arachidonic acid metabolism;Metabolic pathways",Metabolism;Metabolism,"Lipid metabolism;Global and overview maps",HMDB0005050;PW_C002389,"Organic acids and derivatives","Hydroxy acids and derivatives","Medium-chain hydroxy acids and derivatives",877878-78-9,736.474562738,6.21653333333,2M+ACN+Na,C20H32O4,0,43.3,metab_4093,pos_5060,pos,20500,22810,82230,46710,19770,20780,141900,99090,56430,60890,21530,218100,,,,
6-Acetamido-6-deoxy-castanospermine,"6 -ÒÒõ£°±»ù- 6 -ÍÑÑõ-Àõ¾«¼î",0.08118,0.1852,1.0307,1.0961,0.6601,-0.5992,no,down,-,-,-,-,-,-,-,-,-,-,-,-,231.133468981,2.67331666667,M+H,C10H18N2O4,31,0,metab_704,pos_1656,pos,174400,141000,193600,87420,86520,117600,247500,107800,287600,214600,120900,234500,,,,
"PE-NMe(18:0/22:4(7Z,10Z,13Z,16Z))",-,0.08351,0.1816,1.0295,0.9751,0.5389,-0.8919,no,down,"C01241 ",-,-,-,-,-,-,PW_C059227;HMDB0113104,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,854.592266022,7.49183333333,M+FA-H,C46H84NO8P,0,87.7,metab_6620,neg_1248,neg,4525000,5342000,5396000,6499000,11050000,6697000,10200000,12490000,16780000,3287000,9128000,21420000,,,,
"2-Furoic Acid",¿·Ëá,0.06437,0.1534,1.0294,1.0449,0.5399,-0.8892,no,down,C01546,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0000617;MJDBOTE0000456,"Organoheterocyclic compounds",Furans,"Furoic acid and derivatives",88-14-2,111.007717814,0.776766666667,M-H,C5H4O3,36.9,0,metab_8627,neg_629,neg,69030,51760,117700,17750,35870,85540,123700,75680,97990,112600,76660,213200,,,,
Furfural,¿·È©,0.07914,0.1822,1.0276,0.966,0.7123,-0.4894,no,down,C14279,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0032914,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",98-01-1,97.0286931589,2.07191666667,M+H,C5H4O2,52.7,0,metab_651,pos_1607,pos,119200,106000,118200,102200,109100,131800,152600,201400,131700,126800,108400,242700,,,,
"PE(15:0/20:3(8Z,11Z,14Z))",-,0.08813,0.1968,1.0246,0.8884,0.8332,-0.2633,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",PW_C004951;HMDB0008903;LMGP02010466,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,791.532582006,6.79781666667,M+ACN+Na,C40H74NO8P,0,43.2,metab_3361,pos_4342,pos,1238000,1224000,1467000,1105000,1101000,852200,1576000,1215000,1072000,1672000,1443000,1405000,,,,
"13(S)-Hydroperoxylinolenic acid",13£¨S£©-Çâ¹ýÑõÑÇÓÍËá,0.07776,0.1799,1.0234,1.0024,0.9228,-0.1159,no,down,C04785,-,-,map01100;map00592,"Metabolic pathways;alpha-Linolenic acid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0301803,"Lipids and lipid-like molecules","Fatty Acyls","Lineolic acids and derivatives",67597-26-6,333.200908326,5.44551666667,M+Na,C18H30O4,0,75.5,metab_4721,pos_5650,pos,137000,138200,143700,164300,135600,141800,153300,152500,137200,159800,165500,164400,,,,
2-Aminopyridine,2-°±»ùßÁà¤,0.08116,0.1852,1.0201,0.9363,0.9326,-0.1007,no,down,-,-,-,-,-,-,-,HMDB0245026,"Organoheterocyclic compounds","Pyridines and derivatives","Aminopyridines and derivatives",-,95.0606737948,0.71195,M+H,C5H6N2,52.9,0,metab_428,pos_1396,pos,493500,490500,527800,470600,487400,519900,549100,520600,604000,512700,493800,525900,,,,
N-Undecanoylglycine,"N -Ê®Ò»õ£¸Ê°±Ëá",0.08467,0.1912,1.016,1.0644,1.1667,0.2224,no,up,-,-,-,-,-,-,-,HMDB0013286,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,226.179763048,6.16111666667,"M+H-H2O, M+H",C13H25NO3,0,30.1,metab_3853,pos_482,pos,514900,569700,520800,627000,656400,596700,469500,513200,467700,447600,666000,423400,,,,
Chlorobenzene,ÂÈ±½,0.09458,0.2065,1.0157,1.1274,1.0441,0.0623,no,up,C06990,-,-,-,-,-,-,HMDB0041855,Benzenoids,"Benzene and substituted derivatives",Halobenzenes,108-90-7,154.041570583,3.18185,M+ACN+H,C6H5Cl,0,51,metab_4927,pos_5840,pos,60040000,59760000,59350000,59470000,63170000,65030000,62420000,55340000,59580000,56970000,57690000,59340000,,,,
P-CHLOROPHENYLALANINE,-,0.09649,0.2093,1.0078,1.0806,1.0369,0.0523,no,up,-,-,-,-,-,-,-,HMDB0033261,"Phenylpropanoids and polyketides","2-arylbenzofuran flavonoids","Not Available",101365-03-1,200.047000861,3.18185,"M+H, 2M+K, M+2Na-H, M+Na, M+H-H2O",C9H10ClNO2,93.7,0,metab_1082,pos_2,pos,203700000,202700000,204700000,203400000,211600000,222600000,211900000,194300000,200500000,196800000,198800000,201700000,,,,
SM(d19:0/TXB2),-,0.06544,0.1611,1.0076,1.2629,2.2894,1.195,no,up,-,-,-,-,-,-,-,HMDB0290627,"Not Available","Not Available","Not Available",-,855.575525757,6.77386666667,M+Na,C44H85N2O10P,0,61.2,metab_3380,pos_4362,pos,130300,64410,221000,66230,92320,141700,22980,5556,134800,7476,43380,98500,,,,
"Hepoxilin B3",-,0.08103,0.1783,1.0062,0.9629,0.62,-0.6897,no,down,C14810,-,-,map00590,"Arachidonic acid metabolism",Metabolism,"Lipid metabolism",LMFA03090003;HMDB0062479;HMDB0004690,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,-,317.21178362,6.34248333333,M-H2O-H,C20H32O4,0,69.7,metab_6401,neg_1048,neg,211800,275600,500900,477200,199100,250100,334400,503500,568600,532000,291100,858900,,,,
"D-Leucic acid","D ~°×°±Ëá",0.0907,0.2013,1.0041,0.9307,0.9411,-0.0876,no,down,C03264,-,-,-,-,-,-,HMDB0000624;LMFA01050402,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",20312-37-2,150.112249869,7.8623,"M+H-H2O, 2M+NH4, M+NH4",C6H12O3,0,31.8,metab_101,pos_109,pos,533400,476500,540400,546600,521600,535900,591300,527400,525800,600700,532000,574600,,,,
"1,2-Epithiopropane","1£¬2 -»·Áò±ûÍé",0.09128,0.2023,1.0041,0.8789,0.7329,-0.4483,no,down,-,-,-,-,-,-,-,HMDB0302172,"Organoheterocyclic compounds",Thiiranes,"Not Available",-,166.072726776,2.63333333333,2M+NH4,C3H6S,0,42.1,metab_691,pos_1644,pos,45290,37250,66560,41980,32200,63000,66440,56380,100200,59840,53500,54240,,,,
"PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z))",-,0.09671,0.2097,1.0033,1.4029,0.2845,-1.8135,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004554;HMDB0008506;LMGP01011946,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,854.565348728,7.68765,M+Na,C48H82NO8P,0,96.9,metab_2343,pos_3284,pos,392000,241500,247500,1297000,259400,211000,1245000,1527000,1915000,98040,3895000,632200,,,,
"2-amino-5-(amino-dimethylamino-methylidene)amino-pentanoic acid",2-°±»ù-5-£¨°±»ù¶þ¼×°±»ùÑÇ¼×»ù£©°±»ùÎìËá,0.08843,0.1881,1.0031,1.0052,0.2558,-1.9669,no,down,C03626,-,-,-,-,-,-,HMDB0244994;HMDB0001539,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",30315-93-6,239.089619139,5.06931666667,M+K-2H,C8H18N4O2,0,35.5,metab_7406,neg_1963,neg,2099,1144,24310,1168,9516,14460,27190,1073,39680,32540,17810,87660,,,,
"N-Oleoyl Phenylalanine","N -ÓÍõ£»ù±½±û°±Ëá",0.07621,0.1705,1.0029,1.0153,0.584,-0.776,no,down,-,-,-,-,-,-,-,LMFA08020092;HMDB0062336,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,428.316500767,6.73421666667,M-H,C27H43NO3,80.2,0,metab_6513,neg_1151,neg,1354000,407800,1298000,1020000,825200,764100,811600,2126000,1738000,2645000,1532000,857700,,,,
Indole,ßÅßá,0.1044,0.22,1.0008,1.0729,1.0495,0.0697,no,up,C00463,-,-,map01100;map00400;map00380;map04974,"Metabolic pathways;Phenylalanine, tyrosine and tryptophan biosynthesis;Tryptophan metabolism;Protein digestion and absorption","Metabolism;Metabolism;Metabolism;Organismal Systems","Global and overview maps;Amino acid metabolism;Amino acid metabolism;Digestive system",HMDB0035924;HMDB0000738,"Organoheterocyclic compounds","Heteroaromatic compounds","Not Available",120-72-9;109-97-7,118.065160757,3.17431666667,M+H,C8H7N,80.5,0,metab_6337,pos_5844,pos,5145000,5121000,4995000,4924000,5468000,5517000,5280000,4640000,5097000,4782000,4881000,5020000,,,,
"Citral propylene glycol acetal",ÄûÃÊÈ©±û¶þ´¼ËõÈ©,0.0931,0.2044,0.9971,1.0211,1.1766,0.2346,no,up,-,-,-,-,-,-,-,HMDB0037286,"Organoheterocyclic compounds",Dioxolanes,"1,3-dioxolanes",10444-50-5,228.195447358,6.20088333333,"M+H-H2O, M+H, M+NH4, M+H-2H2O",C13H22O2,0,42,metab_432,pos_14,pos,3724000,4448000,4046000,4455000,5104000,4726000,3610000,3881000,3393000,3437000,5108000,3092000,,,,
Tildipirosin,ÌæµØÂÞÐÂ,0.08317,0.1889,0.9936,0.9358,0.6228,-0.6832,no,down,-,-,-,-,-,-,-,HMDB0259090,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,766.561990624,6.35915,M+CH3OH+H,C41H71N3O8,0,39,metab_3871,pos_4837,pos,71030,112800,88350,92050,17790,49570,118400,72010,99580,73100,181700,148400,,,,
Pregnanetriolone,ÈýôÇ»ùÔÐÍª,0.07352,0.1741,0.9922,1.0395,1.1512,0.2031,no,up,C15368,-,-,-,-,-,-,HMDB0041997,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Pregnane steroids",603-99-6,764.507274111,6.47368333333,2M+ACN+Na,C21H34O4,0,32.8,metab_3746,pos_4722,pos,1533000,1278000,1326000,1285000,1035000,1357000,1122000,957300,1295000,1011000,1270000,1129000,,,,
L-Allothreonine,"L -±ðËÕ°±Ëá",0.0956,0.2082,0.9916,0.9767,1.1828,0.2422,no,up,C05519,-,-,map01100;map00260,"Metabolic pathways;Glycine, serine and threonine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0004041,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",28954-12-3;24830-94-2,164.02912156,0.6576,M+2Na-H,C4H9NO3,0,36.7,metab_5502,pos_6387,pos,361400,420900,291400,481400,401000,389100,287400,369900,369700,267400,380300,308300,,,,
12(R)-HETE,12£¨R£©-ºÕÌØ,0.09636,0.1993,0.9888,0.9354,0.7043,-0.5057,no,down,C14822,-,-,map00590;map01100;map04925,"Arachidonic acid metabolism;Metabolic pathways;Aldosterone synthesis and secretion","Metabolism;Metabolism;Organismal Systems","Lipid metabolism;Global and overview maps;Endocrine system",PW_C040453,-,-,-,-,319.227396737,6.4045,"M-H2O-H, M-H",C20H32O3,74.2,0,metab_8054,neg_257,neg,3700000,5240000,4673000,6431000,4135000,5121000,6486000,4654000,6117000,8810000,4772000,10760000,,,,
PA(P-16:0/PGJ2),-,0.1008,0.2154,0.9859,1.0928,0.2368,-2.0783,no,down,-,-,-,-,-,-,-,HMDB0266723,"Not Available","Not Available","Not Available",-,724.463635021,6.09678333333,2M+3H2O+2H,C39H67O9P,0,53.6,metab_1242,pos_2147,pos,14570,14490,69700,29740,25370,14940,253000,20610,71470,86980,20150,260400,,,,
"PC(20:2(11Z,14Z)/15:0)",-,0.07435,0.1755,0.9836,0.9358,0.5602,-0.836,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004378;HMDB0008330;LMGP01011839,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,772.583375502,7.68765,M+H,C43H82NO8P,0,38.3,metab_2342,pos_3282,pos,1091000,571700,171300,217600,343700,380300,906200,730500,895200,912200,318500,1191000,,,,
"Alpha-Bisabolol oxide A",-,0.09673,0.2097,0.9788,1.0466,1.243,0.3138,no,up,C16773,-,-,-,-,-,-,HMDB0038196,"Organoheterocyclic compounds",Oxanes,"Not Available",22567-36-8,271.226274346,6.20866666667,M+CH3OH+H,C15H26O2,0,59.1,metab_1351,pos_2262,pos,254400,298600,285200,324900,390300,346400,231200,280300,236700,224700,373900,181300,,,,
Oleandomycin,ÖñÌÒÃ¹ËØ,0.09587,0.2085,0.9787,1.0455,0.2162,-2.2096,no,down,C01946,Antibiotics,"Polyketides and nonribosomal peptides",map01100;map02010,"Metabolic pathways;ABC transporters","Metabolism;Environmental Information Processing","Global and overview maps;Membrane transport",LMPK04000007;HMDB0255932,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",3922-90-5,705.455123213,6.12923333333,M+NH4,C35H61NO12,0,35.8,metab_4208,pos_5176,pos,39120,6151,7019,5857,12760,7055,90960,12800,57370,37180,6548,155600,,,,
"9-Oxo-nonanoic acid",-,0.09568,0.1985,0.977,0.9872,0.3729,-1.4231,no,down,C16322,-,-,map00592,"alpha-Linolenic acid metabolism",Metabolism,"Lipid metabolism",HMDB0094711;LMFA01060160,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,217.107462668,5.05406666667,M+FA-H,C9H16O3,0,35.3,metab_7407,neg_1964,neg,255300,191800,654200,39160,425000,521600,748500,168700,1181000,765200,559700,2172000,,,,
"Glutathione, oxidized",L-¹Èë×¸ÊëÄ(Ñõ»¯ÐÍ),0.07876,0.1815,0.9762,0.9336,0.6757,-0.5655,no,down,C00127,-,-,map01100;map00480;map01240;map05208;map04918;map05415;map04216,"Metabolic pathways;Glutathione metabolism;Biosynthesis of cofactors;Chemical carcinogenesis - reactive oxygen species;Thyroid hormone synthesis;Diabetic cardiomyopathy;Ferroptosis","Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems;Human Diseases;Cellular Processes","Global and overview maps;Metabolism of other amino acids;Global and overview maps;Cancer: overview;Endocrine system;Cardiovascular disease;Cell growth and death",HMDB0011691;HMDB0003337,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",15718-51-1;27025-41-8,613.158115223,1.88788333333,"M+2H, M+H",C20H32N6O12S2,47.9,0,metab_2763,pos_372,pos,240100,309000,162400,226700,167000,262200,336700,208300,369600,202700,394000,512400,,,,
"CL(18:0/18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.09553,0.2082,0.976,0.9266,0.2823,-1.8247,no,down,C05980,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0057038;PW_C037492,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerophosphoglycerols,-,778.534951586,6.24016666667,M+2H,C89H152O17P2,0,46.9,metab_4058,pos_5021,pos,11110,98980,85990,165900,230100,174100,316100,649200,770300,13380,38550,926300,,,,
DG(LTE4/0:0/i-15:0),-,0.1006,0.2152,0.9739,0.9546,1.689,0.7562,no,up,-,-,-,-,-,-,-,HMDB0299004,"Not Available","Not Available","Not Available",-,782.459445487,6.67033333333,M+2Na-H,C41H71NO8S,0,31,metab_3508,pos_4494,pos,63970,43670,25330,115300,64020,75090,66450,23250,40230,43240,23630,32560,,,,
"Nona-3,6-dienedioylcarnitine","ÈÉ- 3£¬6 -¶þÏ©¶þõ£»ùÈâ¼î",0.1135,0.2334,0.9733,0.888,0.6073,-0.7195,no,down,-,-,-,-,-,-,-,HMDB0241776,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,360.200793932,3.49275,M+CH3OH+H,C16H25NO6,0,60.1,metab_4878,pos_5795,pos,477600,549400,1476000,160700,400800,514100,820900,856000,1482000,979200,662200,1091000,,,,
Formetanate,¿¹òýëß,0.09728,0.2105,0.9725,0.8671,1.2762,0.3519,no,up,C18668,-,-,-,-,-,-,HMDB0252444,Benzenoids,"Benzene and substituted derivatives","Phenyl methylcarbamates",22259-30-9,460.268416688,7.79815,2M+NH4,C11H15N3O2,0,50,metab_2431,pos_3376,pos,931800,692100,644300,850700,1060000,861900,729200,904100,801900,612700,483800,417900,,,,
Syringin,×Ï¶¡ÏãÜÕ,0.1153,0.2355,0.9691,0.8997,0.2695,-1.8916,no,down,C01533,-,-,-,-,-,-,;MJDBOTE0001150,-,-,-,118-34-3,373.146123514,3.25201666667,M+H,C17H24O9,30.2,0,metab_790,pos_1735,pos,26160,84740,469900,16820,73970,85610,189100,18510,1185000,490700,213200,713000,,,,
Alpha-Carboxy-delta-nonalactone,-,0.08259,0.1809,0.9662,1.0353,0.6663,-0.5858,no,down,-,-,-,-,-,-,-,HMDB0030990,"Organoheterocyclic compounds",Lactones,"Delta valerolactones",-,199.096829704,5.99251666667,M-H,C10H16O4,0,41.1,metab_8959,neg_933,neg,213500,155700,249100,85020,188100,163700,244200,158800,387800,237700,188200,367500,,,,
Valaciclovir,·¥ÎôÂåÎ¤,0.09901,0.2132,0.9643,1.0441,0.6532,-0.6144,no,down,C07184,-,-,map04976,"Bile secretion","Organismal Systems","Digestive system",HMDB0014716,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",124832-27-5,342.190420466,4.20768333333,M+NH4,C13H20N6O4,0,41.3,metab_877,pos_1813,pos,117300,159400,259500,55660,113600,110800,236900,129900,286100,192800,130600,272900,,,,
"PA(18:3(9,11,15)-OH(13)/22:5(4Z,7Z,10Z,13Z,16Z))",-,0.1074,0.2241,0.9623,0.8505,0.7087,-0.4968,no,down,-,-,-,-,-,-,-,HMDB0266056,"Not Available","Not Available","Not Available",-,824.484479803,6.61433333333,M+ACN+Na,C43H69O9P,0,31.6,metab_3580,pos_4566,pos,277500,236800,470900,160600,169000,416500,483200,293100,428500,387000,547800,303200,,,,
"Abscisic alcohol",ÍÑÂä´¼,0.1201,0.2324,0.9598,0.9213,0.4649,-1.105,no,down,C13456,-,-,-,-,-,-,HMDB0039635,"Lipids and lipid-like molecules","Prenol lipids",Sesquiterpenoids,113472-20-1,249.149194562,6.28065,M-H,C15H22O3,0,47.5,metab_6389,neg_1037,neg,12820,17760,9982,11520,23030,15390,52370,16580,29520,17550,11260,67490,,,,
"Capric acid",-,0.1125,0.2222,0.9549,0.8588,1.2245,0.2922,no,up,C01571,Lipids,"Fatty acids",map01100;map00061,"Metabolic pathways;Fatty acid biosynthesis",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",PW_C000391;HMDB0000511;LMFA01010010,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",334-48-5,209.094114015,6.84488333333,M+K-2H,C10H20O2,0,50.3,metab_6997,neg_1589,neg,224800,153600,162400,169900,176700,162900,101500,127300,138000,207800,157200,126500,,,,
4-Nitrophenol,4-Ïõ»ù±½·Ó,0.1115,0.2206,0.9536,0.9209,1.0645,0.0902,no,up,C00870,-,-,-,-,-,-,HMDB0001232;HMDB0041950;MJDBOTE0000622,Benzenoids,Phenols,Nitrophenols,98-95-3;100-02-7,138.018648735,5.94051666667,M-H,C6H5NO3,70.3,0,metab_9031,neg_1912,neg,131300,148900,135100,142300,160400,154100,139300,134100,138300,132600,136200,138300,,,,
"5-Aminopentanoic acid","5 -°±»ùÎìËá",0.103,0.2186,0.9488,1.5509,0.8194,-0.2874,no,down,C00431,-,-,map01100;map00310;map00330,"Metabolic pathways;Lysine degradation;Arginine and proline metabolism",Metabolism;Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism;Amino acid metabolism",HMDB0003355;LMFA01100040,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",660-88-8,162.049895474,0.735283333333,M+2Na-H,C5H11NO2,0,40,metab_5371,pos_6260,pos,298800,386600,324600,392000,388100,362800,354100,567800,465700,336800,521400,381800,,,,
"Exo,exo-1,8-Epoxy-p-menthane-2,6-diol",-,0.09307,0.1945,0.9482,0.9436,0.7128,-0.4884,no,down,C17620,-,-,-,-,-,-,HMDB0041376,"Organoheterocyclic compounds",Oxanes,"Not Available",38223-98-2,185.117485452,6.19218333333,M-H,C10H18O3,0,54.2,metab_6350,neg_1001,neg,129400,167800,133500,78170,157700,176400,200000,149400,168400,161000,182700,321100,,,,
L-Glutamine,L-¹È°±õ£°·,0.1007,0.2047,0.9469,0.9418,1.1404,0.1895,no,up,C00064,Peptides,"Amino acids",map01100;map00630;map00220;map00230;map01240;map04964;map02010;map00910;map04978;map01230;map00240;map00250;map04974;map00970;map04727;map00750;map04724;map05230,"Metabolic pathways;Glyoxylate and dicarboxylate metabolism;Arginine biosynthesis;Purine metabolism;Biosynthesis of cofactors;Proximal tubule bicarbonate reclamation;ABC transporters;Nitrogen metabolism;Mineral absorption;Biosynthesis of amino acids;Pyrimidine metabolism;Alanine, aspartate and glutamate metabolism;Protein digestion and absorption;Aminoacyl-tRNA biosynthesis;GABAergic synapse;Vitamin B6 metabolism;Glutamatergic synapse;Central carbon metabolism in cancer","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Organismal Systems;Environmental Information Processing;Metabolism;Organismal Systems;Metabolism;Metabolism;Metabolism;Organismal Systems;Genetic Information Processing;Organismal Systems;Metabolism;Organismal Systems;Human Diseases","Global and overview maps;Carbohydrate metabolism;Amino acid metabolism;Nucleotide metabolism;Global and overview maps;Excretory system;Membrane transport;Energy metabolism;Digestive system;Global and overview maps;Nucleotide metabolism;Amino acid metabolism;Digestive system;Translation;Nervous system;Metabolism of cofactors and vitamins;Nervous system;Cancer: overview",HMDB0003423;PW_C000500;HMDB0000641;MJDBOTE0000775,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",56-85-9;5959-95-5,145.06089918,0.6444,"M-H2O-H, M-H",C5H10N2O3,72.9,0,metab_7402,neg_196,neg,1404000,1351000,1309000,1457000,1528000,1477000,1371000,1126000,1548000,948700,1301000,1184000,,,,
"Undeca-6,9-dienoylcarnitine","Ê®Ò»Ì¼- 6£¬9 -¶þÏ©õ£Èâ¼î",0.09224,0.2036,0.9458,0.881,1.3014,0.3801,no,up,-,-,-,-,-,-,-,HMDB0241188,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,358.258023423,6.09678333333,M+CH3OH+H,C18H31NO4,0,30.1,metab_4252,pos_5220,pos,355600,571900,491900,541000,321300,464500,280400,333900,492700,234000,438100,330900,,,,
"25-Hydroxyvitamin D3-26,23-lactol","25 -ôÇ»ùÎ¬ÉúËØD3 - 26£¬23 -±û¶þ´¼",0.1212,0.2434,0.9447,1.0782,1.1743,0.2318,no,up,-,-,-,-,-,-,-,HMDB0060127,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Vitamin D and derivatives",-,448.341617383,6.34308333333,M+NH4,C27H42O4,0,35,metab_3897,pos_4863,pos,603200,570700,491300,490700,606600,613000,373000,578400,483900,414400,624700,400400,,,,
(3S)-3-hydroxycyclocitral,£¨3S£©-3-ôÇ»ù»·ÄûÃÊÈ©,0.1138,0.2244,0.9411,0.9344,0.489,-1.0321,no,down,C19731,-,-,-,-,-,-,HMDB0303972,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",-,213.112561114,6.04741666667,M+FA-H,C10H16O2,0,61.9,metab_8981,neg_954,neg,110400,92730,163200,50080,128700,110900,190600,109900,239700,131000,165700,504400,,,,
"DL-2-Aminooctanoic acid","DL - 2 -°±»ùÐÁËá",0.1182,0.2393,0.9391,0.8287,1.3728,0.4571,no,up,-,-,-,-,-,-,-,HMDB0000991,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",644-90-6,160.132996598,4.38253333333,M+H,C8H17NO2,58.5,0,metab_4803,pos_5725,pos,81390,162900,88510,90410,77570,92910,53500,110500,63340,63340,63130,78720,,,,
"SM(d17:2(4E,8Z)/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))",-,0.1294,0.2525,0.9371,0.9092,1.2449,0.316,no,up,-,-,-,-,-,-,-,HMDB0290435,"Not Available","Not Available","Not Available",-,781.519085406,6.46001666667,M+H,C42H73N2O9P,0,36.9,metab_3760,pos_4735,pos,308900,401400,295000,316400,334200,452000,270500,373300,277400,162800,371500,237700,,,,
Isokobusone,Òì¿¼²¼ËÉ,0.1079,0.2149,0.9367,0.9235,0.5008,-0.9977,no,down,C16977,-,-,-,-,-,-,HMDB0036791,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",24173-72-6,267.159888665,6.20693333333,M+FA-H,C14H22O2,0,55.2,metab_7232,neg_1803,neg,50020,64780,74940,23650,112400,77140,88710,76380,199000,63220,107100,270200,,,,
Timonacic,àçÄªÎ÷Ëá,0.1121,0.2313,0.9315,0.9356,0.2886,-1.7929,no,down,-,-,-,-,-,-,-,HMDB0258979,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,134.026917055,0.71195,M+H,C4H7NO2S,58.4,0,metab_5400,pos_6289,pos,1516,35510,23340,11750,13630,12880,129300,62900,16490,23810,4051,105200,,,,
"(S)-Oleuropeic acid",-,0.112,0.2311,0.9293,1.0192,0.5857,-0.7718,no,down,-,-,-,-,-,-,-,HMDB0036998,"Lipids and lipid-like molecules","Prenol lipids",Monoterpenoids,5027-76-9,226.143348059,4.2223,M+ACN+H,C10H16O3,0,36.8,metab_878,pos_1814,pos,460100,605700,1133000,183700,567700,591600,919100,383200,1389000,962000,664400,1728000,,,,
"PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))",-,0.1195,0.2409,0.9267,0.9478,0.6602,-0.599,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",PW_C005678;HMDB0009630,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,796.519983535,6.24016666667,M+H-H2O,C47H76NO8P,0,40.4,metab_1383,pos_2297,pos,101500,65590,245000,176200,126000,127700,229600,159200,149200,227600,148300,361000,,,,
PC(14:1(9Z)/18:1(9Z)),-,0.1507,0.2803,0.925,0.788,2.1875,1.1293,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0007906;LMGP01011390;PW_C003956,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,730.536980615,6.59835,M+H,C40H76NO8P,0,41.4,metab_3605,pos_4590,pos,78330,2011000,384500,714800,1568000,1544000,520800,341200,267400,62100,1291000,397100,,,,
"PC(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/14:0)",-,0.1051,0.2207,0.9242,1.0188,0.6684,-0.5812,no,down,-,-,-,-,-,-,-,HMDB0285659,"Not Available","Not Available","Not Available",-,786.524797683,6.71033333333,M+H,C42H76NO10P,0,60.6,metab_1740,pos_2639,pos,199800,93570,127400,191600,114000,211700,181000,226900,139900,166100,338400,351800,,,,
Hypromellosum,-,0.1062,0.2222,0.9228,0.8827,1.4807,0.5663,no,up,-,-,-,-,-,-,-,HMDB0256007,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,790.401063464,6.4289,M+ACN+H,C32H60O19,0,40.6,metab_1524,pos_2432,pos,55280,60380,65850,69040,35400,65930,1.09,33660,42160,41060,57440,63340,,,,
Vigabatrin,°±¼ºÏ©Ëá,0.104,0.2194,0.9227,0.8759,0.9659,-0.0501,no,down,C07500,-,-,-,-,-,-,HMDB0015212,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",60643-86-9,94.0654111178,7.8543,M+H-2H2O,C6H11NO2,0,32.3,metab_2460,pos_3404,pos,324600,307200,310400,299800,332300,313200,334100,317700,318800,340300,325100,318400,,,,
"2-Octenedioic acid","2 -ÐÁ¶þËá",0.09429,0.2062,0.9211,1.1324,1.1037,0.1423,no,up,-,-,-,-,-,-,-,LMFA01170085;HMDB0000341,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",5698-50-0,173.08081569,4.46338333333,"M+H-H2O, M+H",C8H12O4,0,31.4,metab_2830,pos_379,pos,88710,82980,109400,99030,96490,83550,81430,80660,85720,90480,82740,86570,,,,
"Indoxyl Sulfate",ÁòËáßÅßá·Ó,0.1221,0.2345,0.9192,1.1288,1.723,0.7849,no,up,-,-,-,-,-,-,-,HMDB0000682,"Organic acids and derivatives","Organic sulfuric acids and derivatives",Arylsulfates,487-94-5,212.001589004,3.90003333333,M-H,C8H7NO4S,46.1,0,metab_7478,neg_2027,neg,8011000,6150000,9145000,2206000,4117000,3517000,2987000,3269000,6877000,2862000,1556000,1687000,,,,
2-Fluoro-5-hydroxy-L-tyrosine,"2 -·ú- 5 -ôÇ»ù- L -ÀÒ°±Ëá",0.1454,0.2735,0.9189,0.8521,0.6012,-0.7341,no,down,-,-,-,-,-,-,-,HMDB0247059,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,248.094735717,2.88953333333,M+CH3OH+H,C9H10FNO4,0,56.4,metab_736,pos_1685,pos,238500,205500,280400,127000,94150,110000,289400,146100,553600,391100,150600,224500,,,,
"Menthyl ethylene glycol carbonate",±¡ºÉ»ùÒÒ¶þ´¼Ì¼Ëáõ¥,0.09763,0.2111,0.9171,0.9302,1.1649,0.2202,no,up,-,-,-,-,-,-,-,HMDB0036141,"Lipids and lipid-like molecules","Prenol lipids",Monoterpenoids,156324-78-6,245.174290558,7.44245,"M+H-H2O, M+H",C13H24O4,0,54.9,metab_6107,pos_793,pos,1173000,844800,856500,872600,911900,871600,759600,692400,707200,1023000,821000,743600,,,,
"(+)-2-Amino-7-phosphonoheptanoic acid",£¨+£©-2-°±»ù-7-Á×Ëá¸ýËá,0.125,0.2475,0.9164,0.8168,0.6625,-0.594,no,down,-,-,-,-,-,-,-,HMDB0242241,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,226.081817123,0.958466666667,"M+H-H2O, M+H",C7H16NO5P,0,55,metab_2051,pos_297,pos,1100000,970700,2100000,501600,787200,1595000,1374000,1370000,3070000,1568000,1459000,1808000,,,,
Adenosine,ÏÙÜÕ,0.1058,0.2216,0.9159,1.0787,4.321,2.1114,no,up,C00212,"Nucleic acids",Nucleosides,map01100;map04024;map00230;map02010;map04270;map05012;map04080;map04923;map04924;map04022;map05034;map04071;map05032,"Metabolic pathways;cAMP signaling pathway;Purine metabolism;ABC transporters;Vascular smooth muscle contraction;Parkinson disease;Neuroactive ligand-receptor interaction;Regulation of lipolysis in adipocytes;Renin secretion;cGMP-PKG signaling pathway;Alcoholism;Sphingolipid signaling pathway;Morphine addiction","Metabolism;Environmental Information Processing;Metabolism;Environmental Information Processing;Organismal Systems;Human Diseases;Environmental Information Processing;Organismal Systems;Organismal Systems;Environmental Information Processing;Human Diseases;Environmental Information Processing;Human Diseases","Global and overview maps;Signal transduction;Nucleotide metabolism;Membrane transport;Circulatory system;Neurodegenerative disease;Signaling molecules and interaction;Endocrine system;Endocrine system;Signal transduction;Substance dependence;Signal transduction;Substance dependence",HMDB0000050;PW_C000034;HMDB0247583;MJDBOTE0000767,"Nucleosides, nucleotides, and analogues","Purine nucleosides","Not Available",58-61-7,250.092959951,2.65731666667,M+H-H2O,C10H13N5O4,65.7,0,metab_699,pos_1651,pos,100000,100300,490800,90320,79980,146500,10740,25830,70830,27100,91090,7674,,,,
"Tyramine glucuronide",ÀÒ°·ÆÏÌÑÌÇÈ©ËáÜÕ,0.1201,0.2324,0.9155,0.9519,0.5179,-0.9493,no,down,C03033,-,-,map01100;map00040;map04976;map00053;map01240,"Metabolic pathways;Pentose and glucuronate interconversions;Bile secretion;Ascorbate and aldarate metabolism;Biosynthesis of cofactors","Metabolism;Metabolism;Organismal Systems;Metabolism;Metabolism","Global and overview maps;Carbohydrate metabolism;Digestive system;Carbohydrate metabolism;Global and overview maps",HMDB0010328,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",27972-85-6,348.086550745,4.69115,M+Cl,C14H19NO7,0,37.1,metab_8863,neg_847,neg,93310,30150,104000,11630,82880,71430,148000,110000,249200,55720,39820,157100,,,,
"11-((2-Dimethylaminoethyl)oxymethyl)erythromycin A 9-methoxime","11-£¨£¨2-¶þ¼×°±»ùÒÒ»ù£©Ñõ¼×»ù£©ºìÃ¹ËØA 9-¼×Ñõë¿",0.1066,0.2226,0.9147,0.9222,0.735,-0.4442,no,down,-,-,-,-,-,-,-,HMDB0251898,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,864.572871747,6.59835,"M+H, M+NH4, M+ACN+H",C43H81N3O14,0,38.9,metab_620,pos_158,pos,294700,268900,299700,179000,277700,154200,270100,415600,336100,179500,338100,466700,,,,
Glycerylphosphorylcholine,¸ÊÓÍÁ×Ö¬õ£µ¨¼î,0.1254,0.2479,0.9147,1.1128,0.8397,-0.2521,no,down,C00670,-,-,map00565;map00564;map05231,"Ether lipid metabolism;Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Metabolism;Human Diseases","Lipid metabolism;Lipid metabolism;Cancer: overview",HMDB0252858;HMDB0000086,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,28319-77-9,280.091469984,0.626083333333,"M+Na, M+K",C8H20NO6P,0,64.7,metab_1741,pos_264,pos,4991000,3339000,4848000,4704000,5424000,4821000,5078000,7461000,4617000,6292000,5095000,4953000,,,,
"(1R,4E,5'R,6R,6'R,7S,8S,10S,11S,12R,14S,15R,16S,18E,20E,22S,25R,27S,29S)-22-Ethyl-7,11,14,15-tetrahydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,29-octamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione","£¨1R£¬4E£¬5'R£¬6R£¬6'R£¬7S£¬8S£¬10S£¬11S£¬12R£¬14S£¬15R£¬16S£¬18E£¬20E£¬22S£¬25R£¬27S£¬29S£©-22-ÒÒ»ù-7,11,14,15-ËÄôÇ»ù-6'-£¨2-ôÇ±û»ù£©-5'£¬6,8,10,12,14,16,29-°Ë¼×»ùÂÝ[2,26-¶þÑõÔÓ»·[23.3.1]ÈÉ-4,18,20-ÈýÏ©-27,2'-ÑõÍé]-3,9,13-ÈýÍª",0.09823,0.2121,0.9137,0.9963,1.6439,0.7171,no,up,-,-,-,-,-,-,-,HMDB0242333,"Phenylpropanoids and polyketides","Macrolides and analogues","Not Available",-,809.53782226,6.57425,M+CH3OH+H,C44H72O11,0,80.8,metab_3634,pos_4617,pos,194200,122800,252200,268700,175500,155500,277800,116600,75540,97340,111500,32270,,,,
"PE(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))",-,0.1037,0.2084,0.9096,1.1742,0.7534,-0.4085,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0009036;PW_C005084,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,764.522926031,6.68715,"M-H2O-H, M-H",C43H76NO8P,0,38.2,metab_8249,neg_278,neg,10700000,8368000,5432000,7309000,6256000,5281000,9016000,12940000,6899000,8626000,12320000,7730000,,,,
"Hydrocinnamic acid",Çâ»¯Èâ¹ðËá,0.1174,0.2382,0.9077,1.0357,1.0749,0.1042,no,up,C05629,-,-,map01100;map00360,"Metabolic pathways;Phenylalanine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0000764,"Phenylpropanoids and polyketides","Phenylpropanoic acids","Not Available",501-52-0,192.101532633,7.84611666667,M+ACN+H,C9H10O2,0,48.6,metab_2526,pos_3465,pos,110400,90910,106900,106100,115000,103100,102800,95190,106700,91800,90700,101200,,,,
Muroctasin,ÂÞÄªëÄ,0.1141,0.2248,0.9075,0.8538,1.1904,0.2514,no,up,-,-,-,-,-,-,-,HMDB0254954,"Organoheterocyclic compounds",Azoles,Imidazoles,-,867.551230807,7.54671666667,M-H2O-H,C43H78N6O13,0,78.8,metab_6658,neg_1282,neg,862800,727700,563900,764400,829100,870800,711500,494700,592400,869800,579900,631700,,,,
"8-Amino-7-oxononanoic acid","8 -°±»ù- 7 -Ñõ´úÈÉËá",0.1418,0.269,0.9054,0.9753,0.7392,-0.436,no,down,C01092,-,-,map01100;map00780;map01240,"Metabolic pathways;Biotin metabolism;Biosynthesis of cofactors",Metabolism;Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins;Global and overview maps",HMDB0240687;LMFA01060168,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",682799-71-9,229.154310162,0.806533333333,M+ACN+H,C9H17NO3,0,34.9,metab_5277,pos_6166,pos,2608000,2343000,3832000,1347000,1552000,2096000,3285000,2077000,4216000,3741000,2090000,3225000,,,,
11'-Carboxy-gamma-tocotrienol,"11 ' -ôÈ- ¦Ã -ÉúÓýÈýÏ©·Ó",0.1434,0.2707,0.9028,0.9407,0.644,-0.6349,no,down,-,-,-,-,-,-,-,HMDB0012518,"Lipids and lipid-like molecules","Prenol lipids",Sesquiterpenoids,-,842.559472778,6.59031666667,2M+ACN+H,C25H36O4,0,39.2,metab_3610,pos_4596,pos,30160,25250,49540,73770,47250,60060,40170,30890,76120,103500,121600,71800,,,,
"4-(undecan-5-yl)benzene-1-Sulfonic Acid",-,0.1297,0.2446,0.8998,0.86,1.294,0.3718,no,up,-,-,-,-,-,-,-,-,-,-,-,-,311.168403931,6.4819,M-H,C17H28O3S,60.2,0,metab_6432,neg_1077,neg,64350,76850,31400,77430,56730,47570,49930,38680,49460,50870,47220,37690,,,,
N1-Acetylspermidine,"N1 -ÒÒõ£ÑÇ¾«°·",0.1192,0.2406,0.8996,0.8743,1.5392,0.6222,no,up,C00612,-,-,-,-,-,-,HMDB0001276,"Organic acids and derivatives","Carboximidic acids and derivatives","Carboximidic acids",14278-49-0,188.175457498,0.64205,M+H,C9H21N3O,65.5,0,metab_5551,pos_6431,pos,108200,170900,184400,101900,100700,219900,59070,69600,190800,46640,127300,82420,,,,
7-Methylguanine,"7 -¼×»ùÄñàÑßÊ",0.1478,0.2763,0.8968,0.9748,0.7472,-0.4204,no,down,C02242,-,-,-,-,-,-,HMDB0006040;HMDB0000897,"Organoheterocyclic compounds",Imidazopyrimidines,"Purines and purine derivatives",10030-78-1;578-76-7,166.072152513,1.35986666667,M+H,C6H7N5O,51.2,0,metab_6333,pos_1553,pos,261300,222700,445800,224800,169300,256300,373900,235800,504800,366500,241600,392100,,,,
Arbutin,ÐÜ¹ûÜÕ,0.1307,0.2544,0.8968,0.8533,0.0033,-8.2433,no,down,C06186,-,-,map00010,"Glycolysis / Gluconeogenesis",Metabolism,"Carbohydrate metabolism",HMDB0029943;MJDBOTE0001645,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",497-76-7,290.122957444,2.76935,M+NH4,C12H16O7,0,36.1,metab_4998,pos_5907,pos,466.4,464.1,1076,443.5,455.1,478.5,121200,261200,24610,20210,495.9,600200,,,,
"Geranyl Acetate", ½Å£¶ù´¼ÒÒËáõ¥,0.1307,0.2544,0.8948,0.8991,1.0979,0.1347,no,up,C09861,-,-,-,-,-,-,HMDB0035157;MJDBOTE0001728,"Lipids and lipid-like molecules","Fatty Acyls","Fatty alcohol esters",105-87-3,214.179805023,6.12923333333,M+NH4,C12H20O2,35.9,0,metab_1269,pos_2175,pos,87090,107400,91520,101700,106200,107800,87820,90160,87600,97620,106900,78040,,,,
Laminine,À¥²¼°±Ëá,0.1173,0.2295,0.8915,0.9665,0.5058,-0.9834,no,down,-,-,-,-,-,-,-,-,-,-,-,-,187.1436119,5.95426666667,M-H,C9H20N2O2,82.8,0,metab_7346,neg_1907,neg,11890,5585,19320,1154,6705,9789,14290,9378,22310,14890,9268,37470,,,,
"9,10-DHOME","9,10-¶þôÇ»ù-12-Ê®°ËÌ¼Ï©Ëá",0.122,0.2345,0.8899,0.944,1.1112,0.1521,no,up,C14828,-,-,map00591,"Linoleic acid metabolism",Metabolism,"Lipid metabolism",HMDB0004704,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",125356-86-7,313.238146778,6.28755,"M-H, M+Na-2H",C18H34O4,0,59.3,metab_7988,neg_251,neg,1192000,1147000,1199000,1267000,1081000,1370000,864700,1040000,1207000,1173000,1004000,1237000,,,,
Beta-Thujaplicin,"Beta -Å·²à°Ø·Ó",0.1314,0.2553,0.8894,0.9638,0.4788,-1.0625,no,down,C09904,-,-,-,-,-,-,HMDB0035213,"Hydrocarbon derivatives",Tropones,Tropolones,499-44-5,165.090917629,4.56751666667,M+H,C10H12O2,0,50.1,metab_897,pos_1831,pos,71790,59610,144700,22890,96120,118000,151500,37290,202400,154500,120500,405600,,,,
2-Stearoylglycerophosphoglycerol,"2 -Ó²Ö¬õ£¸ÊÓÍÁ×Ëá¸ÊÓÍ",0.1191,0.2321,0.8867,0.9112,0.5712,-0.8079,no,down,-,-,-,-,-,-,-,HMDB0061703,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,511.304037494,7.01423333333,M-H,C24H49O9P,0,78.4,metab_6971,neg_1565,neg,180200,89300,152500,76310,121800,178300,165300,144200,192200,465700,295300,135200,,,,
"PE-NMe(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z))",-,0.1261,0.2396,0.8845,0.8936,0.8588,-0.2196,no,down,"C01241 ",-,-,-,-,-,-,HMDB0113354;PW_C059478,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,840.532227357,7.5624,M+Cl,C46H80NO8P,0,36.4,metab_6676,neg_1299,neg,1021000,766000,614100,944400,779500,795800,1101000,849200,803100,1136000,943700,895800,,,,
Acetyl-L-tyrosine,"ÒÒõ£»ù- L -ÀÒ°±Ëá",0.1393,0.2656,0.884,0.7914,0.8013,-0.3196,no,down,C01657,-,-,-,-,-,-,HMDB0000866;HMDB0244966,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",537-55-3,224.091244796,3.27618333333,M+H,C11H13NO4,77.9,0,metab_4903,pos_5817,pos,97220,71460,129100,56040,99410,122200,119600,108400,160400,116500,121300,92190,,,,
"N-di-Demethyl roxithromycin","N -¶þÈ¥¼×»ùÂÞºìÃ¹ËØ",0.1388,0.2651,0.8822,0.7842,0.8238,-0.2796,no,down,-,-,-,-,-,-,-,HMDB0060612,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,848.555597106,6.4242,M+ACN+H,C40H74N2O14,0,47.5,metab_1519,pos_2428,pos,229500,148500,164500,130000,153500,158300,149900,162700,215200,253700,181100,232900,,,,
"PE(18:0/20:4(5Z,8Z,11Z,14Z))",-,0.1193,0.2323,0.8769,1.2196,0.7352,-0.4438,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",LMGP02010118;PW_C005051;HMDB0009003,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,61216-62-4,748.528916344,6.83641666667,M-H2O-H,C43H78NO8P,0,30.9,metab_6549,neg_1184,neg,1693000,1091000,850900,1384000,1233000,759900,1271000,2054000,1346000,1596000,2279000,997900,,,,
Strophanthidin,¶¾Ã«Ðý»¨ÜÕÅä»ù,0.1404,0.2581,0.8744,0.8471,0.5193,-0.9454,no,down,C19988,-,-,-,-,-,-,HMDB0258516;LMST01120005,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroid lactones",66-28-4,385.199463384,6.34248333333,M-H2O-H,C23H32O6,0,72.7,metab_7177,neg_1754,neg,52600,54610,48680,55870,34300,39740,43410,64860,69670,208000,53310,111000,,,,
"PC(18:3(9Z,12Z,15Z)/18:1(11Z))",-,0.1471,0.2758,0.8743,0.8545,1.4038,0.4893,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008202;LMGP01012178;PW_C004250,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,804.550821336,7.07633333333,M+Na,C44H80NO8P,0,93.6,metab_3074,pos_4044,pos,9573000,27420000,23130000,27550000,33970000,24990000,15860000,18850000,17830000,8659000,30270000,13000000,,,,
"3-Oxo-12,18-ursadien-28-oic acid",-,0.1358,0.2529,0.873,0.8378,1.3034,0.3823,no,up,-,-,-,-,-,-,-,HMDB0037065,"Lipids and lipid-like molecules","Prenol lipids",Triterpenoids,273223-69-1,489.277256522,6.74991666667,M+K-2H,C30H44O3,0,70.9,metab_6521,neg_1159,neg,261500,167900,198400,232600,300500,215400,147200,169500,201900,291800,111100,134400,,,,
PC(18:1(9Z)e/2:0),-,0.1799,0.3176,0.8649,0.7193,0.6838,-0.5484,no,down,C04598,-,-,map00565;map01100;map04080;map05310,"Ether lipid metabolism;Metabolic pathways;Neuroactive ligand-receptor interaction;Asthma","Metabolism;Metabolism;Environmental Information Processing;Human Diseases","Lipid metabolism;Global and overview maps;Signaling molecules and interaction;Immune disease",HMDB0011148,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,572.36783294,7.65663333333,M+Na,C28H56NO7P,0,77.5,metab_2720,pos_3666,pos,1524000,707900,1435000,640400,621800,926200,950600,1385000,1446000,2665000,1007000,1109000,,,,
Lopirazepam,ÀÍÀ­Î÷ãú,0.1723,0.3082,0.8639,0.7309,1.0621,0.0869,no,up,-,-,-,-,-,-,-,HMDB0254160,"Organoheterocyclic compounds",Pyridodiazepines,"Not Available",-,285.996082401,3.16633333333,M+H-2H2O,C14H9Cl2N3O2,0,41.5,metab_4931,pos_5845,pos,475800,479100,473200,516800,540800,573100,520700,476000,443800,467700,499800,471700,,,,
Dec-7-enedioylcarnitine,"¹ï- 7 -Ï©¶þõ£»ùÈâ¼î",0.1427,0.2701,0.8625,0.8939,0.4869,-1.0383,no,down,-,-,-,-,-,-,-,HMDB0241085,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,344.206063568,4.70156666667,M+H,C17H29NO6,0,61.6,metab_4774,pos_5699,pos,264700,243100,679200,123500,376500,415600,536300,381800,951700,354000,442100,1652000,,,,
DL-Homoserine,"DL -¸ßË¿°±Ëá",0.1198,0.2413,0.8583,0.8242,0.9129,-0.1315,no,down,-,-,-,-,-,-,-,-,-,-,-,-,120.065591872,0.6731,M+H,C4H9NO3,49.6,0,metab_5467,pos_6353,pos,591600,698500,570300,643200,608100,667700,733400,656700,807800,615200,642500,684300,,,,
Cytosine,°ûà×à¤,0.1519,0.282,0.8561,0.9456,1.3734,0.4578,no,up,C00380,"Nucleic acids",Bases,map00240;map01100,"Pyrimidine metabolism;Metabolic pathways",Metabolism;Metabolism,"Nucleotide metabolism;Global and overview maps",HMDB0000630;MJDBOTE0000458,"Organoheterocyclic compounds",Diazines,"Pyrimidines and pyrimidine derivatives",71-30-7,112.05065601,3.27618333333,M+H,C4H5N3O,95.1,0,metab_4904,pos_5818,pos,260500,302500,319900,79780,242500,324100,169000,141800,296800,158800,184200,162900,,,,
Phenylacetylglycine,±½ÒÒõ£¸Ê°±Ëá,0.1579,0.2898,0.8558,0.9408,0.6563,-0.6076,no,down,C05598,-,-,map00360,"Phenylalanine metabolism",Metabolism,"Amino acid metabolism",HMDB0000821;MJDBOTE0000576,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",500-98-1,194.08095713,3.9843,M+H,C10H11NO3,73.2,0,metab_4832,pos_5751,pos,1211000,585400,1358000,568200,679500,984900,1727000,769800,2364000,1091000,653200,1601000,,,,
"2-Hydroxyadipic acid","2 -ôÇ»ù¼º¶þËá",0.1534,0.2841,0.8538,1.118,1.0281,0.04,no,up,C02360,-,-,-,-,-,-,LMFA01170049;HMDB0000321,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",18294-85-4,127.03893861,0.458266666667,"M+H-H2O, M+H, M+H-2H2O",C6H10O5,0,30.2,metab_2454,pos_34,pos,3945000,4303000,4198000,4193000,4139000,4207000,4271000,3904000,3922000,4053000,4035000,4117000,,,,
"PE(20:3(8Z,11Z,14Z)/16:0)",-,0.1331,0.249,0.851,1.1947,0.7279,-0.4582,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",LMGP02010908;HMDB0009352;PW_C005400,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,722.513523568,6.83641666667,M-H2O-H,C41H76NO8P,0,38.1,metab_6548,neg_1183,neg,2309000,1470000,1222000,1862000,1515000,1030000,1746000,2693000,1546000,2281000,3269000,1390000,,,,
"Gluconic acid",ÆÏÌÑÌÇËá,0.1771,0.3142,0.8497,0.9315,0.7004,-0.5137,no,down,C00257,Carbohydrates,Monosaccharides,map01100;map00030;map01200,"Metabolic pathways;Pentose phosphate pathway;Carbon metabolism",Metabolism;Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism;Global and overview maps",HMDB0000625;HMDB0303730,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",526-95-4,241.029036751,0.665266666667,M+2Na-H,C6H12O7,0,39.4,metab_5475,pos_6360,pos,306500,229900,573600,126700,201200,325400,451600,230800,517000,616600,279000,422800,,,,
Alpha-Methylene-Gamma-Butyrolactone,"¦Á -ÑÇ¼×»ù- ¦Ã -¶¡ÄÚõ¥",0.1252,0.2476,0.8466,0.9269,0.9682,-0.0466,no,down,C20578,-,-,-,-,-,-,HMDB0246945,"Organoheterocyclic compounds",Lactones,"Gamma butyrolactones",-,99.0443197973,1.91188333333,"M+H-H2O, M+H",C5H6O2,65.4,0,metab_2196,pos_312,pos,492400,474300,481700,475900,486000,508400,526700,480900,502500,491200,488700,524500,,,,
3-ureido-isobutyrate,"3 -ëå»ù-Òì¶¡Ëá",0.1675,0.302,0.8461,0.8046,1.1207,0.1644,no,up,C05100,-,-,-,-,-,-,HMDB0304156,"Organic acids and derivatives","Organic carbonic acids and derivatives",Ureas,-,191.03999548,0.665266666667,"M+Na, M+2Na-H, M+K",C5H10N2O3,0,47.5,metab_719,pos_167,pos,4182000,3544000,3617000,4005000,3952000,3818000,3916000,3226000,4365000,2686000,3384000,3052000,,,,
"Malic Acid",Æ»¹ûËá,0.1621,0.2847,0.8458,0.8247,0.6985,-0.5177,no,down,C00149,"Organic acids","Carboxylic acids",map01100;map00630;map05211;map05200;map04964;map01200;map00620;map04922;map00020;map05230;map04742,"Metabolic pathways;Glyoxylate and dicarboxylate metabolism;Renal cell carcinoma;Pathways in cancer;Proximal tubule bicarbonate reclamation;Carbon metabolism;Pyruvate metabolism;Glucagon signaling pathway;Citrate cycle (TCA cycle);Central carbon metabolism in cancer;Taste transduction","Metabolism;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Metabolism;Metabolism;Organismal Systems;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Carbohydrate metabolism;Cancer: specific types;Cancer: overview;Excretory system;Global and overview maps;Carbohydrate metabolism;Endocrine system;Carbohydrate metabolism;Cancer: overview;Sensory system",PW_C000592;HMDB0000156;MJDBOTE0000694,"Organic acids and derivatives","Hydroxy acids and derivatives","Beta hydroxy acids and derivatives",6915-15-7;617-48-1;97-67-6,133.013228408,0.714166666667,M-H,C4H6O5,96.1,0,metab_9042,neg_2312,neg,1594000,1776000,1603000,1243000,1291000,1793000,2021000,1881000,1750000,1581000,1865000,4217000,,,,
PC(18:1(11Z)/14:1(9Z)),-,0.1643,0.2977,0.8442,1.2995,0.303,-1.7226,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008065;PW_C004114,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,730.536769376,7.71138333333,M+H,C40H76NO8P,0,54.3,metab_2355,pos_3298,pos,216400,253700,86960,1757000,307400,141900,742600,1282000,2102000,39090,4313000,643500,,,,
11-Epi-PGF2a,-,0.165,0.2873,0.8439,0.8089,0.5607,-0.8347,no,down,C05959,-,-,map00590,"Arachidonic acid metabolism",Metabolism,"Lipid metabolism",HMDB0010199;PW_C006776;HMDB0011137,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,-,353.23296848,6.21478333333,M-H,C20H34O5,0,69.9,metab_7223,neg_1796,neg,278100,360300,879900,685300,278100,413600,411500,1269000,1713000,514500,348900,906600,,,,
"3-Hydroxytetradecanoyl carnitine","3 -ôÇ»ùÊ®ËÄÍéõ£»ùÈâ¼î",0.1444,0.2721,0.8435,0.8385,1.291,0.3685,no,up,-,-,-,-,-,-,-,HMDB0061640,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",282523-64-2,370.294454144,6.27195,M+H-H2O,C21H41NO5,0,57,metab_1402,pos_2315,pos,5111000,5943000,8286000,7693000,7706000,8725000,3789000,6822000,8053000,3626000,7498000,3877000,,,,
6-Hydroxynon-5-enoylcarnitine,"6 -ôÇ»ù- 5 -Ï©õ£»ùÈâ¼î",0.1509,0.2804,0.8406,0.871,0.5531,-0.8544,no,down,-,-,-,-,-,-,-,HMDB0241754,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,316.211126687,3.92213333333,M+H,C16H29NO5,0,85,metab_4838,pos_5757,pos,17670,52130,82050,5879,48120,36710,54930,29010,129000,52580,47830,125200,,,,
"Hippuric Acid",ÂíÄòËá,0.1715,0.2956,0.8396,0.8097,0.6105,-0.7119,no,down,C01586,-,-,map01100;map00360,"Metabolic pathways;Phenylalanine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0000714;MJDBOTE0000525,Benzenoids,"Benzene and substituted derivatives","Benzoic acids and derivatives",495-69-2,178.050105925,4.17541666667,M-H,C9H9NO3,41.7,0,metab_7462,neg_2012,neg,63560,33270,73240,174700,64820,52330,159400,54570,174200,102100,57630,208600,,,,
"DG(a-15:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)",-,0.1359,0.2617,0.8391,0.8254,1.3965,0.4818,no,up,-,-,-,-,-,-,-,HMDB0297475,"Not Available","Not Available","Not Available",-,663.452622544,7.29886666667,M+2Na-H,C38H66O6,0,63,metab_2923,pos_3885,pos,2770000,2038000,1666000,1426000,1784000,1688000,929900,1068000,1029000,2628000,1489000,998000,,,,
Daucol,ºúÂÜ²·´¼,0.1748,0.2994,0.8391,0.7537,0.7593,-0.3973,no,down,C09652,-,-,-,-,-,-,HMDB0035287,"Organoheterocyclic compounds",Oxanes,"Not Available",887-08-1,283.191125178,6.28065,M+FA-H,C15H26O2,0,36.1,metab_6390,neg_1038,neg,45280,63490,41390,66140,43220,77660,73290,98970,103500,37990,54060,76350,,,,
"PE(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/22:1(13Z))",-,0.144,0.2619,0.8364,0.8219,0.8784,-0.1871,no,down,-,-,-,-,-,-,-,HMDB0283887,"Not Available","Not Available","Not Available",-,876.57649411,7.48398333333,"M-H, M+Na-2H, M+FA-H",C49H84NO10P,0,58,metab_8362,neg_38,neg,4638000,3344000,2691000,3470000,3598000,3406000,3791000,3866000,4563000,3663000,3742000,4452000,,,,
LysoPC(17:0/0:0),-,0.2003,0.343,0.8354,0.7451,0.7466,-0.4216,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0012108,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,50930-23-9,510.354535675,7.44245,M+H,C25H52NO7P,0,91.3,metab_2226,pos_3149,pos,10590000,5617000,9119000,5237000,4334000,4136000,5944000,9929000,8927000,13540000,8183000,5758000,,,,
"Ethyl octanoate",-,0.1871,0.3152,0.8315,0.7471,1.2198,0.2866,no,up,C12292,-,-,-,-,-,-,HMDB0040195;LMFA07010447,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",106-32-1,209.094115488,6.70285,M+K-2H,C10H20O2,0,39.7,metab_7064,neg_1650,neg,185500,132700,139800,139400,148400,143100,80150,113600,108400,193100,140300,93430,,,,
"PC(18:0/18:3(9Z,12Z,15Z))",-,0.1567,0.2888,0.8295,0.8112,0.5693,-0.8127,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",LMGP01011589;PW_C004090;HMDB0008041,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,806.567545116,6.24801666667,"M+H, M+2Na-H, M+Na",C44H82NO8P,0,89.4,metab_364,pos_133,pos,86090000,81130000,60280000,67040000,82650000,81910000,103900000,148400000,167800000,58920000,48740000,278700000,,,,
"PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))",-,0.1826,0.3212,0.8292,0.7227,1.463,0.5489,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004741;HMDB0008693,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,828.550178133,6.89368333333,M+Na,C46H80NO8P,0,92.6,metab_1891,pos_2800,pos,5469000,35120000,29520000,27240000,41040000,29030000,18910000,19030000,18710000,4843000,32820000,20130000,,,,
"PA(5-iso PGF2VI/P-16:0)",-,0.169,0.3037,0.8245,0.8901,0.2145,-2.221,no,down,-,-,-,-,-,-,-,HMDB0266736,"Not Available","Not Available","Not Available",-,716.460073937,6.12123333333,2M+3H2O+2H,C37H67O10P,0,63.2,metab_1266,pos_2170,pos,9449,20460,24590,28430,9220,12800,83870,10540,32010,55940,32830,273900,,,,
Retaspimycin,ÈðËûÃ¹ËØ,0.1621,0.2847,0.8228,0.816,1.2625,0.3363,no,up,-,-,-,-,-,-,-,HMDB0257169,"Phenylpropanoids and polyketides",Macrolactams,"Not Available",-,586.315170155,6.39361666667,M-H,C31H45N3O8,0,68.2,metab_7166,neg_1743,neg,156200,94130,116700,146900,120700,117200,72800,122100,76980,151200,112600,59920,,,,
"P-Tolyl Sulfate",-,0.1746,0.2993,0.8144,0.8502,1.4711,0.5569,no,up,-,-,-,-,-,-,-,-,-,-,-,-,187.006234641,4.7436,M-H,C7H8O4S,35.8,0,metab_7431,neg_1986,neg,4709000,6724000,5286000,2746000,6191000,9174000,2355000,1794000,8059000,3106000,3720000,4645000,,,,
Sweroside,µ±Ò©¿àÜÕ,0.1906,0.331,0.8144,0.8421,0.4956,-1.0128,no,down,C17071,-,-,-,-,-,-,HMDB0258643;MJDBOTE0001224,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",14215-86-2,359.130331298,3.22081666667,M+H,C16H22O9,0,31.9,metab_785,pos_1730,pos,94750,256200,661000,2665,116700,129700,217600,48250,811500,566700,277400,622900,,,,
PC(24:1(15Z)/16:0),-,0.2044,0.3479,0.8143,0.7218,0.5113,-0.9678,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004839;HMDB0008791,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,826.663329315,7.33083333333,M+H-H2O,C48H94NO8P,0,69.6,metab_2906,pos_3866,pos,42200,5655,26330,23390,19100,27160,15840,50000,111600,64140,11680,28010,,,,
PG(PGJ2/a-21:0),-,0.1868,0.3265,0.8128,0.793,0.3495,-1.5166,no,down,-,-,-,-,-,-,-,HMDB0270874,"Not Available","Not Available","Not Available",-,888.596805604,6.80583333333,"M+NH4, M+ACN+H",C47H83O12P,0,36.1,metab_5690,pos_656,pos,23570,31060,87650,27530,33100,52950,32580,63750,306200,64090,8776,256500,,,,
Oxindole,2-ßÅßáÍª,0.1396,0.266,0.8105,1.0446,1.3829,0.4677,no,up,C12312,-,-,-,-,-,-,HMDB0244886;HMDB0061918,"Organoheterocyclic compounds","Indoles and derivatives",Hydroxyindoles,59-48-3,134.059927403,3.40471666667,M+H,C8H7NO,77.8,0,metab_4889,pos_5804,pos,138700,113900,166900,68310,94450,76770,80530,78210,128700,72770,56790,59360,,,,
"P-Coumaric Acid",-,0.19,0.3301,0.8105,0.808,0.8168,-0.2919,no,down,C00811,-,-,map01100;map00130;map00350,"Metabolic pathways;Ubiquinone and other terpenoid-quinone biosynthesis;Tyrosine metabolism",Metabolism;Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins;Amino acid metabolism",HMDB0003654;HMDB0002035;HMDB0030677;MJDBOTE0000719,"Phenylpropanoids and polyketides","Cinnamyl alcohols","Not Available",20649-40-5;7400-08-0;501-98-4;4501-31-9;501-98-4,182.080971131,0.806533333333,"M+H, M+NH4",C9H8O3,41.8,0,metab_6342,pos_282,pos,2300000,2670000,1827000,2248000,1991000,2582000,3231000,2097000,2945000,3682000,3152000,1567000,,,,
"PA(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))",PA£¨22:5£¨7Z£¬10Z£¬13Z£¬16Z£¬19Z£©/22:5£¨4Z£¬7Z£¬10Z£¬13Z£¬16Z£©£©,0.1859,0.3252,0.8104,1.0085,1.9249,0.9448,no,up,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",HMDB0115396;PW_C062822,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,814.537164475,7.1632,M+NH4,C47H73O8P,0,30.4,metab_3010,pos_3973,pos,31980,35500,85050,29150,13400,115300,31530,26300,29700,21720,15960,36040,,,,
"3,4-Dihydro-9-hydroxy-[1]benzothieno[2,3-f]-1,4-thiazepin-5(2H)-one","3,4-¶þÇâ-9-ôÇ»ù-[1]±½²¢àç·Ô²¢[2,3-f]-1,4-ÁòµªÔÓ-5£¨2H£©-Íª",0.1802,0.3064,0.81,0.8544,1.4972,0.5823,no,up,-,-,-,-,-,-,-,HMDB0253770,"Organoheterocyclic compounds",Benzothiophenes,1-benzothiophenes,-,271.984361557,4.7436,M+Na-2H,C11H9NO2S2,0,39.8,metab_7430,neg_1985,neg,134600,189500,151800,67610,169700,244600,58370,41450,230000,76940,103500,129100,,,,
"PE(18:0/20:4(8Z,11Z,14Z,17Z))",-,0.1582,0.29,0.8019,1.1589,0.8268,-0.2744,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0009004;PW_C005052,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,768.553255402,7.53776666667,M+H,C43H78NO8P,0,72.2,metab_2788,pos_3748,pos,5858000,5267000,3651000,4411000,4021000,3623000,5299000,6589000,3693000,4565000,6821000,5490000,,,,
Rhamnose,ÊóÀîÌÇ,0.1774,0.3026,0.799,0.7987,0.9054,-0.1434,no,down,C00507,Carbohydrates,Monosaccharides,map01100;map00051,"Metabolic pathways;Fructose and mannose metabolism",Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism",HMDB0000849;MJDBOTE0001343,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",3615-41-6,163.060233621,0.266333333333,M-H,C6H12O5,79.4,0,metab_8224,neg_2724,neg,116400,113200,114300,112400,121900,128400,124400,111000,121100,126400,131500,165300,,,,
Acetylglycine,N-ÒÒõ£¸Ê°±Ëá,0.1451,0.2635,0.7983,0.7936,0.8691,-0.2024,no,down,-,-,-,-,-,-,-,HMDB0000532,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",543-24-8,116.034263074,0.761133333333,M-H,C4H7NO3,49,0,metab_7725,neg_2258,neg,360400,309000,370400,270600,375200,394000,395300,315400,425100,487600,435800,333600,,,,
"PE(22:2(13Z,16Z)/PGD2)",-,0.1799,0.3176,0.7967,0.7134,0.7061,-0.5021,no,down,-,-,-,-,-,-,-,HMDB0283948,"Not Available","Not Available","Not Available",-,909.604367062,6.63835,M+ACN+H,C47H82NO11P,0,31.5,metab_1681,pos_2579,pos,46050,122100,259000,220900,236100,171300,275500,367500,159000,278600,113800,300100,,,,
"8,8-Diethoxy-2,6-dimethyl-2-octanol","8£¬8 -¶þÒÒÑõ»ù- 2£¬6 -¶þ¼×»ù- 2 -ÐÁ´¼",0.1888,0.3289,0.7966,0.8365,1.669,0.739,no,up,-,-,-,-,-,-,-,HMDB0034557,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",7779-94-4,310.234693882,6.19298333333,M+ACN+Na,C14H30O3,0,79.6,metab_4136,pos_5101,pos,85860,160100,180000,188800,323600,217200,97960,87730,50170,76510,331900,48010,,,,
"1,11-Undecanedicarboxylic acid","1£¬11 -Ê®Ò»Íé¶þôÈËá",0.1994,0.3288,0.7942,0.7756,0.676,-0.5649,no,down,-,-,-,-,-,-,-,HMDB0002327,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",505-52-2,265.14418369,6.20003333333,"M-H, M+Na-2H",C13H24O4,0,42.8,metab_7881,neg_241,neg,64300,73560,52450,38320,76950,64290,135200,80570,75640,51590,41210,163000,,,,
"Nonactinic Acid",·Ç¹â»¯ÐÔµÄËá,0.1679,0.2913,0.7932,0.9523,0.7643,-0.3878,no,down,-,-,-,-,-,-,-,-,-,-,-,-,201.112495412,5.02508333333,M-H,C10H18O4,47.5,0,metab_7410,neg_1967,neg,293200,163800,266600,122000,154200,233600,348600,178100,287700,266500,177300,355900,,,,
"Dodecylbenzenesulfonic Acid",±íÃæ»îÐÔ¼ÁD,0.1821,0.3086,0.7932,0.7345,1.2571,0.3301,no,up,-,-,-,-,-,-,-,HMDB0059915;HMDB0031031,Benzenoids,"Benzene and substituted derivatives","Benzenesulfonic acids and derivatives",-,325.183957866,6.57505,M-H,C18H30O3S,69.6,0,metab_7120,neg_1701,neg,94760,92300,45310,93980,81340,52620,62200,46450,73210,82110,56000,46190,,,,
"4-hydroxy Nonenal",-,0.165,0.2989,0.7922,0.8165,1.1185,0.1616,no,up,-,-,-,-,-,-,-,-,-,-,-,-,139.111511793,7.44245,"M+H-2H2O, M+H-H2O, M+H",C9H16O2,49.2,0,metab_6299,pos_97,pos,850000,670700,644800,692400,710100,692200,607400,573900,548800,825900,631100,621500,,,,
"2,2'-Anhydrocytidine","2£¬2 ' -ÍÑË®°ûÜÕ",0.2042,0.3477,0.7905,0.7017,0.6898,-0.5357,no,down,-,-,-,-,-,-,-,HMDB0243629,"Organic oxygen compounds","Organooxygen compounds",Ethers,-,248.063737993,0.704516666667,"M+Na, M+K, M+H",C9H11N3O4,0,42.7,metab_828,pos_177,pos,800200,780200,1783000,361300,718100,1252000,1053000,1032000,2520000,1480000,1034000,1138000,,,,
"Pipecolic Acid",ßß¿ÉËá,0.1641,0.2975,0.7903,0.8008,1.1138,0.1555,no,up,C00408,-,-,map01100;map00310,"Metabolic pathways;Lysine degradation",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0000716;HMDB0000070;MJDBOTE0000664,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",535-75-1;3105-95-1,130.086199224,0.71195,M+H,C6H11NO2,58.5,0,metab_5401,pos_6290,pos,1218000,1498000,1317000,1640000,1285000,1379000,1200000,1018000,1531000,1276000,1301000,1162000,,,,
PE(16:0/18:1(11Z)),-,0.1638,0.2863,0.7898,1.0236,0.784,-0.3511,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",PW_C004974;HMDB0008926;LMGP02010010,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,738.508343456,6.68715,M+Na-2H,C39H76NO8P,0,67.9,metab_7075,neg_1660,neg,11150000,7449000,5880000,7652000,5673000,5041000,8233000,12350000,6374000,9350000,11170000,7170000,,,,
"1-Nitro-5-hydroxy-6-glutathionyl-5,6-dihydronaphthalene","1-Ïõ»ù-5-ôÇ»ù-6-¹Èë×¸ÊëÄ-5,6-¶þÇâÝÁ",0.191,0.3312,0.7894,0.7677,0.5385,-0.893,no,down,C14805,-,-,map00980,"Metabolism of xenobiotics by cytochrome P450",Metabolism,"Xenobiotics biodegradation and metabolism",HMDB0060327,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,497.13270938,4.159,M+H,C20H24N4O9S,0,60.7,metab_875,pos_1811,pos,183600,66770,207200,21010,132600,110400,225600,178800,502300,96850,56160,280500,,,,
"PE-NMe2(15:0/20:3(8Z,11Z,14Z))",-,0.1767,0.3018,0.7891,0.7586,1.1766,0.2346,no,up,C04308,-,-,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0113927;PW_C059943,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,800.545282084,7.49183333333,M+FA-H,C42H78NO8P,0,77.6,metab_6918,neg_1517,neg,3817000,2981000,2365000,4070000,4076000,3799000,2511000,2359000,3773000,3211000,3390000,2694000,,,,
PE(PGJ2/22:0),-,0.1752,0.3117,0.7846,1.1172,1.4682,0.554,no,up,-,-,-,-,-,-,-,HMDB0283747,"Not Available","Not Available","Not Available",-,876.568061959,7.65663333333,M+Na,C47H84NO10P,0,58.9,metab_2329,pos_3266,pos,5950000,6720000,4556000,5279000,1005000,6936000,4821000,3119000,3331000,5214000,728100,3526000,,,,
Lysyl-Glycine,Àµ°±õ£-¸Ê°±Ëá,0.2181,0.3651,0.7818,0.8552,0.7739,-0.3698,no,down,-,-,-,-,-,-,-,HMDB0028951;HMDB0304784,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",7563-03-3,245.160309614,1.90388333333,M+ACN+H,C8H17N3O3,0,35.9,metab_623,pos_1582,pos,140900,176100,252600,116900,111200,151000,207100,106000,307400,241700,165300,198400,,,,
"Smilanippin A",³¤Ò¶Å£Î²²Ë½ä,0.2122,0.3584,0.7787,0.7139,1.5909,0.6698,no,up,-,-,-,-,-,-,-,HMDB0041354,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroidal glycosides",166736-13-6,788.455491517,6.9337,M+ACN+Na,C39H64O12,0,36.9,metab_1922,pos_2831,pos,109200,178.1,56830,52960,119000,104000,19200,66190,44160,46120,58440,43780,,,,
LysoPA(16:0/0:0),-,0.2217,0.3544,0.7772,0.7419,1.906,0.9305,no,up,C04036,-,-,-,-,-,-,HMDB0007853,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,391.225130133,6.92971666667,M-H2O-H,C19H39O7P,0,62.9,metab_6571,neg_1203,neg,340200,365500,448900,230200,539300,496800,26740,25070,126300,870400,73950,148100,,,,
Deoxyloganin,-,0.2053,0.3491,0.7755,0.9306,0.4975,-1.0072,no,down,C06071,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",LMPR0102070005;HMDB0251007,"Lipids and lipid-like molecules","Prenol lipids","Terpene glycosides",26660-57-1,357.151128378,4.44733333333,M+H-H2O,C17H26O9,0,60,metab_888,pos_1823,pos,46170,74300,213700,6570,43400,52840,88970,15940,244600,157800,69000,301800,,,,
Mevastatin,ÃÀ·¥ËûÍ¡,0.1902,0.3192,0.7743,0.7567,0.6852,-0.5454,no,down,C13963,-,-,-,-,-,-,HMDB0254692;MJDBOTE0001563,"Organoheterocyclic compounds",Lactones,"Delta valerolactones",73573-88-3,411.214994325,6.37583333333,M+Na-2H,C23H34O5,0,63.3,metab_6410,neg_1056,neg,53710,47380,43410,59550,38980,52580,52220,32400,53490,135600,70540,87180,,,,
"PE(PGD2/18:2(9Z,12Z))",-,0.1661,0.3003,0.7709,0.746,0.4665,-1.1001,no,down,-,-,-,-,-,-,-,HMDB0261429,"Not Available","Not Available","Not Available",-,875.512218582,7.21893333333,M+ACN+Na,C43H74NO11P,0,52.6,metab_2129,pos_3049,pos,30740,103300,20920,17460,17920,18840,26330,94100,85390,26990,45830,169700,,,,
Cortolone,Æ¤ÍªËÄ´¼,0.2064,0.3373,0.7701,0.7632,0.654,-0.6126,no,down,C05481,-,-,map00140,"Steroid hormone biosynthesis",Metabolism,"Lipid metabolism",HMDB0003128;LMST02030227,"Lipids and lipid-like molecules","Steroids and steroid derivatives",Hydroxysteroids,516-42-7,387.214904136,6.39361666667,M+Na-2H,C21H34O5,0,58.9,metab_6412,neg_1058,neg,277400,406800,416100,566200,338500,399300,625100,223600,490100,1128000,300000,909400,,,,
LysoPE(0:0/16:0),-,0.1795,0.3172,0.7694,0.7536,1.4163,0.5021,no,up,-,-,-,-,-,-,-,HMDB0011473,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,476.274196396,6.77386666667,M+Na,C21H44NO7P,0,84.4,metab_3385,pos_4367,pos,350500,259900,214500,251000,243200,209500,185800,82630,105300,361500,257000,87440,,,,
N-Isobutyryl-L-cysteine,"N -Òì¶¡õ£»ù- L -°ëë×°±Ëá",0.2072,0.3517,0.7668,0.7202,0.6734,-0.5705,no,down,-,-,-,-,-,-,-,HMDB0255162,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,174.058164039,2.80135,M+H-H2O,C7H13NO3S,0,33.5,metab_4993,pos_5902,pos,157800,90380,277800,31120,71130,257200,150500,302600,334600,143400,199600,184600,,,,
7-O-Acetylaustroinulin,"7 - O -ÒÒõ£¸²Åè×ÓËØ",0.1838,0.3226,0.7654,0.7153,0.6525,-0.616,no,down,-,-,-,-,-,-,-,HMDB0036804,"Lipids and lipid-like molecules","Prenol lipids",Diterpenoids,-,382.294286231,6.24801666667,"M+NH4, 2M+ACN+Na",C22H36O4,0,42,metab_4112,pos_508,pos,194300,288300,543200,104500,502600,299400,197000,408200,615800,317400,563700,858700,,,,
Acetylcysteine,ÒÒõ£°ëë×°±Ëá,0.2338,0.3819,0.7636,0.7731,0.6973,-0.5201,no,down,C06809,-,-,-,-,-,-,HMDB0001890;HMDB0000574;MJDBOTE0001037,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",616-91-1;52-90-4,164.037358044,3.62498333333,M+H,C5H9NO3S,64.8,0,metab_6334,pos_5783,pos,22100,9116,38360,6411,11770,17970,22610,14420,41020,26170,20420,26980,,,,
"4-Vinylphenol sulfate","4 -ÒÒÏ©»ù±½·ÓÁòËáÑÎ",0.2154,0.3476,0.759,0.87,0.3418,-1.5488,no,down,-,-,-,-,-,-,-,HMDB0062775,"Organic acids and derivatives","Organic sulfuric acids and derivatives",Arylsulfates,131351-90-1,245.011994946,4.32715,M+FA-H,C8H8O4S,0,74.7,metab_8847,neg_832,neg,6445,1250,50320,12850,1310,34060,43620,10350,92510,16220,1206,147000,,,,
LysoPC(18:0/0:0),-,0.2018,0.3317,0.7569,1.0397,1.1597,0.2138,no,up,C04317;C04230,-;Lipids,-;Phospholipids,map00565;map01100;map05231;map00564,"Ether lipid metabolism;Metabolic pathways;Choline metabolism in cancer;Glycerophospholipid metabolism","Metabolism;Metabolism;Human Diseases;Metabolism","Lipid metabolism;Global and overview maps;Cancer: overview;Lipid metabolism",HMDB0011149;HMDB0010384,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,74430-89-0;19420-57-6,568.361808376,7.51535,M+FA-H,C26H54NO7P,0,87.8,metab_9041,neg_1510,neg,29080000,29870000,40900000,27910000,24700000,27090000,24580000,25380000,26230000,34660000,20920000,23010000,,,,
Pro-leu,¸¬°±Ëá-ÁÁ°±Ëá,0.237,0.3859,0.7568,0.9247,0.8486,-0.2368,no,down,-,-,-,-,-,-,-,HMDB0253028,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,229.154265287,2.0399,"M+H-H2O, M+H",C11H20N2O3,0,30.9,metab_2245,pos_317,pos,1503000,1358000,2050000,1084000,1106000,1343000,1749000,1207000,2129000,1811000,1335000,1714000,,,,
Clarithromycin,¿ËÀ­Ã¹ËØ,0.1893,0.3293,0.7551,0.7337,0.769,-0.3789,no,down,C06912,-,-,-,-,-,-,PW_C009624;HMDB0015342;LMPK04000014;MJDBOTE0001505,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",81103-11-9,789.515153162,6.29546666667,M+ACN+H,C38H69NO13,0,31.7,metab_1428,pos_2343,pos,338600,101500,165000,335400,389100,325600,406600,277500,235300,462500,363400,407300,,,,
Lysylglutamine,Àµ°±õ£¹È°±õ£°·,0.2267,0.3751,0.7527,0.8307,0.5831,-0.7782,no,down,-,-,-,-,-,-,-,HMDB0028949,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",92352-82-4,319.137954726,3.2365,M+2Na-H,C11H22N4O4,0,48.6,metab_4914,pos_5829,pos,16870,80600,173400,12270,57160,47970,72120,13500,183800,147900,84290,164400,,,,
"MG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0/0:0)",-,0.2172,0.3644,0.7514,0.9176,1.2321,0.3011,no,up,-,-,-,-,-,-,-,HMDB0011580,"Lipids and lipid-like molecules",Glycerolipids,Monoradylglycerols,-,394.294608345,6.26395,M+NH4,C23H36O4,0,73.8,metab_1394,pos_2308,pos,1631000,1670000,1898000,1651000,1960000,1700000,951500,1750000,1921000,932200,2107000,871300,,,,
"Allyl nonanoate",-,0.2554,0.4077,0.7497,1.0035,0.7659,-0.3848,no,down,-,-,-,-,-,-,-,HMDB0029763;LMFA07010778,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",7493-72-3,414.357293628,6.48976666667,2M+NH4,C12H22O2,0,31,metab_3734,pos_4711,pos,71500,42190,105800,66850,64560,62710,56060,149400,97400,100700,89520,46850,,,,
1H-Imidazole-4-carboxamide,"1H -ßäßò- 4 -¼×õ£°·",0.2252,0.3738,0.7477,0.7499,0.7736,-0.3703,no,down,-,-,-,-,-,-,-,HMDB0244880,"Organic acids and derivatives","Carboxylic acids and derivatives","Carboxylic acid derivatives",-,112.0506673,0.704516666667,M+H,C4H5N3O,0,48.4,metab_420,pos_1388,pos,123900,143300,234700,43140,125000,184700,199000,125900,255700,200500,162400,161700,,,,
"PC(14:0/18:2(9Z,12Z))",-,0.1981,0.3272,0.7466,0.7532,1.3983,0.4837,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0007874;LMGP01010496;PW_C003924,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,92345-33-0,774.531128405,6.18483333333,M+FA-H,C40H76NO8P,0,87,metab_7246,neg_1816,neg,109700,523100,319100,385300,543500,531300,280000,283900,311300,89140,392000,368700,,,,
GPEtn(18:3/18:1),-,0.204,0.3475,0.7422,0.9388,0.7668,-0.3831,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0009125;HMDB0009158;HMDB0009157;HMDB0009150;HMDB0009124,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,740.521388062,6.9895,M+H,C41H74NO8P,97.5,0,metab_1963,pos_2875,pos,3321000,2592000,1325000,2286000,1434000,1354000,3049000,3490000,1297000,2686000,3124000,2411000,,,,
3-Hydroxy-3-methylglutarate,"3 -ôÇ»ù- 3 -¼×»ùÎì¶þËá",0.2122,0.3438,0.7385,0.9177,0.855,-0.226,no,down,C03761,-,-,-,-,-,-,HMDB0000355,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",503-49-1,161.044595289,0.854416666667,M-H,C6H10O5,77.5,0,metab_8660,neg_661,neg,940500,696900,1372000,742400,795800,946100,1175000,890600,1251000,972900,1017000,1121000,,,,
Gamithromycin,¼ÓÃ×Ã¹ËØ,0.1925,0.3331,0.7377,0.9625,0.597,-0.7442,no,down,-,-,-,-,-,-,-,HMDB0252606,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,799.530039355,7.1632,M+Na,C40H76N2O12,0,60.9,metab_2092,pos_3013,pos,27840,20310,16650,19500,52940,21390,20960,26090,45300,19710,84840,68880,,,,
"LysoPC(22:4(7Z,10Z,13Z,16Z)/0:0)",-,0.2842,0.4379,0.7363,0.7511,0.7321,-0.4499,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010401,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,572.37037606,6.90168333333,M+H,C30H54NO7P,0,75.1,metab_3252,pos_4229,pos,843700,462600,1012000,1084000,477800,506700,514300,1268000,810800,1840000,977200,580900,,,,
"PC(18:3(9Z,12Z,15Z)/16:0)",-,0.2282,0.3764,0.7314,1.1921,0.5569,-0.8445,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008199;LMGP01011677;PW_C004247,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,756.552002673,7.71138333333,M+H,C42H78NO8P,0,75.2,metab_2678,pos_3622,pos,7762000,10950000,7928000,19850000,12550000,10540000,15140000,16860000,26990000,2036000,49600000,14380000,,,,
Indole-3-acetaldehyde,ßÅßá-3-ÒÒÈ©,0.1906,0.3195,0.728,0.8149,0.8309,-0.2673,no,down,C00637,-,-,map01100;map00380,"Metabolic pathways;Tryptophan metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0001190,"Organoheterocyclic compounds","Indoles and derivatives",Indoles,2591-98-2,204.065875503,5.46773333333,"M-H, M+FA-H",C10H9NO,40.3,0,metab_7514,neg_206,neg,1570000,1631000,1803000,777500,1016000,1629000,1484000,1595000,2242000,1574000,1544000,1707000,,,,
"SM(d18:2(4E,14Z)/16:0)",-,0.2461,0.3963,0.7273,1.2728,0.2527,-1.9845,no,down,-,-,-,-,-,-,-,HMDB0240638,"Lipids and lipid-like molecules",Sphingolipids,Phosphosphingolipids,2292199-28-9,701.557763942,7.71925,M+H,C39H77N2O6P,0,48.4,metab_2366,pos_3308,pos,331500,285000,201300,625400,127100,94690,323500,1016000,800700,28360,4119000,297300,,,,
"Dioctyl succinate",¶¡¶þËá¶þÐÁõ¥,0.207,0.3515,0.7262,0.7119,1.0973,0.134,no,up,-,-,-,-,-,-,-,-,-,-,-,-,427.377323691,7.44245,"M+H, M+NH4",C26H50O4,50.5,0,metab_6102,pos_789,pos,37580000,29980000,28060000,29590000,31580000,30000000,27100000,25470000,25550000,35390000,29400000,27300000,,,,
GPEtn(18:3/18:0),-,0.2318,0.3802,0.7223,1.0072,0.7772,-0.3636,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0009148;HMDB0009156;HMDB0009123,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,742.536946967,7.1632,M+H,C41H76NO8P,94.4,0,metab_2091,pos_3012,pos,1003000,568200,369300,578600,444400,416600,711700,928900,433800,876400,877800,520000,,,,
"Trimethylamine N-oxide",Èý¼×°·N-Ñõ»¯Îï,0.2766,0.4302,0.7212,0.8368,0.6529,-0.6151,no,down,C01104,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0000925,"Organic nitrogen compounds","Organonitrogen compounds",Aminoxides,1184-78-7,76.0761552137,0.6731,"M+H, M+Na, 2M+H",C3H9NO,96.3,0,metab_741,pos_169,pos,498200,746100,2537000,1234000,391200,781600,1450000,657500,2827000,2161000,649800,1730000,,,,
VERATRAMINE,Þ¼Â«°·,0.281,0.4348,0.7211,0.6729,0.7769,-0.3642,no,down,C10829,-,-,-,-,-,-,HMDB0259781,Benzenoids,Fluorenes,"Not Available",60-70-8,473.31515601,6.25598333333,M+ACN+Na,C27H39NO2,0,60.7,metab_4039,pos_5000,pos,216000,481700,503700,449200,368500,279100,370500,408000,555300,831900,544400,247800,,,,
"PC(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))",-,0.2357,0.3843,0.7183,1.0025,0.5378,-0.8949,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008240;LMGP01011716;PW_C004288,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,815.540434101,7.21095,M+ACN+H,C44H72NO8P,0,54.4,metab_2970,pos_3933,pos,37460,27460,31450,57210,54140,45630,42050,34750,49700,37230,200100,107200,,,,
"Acetoacetic acid",ÒÒõ£ÒÒËá,0.2246,0.3576,0.7164,0.9488,0.8505,-0.2336,no,down,C00164,"Organic acids","Carboxylic acids",map01100;map00310;map00640;map00650;map00350;map00280,"Metabolic pathways;Lysine degradation;Propanoate metabolism;Butanoate metabolism;Tyrosine metabolism;Valine, leucine and isoleucine degradation",Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism;Carbohydrate metabolism;Carbohydrate metabolism;Amino acid metabolism;Amino acid metabolism",PW_C000042;HMDB0304256;HMDB0000060;LMFA01060003,"Organic acids and derivatives","Keto acids and derivatives","Short-chain keto acids and derivatives",541-50-4,147.028898342,0.846733333333,"M+FA-H, 2M+Hac-H",C4H6O3,0,32.9,metab_6822,neg_143,neg,226100,215000,279100,205300,161000,234000,253700,194800,294900,259700,194900,355000,,,,
Dimethylethanolamine,¶þ¼×»ùÒÒ´¼°·,0.2418,0.3918,0.7155,0.9883,1.0825,0.1144,no,up,C04308,-,-,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0032231,"Organic nitrogen compounds","Organonitrogen compounds",Amines,108-01-0,90.0916857215,0.990466666667,M+H,C4H11NO,0,39.3,metab_5207,pos_6099,pos,399600,337700,300000,345800,315000,348500,359000,318400,326300,314500,244300,328100,,,,
PG(16:0/0:0)[U],-,0.2071,0.3381,0.7139,0.7531,0.6906,-0.5341,no,down,-,-,-,-,-,-,-,-,-,-,-,-,483.272528135,6.71068333333,M-H,C22H45O9P,66.6,0,metab_7057,neg_1644,neg,370900,157600,307400,239500,211300,206600,211600,281000,326400,684100,443400,216100,,,,
3-Hydroxybenzaldehyde,3-ôÇ»ù±½¼×È©,0.2663,0.4197,0.7073,0.806,0.8499,-0.2346,no,down,C03067,-,-,-,-,-,-,-,-,-,-,100-83-4,123.044086754,1.7919,M+H,C7H6O2,56.5,0,metab_5164,pos_6059,pos,95880,108100,79290,97880,89900,100600,125100,88420,128800,138900,133400,57760,,,,
"2-Hydroxycinnamic acid","2 -ôÇ»ùÈâ¹ðËá",0.2665,0.4198,0.707,0.7896,0.8458,-0.2416,no,down,C05838;C01772,-,-,map01100;map00360,"Metabolic pathways;Phenylalanine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0002641;HMDB0041592,"Phenylpropanoids and polyketides","Cinnamic acids and derivatives","Hydroxycinnamic acids and derivatives",495-79-4;614-60-8,182.080957212,1.7919,"M+H, M+NH4, M+H-H2O",C9H8O3,64.5,0,metab_6332,pos_61,pos,1536000,1733000,1257000,1493000,1371000,1593000,1972000,1369000,1998000,2239000,2135000,907300,,,,
"PC(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.1987,0.3411,0.706,0.9257,0.8338,-0.2622,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",LMGP01011925;PW_C004500;HMDB0008452,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,854.56712015,6.98155,M+H,C50H80NO8P,0,81.9,metab_3166,pos_4143,pos,746300,543000,373400,668300,658900,483300,828300,703500,490100,530300,850200,763600,,,,
2-Lysophosphatidylcholine,"2 -ÈÜÑªÁ×Ö¬õ£µ¨¼î",0.2071,0.3516,0.7047,0.7347,1.2535,0.326,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0258493,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,524.370374367,6.20088333333,"M+H-H2O, M+Na, M+H",C26H54NO7P,0,82.2,metab_320,pos_129,pos,489200000,318600000,265100000,434900000,350300000,287200000,211700000,245000000,259800000,413100000,399600000,182000000,,,,
13(S)-HODE,13£¨S£©-»ôµÂ,0.2389,0.373,0.7031,0.7068,0.8418,-0.2485,no,down,C14762,-,-,map00591;map03320,"Linoleic acid metabolism;PPAR signaling pathway","Metabolism;Organismal Systems","Lipid metabolism;Endocrine system",-,-,-,-,-,295.227393344,6.37583333333,M-H,C18H32O3,67.2,0,metab_7171,neg_1748,neg,103400,100200,103500,107600,93890,126700,93480,96620,129500,139500,107500,188300,,,,
Deoxynivalenol,ºìËóÃ¹¶¾ËØ,0.259,0.4113,0.7022,0.877,0.7273,-0.4594,no,down,C09747,-,-,-,-,-,-,HMDB0036156,"Lipids and lipid-like molecules","Prenol lipids",Sesquiterpenoids,51481-10-8,314.159093397,2.97748333333,M+NH4,C15H20O6,0,35.5,metab_755,pos_1701,pos,118500,273200,306500,118600,116700,121200,274600,116600,397200,252200,143000,267000,,,,
Dithizone,Ë«Áòëê,0.2883,0.4417,0.7002,0.6806,0.7495,-0.416,no,down,-,-,-,-,-,-,-,HMDB0251496,Benzenoids,"Benzene and substituted derivatives",Phenylhydrazines,-,274.110151658,3.79813333333,M+NH4,C13H12N4S,0,43.4,metab_4851,pos_5769,pos,212200,181000,226300,84620,111000,109700,180000,118800,309400,337100,136000,152400,,,,
"PS(18:2(9Z,11E)+=O(13)/22:0)",-,0.2327,0.3812,0.6982,1.3113,0.5739,-0.8011,no,down,-,-,-,-,-,-,-,HMDB0282929,"Not Available","Not Available","Not Available",-,896.537243542,7.65663333333,M+K,C46H84NO11P,0,73.5,metab_2713,pos_3658,pos,553200,355800,56950,1266000,903200,329000,844300,1033000,1010000,289800,2289000,570200,,,,
"Xanthurenic Acid",»ÆÄòËá,0.2384,0.3877,0.6965,0.8489,0.4356,-1.1989,no,down,C02470,-,-,map00380,"Tryptophan metabolism",Metabolism,"Amino acid metabolism",HMDB0000881;PW_C000703;MJDBOTE0001103,"Organoheterocyclic compounds","Quinolines and derivatives","Quinoline carboxylic acids",59-00-7,206.044429808,3.42071666667,M+H,C10H7NO4,83.1,0,metab_4887,pos_5802,pos,40170,27780,15250,34470,21670,23730,61830,15830,57550,39690,12900,186500,,,,
"4-Oxododecanedioic acid","4 -Ñõ´úÊ®¶þÍé¶þËá",0.2346,0.3677,0.6953,0.7243,0.5529,-0.8549,no,down,-,-,-,-,-,-,-,-,-,-,-,-,243.123309262,5.87513333333,"M-H, M+Na-2H",C12H20O5,51.9,0,metab_7546,neg_209,neg,363000,363600,810900,41020,858200,1076000,846100,313300,987100,689800,888200,2630000,,,,
Levorphanol,ôÇ¼××óÂðà«,0.2148,0.3615,0.6936,0.7312,1.4564,0.5424,no,up,C08014,-,-,-,-,-,-,PW_C009310;HMDB0014992,"Alkaloids and derivatives",Morphinans,"Not Available",77-07-6,258.184771085,6.98155,M+H,C17H23NO,0,64.4,metab_3172,pos_4149,pos,85640,150900,149100,122900,140800,91400,66650,47250,70830,204600,94420,24670,,,,
Dihydropanaxacol,¶þÇâÈË²Î¶þ´¼,0.2468,0.381,0.6936,0.7421,1.3422,0.4246,no,up,-,-,-,-,-,-,-,LMFA05000651;HMDB0032675,"Lipids and lipid-like molecules","Fatty Acyls","Fatty alcohols",113122-25-1,605.405837459,7.02416666667,2M+FA-H,C17H28O3,0,40.7,metab_6580,neg_1211,neg,179200,71670,109600,140300,110000,114000,68750,57760,91110,186200,54510,81660,,,,
PA(14:1(9Z)/PGJ2),-,0.2413,0.3911,0.6915,0.7931,0.0417,-4.5838,no,down,-,-,-,-,-,-,-,HMDB0263090,"Not Available","Not Available","Not Available",-,371.191642168,2.56861666667,M+2Na,C37H61O10P,0,35,metab_689,pos_1642,pos,2856,2842,3254,2715,2787,2930,60310,2987,26490,8054,3036,315800,,,,
"LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)",-,0.2556,0.3909,0.6861,0.6795,1.1481,0.1992,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010404,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,162440-05-3,612.330470616,6.45136666667,"M+Cl, M+FA-H",C30H50NO7P,0,91.2,metab_8175,neg_268,neg,9499000,6837000,9205000,10020000,8575000,8844000,5538000,8664000,7202000,10720000,8405000,5611000,,,,
Metronidazole,ÃðµÎÁé,0.3011,0.4543,0.6819,0.6259,144.0135,7.1701,no,up,C07203,-,-,-,-,-,-,HMDB0254689;HMDB0015052;MJDBOTE0001439,"Organoheterocyclic compounds",Azoles,Imidazoles,443-48-1,172.071432409,2.77735,M+H,C6H9N3O3,88,0,metab_725,pos_1675,pos,21400,1359000,23140,62370,37510,33620,1733,1776,1769,1637,2016,1743,,,,
"Isoketocamphoric acid",ÒìÍªÕÁÄÔËá,0.282,0.4359,0.6808,0.871,0.8529,-0.2296,no,down,-,-,-,-,-,-,-,HMDB0301824,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,217.106683957,4.45536666667,"M+H, M+Na, M+NH4",C10H16O5,0,42.5,metab_6115,pos_80,pos,470900,439500,735300,480800,480300,482900,546900,442700,808400,579600,466700,777600,,,,
Agar,ÇíÖ¬,0.2153,0.3476,0.6808,0.8136,0.6547,-0.6111,no,down,C08815,-,-,-,-,-,-,HMDB0248056,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",9002-18-0,335.134365425,3.76111666667,M-H,C14H24O9,0,32.9,metab_8816,neg_803,neg,226800,570200,798400,122500,454900,324800,397500,177000,998200,784600,529900,928200,,,,
"3-O-Sulfogalactosylceramide (d18:1/14:0)",-,0.2467,0.3968,0.6802,0.6872,0.7471,-0.4206,no,down,C06125,Lipids,Glycolipids,map00600;map01100,"Sphingolipid metabolism;Metabolic pathways",Metabolism;Metabolism,"Lipid metabolism;Global and overview maps",HMDB0012312,"Lipids and lipid-like molecules",Sphingolipids,Glycosphingolipids,-,793.530400675,6.87766666667,M+ACN+H,C38H73NO11S,0,33,metab_3278,pos_4258,pos,187400,215500,190000,154200,143000,109500,255000,283400,60770,142000,263400,333300,,,,
Isoline,3-äå-9-±½»ùßÇßò,0.2313,0.3799,0.6771,0.8586,1.5086,0.5932,no,up,-,-,-,-,-,-,-,HMDB0253654,"Alkaloids and derivatives","Not Available","Not Available",-,791.400226981,6.3943,2M+H,C20H29NO7,0,42.4,metab_3838,pos_4805,pos,83070,106800,160000,170400,119400,137400,120300,56200,201000,116400,20110,1141,,,,
1-Methylhistamine,"1 -¼×»ù×é°·",0.2199,0.3676,0.6764,0.6686,1.2295,0.2981,no,up,C05127,-,-,map01100;map00340,"Metabolic pathways;Histidine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0000898;PW_C000717,"Organic nitrogen compounds","Organonitrogen compounds",Amines,501-75-7,126.102555691,0.618083333333,"M+H, M+ACN+Na",C6H11N3,81.4,0,metab_21,pos_1017,pos,86970,97110,115800,135100,63230,114500,72800,88180,129500,63280,83800,60680,,,,
"Fructose 1-phosphate","1 -Á×Ëá¹ûÌÇ",0.2657,0.4021,0.6762,0.9898,1.5244,0.6082,no,up,C01094,-,-,map01100;map00400;map00051,"Metabolic pathways;Phenylalanine, tyrosine and tryptophan biosynthesis;Fructose and mannose metabolism",Metabolism;Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism;Carbohydrate metabolism",PW_C000847;HMDB0001076;HMDB0060467,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",15978-08-2,296.979417592,3.90003333333,M+K-2H,C6H13O9P,0,64.8,metab_7477,neg_2026,neg,59470,54290,85860,19070,33350,19880,35490,34880,62290,18890,11320,15520,,,,
Cyclopentanol,»·Îì´¼,0.3181,0.4719,0.6715,0.568,1.116,0.1583,no,up,C02020,-,-,-,-,-,-,HMDB0302463,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",96-41-3,104.107200181,0.6576,M+NH4,C5H10O,0,37.5,metab_5504,pos_6389,pos,13160000,13690000,8219000,14540000,13970000,12030000,11950000,12080000,7898000,10080000,12200000,13530000,,,,
"PC(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))",-,0.3082,0.4617,0.6686,0.5695,0.8072,-0.309,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",LMGP01011912;HMDB0008437;PW_C004485,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,802.534661549,6.83773333333,"M+H, M+NH4",C46H76NO8P,0,44.7,metab_5787,pos_665,pos,233400,59850,250000,128600,127000,284100,220600,177200,266100,269300,224800,183700,,,,
"Tetraphyllin B",ËÄÒ¶ËØB,0.2847,0.4238,0.6669,1.0821,1.4887,0.5741,no,up,-,-,-,-,-,-,-,HMDB0029914,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",34323-07-4,308.077305333,4.03506666667,M+Na-2H,C12H17NO7,0,53.3,metab_8834,neg_820,neg,88180,66940,148800,19670,73340,44850,55690,29450,88230,67740,11090,44550,,,,
3-Isopropyl-2-methoxy-5-methylpyrazine,"3 -Òì±û»ù- 2 -¼×Ñõ»ù- 5 -¼×»ùßÁàº",0.2633,0.3996,0.6654,0.7344,1.0483,0.0681,no,up,-,-,-,-,-,-,-,HMDB0029742,"Organoheterocyclic compounds",Diazines,Pyrazines,32021-41-3,203.059472447,7.5624,M+K-2H,C9H14N2O,0,36.5,metab_6668,neg_1291,neg,71440,83110,79440,79090,83060,79530,71990,71920,77090,72290,72920,87560,,,,
"2,6-Diethylaniline","2,6-¶þÒÒ»ù±½°·",0.3013,0.4546,0.664,0.6189,1.3957,0.481,no,up,C11001,-,-,-,-,-,-,HMDB0032782,Benzenoids,"Benzene and substituted derivatives","Aniline and substituted anilines",579-66-8,167.154020489,7.45831666667,M+NH4,C10H15N,0,32.6,metab_2832,pos_3791,pos,2902000,1205000,771700,560000,2097000,1458000,1074000,997800,1154000,1584000,707100,926900,,,,
N-Acetyl-D-tryptophan,"N -ÒÒõ£- D -É«°±Ëá",0.3017,0.4389,0.664,0.7136,1.2388,0.3089,no,up,C03137,-,-,-,-,-,-,HMDB0255052,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",2280-01-5,245.092700894,5.47365,M-H,C13H14N2O3,0,43.6,metab_7393,neg_1951,neg,163200,105000,140100,38080,124400,140400,92520,76160,141100,71850,106700,85630,,,,
Dodecanedioylcarnitine,Ê®¶þÍé¶þõ£»ùÈâ¼î,0.2964,0.4492,0.6633,0.7376,0.6949,-0.5251,no,down,-,-,-,-,-,-,-,HMDB0013327,"Organic acids and derivatives","Carboxylic acids and derivatives","Tricarboxylic acids and derivatives",-,785.461096094,6.65435,2M+K,C19H35NO6,0,46.2,metab_3532,pos_4519,pos,47100,47440,110900,76030,91130,94010,28320,195300,47150,175200,84910,140600,,,,
Dodecyl-beta-D-maltoside,"Ê®¶þÍé»ù- ¦Â - D -ÂóÑ¿ÌÇÜÕ",0.2926,0.4308,0.6618,0.6863,0.4133,-1.2747,no,down,-,-,-,-,-,-,-,HMDB0247203,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acyl glycosides",-,491.288722652,6.59523333333,M-H2O-H,C24H46O11,0,60.8,metab_7107,neg_1690,neg,10250,75000,211600,68470,92000,24820,334000,125000,8279,86520,13390,599400,,,,
Ethotoin,ÒÒ»ù±½Í×Ó¢,0.2969,0.435,0.6608,0.6756,0.4436,-1.1727,no,down,C07839,-,-,-,-,-,-,HMDB0014892,"Organoheterocyclic compounds",Azolidines,Imidazolidines,86-35-1,241.038064716,5.78538333333,M+K-2H,C11H12N2O2,0,47,metab_8914,neg_893,neg,3298,10790,18270,7361,7660,3440,32710,13980,3567,3672,3238,57400,,,,
"Succinic Acid",çúçêËá,0.2942,0.4322,0.6597,0.6559,0.7708,-0.3756,no,down,C00042,"Organic acids","Carboxylic acids",map01100;map00630;map00310;map00640;map00920;map00650;map01200;map00620;map00760;map04024;map04727;map00250;map04922;map00360;map00350;map00020;map05230;map00190,"Metabolic pathways;Glyoxylate and dicarboxylate metabolism;Lysine degradation;Propanoate metabolism;Sulfur metabolism;Butanoate metabolism;Carbon metabolism;Pyruvate metabolism;Nicotinate and nicotinamide metabolism;cAMP signaling pathway;GABAergic synapse;Alanine, aspartate and glutamate metabolism;Glucagon signaling pathway;Phenylalanine metabolism;Tyrosine metabolism;Citrate cycle (TCA cycle);Central carbon metabolism in cancer;Oxidative phosphorylation","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Environmental Information Processing;Organismal Systems;Metabolism;Organismal Systems;Metabolism;Metabolism;Metabolism;Human Diseases;Metabolism","Global and overview maps;Carbohydrate metabolism;Amino acid metabolism;Carbohydrate metabolism;Energy metabolism;Carbohydrate metabolism;Global and overview maps;Carbohydrate metabolism;Metabolism of cofactors and vitamins;Signal transduction;Nervous system;Amino acid metabolism;Endocrine system;Amino acid metabolism;Amino acid metabolism;Carbohydrate metabolism;Cancer: overview;Energy metabolism",LMFA01170043;PW_C000174;HMDB0000254;MJDBOTE0000409,"Organic acids and derivatives","Carboxylic acids and derivatives","Dicarboxylic acids and derivatives",110-15-6,117.018253756,0.846733333333,M-H,C4H6O4,94.8,0,metab_7674,neg_2206,neg,370300,449500,432900,379000,402900,485300,563000,511700,417700,366600,362500,1048000,,,,
"PS(18:4(6Z,9Z,12Z,15Z)/15:0)",-,0.2586,0.4107,0.6587,0.6132,1.6536,0.7256,no,up,C02737,Lipids,Phospholipids,map01100;map00564;map05146;map05322;map00260;map05140,"Metabolic pathways;Glycerophospholipid metabolism;Amoebiasis;Systemic lupus erythematosus;Glycine, serine and threonine metabolism;Leishmaniasis","Metabolism;Metabolism;Human Diseases;Human Diseases;Metabolism;Human Diseases","Global and overview maps;Lipid metabolism;Infectious disease: parasitic;Immune disease;Amino acid metabolism;Infectious disease: parasitic",HMDB0112487;PW_C060894;LMGP03010429,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoserines,-,805.4721073,6.53411666667,M+ACN+Na,C39H68NO10P,0,54.1,metab_1592,pos_2494,pos,88880,222400,181400,20510,55080,112500,1353,142400,67700,77150,92120,31130,,,,
"1,2-Dipalmitoylphosphatidylcholine","1£¬2 -¶þ×Øéµõ£Á×Ö¬õ£µ¨¼î",0.267,0.4204,0.656,0.6681,1.5952,0.6737,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0245715;HMDB0255793;HMDB0000564,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,63-89-8,778.533663845,7.07633333333,M+2Na-H,C40H80NO8P,0,42.6,metab_3075,pos_4045,pos,75760,360700,267500,302000,270600,120600,88580,98320,277100,1801,364800,45120,,,,
LysoPG(18:1(9Z)/0:0),-,0.2644,0.4006,0.651,0.6856,0.6913,-0.5326,no,down,-,-,-,-,-,-,-,HMDB0240602,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerols,-,509.28801871,6.72636666667,M-H,C24H47O9P,0,76,metab_7048,neg_1636,neg,4832000,1631000,4531000,3685000,3051000,3398000,2606000,6060000,3912000,10510000,4635000,2839000,,,,
"Cyclosquamosin G",-,0.274,0.428,0.6502,0.6169,0.6379,-0.6486,no,down,-,-,-,-,-,-,-,HMDB0303372,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,815.414555376,6.61433333333,M+H-H2O,C39H60N8O10S,0,33.4,metab_3581,pos_4567,pos,134300,137300,33860,42030,55220,106800,55410,176800,268600,153300,22470,121800,,,,
18-HEPE,-,0.2461,0.3802,0.6497,0.6745,2.5004,1.3222,no,up,C18177,-,-,-,-,-,-,HMDB0012611;HMDB0062222,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,-,363.217456589,6.14011666667,M+FA-H,C20H30O3,84.9,0,metab_7270,neg_1838,neg,60470,108300,24200,302100,35250,47690,15380,86030,77060,18020,13380,21330,,,,
"11H-14,15-EETA",-,0.3127,0.4497,0.6478,0.5878,1.263,0.3369,no,up,C14813,-,-,map00590;map01100,"Arachidonic acid metabolism;Metabolic pathways",Metabolism;Metabolism,"Lipid metabolism;Global and overview maps",HMDB0004693;PW_C002180,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",219535-29-2,381.225553712,6.29345,M+FA-H,C20H32O4,0,42.2,metab_6393,neg_1040,neg,75380,43200,50870,48590,47730,61010,18710,35690,42170,86160,42530,33440,,,,
Spergualin,¾«ëÒ¾úËØ,0.3131,0.4674,0.6472,0.9678,0.7519,-0.4114,no,down,C16747,-,-,-,-,-,-,HMDB0258417,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",80902-43-8,386.289213136,6.20866666667,M+H-H2O,C17H37N7O4,0,34.8,metab_4098,pos_5067,pos,787700,967200,1689000,1257000,1030000,1433000,869800,2188000,2706000,918100,2026000,820500,,,,
Rishitin,-,0.3433,0.4979,0.6459,0.8465,0.7692,-0.3786,no,down,C09715,-,-,-,-,-,-,HMDB0302980;HMDB0035593,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",18178-54-6,508.339182655,6.86163333333,2M+ACN+Na,C14H22O2,0,44.4,metab_1859,pos_2765,pos,1143000,431700,901100,564800,573600,560000,419300,1159000,850800,1479000,1117000,400900,,,,
"Floionolic acid",-,0.264,0.4169,0.6451,0.6285,1.1289,0.1749,no,up,C19621,-,-,-,-,-,-,HMDB0034295,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",17705-68-9,315.252282608,7.44245,M+H-H2O,C18H36O5,0,73.1,metab_2224,pos_3147,pos,498200,374600,347300,376900,435000,359800,358000,315200,287600,493200,358400,306600,,,,
"Threonic Acid",ËÕÌÇËá,0.277,0.4158,0.6449,0.6768,0.8952,-0.1597,no,down,C01620,-,-,map01100;map00053,"Metabolic pathways;Ascorbate and aldarate metabolism",Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism",HMDB0000943,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",7306-96-9,135.028794068,0.501933333333,M-H,C4H8O5,59.4,0,metab_8369,neg_386,neg,160800,172400,174400,157000,171200,173800,170200,158200,153800,186400,199300,260400,,,,
N-Acetylleucine,n-ÒÒõ£»ùÁÁ°±Ëá,0.2812,0.4195,0.6428,0.6223,1.184,0.2437,no,up,C02710,-,-,-,-,-,-,HMDB0011756,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1188-21-2,172.09701341,5.4205,M-H,C8H15NO3,46.1,0,metab_8903,neg_883,neg,620700,361500,448400,603100,570600,612400,416600,257900,427100,397100,680500,537600,,,,
"CL(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:0)",-,0.2805,0.4343,0.6426,1.1055,0.5801,-0.7856,no,down,C05980,Lipids,Phospholipids,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0058258;PW_C038712,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoglycerophosphoglycerols,-,778.534226472,7.68765,M+2H,C89H152O17P2,0,50.4,metab_2698,pos_3640,pos,201100,313600,149200,951700,448000,293200,512900,556200,1013000,8889,1527000,445100,,,,
PE(16:1/0:0),-,0.3185,0.4552,0.6425,0.6257,0.8588,-0.2196,no,down,-,-,-,-,-,-,-,-,-,-,-,-,450.262372216,6.44096666667,M-H,C21H42NO7P,41.2,0,metab_7153,neg_1731,neg,111900,76090,110200,168900,78730,88690,121400,118600,152100,143400,100600,103300,,,,
PS(15:0/22:1(13Z)),-,0.2816,0.4197,0.6416,0.8155,1.3215,0.4022,no,up,C02737,Lipids,Phospholipids,map01100;map00564;map05146;map05322;map00260;map05140,"Metabolic pathways;Glycerophospholipid metabolism;Amoebiasis;Systemic lupus erythematosus;Glycine, serine and threonine metabolism;Leishmaniasis","Metabolism;Metabolism;Human Diseases;Human Diseases;Metabolism;Human Diseases","Global and overview maps;Lipid metabolism;Infectious disease: parasitic;Immune disease;Amino acid metabolism;Infectious disease: parasitic",PW_C060733;HMDB0112335,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoserines,-,802.560515812,6.18483333333,"M-H, M+K-2H, M+Na-2H",C43H82NO10P,0,41.7,metab_8262,neg_29,neg,26370000,17540000,15810000,15940000,6220000,16050000,12390000,11800000,11190000,22080000,4377000,12270000,,,,
Octanoylglucuronide,ÐÁõ£ÆÏÌÑÌÇÈ©ËáÜÕ,0.3144,0.4685,0.6393,0.7247,0.6618,-0.5955,no,down,-,-,-,-,-,-,-,HMDB0010347,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",99910-55-1,343.135645945,3.8595,M+Na,C14H24O8,0,52,metab_4844,pos_5762,pos,42300,97440,190700,11150,71800,61040,74590,29880,229200,139500,90200,153800,,,,
"PE-NMe(18:0/20:2(11Z,14Z))",-,0.2612,0.3971,0.6385,0.914,1.233,0.3022,no,up,"C01241 ",-,-,-,-,-,-,HMDB0113095;PW_C059218,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,830.591964498,6.9804,M+FA-H,C44H84NO8P,0,89.2,metab_6974,neg_1568,neg,24550000,23460000,17960000,18360000,10330000,21860000,23610000,14550000,15410000,19250000,7187000,14500000,,,,
Norbutorphanol,-,0.3054,0.4427,0.6385,0.6526,0.4377,-1.192,no,down,-,-,-,-,-,-,-,HMDB0041954,Benzenoids,"Phenol esters","Not Available",3792-68-5,517.304505896,6.59523333333,2M-H,C16H21NO2,0,60.9,metab_6460,neg_1102,neg,10440,25930,196700,48010,58590,10890,183700,158900,11290,36770,10250,399900,,,,
"Dehydrotumulosic acid",È¥ÇâÍÁÄªËá,0.3097,0.4474,0.6371,0.6803,0.4589,-1.1237,no,down,-,-,-,-,-,-,-,HMDB0250960,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",-,519.319972318,6.81288333333,M+Cl,C31H48O4,0,67.3,metab_7026,neg_1615,neg,42170,103300,361400,92660,139600,43990,485700,205100,45610,87080,41410,841300,,,,
PE(17:0/0:0),-,0.2425,0.377,0.6369,0.7255,0.7687,-0.3795,no,down,-,-,-,-,-,-,-,LMGP02050030;HMDB0061691,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,466.293415867,6.67931666667,M-H,C22H46NO7P,86.1,0,metab_6480,neg_1121,neg,561100,299600,445600,277700,297700,273200,297300,459100,443800,717000,617800,269000,,,,
"PC(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))",-,0.332,0.4868,0.6356,0.6715,0.78,-0.3585,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004656;HMDB0008608,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,906.597826936,6.65435,M+2Na-H,C50H88NO8P,0,48.1,metab_1694,pos_2592,pos,97760,45340,88540,84950,27110,51030,50260,140000,48600,95470,75620,96180,,,,
"PE(20:3(8Z,11Z,14Z)-O(5,6)/22:0)",-,0.3129,0.4497,0.6335,0.6363,2.5801,1.3674,no,up,-,-,-,-,-,-,-,HMDB0283717,"Not Available","Not Available","Not Available",-,838.597153432,6.22216666667,M-H,C47H86NO9P,0,76.5,metab_7218,neg_1791,neg,1323000,187400,154200,282000,4169,301400,62890,65730,119600,543300,3837,77610,,,,
GPEtn(16:1/22:5),-,0.2958,0.4486,0.6323,0.7592,0.8427,-0.2469,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0011359;HMDB0008977;HMDB0011360;HMDB0008978,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,764.521423504,6.76605,M+H,C43H74NO8P,90.7,0,metab_3392,pos_4375,pos,15140000,12110000,9482000,9174000,6650000,9478000,13680000,14790000,6596000,13210000,14680000,10700000,,,,
Indolophenanthridine,-,0.2996,0.4526,0.6292,0.5759,1.9162,0.9382,no,up,-,-,-,-,-,-,-,HMDB0253475,"Organoheterocyclic compounds","Quinolines and derivatives",Benzoquinolines,-,292.180253997,5.9761,M+NH4,C19H18N2,0,52.4,metab_1171,pos_2079,pos,194300,53800,342400,53770,751700,278100,27520,115500,90240,415900,143900,80290,,,,
Metaraminol,¼äôÇ°·,0.2457,0.3961,0.624,0.6245,0.9097,-0.1365,no,down,C07146,-,-,-,-,-,-,HMDB0245769;HMDB0014748,Benzenoids,"Benzene and substituted derivatives",Phenylpropanes,54-49-9,132.080653967,3.15083333333,M+H-2H2O,C9H13NO2,0,43.4,metab_773,pos_1719,pos,208400,194800,143300,148200,184800,196500,234100,172400,175100,205200,196800,198900,,,,
"PE(DiMe(11,3)/18:1(12Z)-2OH(9,10))",-,0.2599,0.4125,0.6232,0.6116,0.7693,-0.3784,no,down,-,-,-,-,-,-,-,HMDB0284704,"Not Available","Not Available","Not Available",-,816.544517806,6.82188333333,"M+H, M+Na",C43H78NO11P,0,46,metab_5733,pos_660,pos,153000,313100,242600,122700,168300,280700,429600,298300,126300,194900,285900,329500,,,,
"Azelaic acid",ÈÉ¶þËá,0.2951,0.4482,0.6221,0.9028,0.8095,-0.3049,no,down,C08261,-,-,-,-,-,-,LMFA01170054;HMDB0000784,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",123-99-9,211.09311982,3.89813333333,M+Na,C9H16O4,0,69.1,metab_4842,pos_5760,pos,102700,116400,149700,69580,109100,115500,126800,71680,167700,123400,111500,218000,,,,
"PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.2713,0.4094,0.6177,0.6352,1.328,0.4093,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004106;LMGP01010821;HMDB0008057,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,878.591885415,7.48398333333,M+FA-H,C48H84NO8P,0,89.4,metab_6619,neg_1247,neg,1561000,9800000,9062000,9683000,10790000,8871000,6675000,6721000,7248000,1148000,6577000,9106000,,,,
"Oxidized Glutathione",Ñõ»¯¹Èë×¸ÊëÄ,0.2987,0.4358,0.6153,0.6322,0.8246,-0.2782,no,down,C00127,-,-,map01100;map00480;map01240;map05208;map04918;map05415;map04216,"Metabolic pathways;Glutathione metabolism;Biosynthesis of cofactors;Chemical carcinogenesis - reactive oxygen species;Thyroid hormone synthesis;Diabetic cardiomyopathy;Ferroptosis","Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems;Human Diseases;Cellular Processes","Global and overview maps;Metabolism of other amino acids;Global and overview maps;Cancer: overview;Endocrine system;Cardiovascular disease;Cell growth and death",HMDB0011691;PW_C001847;HMDB0003337;MJDBOTE0000407,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",15718-51-1;27025-41-8,611.144374293,1.9081,M-H,C20H32N6O12S2,85.5,0,metab_8720,neg_717,neg,147900,201600,112200,132900,116700,134700,180800,136100,152400,103000,181900,271800,,,,
LysoPC(0:0/18:0),-,0.2785,0.4326,0.615,0.7296,1.2602,0.3337,no,up,-,-,-,-,-,-,-,HMDB0011128,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,4421-58-3,562.326102016,6.17711666667,"M+K, M+2Na-H",C26H54NO7P,0,91,metab_3937,pos_490,pos,923400,576300,494200,772500,647500,590100,313300,404400,551700,757500,878900,271200,,,,
3-Aminopyrazin-2-ol,"3 -°±»ùßÁàº- 2 - Ol",0.3097,0.4632,0.6146,0.6672,0.8217,-0.2833,no,down,-,-,-,-,-,-,-,HMDB0245823,"Organoheterocyclic compounds",Diazines,Pyrazines,-,112.050662859,1.14315,M+H,C4H5N3O,0,52.9,metab_5197,pos_6089,pos,419500,499400,738900,169900,432800,690400,655100,421800,796600,533200,581200,603000,,,,
"PA(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))",-,0.3371,0.4917,0.6073,0.5934,0.6904,-0.5345,no,down,C00416,Lipids,Phospholipids,map01100;map00564;map04070;map00561;map05212;map05200;map04975;map04024;map04072;map04912;map05231;map04666,"Metabolic pathways;Glycerophospholipid metabolism;Phosphatidylinositol signaling system;Glycerolipid metabolism;Pancreatic cancer;Pathways in cancer;Fat digestion and absorption;cAMP signaling pathway;Phospholipase D signaling pathway;GnRH signaling pathway;Choline metabolism in cancer;Fc gamma R-mediated phagocytosis","Metabolism;Metabolism;Environmental Information Processing;Metabolism;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Signal transduction;Lipid metabolism;Cancer: specific types;Cancer: overview;Digestive system;Signal transduction;Signal transduction;Endocrine system;Cancer: overview;Immune system",HMDB0115344;PW_C062768,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,799.529713514,7.75825,M+H,C47H75O8P,0,38.7,metab_2400,pos_3344,pos,83940,68770,167000,251300,52650,184700,60870,189800,208800,285000,58310,367800,,,,
N-Acetyl-L-Tyrosine,N-ÒÒõ£-L-ÀÒ°±Ëá,0.2909,0.4293,0.6042,0.6281,0.7389,-0.4365,no,down,C01657,-,-,-,-,-,-,HMDB0000866;HMDB0244966;MJDBOTE0000672,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",537-55-3,222.076477685,3.82046666667,M-H,C11H13NO4,74,0,metab_8822,neg_809,neg,105900,70940,161600,26140,119500,194900,134400,133300,277100,140600,142500,91320,,,,
Anethole,ÜîÏãÄÔ,0.3463,0.4816,0.602,0.5956,1.0449,0.0634,no,up,C10428,-,-,-,-,-,-,HMDB0030837;MJDBOTE0001677,Benzenoids,"Phenol ethers",Anisoles,4180-23-8;4180-23-8;104-46-1,193.086227944,6.18483333333,M+FA-H,C10H12O,0,30.1,metab_7253,neg_1822,neg,81390,78020,72140,74860,83720,88350,72450,67860,74950,82590,83770,76300,,,,
O-Acetylcarnitine,O-ÒÒõ£Èâ¶¾¼î,0.333,0.4874,0.6004,0.6525,1.089,0.123,no,up,C02571,-,-,map04931,"Insulin resistance","Human Diseases","Endocrine and metabolic disease",HMDB0000201;HMDB0240773,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",3040-38-8,204.122783525,0.71195,"M+H, M+Na",C9H17NO4,83.4,0,metab_142,pos_1126,pos,52910000,46110000,58790000,43960000,55300000,63750000,57240000,40250000,49900000,41780000,57450000,48010000,,,,
"2-[3-(sulfooxy)phenyl]acetic acid",2-[3-£¨»Çõ£Ñõ»ù£©±½»ù]ÒÒËá,0.3129,0.4497,0.5999,0.8489,0.6943,-0.5264,no,down,-,-,-,-,-,-,-,HMDB0125163,"Organic acids and derivatives","Organic sulfuric acids and derivatives",Arylsulfates,-,230.996293249,3.50506666667,"M-H, M+Na-2H",C8H8O6S,0,43.9,metab_7151,neg_173,neg,1708000,2429000,2242000,560900,1318000,1325000,3110000,1451000,4600000,2264000,445600,1932000,,,,
3-beta-D-galactosyl-sn-glycerol,3-¦Â-D-°ëÈéÌÇ»ù-sn-¸ÊÓÍ,0.3044,0.4414,0.5988,0.8037,0.5578,-0.8422,no,down,C05401,-,-,map00561;map00052,"Glycerolipid metabolism;Galactose metabolism",Metabolism;Metabolism,"Lipid metabolism;Carbohydrate metabolism",HMDB0304157;HMDB0006790,"Lipids and lipid-like molecules",Glycerolipids,Glycosylglycerols,-,235.081772398,2.62868333333,M-H2O-H,C9H18O8,0,57,metab_8747,neg_741,neg,307100,361200,2119000,186700,287200,420500,812200,808100,2747000,855800,618000,756700,,,,
"PC(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/16:1(9Z))",-,0.2978,0.4509,0.5959,0.6451,1.4813,0.5669,no,up,-,-,-,-,-,-,-,HMDB0286060,"Not Available","Not Available","Not Available",-,776.516225441,6.9337,"M+H-H2O, M+H",C44H76NO9P,0,30.1,metab_5994,pos_690,pos,47060,124300,229800,67860,217400,91750,116500,43450,33360,149800,136000,46240,,,,
GPCho(20:3/20:4),-,0.3461,0.5007,0.5926,0.5286,0.7602,-0.3955,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008411;HMDB0008410;HMDB0008379;HMDB0008378,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,854.566731051,6.82188333333,M+Na,C48H82NO8P,68.3,0,metab_1832,pos_2737,pos,101600,99610,113500,34340,117900,37050,62550,58190,200600,122200,129300,90130,,,,
2-Pentyl-3-phenyl-2-propenal,"2 -Îì»ù- 3 -±½»ù- 2 -±ûÏ©È©",0.4064,0.556,0.5903,0.4641,0.6119,-0.7086,no,down,C12288,-,-,-,-,-,-,HMDB0031313,"Phenylpropanoids and polyketides",Cinnamaldehydes,"Not Available",122-40-7,422.304650887,6.87766666667,2M+NH4,C14H18O,0,59.2,metab_1873,pos_2780,pos,22730,42040,62410,53420,7557,18110,39260,29450,30310,169000,49670,19510,,,,
DG(i-20:0/0:0/PGF1alpha),-,0.3165,0.4706,0.587,0.543,0.8902,-0.1678,no,down,-,-,-,-,-,-,-,HMDB0300164,"Not Available","Not Available","Not Available",-,766.620045405,6.34308333333,M+ACN+H,C43H80O8,0,37.8,metab_3893,pos_4859,pos,301700,268000,167700,235700,216600,250600,321200,194000,286900,320100,268800,226600,,,,
6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine,6-£¨2-ôÇ»ùÒÒÑõ»ù£©-6-Ñõ´ú¼ºõ£»ùÈâ¼î,0.3813,0.5315,0.5859,0.7162,0.8108,-0.3026,no,down,-,-,-,-,-,-,-,HMDB0241809,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,334.185240034,2.6813,M+H,C15H27NO7,0,44.8,metab_5019,pos_5926,pos,2972000,3288000,5881000,1573000,2871000,2550000,3535000,2791000,6161000,4897000,2530000,3687000,,,,
"PE(20:1(11Z)/18:3(9Z,12Z,15Z))",-,0.3318,0.4867,0.5853,0.7786,0.832,-0.2653,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0009260;LMGP02010856;PW_C005308,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,790.533920083,7.59343333333,M+Na,C43H78NO8P,0,74.3,metab_2753,pos_3708,pos,2000000,1197000,990800,988500,1340000,823600,1385000,1565000,742500,1842000,1898000,1389000,,,,
13-Hode,-,0.3888,0.5245,0.5841,0.6002,1.1036,0.1422,no,up,C14762,-,-,map00591;map03320,"Linoleic acid metabolism;PPAR signaling pathway","Metabolism;Organismal Systems","Lipid metabolism;Endocrine system",HMDB0004667;HMDB0242324,"Lipids and lipid-like molecules","Fatty Acyls","Lineolic acids and derivatives",29623-28-7,295.227434083,6.56818333333,M-H,C18H32O3,46.2,0,metab_6445,neg_1089,neg,359900,288500,264100,255800,303500,292400,153400,271100,298300,295500,339800,240400,,,,
4-Hydroxybenzaldehyde,4-ôÇ»ù±½¼×È©,0.3535,0.5068,0.5822,0.6778,0.8474,-0.2389,no,down,C00633,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0011718;MJDBOTE0000554,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",123-08-0,123.044076459,0.806533333333,M+H,C7H6O2,66.4,0,metab_516,pos_1480,pos,101200,118400,74030,98070,96180,119000,140700,92480,131400,163200,139000,49140,,,,
"PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))",-,0.4087,0.5585,0.5782,0.4544,1.2054,0.2695,no,up,-,-,-,-,-,-,-,HMDB0009711,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,796.524305164,7.7269,"M+H, M+Na",C45H76NO7P,0,58.7,metab_6162,pos_845,pos,921500,3181000,2167000,2257000,3156000,3529000,2166000,1865000,1434000,1198000,2856000,3100000,,,,
"PC(PGJ2/18:2(9Z,12Z))",-,0.4137,0.5626,0.5647,0.5865,0.7494,-0.4162,no,down,-,-,-,-,-,-,-,HMDB0286551,"Not Available","Not Available","Not Available",-,836.550065568,6.46001666667,"M+H, M+CH3OH+H",C46H78NO10P,0,31.4,metab_4764,pos_569,pos,62930,31000,188300,28050,65900,83330,62830,105900,86770,124200,175400,58040,,,,
"4-(4-Methylcyclohexyl)-4-oxobutanoic acid",4-£¨4-¼×»ù»·¼º»ù£©-4-Ñõ´ú¶¡Ëá,0.3153,0.4698,0.5639,0.7397,0.4207,-1.2491,no,down,-,-,-,-,-,-,-,HMDB0253742,"Organic acids and derivatives","Keto acids and derivatives","Gamma-keto acids and derivatives",-,240.158430257,4.71611666667,M+ACN+H,C11H18O3,0,31.5,metab_903,pos_1837,pos,11850,34820,55960,9573,59850,158900,145100,7280,65060,49150,73160,446500,,,,
DG(PGF2alpha/0:0/22:0),-,0.4171,0.5658,0.5619,0.5726,0.7886,-0.3426,no,down,-,-,-,-,-,-,-,HMDB0296710,"Not Available","Not Available","Not Available",-,792.639594411,6.37515,M+ACN+H,C45H82O8,0,52.5,metab_3852,pos_4819,pos,63830,47580,67030,56980,44300,60070,51300,48900,64440,152400,39170,74610,,,,
"Polyethylene, oxidized",¾ÛÒÒÏ©£¬Ñõ»¯,0.3242,0.4789,0.5607,0.7076,0.588,-0.7661,no,down,-,-,-,-,-,-,-,HMDB0032472,"Organic acids and derivatives","Keto acids and derivatives","Medium-chain keto acids and derivatives",68441-17-8,267.119703833,5.58895,"M+H-2H2O, M+H, M+H-H2O, M+Na",C12H20O5,0,47.3,metab_112,pos_11,pos,165600,169100,397100,25300,370000,477200,347800,82940,350800,314500,402500,1230000,,,,
"PE-NMe2(20:4(5Z,8Z,11Z,14Z)/16:0)",-,0.3653,0.5003,0.5587,0.5946,0.7617,-0.3927,no,down,C04308,-,-,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",PW_C060346;HMDB0114327,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,766.53951135,6.53858333333,M-H,C43H78NO8P,0,83.5,metab_6444,neg_1088,neg,286100,2351000,1781000,1984000,2860000,2092000,2550000,2513000,2847000,173000,2875000,3947000,,,,
Nirvanol,±½ÒÒ»ùÄÚõ£ëå,0.3414,0.4961,0.5587,0.7923,0.4832,-1.0493,no,down,C14916,-,-,-,-,-,-,HMDB0060533,"Organoheterocyclic compounds",Azolidines,Imidazolidines,631-07-2,243.052642094,5.4081,M+K,C11H12N2O2,0,32.8,metab_944,pos_1874,pos,450.1,15030,28620,12740,15480,7712,47340,22870,392.2,11470,307.1,83280,,,,
Propionylcarnitine,±ûõ£Èâ¼î,0.2897,0.4428,0.5586,0.6963,0.8734,-0.1953,no,down,C03017,-,-,-,-,-,-,HMDB0000824;PW_C000658;LMFA07070105,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",17298-37-2;20064-19-1,218.138377917,0.8145,M+H,C10H19NO4,81.4,0,metab_521,pos_1487,pos,399000,477400,398000,296300,466300,509000,581100,345100,435600,419000,492800,641800,,,,
PS(16:1(9Z)/PGD2),-,0.3553,0.5084,0.5581,0.5565,0.6228,-0.6832,no,down,-,-,-,-,-,-,-,HMDB0281240,"Not Available","Not Available","Not Available",-,794.463720644,7.13166666667,M+H-2H2O,C42H72NO13P,0,41.6,metab_2075,pos_2997,pos,25700,11.5,26590,18870,15980,11.86,30470,31040,15.7,15.59,36060,42380,,,,
L-Tryptophan,L-É«°±Ëá,0.3004,0.4535,0.556,0.5631,0.9183,-0.123,no,down,C00078,Peptides,"Amino acids",map01100;map04978;map05143;map00260;map01240;map01210;map04974;map00380;map01230;map00970;map04726;map00400;map05230,"Metabolic pathways;Mineral absorption;African trypanosomiasis;Glycine, serine and threonine metabolism;Biosynthesis of cofactors;2-Oxocarboxylic acid metabolism;Protein digestion and absorption;Tryptophan metabolism;Biosynthesis of amino acids;Aminoacyl-tRNA biosynthesis;Serotonergic synapse;Phenylalanine, tyrosine and tryptophan biosynthesis;Central carbon metabolism in cancer","Metabolism;Organismal Systems;Human Diseases;Metabolism;Metabolism;Metabolism;Organismal Systems;Metabolism;Metabolism;Genetic Information Processing;Organismal Systems;Metabolism;Human Diseases","Global and overview maps;Digestive system;Infectious disease: parasitic;Amino acid metabolism;Global and overview maps;Global and overview maps;Digestive system;Amino acid metabolism;Global and overview maps;Translation;Nervous system;Amino acid metabolism;Cancer: overview",PW_C000741;HMDB0000929;MJDBOTE0000426,"Organoheterocyclic compounds","Indoles and derivatives","Indolyl carboxylic acids and derivatives",73-22-3,205.09677092,3.14315,"M+H, M+2Na-H, M+K, M+Na",C11H12N2O2,96,0,metab_1,pos_10,pos,16240000,14850000,10660000,11430000,14490000,14680000,17350000,13040000,13230000,15880000,15140000,15010000,,,,
"PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)",-,0.3412,0.4775,0.552,0.7615,0.8515,-0.2319,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",LMGP02011161;PW_C005730;HMDB0009682,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,762.508044596,6.68715,M-H,C43H74NO8P,0,77.3,metab_7073,neg_1659,neg,5257000,3569000,3285000,3226000,2478000,2961000,4012000,5635000,2535000,4302000,4828000,3090000,,,,
DG(PGF1alpha/0:0/22:0),-,0.3835,0.5338,0.5519,0.5295,1.1212,0.165,no,up,-,-,-,-,-,-,-,HMDB0296842,"Not Available","Not Available","Not Available",-,794.647212286,6.4289,M+ACN+H,C45H84O8,0,34.5,metab_3796,pos_4768,pos,272300,218200,276900,202200,386500,253200,225400,182200,308600,221100,254200,243500,,,,
Kentsin,±ÜÔÐËÄëÄ,0.3961,0.5459,0.5511,0.7245,1.3336,0.4153,no,up,-,-,-,-,-,-,-,HMDB0005776,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",56767-30-7,483.299749587,6.9737,M+H-H2O,C21H40N8O6,0,62.7,metab_3177,pos_4155,pos,116800,101500,20470,77830,26640,89430,100600,24250,24400,58740,44020,72460,,,,
Asparaginyl-Lysine,Ìì¶¬õ£°·-Àµ°±Ëá,0.3107,0.4644,0.5501,0.7228,1.3003,0.3788,no,up,-,-,-,-,-,-,-,HMDB0028736,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,562.326080393,7.7269,2M+ACN+H,C10H20N4O4,0,72.8,metab_2663,pos_3603,pos,5795000,3596000,4814000,3298000,3459000,3638000,2430000,2386000,2274000,7007000,2578000,2241000,,,,
(+/-)-6-Chlorotryptophan,-,0.3913,0.5262,0.5488,0.5931,0.7196,-0.4747,no,down,-,-,-,-,-,-,-,HMDB0033557,"Organoheterocyclic compounds","Indoles and derivatives","Indolyl carboxylic acids and derivatives",17808-21-8,237.043101723,5.90265,"M-H, M+Cl",C11H11ClN2O2,0,38.9,metab_7580,neg_212,neg,456400,768800,973100,628500,797700,680400,1416000,823100,484400,552500,446100,2261000,,,,
Galactosylglycerol,°ëÈéÌÇ»ù¸ÊÓÍ,0.3562,0.4902,0.5398,0.7755,0.594,-0.7515,no,down,C05401,-,-,map00561;map00052,"Glycerolipid metabolism;Galactose metabolism",Metabolism;Metabolism,"Lipid metabolism;Carbohydrate metabolism",HMDB0304157;PW_C002928;HMDB0006790,"Lipids and lipid-like molecules",Glycerolipids,Glycosylglycerols,-,235.081763457,1.97766666667,M-H2O-H,C9H18O8,0,55.3,metab_8739,neg_734,neg,253000,331600,1797000,166200,249700,359500,664600,647900,2229000,664800,522800,585500,,,,
"LysoPC(20:4(5Z,8Z,11Z,14Z)/0:0)",-,0.3587,0.4926,0.5375,0.5644,0.8767,-0.1898,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010395,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,60701-99-7,588.330610639,6.50158333333,"M+Cl, M+FA-H",C28H50NO7P,0,90.6,metab_8121,neg_263,neg,10640000,6630000,10610000,10890000,8567000,8685000,8065000,10900000,9970000,16030000,10380000,8560000,,,,
"Nonadecanoic acid",Ê®¾ÅÍéËá,0.4331,0.5805,0.5341,0.6415,1.2047,0.2687,no,up,C16535,-,-,-,-,-,-,LMFA01010019;HMDB0000772,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",646-30-0,316.320523197,6.3113,M+NH4,C19H38O2,0,43.7,metab_3949,pos_4910,pos,75370,194300,96970,159000,223500,140300,135800,111100,73310,89070,215600,113600,,,,
1-Naphthylamine,1-ÝÁ°·,0.3116,0.4656,0.5336,0.5635,0.9205,-0.1195,no,down,C14790,-,-,map00980,"Metabolism of xenobiotics by cytochrome P450",Metabolism,"Xenobiotics biodegradation and metabolism",HMDB0243964,Benzenoids,Naphthalenes,"Not Available",134-32-7,144.080587389,3.15083333333,M+H,C10H9N,58.2,0,metab_4939,pos_5852,pos,650700,596400,418200,431300,584500,577600,661000,554400,540000,585700,575700,623100,,,,
2-Undecanone,2-Ê®Ò»ÍéÍª,0.3488,0.4826,0.5335,0.552,1.1983,0.261,no,up,C01875,-,-,-,-,-,-,HMDB0033713,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",112-12-9,215.164623353,6.33701666667,M+FA-H,C11H22O,0,32.9,metab_7179,neg_1756,neg,28190,57460,37900,64750,34630,74070,32350,45520,44600,31950,48860,44590,,,,
Jasmolone,2-»·ÎìÏ©-1-Íª£¬4-ôÇ»ù-3-¼×»ù-2-£¨2-ÎìÏ©-1-»ù£©-,0.3448,0.4994,0.5327,0.6938,0.6698,-0.5782,no,down,-,-,-,-,-,-,-,HMDB0030039,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",54383-66-3,181.122012821,5.59695,M+H,C11H16O2,0,34.1,metab_4702,pos_5633,pos,36430,40310,71600,15410,71120,87750,66160,22280,65480,60450,74540,192700,,,,
"Resolvin D2",-,0.3934,0.5282,0.5324,0.631,0.6356,-0.6538,no,down,C18179,-,-,-,-,-,-,HMDB0002294;LMFA04030001,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",82864-77-5,421.220606847,6.20693333333,M+FA-H,C22H32O5,0,46.1,metab_7230,neg_1801,neg,20160,23260,118700,90000,21230,39060,24340,109900,206900,60890,20290,69230,,,,
PS(22:0/14:1(9Z)),-,0.4541,0.5995,0.5314,0.6337,1.3637,0.4475,no,up,C02737,Lipids,Phospholipids,map01100;map00564;map05146;map05322;map00260;map05140,"Metabolic pathways;Glycerophospholipid metabolism;Amoebiasis;Systemic lupus erythematosus;Glycine, serine and threonine metabolism;Leishmaniasis","Metabolism;Metabolism;Human Diseases;Human Diseases;Metabolism;Human Diseases","Global and overview maps;Lipid metabolism;Infectious disease: parasitic;Immune disease;Amino acid metabolism;Infectious disease: parasitic",LMGP03010702;PW_C061132;HMDB0112708,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoserines,-,754.535602642,6.25598333333,"M+H-2H2O, M+ACN+H",C42H80NO10P,0,39.2,metab_6257,pos_930,pos,344100,1403000,627200,353500,2091000,1309000,683400,814200,516200,198400,1659000,620900,,,,
"7-Aminoheptanoic acid","7 -°±»ù¸ýËá",0.4732,0.6154,0.527,0.4564,0.981,-0.0277,no,down,-,-,-,-,-,-,-,HMDB0247233,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,184.072990202,7.70341666667,M+K,C7H15NO2,0,48.3,metab_2346,pos_3287,pos,2734000,2747000,3060000,3024000,2694000,2761000,2830000,2873000,2824000,2894000,3044000,2889000,,,,
GPEtn(16:1/18:1),-,0.4315,0.5792,0.5266,0.6115,0.8729,-0.1961,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0008984;HMDB0011342;HMDB0008960;HMDB0008985;HMDB0008959,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,65289-02-3,716.521453867,7.17905,M+H,C39H74NO8P,98.6,0,metab_2999,pos_3963,pos,1915000,1199000,1539000,1243000,990000,1066000,1525000,1862000,728100,1915000,1811000,1266000,,,,
Indole-3-Carboxaldehyde,ßÅßá-3-¼×È©,0.332,0.4868,0.5251,0.5638,0.9432,-0.0844,no,down,C08493,-,-,-,-,-,-,HMDB0000197;HMDB0029737;HMDB0000195;MJDBSJD0000088,"Organoheterocyclic compounds","Indoles and derivatives","Indolyl carboxylic acids and derivatives",58-63-9;87-51-4;487-89-8,146.059823482,3.15083333333,M+H,C9H7NO,95.9,0,metab_6338,pos_1720,pos,1199000,1138000,935200,870600,1110000,1117000,1226000,982100,1182000,1148000,1088000,1130000,,,,
Ubiquinone-8,-,0.3764,0.5266,0.525,0.6389,1.7059,0.7705,no,up,C17569,-,-,-,-,-,-,HMDB0304524,"Lipids and lipid-like molecules","Prenol lipids","Quinone and hydroquinone lipids",2394-68-5,768.58778347,6.89368333333,M+ACN+H,C49H74O4,0,48.1,metab_3261,pos_4239,pos,11540000,2964000,1797000,2411000,782400,4145000,2392000,1538000,2175000,5366000,555600,1827000,,,,
"LysoPA(20:2(11Z,14Z)/0:0)",-,0.3553,0.4896,0.5247,0.575,0.7803,-0.3579,no,down,-,-,-,-,-,-,-,HMDB0114758,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,507.272314793,6.57505,M+FA-H,C23H43O7P,0,43.9,metab_7116,neg_1699,neg,3079000,1382000,3237000,2145000,2421000,2544000,1719000,3271000,2492000,6092000,3374000,2030000,,,,
Imexon,°±»ù¶þµªË«»·¼ºÏ©Íª,0.3788,0.5291,0.5207,0.7832,1.2107,0.2758,no,up,-,-,-,-,-,-,-,HMDB0253411,"Organoheterocyclic compounds",Diazines,"Pyrimidines and pyrimidine derivatives",-,112.050666979,2.94551666667,M+H,C4H5N3O,0,48.6,metab_748,pos_1696,pos,212600,234900,304700,69440,183000,271200,161500,129000,279700,168500,160900,154100,,,,
Rifampicin,Àû¸£Æ½,0.396,0.5459,0.5204,1.104,1.2686,0.3432,no,up,C06688,Antibiotics,"Polyketides and nonribosomal peptides",map04976,"Bile secretion","Organismal Systems","Digestive system",HMDB0257225,"Phenylpropanoids and polyketides",Macrolactams,"Not Available",13292-46-1,787.398756644,6.57425,M+H-2H2O,C43H58N4O12,0,40.1,metab_3636,pos_4619,pos,268700,86200,195100,84690,161100,204600,226300,64360,108900,130500,67870,190700,,,,
Thymidine,ÐØÜÕ,0.3395,0.494,0.5195,0.5668,1.1921,0.2535,no,up,C00214,"Nucleic acids",Nucleosides,map00240;map01100,"Pyrimidine metabolism;Metabolic pathways",Metabolism;Metabolism,"Nucleotide metabolism;Global and overview maps",PW_C000187;HMDB0000273;MJDBOTE0000448,"Nucleosides, nucleotides, and analogues","Pyrimidine nucleosides","Pyrimidine 2''-deoxyribonucleosides",50-89-5,265.078921101,2.65731666667,M+Na,C10H14N2O5,0,36.8,metab_5037,pos_5942,pos,52890,73750,71950,63210,45450,36030,52830,47670,43600,43870,75790,24180,,,,
"PE-NMe(22:4(7Z,10Z,13Z,16Z)/16:1(9Z))",-,0.3949,0.5291,0.5182,0.7809,0.8952,-0.1597,no,down,"C01241 ",-,-,-,-,-,-,HMDB0113596;PW_C059725,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,824.547296095,7.17786666667,M+FA-H,C44H78NO8P,0,71.8,metab_6952,neg_1548,neg,606700,364600,255800,477300,450100,396900,527000,520500,449700,491500,512600,349500,,,,
Demethylphylloquinone,-,0.43,0.5595,0.5146,0.5024,1.1272,0.1727,no,up,C13309,-,-,map01100;map00130;map01240,"Metabolic pathways;Ubiquinone and other terpenoid-quinone biosynthesis;Biosynthesis of cofactors",Metabolism;Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins;Global and overview maps",HMDB0004649,"Lipids and lipid-like molecules","Prenol lipids","Quinone and hydroquinone lipids",34625-86-0,473.282105418,6.92216666667,M+K-2H,C30H44O2,0,56.7,metab_6980,neg_1573,neg,657400,386100,374700,407000,455000,442000,326000,391400,319200,599800,457900,320600,,,,
"1,4-Cyclohexanedicarboxylic Acid","1,4-»·¼º¶þ¼×Ëá",0.3781,0.5135,0.5118,0.7853,0.8101,-0.3038,no,down,-,-,-,-,-,-,-,-,-,-,-,-,171.065408226,5.01723333333,M-H,C8H12O4,51.8,0,metab_8889,neg_870,neg,73770,28110,63040,18370,31240,58020,62170,39500,72170,47820,37010,77820,,,,
Drostanolone,ÇüËûÐÛÍª,0.413,0.5618,0.5104,1.0221,0.8275,-0.2732,no,down,C14605,-,-,-,-,-,-,HMDB0014996,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Androstane steroids",58-19-5,337.272928462,6.62236666667,M+CH3OH+H,C20H32O2,0,73.7,metab_1664,pos_2563,pos,2855000,1349000,1327000,1637000,1525000,1205000,2154000,2871000,1161000,1935000,2780000,1061000,,,,
"(R)-2-Hydroxycaprylic acid","£¨R£© -2-ôÇ»ùÐÁËá",0.3974,0.5316,0.5096,0.4794,1.12,0.1635,no,up,-,-,-,-,-,-,-,HMDB0002264,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",30117-44-3,159.101727197,6.118,M-H,C8H16O3,33.5,0,metab_9010,neg_980,neg,43990,73460,43760,52960,38370,49270,39610,53500,36510,52320,36580,50910,,,,
Streptidine,Á´Ã¹ëÒ,0.3643,0.5164,0.5069,0.6747,0.7322,-0.4497,no,down,C00837,-,-,-,-,-,-,HMDB0258506,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",85-17-6,304.174769466,2.93751666667,M+ACN+H,C8H18N6O4,0,58.3,metab_4972,pos_5884,pos,1350000,3481000,4191000,1183000,4277000,3120000,3468000,1670000,4495000,2388000,3622000,8401000,,,,
Asparagine-betaxanthin,Ìì¶¬õ£°·-Ìð²Ë»ÆËØ,0.3848,0.5352,0.5028,0.8549,1.151,0.2029,no,up,-,-,-,-,-,-,-,HMDB0304648,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,348.078774994,0.626083333333,"M+Na, M+K",C13H15N3O7,0,32.8,metab_1691,pos_259,pos,593100,338900,592200,613500,677500,560500,317000,751200,387700,476700,598500,402000,,,,
"10-Hydroxydecanoic Acid",-,0.3903,0.5251,0.5016,0.5019,1.1307,0.1772,no,up,C02774,-,-,-,-,-,-,HMDB0244272;MJDBOTE0001753,"Organic acids and derivatives","Hydroxy acids and derivatives","Medium-chain hydroxy acids and derivatives",1679-53-4,187.133137065,6.25165,"M-H, M+Na-2H",C10H20O3,32,0,metab_8010,neg_253,neg,53240,104600,58170,77820,58250,90320,64800,80220,53030,68130,57240,67830,,,,
(10Z)-12-Hydroxyhexadecenoylcarnitine,£¨10Z£©-12-ôÇ»ùÊ®ÁùÍé»ùÈâ¼î,0.4295,0.5769,0.4999,1.0119,0.8309,-0.2673,no,down,-,-,-,-,-,-,-,HMDB0241477,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,396.310199856,6.28761666667,"M+H-H2O, M+H",C23H43NO5,0,32.7,metab_6251,pos_925,pos,2406000,2575000,4199000,2545000,3361000,3870000,2017000,5669000,5404000,2376000,4976000,2371000,,,,
"PI(16:1(9Z)/18:2(9Z,11E)+=O(13))",-,0.3954,0.5453,0.4987,0.9065,0.7514,-0.4123,no,down,-,-,-,-,-,-,-,HMDB0276184,"Not Available","Not Available","Not Available",-,829.483069068,6.48976666667,"M+H-H2O, M+CH3OH+H",C43H75O14P,0,30.5,metab_4830,pos_575,pos,155200,66190,83680,70760,74580,79760,195800,90540,92180,109400,13960,203400,,,,
"LysoPC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)",-,0.3476,0.5015,0.4972,0.5132,1.3339,0.4157,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010397,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,542.320998486,6.76605,M+H,C28H48NO7P,0,79.3,metab_3395,pos_4378,pos,50980000,20340000,34020000,30160000,26950000,24050000,11810000,21120000,13640000,52320000,29730000,11160000,,,,
Octanoate,-,0.3808,0.5312,0.4959,0.6287,1.1007,0.1384,no,up,C06423,"Organic acids;Lipids","Carboxylic acids;Fatty acids",map01100;map00785;map00061;map01240,"Metabolic pathways;Lipoic acid metabolism;Fatty acid biosynthesis;Biosynthesis of cofactors",Metabolism;Metabolism;Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins;Lipid metabolism;Global and overview maps",HMDB0303345;HMDB0304443;HMDB0000482,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",124-07-2;74-81-7;124-07-2,287.221019363,7.4504,2M+H,C8H15O2-,0,32.2,metab_2838,pos_3797,pos,562500,406200,409300,410700,439500,402600,365400,334900,339800,567400,380700,402300,,,,
"PC(20:2(11Z,14Z)/14:1(9Z))",-,0.4872,0.6288,0.4899,0.416,1.2455,0.3167,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",LMGP01011838;HMDB0008329;PW_C004377,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,756.552614606,6.82985,M+H,C42H78NO8P,0,57.6,metab_1836,pos_2740,pos,3126000,58120000,40180000,33900000,60690000,52970000,37120000,33700000,32270000,1435000,54280000,41130000,,,,
Pactimibe,ÅÁÌæÂó²¼,0.3904,0.5402,0.4892,0.5812,1.4338,0.5198,no,up,-,-,-,-,-,-,-,HMDB0256074,"Organoheterocyclic compounds","Indoles and derivatives","Indolyl carboxylic acids and derivatives",-,455.268008534,6.86965,M+K,C25H40N2O3,0,81.9,metab_3285,pos_4267,pos,53390,94930,42130,35340,28600,9354,37450,32650,24750,68310,12960,7818,,,,
"PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.4088,0.5415,0.4878,0.7703,0.9181,-0.1233,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",LMGP02010094;HMDB0009012;PW_C005060,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,790.53956268,6.84488333333,M-H,C45H78NO8P,0,84,metab_6991,neg_1583,neg,8049000,6795000,6545000,7482000,5196000,6247000,6382000,8710000,5211000,7705000,8741000,7161000,,,,
"6-Keto-prostaglandin F1a",6-ÍªÇ°ÁÐÏÙËØ,0.4023,0.5521,0.4866,0.7953,1.4897,0.575,no,up,C05961,-,-,map00590;map01100,"Arachidonic acid metabolism;Metabolic pathways",Metabolism;Metabolism,"Lipid metabolism;Global and overview maps",HMDB0002886;PW_C001726,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,58962-34-8,782.509790622,6.3113,2M+ACN+H,C20H34O6,0,43.3,metab_1448,pos_2362,pos,38680,217600,142100,57120,92850,70190,35020,25540,33160,194500,25960,101000,,,,
L-Carnitine,L-Èâ¼î,0.4821,0.6241,0.4863,0.9508,1.0656,0.0917,no,up,C00318,-,-,map05415;map04976;map04714,"Diabetic cardiomyopathy;Bile secretion;Thermogenesis","Human Diseases;Organismal Systems;Organismal Systems","Cardiovascular disease;Digestive system;Environmental adaptation",PW_C000044;HMDB0000062;MJDBOTE0000806,"Organic nitrogen compounds","Organonitrogen compounds","Quaternary ammonium salts",541-15-1,162.112233605,0.665266666667,M+H,C7H15NO3,76,0,metab_5477,pos_6362,pos,5837000,5526000,5831000,4439000,5541000,6553000,6471000,4528000,5010000,4293000,4969000,6379000,,,,
"Hexadecanedioic acid",Ê®ÁùÍé¶þËá,0.4619,0.585,0.4836,0.4186,0.8904,-0.1675,no,down,C19615,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0000672;LMFA01170022;HMDB0304377;HMDB0000712,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",42150-38-9;505-54-4,285.206779244,6.34745,M-H,C16H30O4,0,57.1,metab_9038,neg_1753,neg,106300,162900,109700,173200,105200,157100,135100,180600,207900,100400,112400,178300,,,,
"Phenyl glucuronide",ÆÏÌÇ±½ÜÕËá,0.4125,0.5447,0.4825,0.8728,0.5745,-0.7996,no,down,-,-,-,-,-,-,-,HMDB0060014,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,269.066345578,3.94273333333,M-H,C12H14O7,45.9,0,metab_7476,neg_2025,neg,155700,27420,485700,708.9,18580,40170,201000,142800,545900,186600,15720,175500,,,,
PC(16:0/0:0),-,0.425,0.5735,0.4807,0.7974,1.1305,0.177,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",LMGP01050018;HMDB0010382,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,17364-16-8,518.321018196,6.18503333333,M+Na,C24H50NO7P,95.5,0,metab_4147,pos_5112,pos,8296000,6727000,6028000,9746000,9596000,6895000,5357000,5667000,7326000,6859000,11080000,5539000,,,,
"Indoleacrylic acid",ßÅßá±ûÏ©Ëá,0.3645,0.5165,0.4796,0.5028,0.9306,-0.1038,no,down,-,-,-,-,-,-,-,HMDB0000734,"Organoheterocyclic compounds","Indoles and derivatives",Indoles,29953-71-7,188.070328087,3.14315,"M+H, M+H-H2O",C11H9NO2,0,30.9,metab_2755,pos_371,pos,15940000,14890000,11020000,11060000,14450000,14690000,17130000,12820000,13290000,15490000,14530000,14920000,,,,
"DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0/0:0)",-,0.4338,0.5811,0.4791,0.7116,0.8347,-0.2607,no,down,C00165,-,-,map05214;map05167;map05143;map05163;map05146;map04915;map04015;map04014;map04659;map04658;map04270;map04012;map05231;map04650;map04370;map04371;map04072;map04071;map05235;map04921;map05415;map04750;map04919;map04933;map04961;map05012;map04920;map04923;map04925;map05017;map04926;map05171;map04726;map04725;map04724;map04723;map04728;map05223;map04720;map04666;map05170;map04664;map04540;map04662;map04660;map05200;map04261;map04010;map04024;map04929;map04020;map04928;map04062;map05225;map04064;map04066;map04625;map01521;map04972;map04973;map04970;map04971;map04730;map04975;map04918;map04713;map04916;map04714;map04722;map04911;map04912;map04935;map04613;map05022;map04611;map04931,"Glioma;Kaposi sarcoma-associated herpesvirus infection;African trypanosomiasis;Human cytomegalovirus infection;Amoebiasis;Estrogen signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Th17 cell differentiation;Th1 and Th2 cell differentiation;Vascular smooth muscle contraction;ErbB signaling pathway;Choline metabolism in cancer;Natural killer cell mediated cytotoxicity;VEGF signaling pathway;Apelin signaling pathway;Phospholipase D signaling pathway;Sphingolipid signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;Oxytocin signaling pathway;Diabetic cardiomyopathy;Inflammatory mediator regulation of TRP channels;Thyroid hormone signaling pathway;AGE-RAGE signaling pathway in diabetic complications;Endocrine and other factor-regulated calcium reabsorption;Parkinson disease;Adipocytokine signaling pathway;Regulation of lipolysis in adipocytes;Aldosterone synthesis and secretion;Spinocerebellar ataxia;Relaxin signaling pathway;Coronavirus disease - COVID-19;Serotonergic synapse;Cholinergic synapse;Glutamatergic synapse;Retrograde endocannabinoid signaling;Dopaminergic synapse;Non-small cell lung cancer;Long-term potentiation;Fc gamma R-mediated phagocytosis;Human immunodeficiency virus 1 infection;Fc epsilon RI signaling pathway;Gap junction;B cell receptor signaling pathway;T cell receptor signaling pathway;Pathways in cancer;Adrenergic signaling in cardiomyocytes;MAPK signaling pathway;cAMP signaling pathway;GnRH secretion;Calcium signaling pathway;Parathyroid hormone synthesis, secretion and action;Chemokine signaling pathway;Hepatocellular carcinoma;NF-kappa B signaling pathway;HIF-1 signaling pathway;C-type lectin receptor signaling pathway;EGFR tyrosine kinase inhibitor resistance;Pancreatic secretion;Carbohydrate digestion and absorption;Salivary secretion;Gastric acid secretion;Long-term depression;Fat digestion and absorption;Thyroid hormone synthesis;Circadian entrainment;Melanogenesis;Thermogenesis;Neurotrophin signaling pathway;Insulin secretion;GnRH signaling pathway;Growth hormone synthesis, secretion and action;Neutrophil extracellular trap formation;Pathways of neurodegeneration - multiple diseases;Platelet activation;Insulin resistance","Human Diseases;Human Diseases;Human Diseases;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Organismal Systems;Organismal Systems;Environmental Information Processing;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Environmental Information Processing;Environmental Information Processing;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Cellular Processes;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Environmental Information Processing;Organismal Systems;Organismal Systems;Human Diseases;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases","Cancer: specific types;Infectious disease: viral;Infectious disease: parasitic;Infectious disease: viral;Infectious disease: parasitic;Endocrine system;Signal transduction;Signal transduction;Immune system;Immune system;Circulatory system;Signal transduction;Cancer: overview;Immune system;Signal transduction;Signal transduction;Signal transduction;Signal transduction;Cancer: overview;Endocrine system;Cardiovascular disease;Sensory system;Endocrine system;Endocrine and metabolic disease;Excretory system;Neurodegenerative disease;Endocrine system;Endocrine system;Endocrine system;Neurodegenerative disease;Endocrine system;Infectious disease: viral;Nervous system;Nervous system;Nervous system;Nervous system;Nervous system;Cancer: specific types;Nervous system;Immune system;Infectious disease: viral;Immune system;Cellular community - eukaryotes;Immune system;Immune system;Cancer: overview;Circulatory system;Signal transduction;Signal transduction;Endocrine system;Signal transduction;Endocrine system;Immune system;Cancer: specific types;Signal transduction;Signal transduction;Immune system;Drug resistance: antineoplastic;Digestive system;Digestive system;Digestive system;Digestive system;Nervous system;Digestive system;Endocrine system;Environmental adaptation;Endocrine system;Environmental adaptation;Nervous system;Endocrine system;Endocrine system;Endocrine system;Immune system;Neurodegenerative disease;Immune system;Endocrine and metabolic disease",HMDB0007765;PW_C003816,"Lipids and lipid-like molecules",Glycerolipids,Diradylglycerols,-,623.502321508,6.77386666667,M+H-H2O,C41H68O5,0,50,metab_3384,pos_4366,pos,928400,768800,531600,494600,347800,488500,873600,1008000,262000,725100,891100,504900,,,,
"(3a,5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl-b-D-Glucopyranosiduronic acid",£¨3a£¬5b£©-24-Ñõ´ú-24-[£¨2-»ÇÒÒ»ù£©°±»ù]µ¨-3-»ù-b-D-ßÁà«ÆÏÌÑÌÇÈ©Ëá,0.3786,0.529,0.4768,0.5336,1.3836,0.4684,no,up,-,-,-,-,-,-,-,HMDB0002429,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",99794-82-8,682.326618133,7.65663333333,M+Na,C32H53NO11S,0,49.3,metab_2718,pos_3664,pos,3017000,1296000,1446000,1133000,1145000,1098000,613200,766700,732700,2783000,1082000,619900,,,,
"Monomenthyl succinate",çúçêËáµ¥±¡ºÉõ¥,0.4468,0.5733,0.4759,0.7072,1.2464,0.3178,no,up,-,-,-,-,-,-,-,HMDB0036143,"Lipids and lipid-like molecules","Prenol lipids",Monoterpenoids,188709-97-9,293.115724873,6.118,M+K-2H,C14H24O4,0,71.4,metab_9011,neg_981,neg,34350,68410,49770,21210,19180,72060,33460,29000,54140,49790,19100,27080,,,,
"PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)",-,0.3986,0.5482,0.4741,0.475,0.9036,-0.1462,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",LMGP01012107;PW_C004775;HMDB0008727,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,834.598656295,7.70341666667,M+H,C48H84NO8P,0,76.5,metab_2352,pos_3295,pos,109200000,139000000,129300000,152900000,133000000,123800000,138100000,141600000,159500000,93170000,137800000,201000000,,,,
"DL-p-Chlorophenylalanine methyl ester hydrochloride",DL-¶ÔÂÈ±½±û°±Ëá¼×õ¥ÑÎËáÑÎ,0.4287,0.5764,0.4721,0.9155,1.0242,0.0345,no,up,-,-,-,-,-,-,-,-,-,-,-,-,214.062587343,4.06346666667,M+H,C10H12ClNO2,94,0,metab_866,pos_1803,pos,389000,430500,417000,439700,385400,427800,428400,376400,417300,399700,396300,412400,,,,
Lefamulin,-,0.4399,0.5686,0.4712,0.6437,1.4805,0.5661,no,up,-,-,-,-,-,-,-,HMDB0254002,"Lipids and lipid-like molecules","Prenol lipids",Diterpenoids,-,528.274466321,6.59523333333,M+Na-2H,C28H45NO5S,0,48.4,metab_7105,neg_1689,neg,51470,81590,369400,87280,179700,53690,68350,166900,55670,70230,50540,144300,,,,
LysoPC(14:0/0:0),-,0.3755,0.5263,0.4688,0.745,1.13,0.1763,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",PW_C006388;HMDB0010379,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,20559-16-4,468.307712401,6.66235,M+H,C22H46NO7P,0,79.9,metab_3525,pos_4511,pos,1050000,717900,805900,937200,763500,699700,534800,877100,790900,903900,883200,411500,,,,
"Tetradec-5-Ynoic Acid",Ê®ËÄÌ¼ÎåÏ©Ëá,0.4116,0.5438,0.4625,0.4835,0.7988,-0.3241,no,down,-,-,-,-,-,-,-,-,-,-,-,-,223.169768883,6.20003333333,M-H,C14H24O2,33,0,metab_7238,neg_1809,neg,33480,27320,22120,11190,25750,30930,13110,32370,55940,17940,26620,42750,,,,
"Chikusetsusaponin Ia",Öñ½Ú²ÎÔíÜÕIa,0.4751,0.6175,0.4598,0.6711,0.7621,-0.3919,no,down,C17544,-,-,-,-,-,-,HMDB0034994,"Lipids and lipid-like molecules","Prenol lipids",Triterpenoids,59252-86-7,796.526777982,7.1553,M+ACN+H,C41H70O12,0,39.7,metab_2088,pos_3009,pos,56360,107000,86150,309700,6433,160900,178600,206500,224200,82510,188400,73650,,,,
D-Apiose,"D -ÇÛ²ËÌÇ",0.4114,0.5438,0.4596,0.7557,0.8159,-0.2935,no,down,C01488;C21040,-,-,-,-,-,-,HMDB0029941,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",639-97-4,149.044586287,0.698583333333,M-H,C5H10O5,0,62.8,metab_9034,neg_565,neg,1336000,1355000,2548000,484300,892500,1783000,1604000,1059000,2657000,1967000,1579000,1430000,,,,
"Ethyl 3-hydroxydodecanoate",ÒÒ»ù3-ôÇ»ùÊ®¶þËáõ¥,0.4432,0.59,0.4572,0.4546,2.186,1.1283,no,up,-,-,-,-,-,-,-,HMDB0059850,"Lipids and lipid-like molecules","Fatty Acyls","Fatty alcohols",-,262.237151109,5.80473333333,M+NH4,C14H28O3,0,61.5,metab_4641,pos_5579,pos,155200,8144,8761,16560,38230,2289,764.9,5427,8913,55930,16840,16930,,,,
"PG(5-iso PGF2VI/18:3(6Z,9Z,12Z))",-,0.436,0.5833,0.4564,0.5758,1.3381,0.4202,no,up,-,-,-,-,-,-,-,HMDB0269328,"Not Available","Not Available","Not Available",-,779.4548727,7.1474,"M+H-2H2O, M+ACN+Na",C42H71O13P,0,42.9,metab_6055,pos_745,pos,24690,121400,175100,90930,160800,24060,24300,46780,96280,67610,81910,129200,,,,
"LysoPC(20:4(8Z,11Z,14Z,17Z)/0:0)",-,0.5454,0.6808,0.4537,0.5546,0.8932,-0.1629,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010396,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,544.338598931,6.67033333333,"M+H, M+Na",C28H50NO7P,0,91.7,metab_5495,pos_638,pos,175600000,85150000,158300000,153100000,123800000,121800000,100800000,171900000,128600000,245600000,163700000,104800000,,,,
PE(16:0/0:0),-,0.4085,0.5414,0.4519,0.5363,0.8651,-0.2091,no,down,-,-,-,-,-,-,-,LMGP02050002;HMDB0011503,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,53862-35-4,452.277821222,6.5893,M-H,C21H44NO7P,96.2,0,metab_6453,neg_1097,neg,15620000,10400000,12750000,11550000,11470000,10120000,10750000,9782000,14010000,20950000,18190000,9449000,,,,
"PC(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))",-,0.4065,0.556,0.4491,0.4846,0.7862,-0.347,no,down,-,-,-,-,-,-,-,HMDB0286073,"Not Available","Not Available","Not Available",-,812.538723028,7.02138333333,M+H,C44H78NO10P,0,32.9,metab_1991,pos_2901,pos,184800,78370,135600,183200,340500,222900,267800,170200,399600,115900,149000,354400,,,,
"PC(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))",-,0.4559,0.6004,0.449,0.6988,1.2939,0.3717,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004299;HMDB0008251;LMGP01011728,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,856.581382943,6.2243,M+Na,C48H84NO8P,0,95.3,metab_1370,pos_2282,pos,5006000,5633000,6323000,7824000,324200,10390000,6395000,6516000,6429000,2523000,292600,5285000,,,,
"15-Deoxy-d-12,14-PGJ2",-,0.4112,0.5438,0.4465,0.5005,1.8649,0.8991,no,up,C14717,-,-,map00590,"Arachidonic acid metabolism",Metabolism,"Lipid metabolism",PW_C002398;HMDB0005079,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,87893-55-8,361.201713187,6.07096666667,M+FA-H,C20H28O3,0,46.2,metab_7298,neg_1863,neg,119200,122900,49480,568000,63570,49360,54480,158900,138100,53680,48670,67680,,,,
6-Hydroxynon-3-enoylcarnitine,"6 -ôÇ»ù- 3 -Ï©õ£»ùÈâ¼î",0.5081,0.6477,0.4433,0.4942,1.2052,0.2693,no,up,-,-,-,-,-,-,-,HMDB0241752,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,316.211130674,4.39053333333,M+H,C16H29NO5,0,33.8,metab_887,pos_1822,pos,149300,479200,356200,128400,405600,387800,163500,69170,339900,248700,377000,384200,,,,
Leflunomide,À´·úÃ×ÌØ,0.4922,0.6143,0.4433,0.5331,0.7666,-0.3835,no,down,C07905,-,-,-,-,-,-,HMDB0015229,Benzenoids,"Benzene and substituted derivatives",Anilides,75706-12-6,305.030652074,5.90265,M+Cl,C12H9F3N2O2,0,30.3,metab_7364,neg_1924,neg,17550,36210,46830,29620,31500,29610,58720,33270,17110,23730,19780,96980,,,,
"P-Menthane-3,8-diol",-,0.429,0.5587,0.4431,0.495,1.0519,0.073,no,up,C02904,-,-,-,-,-,-,HMDB0036145;HMDB0035595,"Lipids and lipid-like molecules","Prenol lipids",Monoterpenoids,565-50-4;42822-86-6;91739-72-9,209.094103514,6.08663333333,M+K-2H,C10H20O2,0,46.9,metab_9000,neg_971,neg,131200,171400,154300,167600,183700,165100,162100,158000,159400,123100,158300,164500,,,,
"PE-NMe2(15:0/20:3(5Z,8Z,11Z))",-,0.4451,0.5728,0.4414,0.4915,1.2847,0.3614,no,up,C04308,-,-,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0113926;PW_C059942,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,800.545427905,6.17698333333,M+FA-H,C42H78NO8P,0,90.8,metab_9027,neg_997,neg,84540,8368000,5729000,5920000,9072000,7864000,5532000,4345000,4751000,17390,6386000,7799000,,,,
"PS(22:4(7Z,10Z,13Z,16Z)/15:0)",-,0.4922,0.634,0.438,0.4119,0.8337,-0.2624,no,down,C02737,Lipids,Phospholipids,map01100;map00564;map05146;map05322;map00260;map05140,"Metabolic pathways;Glycerophospholipid metabolism;Amoebiasis;Systemic lupus erythematosus;Glycine, serine and threonine metabolism;Leishmaniasis","Metabolism;Metabolism;Human Diseases;Human Diseases;Metabolism;Human Diseases","Global and overview maps;Lipid metabolism;Infectious disease: parasitic;Immune disease;Amino acid metabolism;Infectious disease: parasitic",HMDB0112790;LMGP03010791;PW_C061220,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoserines,-,839.559395198,6.76605,M+ACN+H,C43H76NO10P,0,34.8,metab_1795,pos_2696,pos,158700,304100,184100,539000,158500,283500,383500,231500,505700,361200,189400,281200,,,,
2-Polyprenyl-6-methoxyphenol,"2 -¾ÛÎìÏ©»ù- 6 -¼×Ñõ»ù±½·Ó",0.4665,0.6104,0.4368,0.815,0.8534,-0.2287,no,down,C17552,-,-,map01100;map00130;map01240,"Metabolic pathways;Ubiquinone and other terpenoid-quinone biosynthesis;Biosynthesis of cofactors",Metabolism;Metabolism;Metabolism,"Global and overview maps;Metabolism of cofactors and vitamins;Global and overview maps",HMDB0060355,"Lipids and lipid-like molecules","Prenol lipids",Monoterpenoids,-,538.385945141,6.24801666667,"M+ACN+H, 2M+NH4",C17H24O2,0,43.4,metab_6267,pos_940,pos,4220000,3174000,3837000,7852000,6592000,2998000,5260000,5266000,7161000,2833000,7853000,5224000,,,,
(2E)-4-hydroxy-5-methyl-2-propylidene-3(2H)-furanone,£¨2E£©-4-ôÇ»ù-5-¼×»ù-2-ÑÇ±û»ù-3£¨2H£©-ß»à«Íª,0.5229,0.6613,0.435,0.4386,1.029,0.0412,no,up,-,-,-,-,-,-,-,HMDB0303967,"Organoheterocyclic compounds",Dihydrofurans,Furanones,-,118.041673746,3.18185,M+H-2H2O,C8H9O3-,0,31.9,metab_4923,pos_5837,pos,131800,128900,128800,112600,140000,146500,123800,133600,133600,132700,115100,127500,,,,
"CPA(18:2(9Z,12Z)/0:0)",-,0.5223,0.6404,0.4328,0.3916,1.5703,0.651,no,up,-,-,-,-,-,-,-,HMDB0007007,"Lipids and lipid-like molecules","Fatty Acyls","Lineolic acids and derivatives",-,415.225076319,6.70285,M-H,C21H37O6P,0,52.3,metab_7062,neg_1649,neg,182300,56270,123800,55530,190800,128200,1681,8195,24350,385000,23190,26810,,,,
LysoPC(18:1(11Z)/0:0),-,0.5896,0.7163,0.4208,0.5839,0.9011,-0.1502,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010385,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,522.354605685,7.06845,"M+H-H2O, M+H",C26H52NO7P,0,69.2,metab_6035,pos_727,pos,182500000,96210000,174900000,163900000,126700000,135800000,102300000,181500000,158300000,260700000,183300000,90690000,,,,
Gamma-Glutamylleucine,-,0.4931,0.6146,0.4167,0.6533,1.2009,0.2641,no,up,-,-,-,-,-,-,-,HMDB0011171,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",2566-39-4,259.129560281,3.97616666667,M-H,C11H20N2O5,0,37.6,metab_8829,neg_816,neg,157900,347300,82060,279800,171600,145400,135800,174400,165100,108500,268700,133700,,,,
"PE(20:4(5Z,8Z,11Z,14Z)/18:0)",-,0.5026,0.6233,0.4153,0.6936,0.9318,-0.1019,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",LMGP02010943;HMDB0009387;PW_C005435,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,766.539630854,7.05978333333,M-H,C43H78NO8P,0,80.9,metab_6590,neg_1220,neg,4010000,4253000,3309000,3966000,3017000,3342000,3943000,5034000,2560000,3873000,4175000,3917000,,,,
"LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)",-,0.5149,0.6346,0.4137,0.5281,1.2134,0.2791,no,up,-,-,-,-,-,-,-,HMDB0011526,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,524.277903396,7.5624,M-H,C27H44NO7P,0,97,metab_6674,neg_1297,neg,99470,96480,185900,117800,124900,126200,25010,192800,72970,131300,168000,28500,,,,
"Cis,cis-Muconic acid",-,0.5398,0.6758,0.4017,0.4408,0.957,-0.0634,no,down,C02480,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",LMFA01170077;HMDB0006331,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",1119-72-8,143.03374998,2.0399,M+H,C6H6O4,52.7,0,metab_645,pos_1601,pos,52120,56230,57970,45160,48420,57580,46520,53470,52810,67870,51490,59570,,,,
Spermidine,ÑÇ¾«°·,0.5719,0.705,0.4015,0.4921,1.2313,0.3002,no,up,C00315,-,-,map01100;map00480;map00330;map02010;map04976;map00410,"Metabolic pathways;Glutathione metabolism;Arginine and proline metabolism;ABC transporters;Bile secretion;beta-Alanine metabolism","Metabolism;Metabolism;Metabolism;Environmental Information Processing;Organismal Systems;Metabolism","Global and overview maps;Metabolism of other amino acids;Amino acid metabolism;Membrane transport;Digestive system;Metabolism of other amino acids",HMDB0001257;PW_C000971,"Organic nitrogen compounds","Organonitrogen compounds",Amines,124-20-9,146.164982867,0.602133333333,M+H,C7H19N3,48.8,0,metab_5727,pos_6595,pos,62780,266700,95600,206400,146500,122700,231200,177900,46320,43040,31380,201700,,,,
"Okadaic acid",¸ÔÌïËá,0.4611,0.6052,0.3977,0.5802,0.7759,-0.3661,no,down,C01945,-,-,-,-,-,-,HMDB0030441,"Organic oxygen compounds","Organooxygen compounds",Ethers,78111-17-8,805.47032281,7.21095,M+H,C44H68O13,0,41,metab_2971,pos_3934,pos,16400,16320,18690,15590,24600,62380,59550,17150,30690,32850,21100,37070,,,,
"RHODAMINE 6G",ÂÞµ¤Ã÷6G,0.4974,0.6388,0.3974,0.4076,1.6879,0.7552,no,up,C11177,-,-,-,-,-,-,HMDB0257199,"Organoheterocyclic compounds",Benzopyrans,1-benzopyrans,989-38-8,443.232688508,6.12123333333,M+H,C28H30N2O3,0,55.6,metab_4221,pos_5190,pos,426300,148000,1145000,51550,2424000,837900,15590,225200,219300,2119000,228000,174300,,,,
Dihydrodigoxin,¶þÇâµØ¸ßÐÁ,0.5832,0.7127,0.3968,0.3175,0.8274,-0.2733,no,down,-,-,-,-,-,-,-,HMDB0041879,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroid lactones",5297-10-9,815.479858865,7.02921666667,M+CH3OH+H,C41H66O14,0,42.8,metab_3126,pos_4103,pos,233400,37230,163900,109300,60770,48030,118900,230200,161000,132500,55860,90400,,,,
"2-Methylhexadecanoic acid","2 -¼×»ùÊ®ÁùÍéËá",0.5724,0.7052,0.3952,0.632,1.0833,0.1154,no,up,-,-,-,-,-,-,-,HMDB0245229,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,288.289036188,6.24016666667,M+NH4,C17H34O2,0,42.2,metab_1378,pos_2291,pos,1665000,2919000,2353000,2837000,3644000,2813000,2706000,2405000,2318000,1897000,3532000,2123000,,,,
"PC(20:3(8Z,11Z,14Z)/18:0)",-,0.4854,0.627,0.3948,0.5527,1.3902,0.4753,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008399;LMGP01011877;PW_C004447,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,794.604105507,6.90168333333,"M+H-H2O, M+2Na-H",C46H86NO8P,0,76.7,metab_5987,pos_684,pos,15060000,4107000,3977000,3599000,2065000,6383000,4056000,2941000,4084000,9816000,1738000,2672000,,,,
"SM(d16:2(4E,8Z)/TXB2)",-,0.4708,0.6136,0.3917,0.5537,0.8354,-0.2595,no,down,-,-,-,-,-,-,-,HMDB0290315,"Not Available","Not Available","Not Available",-,804.550941867,6.2243,"M+NH4, M+H-H2O",C41H75N2O10P,0,90.5,metab_4056,pos_502,pos,4361000,4724000,3860000,3833000,3108000,5597000,5235000,5756000,6347000,2018000,2415000,8734000,,,,
"Dihydro-4,4-Dimethyl-2,3-furandione","¶þÇâ- 4£¬4 -¶þ¼×»ù- 2£¬3 -ß»à«¶þÍª",0.5771,0.6835,0.3913,0.6862,1.134,0.1814,no,up,C01125,-,-,-,-,-,-,-,-,-,-,13031-04-4,127.039018122,4.31933333333,M-H,C6H8O3,91.5,0,metab_7458,neg_2009,neg,253600,353100,355100,129500,166100,174200,160000,157800,317400,272300,186900,168100,,,,
Solamine,ÜÐË÷ÂÈï§,0.4803,0.6228,0.3901,0.4431,0.8812,-0.1825,no,down,-,-,-,-,-,-,-,HMDB0031202,"Organic nitrogen compounds","Organonitrogen compounds",Amines,17232-87-0,238.22729918,7.83811666667,M+Na,C12H29N3,0,42.6,metab_2534,pos_3472,pos,220400,117400,111200,83030,207400,132700,188100,164200,179800,176400,97660,184100,,,,
"2-(4-Methyl-5-thiazolyl)ethyl formate",2-£¨4-¼×»ù-5-àçßò»ù£©¼×ËáÒÒõ¥,0.5018,0.6417,0.389,0.7586,0.9537,-0.0684,no,down,-,-,-,-,-,-,-,HMDB0032420,"Organoheterocyclic compounds",Azoles,Thiazoles,90731-56-9,204.069221421,0.727316666667,"M+NH4, M+CH3OH+H",C7H9NO2S,0,39.3,metab_152,pos_1135,pos,1215000,1114000,1339000,1065000,1238000,1325000,1495000,1010000,1306000,1154000,1289000,1393000,,,,
"6-Hydroxyhexanoic Acid",6-ôÇ»ù¼ºËá,0.5685,0.6766,0.3844,0.427,0.94,-0.0893,no,down,C06103,-,-,-,-,-,-,HMDB0012843,"Organic acids and derivatives","Hydroxy acids and derivatives","Medium-chain hydroxy acids and derivatives",1191-25-9,131.070330304,4.89,M-H,C6H12O3,76.8,0,metab_7422,neg_1978,neg,870300,769400,800200,965200,604000,703300,750600,1042000,1001000,734200,617700,867500,,,,
"Penitrem D",-,0.4704,0.6132,0.3795,0.7143,1.114,0.1557,no,up,C20596,-,-,-,-,-,-,HMDB0256240;HMDB0242736,"Organoheterocyclic compounds",Naphthopyrans,"Not Available",78213-64-6,568.338936822,6.60633333333,"M+H, M+Na",C37H45NO4,0,33.9,metab_5121,pos_602,pos,87050000,55270000,77890000,84000000,75150000,75800000,42070000,88380000,60890000,93660000,79500000,44080000,,,,
Digitoxin,ÑóµØ»Æ¶¾ÜÕ,0.4994,0.6399,0.3768,0.4016,1.5208,0.6048,no,up,C06955,Steroids,"23-Carbon atoms",-,-,-,-,HMDB0251273;LMST01120018;HMDB0015468,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroid lactones",71-63-6,797.465631877,6.86163333333,M+CH3OH+H,C41H64O13,0,31.7,metab_1860,pos_2766,pos,17170,24140,12350,17670,703.2,739.4,1034,753.8,22170,972.1,21870,1056,,,,
"PS(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))",-,0.546,0.6812,0.3754,0.9104,1.1835,0.2431,no,up,C02737,Lipids,Phospholipids,map01100;map00564;map05146;map05322;map00260;map05140,"Metabolic pathways;Glycerophospholipid metabolism;Amoebiasis;Systemic lupus erythematosus;Glycine, serine and threonine metabolism;Leishmaniasis","Metabolism;Metabolism;Human Diseases;Human Diseases;Metabolism;Human Diseases","Global and overview maps;Lipid metabolism;Infectious disease: parasitic;Immune disease;Amino acid metabolism;Infectious disease: parasitic",PW_C060900;LMGP03010438;HMDB0112493,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoserines,-,802.465083057,6.38315,M+Na,C42H70NO10P,0,32.1,metab_3848,pos_4815,pos,123800,41900,103400,108900,118400,99120,141800,26880,27350,101700,66150,139300,,,,
"PE(16:0/18:2(9Z,12Z))",-,0.5132,0.6334,0.3741,0.5995,0.9002,-0.1517,no,down,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",HMDB0008928;LMGP02010042;PW_C004976,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,26662-95-3,714.508202316,6.81288333333,M-H,C39H74NO8P,0,81.4,metab_6536,neg_1172,neg,6881000,3860000,5629000,4726000,4006000,3632000,4464000,7211000,3693000,5885000,6600000,4066000,,,,
"3-Indole carboxylic acid glucuronide","3 -ßÅßáôÈËáÆÏÌÑÌÇÈ©ËáÜÕ",0.5084,0.6293,0.3736,0.5685,0.7228,-0.4683,no,down,-,-,-,-,-,-,-,HMDB0013189,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,336.072191659,4.84431666667,M-H,C15H15NO8,0,55.1,metab_7426,neg_1981,neg,26790,23790,85240,6192,7591,39090,23150,40120,94840,59590,41260,2126,,,,
"(3Z,5E)-Hepta-3,5-dienoylcarnitine","£¨3Z£¬5E£©-Æß-3,5-¶þÏ©õ£»ùÈâ¼î",0.5811,0.7111,0.3719,0.68,0.8386,-0.2539,no,down,-,-,-,-,-,-,-,HMDB0241692,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,302.195574892,3.8741,M+CH3OH+H,C14H23NO4,0,51.5,metab_4843,pos_5761,pos,317700,364100,1144000,322300,248200,612700,539200,443800,827100,342300,488000,947000,,,,
Thromboxane,ÑªË¨ËØ,0.5833,0.6889,0.3697,0.3677,2.1325,1.0925,no,up,C02198,Lipids,Eicosanoids,map01100;map00590;map04080;map04611;map04726,"Metabolic pathways;Arachidonic acid metabolism;Neuroactive ligand-receptor interaction;Platelet activation;Serotonergic synapse","Metabolism;Metabolism;Environmental Information Processing;Organismal Systems;Organismal Systems","Global and overview maps;Lipid metabolism;Signaling molecules and interaction;Immune system;Nervous system",LMFA03030015;HMDB0003208;HMDB0001452,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,66719-58-2;57576-52-0,341.305676848,6.89006666667,M+FA-H,C20H40O,0,65.8,metab_6981,neg_1574,neg,83470,915.7,956.2,935,5151,938.5,903.9,4203,23500,8890,3553,2253,,,,
Gamma-Glu-leu,¦Ã-¹È°±õ£-ÁÁ°±Ëá,0.5847,0.714,0.3647,0.6276,1.1264,0.1717,no,up,-,-,-,-,-,-,-,HMDB0011171,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",2566-39-4,261.14391932,3.42071666667,M+H,C11H20N2O5,53.7,0,metab_813,pos_1756,pos,327100,647900,211900,567000,367300,295000,309800,363900,393300,255600,528500,293700,,,,
"5-(4-Methyl-5-Oxo-2H-Furan-3-Yl)Pentanoic Acid",-,0.5612,0.6702,0.3622,0.8477,0.8716,-0.1983,no,down,-,-,-,-,-,-,-,-,-,-,-,-,197.081151479,5.71641666667,M-H,C10H14O4,83.4,0,metab_8909,neg_889,neg,95070,41560,101000,57970,52390,71400,92600,53110,112700,58080,40870,123900,,,,
PE(18:1(9Z)/0:0),-,0.5168,0.6361,0.3552,0.479,0.8801,-0.1843,no,down,-,-,-,-,-,-,-,LMGP02050004,-,-,-,-,478.293613375,6.59523333333,M-H,C23H46NO7P,97,0,metab_7108,neg_1691,neg,11060000,5412000,10670000,8612000,7408000,7153000,5603000,9605000,10160000,13760000,12720000,5315000,,,,
"PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)",-,0.6243,0.7443,0.3534,0.367,1.1467,0.1975,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",LMGP01011116;PW_C004773;HMDB0008725,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,806.567994016,6.71823333333,M+H,C46H80NO8P,0,79.2,metab_3452,pos_4435,pos,45540000,400500000,344100000,301300000,478000000,325200000,287100000,302700000,293600000,29310000,415000000,324800000,,,,
4-Amino-3-hydroxybutyrate,"4 -°±»ù- 3 -ôÇ»ù¶¡Ëá",0.5915,0.7176,0.3531,0.8259,1.0071,0.0102,no,up,C03678,-,-,-,-,-,-,HMDB0061877,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,102.05520724,0.530266666667,M+H-H2O,C4H9NO3,0,51,metab_231,pos_1206,pos,534600,559500,558200,559500,556800,559800,573800,533200,542500,548300,549300,558100,,,,
1-Nonadecanoyl-glycero-3-phosphoethanolamine,"1 -Ê®¾ÅÍéõ£»ù-±ûÈý»ù3 -Á×ËáÒÒ´¼°·",0.6876,0.7944,0.3499,0.3945,0.8934,-0.1626,no,down,-,-,-,-,-,-,-,HMDB0243971;LMGP02050028,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,991.669931115,7.04486666667,2M+H,C24H50NO7P,0,72,metab_2017,pos_2931,pos,3158000,1236000,3318000,2146000,1496000,1263000,1286000,2639000,2437000,4064000,2825000,871600,,,,
Trans-2-pentenol,-,0.5122,0.651,0.3459,0.5083,1.1444,0.1946,no,up,-,-,-,-,-,-,-,HMDB0031611;HMDB0304503;HMDB0031604,"Organic oxygen compounds","Organooxygen compounds","Alcohols and polyols",1576-96-1;185044-12-6,104.107165155,7.75825,M+NH4,C5H10O,0,32,metab_2633,pos_3572,pos,1929000,1118000,1466000,1032000,1373000,1214000,959200,964300,996300,2243000,995800,946600,,,,
DG(8:0/i-12:0/0:0),-,0.5843,0.7137,0.3458,0.9113,0.91,-0.1361,no,down,C00165,-,-,map05214;map05167;map05143;map05163;map05146;map04915;map04015;map04014;map04659;map04658;map04270;map04012;map05231;map04650;map04370;map04371;map04072;map04071;map05235;map04921;map05415;map04750;map04919;map04933;map04961;map05012;map04920;map04923;map04925;map05017;map04926;map05171;map04726;map04725;map04724;map04723;map04728;map05223;map04720;map04666;map05170;map04664;map04540;map04662;map04660;map05200;map04261;map04010;map04024;map04929;map04020;map04928;map04062;map05225;map04064;map04066;map04625;map01521;map04972;map04973;map04970;map04971;map04730;map04975;map04918;map04713;map04916;map04714;map04722;map04911;map04912;map04935;map04613;map05022;map04611;map04931,"Glioma;Kaposi sarcoma-associated herpesvirus infection;African trypanosomiasis;Human cytomegalovirus infection;Amoebiasis;Estrogen signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Th17 cell differentiation;Th1 and Th2 cell differentiation;Vascular smooth muscle contraction;ErbB signaling pathway;Choline metabolism in cancer;Natural killer cell mediated cytotoxicity;VEGF signaling pathway;Apelin signaling pathway;Phospholipase D signaling pathway;Sphingolipid signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;Oxytocin signaling pathway;Diabetic cardiomyopathy;Inflammatory mediator regulation of TRP channels;Thyroid hormone signaling pathway;AGE-RAGE signaling pathway in diabetic complications;Endocrine and other factor-regulated calcium reabsorption;Parkinson disease;Adipocytokine signaling pathway;Regulation of lipolysis in adipocytes;Aldosterone synthesis and secretion;Spinocerebellar ataxia;Relaxin signaling pathway;Coronavirus disease - COVID-19;Serotonergic synapse;Cholinergic synapse;Glutamatergic synapse;Retrograde endocannabinoid signaling;Dopaminergic synapse;Non-small cell lung cancer;Long-term potentiation;Fc gamma R-mediated phagocytosis;Human immunodeficiency virus 1 infection;Fc epsilon RI signaling pathway;Gap junction;B cell receptor signaling pathway;T cell receptor signaling pathway;Pathways in cancer;Adrenergic signaling in cardiomyocytes;MAPK signaling pathway;cAMP signaling pathway;GnRH secretion;Calcium signaling pathway;Parathyroid hormone synthesis, secretion and action;Chemokine signaling pathway;Hepatocellular carcinoma;NF-kappa B signaling pathway;HIF-1 signaling pathway;C-type lectin receptor signaling pathway;EGFR tyrosine kinase inhibitor resistance;Pancreatic secretion;Carbohydrate digestion and absorption;Salivary secretion;Gastric acid secretion;Long-term depression;Fat digestion and absorption;Thyroid hormone synthesis;Circadian entrainment;Melanogenesis;Thermogenesis;Neurotrophin signaling pathway;Insulin secretion;GnRH signaling pathway;Growth hormone synthesis, secretion and action;Neutrophil extracellular trap formation;Pathways of neurodegeneration - multiple diseases;Platelet activation;Insulin resistance","Human Diseases;Human Diseases;Human Diseases;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Organismal Systems;Organismal Systems;Environmental Information Processing;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Environmental Information Processing;Environmental Information Processing;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Cellular Processes;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Environmental Information Processing;Organismal Systems;Organismal Systems;Human Diseases;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases","Cancer: specific types;Infectious disease: viral;Infectious disease: parasitic;Infectious disease: viral;Infectious disease: parasitic;Endocrine system;Signal transduction;Signal transduction;Immune system;Immune system;Circulatory system;Signal transduction;Cancer: overview;Immune system;Signal transduction;Signal transduction;Signal transduction;Signal transduction;Cancer: overview;Endocrine system;Cardiovascular disease;Sensory system;Endocrine system;Endocrine and metabolic disease;Excretory system;Neurodegenerative disease;Endocrine system;Endocrine system;Endocrine system;Neurodegenerative disease;Endocrine system;Infectious disease: viral;Nervous system;Nervous system;Nervous system;Nervous system;Nervous system;Cancer: specific types;Nervous system;Immune system;Infectious disease: viral;Immune system;Cellular community - eukaryotes;Immune system;Immune system;Cancer: overview;Circulatory system;Signal transduction;Signal transduction;Endocrine system;Signal transduction;Endocrine system;Immune system;Cancer: specific types;Signal transduction;Signal transduction;Immune system;Drug resistance: antineoplastic;Digestive system;Digestive system;Digestive system;Digestive system;Nervous system;Digestive system;Endocrine system;Environmental adaptation;Endocrine system;Environmental adaptation;Nervous system;Endocrine system;Endocrine system;Endocrine system;Immune system;Neurodegenerative disease;Immune system;Endocrine and metabolic disease",HMDB0092905;PW_C064417,"Lipids and lipid-like molecules",Glycerolipids,Diradylglycerols,-,801.651152801,6.40388333333,2M+H,C23H44O5,0,36.8,metab_1503,pos_2412,pos,55460,53190,69370,60280,50940,34260,88300,42740,54690,47200,43130,79440,,,,
"6,7-Dinitro-1,4-dihydroquinoxaline-2,3-dione","6£¬7 -¶þÏõ»ù- 1£¬4 -¶þÇâà­à¸ßø- 2£¬3 -¶þÍª",0.5936,0.6971,0.3438,0.5441,0.9101,-0.1359,no,down,-,-,-,-,-,-,-,HMDB0251552,"Organoheterocyclic compounds",Diazanaphthalenes,Benzodiazines,-,232.997401734,1.69138333333,M-H2O-H,C8H4N4O6,0,43,metab_8713,neg_710,neg,30910,38860,55430,47720,55830,65350,45660,82550,57490,45450,60450,31550,,,,
"3,7,8,15-Scirpenetetrol","3£¬7£¬8£¬15 -ÈýÝÆ´¼",0.5243,0.6618,0.3406,0.5213,1.1475,0.1985,no,up,-,-,-,-,-,-,-,HMDB0037560,"Lipids and lipid-like molecules","Prenol lipids",Sesquiterpenoids,128534-67-8,316.174779336,3.34003333333,M+NH4,C15H22O6,0,64.1,metab_805,pos_1749,pos,844300,919100,1651000,532100,952000,777500,621700,810000,1289000,629400,830500,766000,,,,
"N6,N6,N6-Trimethyl-L-lysine","N6£¬N6£¬N6 -Èý¼×»ù- L -Àµ°±Ëá",0.497,0.6387,0.3405,0.8757,1.1101,0.1507,no,up,C03793,-,-,map01100;map00310,"Metabolic pathways;Lysine degradation",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",PW_C001022;HMDB0001325,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",19253-88-4,189.159502244,0.618083333333,"M+H, M+Na, M+K",C9H20N2O2,0,35.3,metab_3936,pos_49,pos,1252000,1417000,1693000,1068000,1023000,1110000,1142000,737800,1598000,1513000,936900,880100,,,,
PA(PGD1/P-16:0),-,0.6085,0.7317,0.3392,0.7808,0.9431,-0.0845,no,down,-,-,-,-,-,-,-,HMDB0266786,"Not Available","Not Available","Not Available",-,772.509086931,6.33508333333,M+ACN+H,C39H71O10P,0,33.9,metab_3908,pos_4873,pos,1337000,1285000,1573000,1658000,1400000,1209000,2000000,1160000,1810000,1342000,1155000,1505000,,,,
PE(14:0/TXB2),-,0.5864,0.7145,0.333,0.3759,1.347,0.4297,no,up,-,-,-,-,-,-,-,HMDB0260608,"Not Available","Not Available","Not Available",-,841.487854435,6.70236666667,M+ACN+Na,C39H72NO12P,0,48.7,metab_1735,pos_2634,pos,3486,180700,7978,177400,61120,63180,0.9158,83510,108500,111300,34920,28440,,,,
Citrulline,¹Ï°±Ëá,0.5398,0.6537,0.3321,0.4604,0.9182,-0.1231,no,down,C00327,Peptides,"Amino acids",map01100;map00220;map01230,"Metabolic pathways;Arginine biosynthesis;Biosynthesis of amino acids",Metabolism;Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism;Global and overview maps",PW_C000723;HMDB0000904;MJDBOTE0000481,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",372-75-8,174.08759437,0.675266666667,M-H,C6H13N3O3,91.3,0,metab_8547,neg_548,neg,138000,138900,172500,80560,135900,188900,127000,141800,218100,141800,155400,147400,,,,
Rolipram,»·Îì±½ßÁÍª,0.6623,0.7741,0.3234,0.7534,0.9252,-0.1122,no,down,-,-,-,-,-,-,-,HMDB0257294,"Organoheterocyclic compounds",Pyrrolidines,Phenylpyrrolidines,-,568.338490595,7.75028333333,2M+NH4,C16H21NO3,0,37,metab_2646,pos_3584,pos,501400,308800,543300,519700,493400,557300,265500,765200,503000,720600,519900,386000,,,,
"PC(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))",-,0.6547,0.7677,0.3223,0.25,0.7877,-0.3443,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004492;HMDB0008444,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,852.551701393,7.4504,"M+Na, M+ACN+H",C48H80NO8P,0,82.9,metab_6105,pos_791,pos,618500,115600,183400,129500,219100,199400,190400,157800,211200,896900,284700,119200,,,,
"4-(2,6,6-Trimethyl-1-cyclohexenyl)-2-butanol","4-£¨2,6,6-Èý¼×»ù-1-»·¼ºÏ©»ù£©-2-¶¡´¼",0.6223,0.7189,0.3219,0.3372,0.9169,-0.1252,no,down,-,-,-,-,-,-,-,HMDB0036172,"Lipids and lipid-like molecules","Prenol lipids",Sesquiterpenoids,3293-47-8,241.180447786,6.39858333333,M+FA-H,C13H24O,0,30.7,metab_6413,neg_1059,neg,418000,609700,584200,571000,464800,953600,526800,894900,825600,417400,684400,578700,,,,
27-O-demethylrifabutin,"27 - O -È¥¼×Àû¸£²¼Í¡",0.5624,0.6965,0.3217,0.675,0.8266,-0.2747,no,down,-,-,-,-,-,-,-,HMDB0061043,Benzenoids,"Benzene and substituted derivatives","Not Available",-,797.406145331,6.49781666667,M+H-2H2O,C45H60N4O11,0,56.8,metab_3723,pos_4701,pos,12470,31130,49170,19290,42590,47830,81460,27550,53120,16820,21220,44800,,,,
"Polypodoside B",-,0.5648,0.6986,0.3164,0.3651,1.1979,0.2605,no,up,-,-,-,-,-,-,-,HMDB0040744,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroidal glycosides",120015-16-9,771.451767802,6.47368333333,M+CH3OH+H,C39H62O13,0,34.4,metab_3745,pos_4721,pos,91010,28240,129500,58710,59190,170600,75000,66410,117100,83270,80940,25720,,,,
Cysteinyl-Alanine,°ëë×°±Ëá-±û°±Ëá,0.5825,0.7122,0.315,0.6663,1.1513,0.2033,no,up,-,-,-,-,-,-,-,HMDB0028768,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,256.074474559,2.8334,M+ACN+Na,C6H12N2O3S,0,34.3,metab_734,pos_1683,pos,776700,799100,1176000,164400,595400,971000,563200,445800,1125000,625200,564400,569700,,,,
(9E)-Heptadec-9-enoylcarnitine,£¨9E£©-ÆßÍé»ù-9-Ï©õ£»ùÈâ¼î,0.684,0.7922,0.3146,0.4738,0.9202,-0.12,no,down,-,-,-,-,-,-,-,HMDB0241516,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,412.341689256,6.39736666667,"M+H, 2M+NH4",C24H45NO4,0,44.8,metab_4587,pos_553,pos,112300,101700,207700,158200,114700,169900,82590,241800,199800,175200,128800,111100,,,,
"PC(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/20:3(5Z,8Z,11Z))",-,0.5914,0.7176,0.3144,0.2966,0.923,-0.1156,no,down,-,-,-,-,-,-,-,HMDB0287326,"Not Available","Not Available","Not Available",-,836.555700241,6.63035,"M+H-2H2O, M+H-H2O, M+NH4",C50H82NO9P,0,36.6,metab_631,pos_159,pos,1229000,1519000,2263000,1794000,2088000,1471000,1887000,1737000,1482000,1251000,2295000,2575000,,,,
Stearaldehyde,Ó²Ö¬È©,0.6473,0.737,0.3129,0.3053,1.8242,0.8673,no,up,C01838,-,-,-,-,-,-,LMFA06000098;HMDB0002384,"Lipids and lipid-like molecules","Fatty Acyls","Fatty aldehydes",638-66-4,313.274571915,6.71851666667,M+FA-H,C18H36O,0,48.1,metab_6505,neg_1144,neg,191800,3433,1265,1170,8948,1346,1131,21850,55660,13140,12630,9622,,,,
"5-Phenyl-1,3-oxazinane-2,4-dione","5 -±½»ù- 1,3-fàºÍé- 2£¬4 -¶þÍª",0.6436,0.7337,0.3121,0.4444,0.7793,-0.3597,no,down,C16596,-,-,map00982,"Drug metabolism - cytochrome P450",Metabolism,"Xenobiotics biodegradation and metabolism",PW_C040533;HMDB0060400,Benzenoids,"Benzene and substituted derivatives","Not Available",-,226.027022944,5.88696666667,M+Cl,C10H9NO3,0,31.1,metab_8923,neg_900,neg,25150,382200,582300,286400,479200,268500,799900,416700,48880,177200,32960,1121000,,,,
(5R)-5-Hydroxyhexanoylcarnitine,£¨5R£©-5-ôÇ»ù¼ºõ£»ùÈâ¼î,0.5828,0.7124,0.3033,0.6109,1.1372,0.1855,no,up,-,-,-,-,-,-,-,HMDB0241666,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,276.180060805,2.65731666667,M+H,C13H25NO5,0,37.3,metab_700,pos_1652,pos,76940,54790,128300,56990,61110,105200,63970,46950,123800,41380,74190,74630,,,,
"Cholic Acid",µ¨Ëá,0.5877,0.6915,0.3018,0.4328,1.342,0.4244,no,up,C00695,Steroids,"24-Carbon atoms",map01100;map04976;map00120,"Metabolic pathways;Bile secretion;Primary bile acid biosynthesis","Metabolism;Organismal Systems;Metabolism","Global and overview maps;Digestive system;Lipid metabolism",LMST04010001;HMDB0000619;PW_C000480;MJDBDZS0000046,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",81-25-4,407.279870605,6.25951666667,M-H,C24H40O5,77.8,0,metab_7201,neg_1776,neg,195400,49470,2201,158100,38540,114600,14070,202000,27360,86140,16730,69740,,,,
1-Linoleoyl-sn-Glycero-3-Phosphocholine,1-ÑÇÓÍõ£»ù-sn-¸ÊÓÍ-3-Á×Ëáµ¨¼î,0.6631,0.7511,0.3004,0.3187,1.0793,0.1101,no,up,C04100,-,-,-,-,-,-,HMDB0010386;LMGP01050137,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,22252-07-9,564.330315138,6.5608,"M+Cl, M+FA-H",C26H50NO7P,68.7,0,metab_8153,neg_266,neg,32100000,17520000,27580000,24660000,22670000,20040000,14440000,22830000,20460000,35970000,25630000,14650000,,,,
"PI(18:0/20:4(8Z,11Z,14Z,17Z))",-,0.6226,0.7189,0.2909,0.5353,1.0621,0.0869,no,up,-,-,-,-,-,-,-,HMDB0009816,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoinositols,-,885.549769177,7.42125,M-H,C47H83O13P,0,42.6,metab_6608,neg_1237,neg,1066000,1138000,1129000,901300,1316000,1219000,1135000,1106000,1330000,655800,787200,1356000,,,,
"Decanedioic acid",-,0.5966,0.6997,0.2908,0.5611,0.8577,-0.2215,no,down,C08277,-,-,-,-,-,-,HMDB0000792;LMFA01170006,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",111-20-6,201.112485738,6.03171666667,M-H,C10H18O4,79.7,0,metab_7313,neg_1878,neg,675500,565800,922200,240800,887300,580700,644300,365500,950200,481400,595100,1478000,,,,
1-Palmitoylphosphatidylcholine,"1 -×Øéµõ£Á×Ö¬õ£µ¨¼î",0.7385,0.8301,0.2877,0.2205,0.9513,-0.072,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0256091;HMDB0010382,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,17364-16-8,496.338862274,7.71138333333,M+H,C24H50NO7P,0,86.6,metab_2353,pos_3296,pos,137500000,80680000,113400000,92340000,85900000,86110000,81060000,97790000,101200000,158800000,109600000,78250000,,,,
"2,4-Dichloro-6-nitrophenol","2,4-¶þÂÈ-6-Ïõ»ù±½·Ó",0.5793,0.6851,0.2864,0.4502,1.0166,0.0238,no,up,-,-,-,-,-,-,-,HMDB0245449,Benzenoids,Phenols,Nitrophenols,-,243.898901543,7.71921666667,M+K-2H,C6H3Cl2NO3,0,38.3,metab_6734,neg_1350,neg,141300,149900,152400,159300,154800,160400,162200,138800,146400,151100,149000,155700,,,,
"N-Palmitoyl Threonine","N -×Øéµõ£ËÕ°±Ëá",0.6074,0.7071,0.2857,0.4182,0.8607,-0.2164,no,down,-,-,-,-,-,-,-,LMFA08020107;HMDB0241933,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,356.280207993,6.61696666667,M-H,C20H39NO4,0,72.3,metab_7100,neg_1684,neg,108000,35590,74530,95150,70740,58960,21720,80790,142900,109500,122300,37440,,,,
Corticosterone,Æ¤ÖÊÍª,0.6108,0.7335,0.2826,0.8488,1.1322,0.1791,no,up,C02140,"Steroids;Hormones and transmitters","21-Carbon atoms;Steroid hormones",map01100;map04923;map00140;map04925;map05020,"Metabolic pathways;Regulation of lipolysis in adipocytes;Steroid hormone biosynthesis;Aldosterone synthesis and secretion;Prion disease","Metabolism;Organismal Systems;Metabolism;Organismal Systems;Human Diseases","Global and overview maps;Endocrine system;Lipid metabolism;Endocrine system;Neurodegenerative disease",HMDB0001547;LMST02030186;PW_C001190;MJDBOTE0000847,"Lipids and lipid-like molecules","Steroids and steroid derivatives",Hydroxysteroids,50-22-6,347.220952378,6.04078333333,M+H,C21H30O4,60.7,0,metab_4296,pos_5261,pos,271200,220800,138900,318200,133100,150900,102400,305800,195400,152600,235500,97080,,,,
"4-Trimethylammoniobutanoic Acid","4 -Èý¼×»ù°±»ù¶¡Ëá",0.6144,0.7362,0.2823,1.1653,1.0512,0.072,no,up,C01181,-,-,map01100;map00310;map02010,"Metabolic pathways;Lysine degradation;ABC transporters","Metabolism;Metabolism;Environmental Information Processing","Global and overview maps;Amino acid metabolism;Membrane transport",PW_C000899;HMDB0001161,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",407-64-7,146.117354994,0.696666666667,M+H,C7H15NO2,45.4,0,metab_5428,pos_6317,pos,342600,368700,453500,281900,316500,330500,427300,281500,329700,318600,280500,353900,,,,
Kynurenine,È®Äò°±Ëá,0.7142,0.8122,0.281,0.4201,1.069,0.0963,no,up,C00328,-,-,map01100;map05143;map00380;map01240,"Metabolic pathways;African trypanosomiasis;Tryptophan metabolism;Biosynthesis of cofactors","Metabolism;Human Diseases;Metabolism;Metabolism","Global and overview maps;Infectious disease: parasitic;Amino acid metabolism;Global and overview maps",HMDB0000684;MJDBOTE0001164,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",2922-83-0;343-65-7,209.091725922,2.34395,M+H,C10H12N2O3,91,0,metab_6340,pos_5972,pos,955500,1221000,790000,835800,1041000,918800,654000,1554000,832700,601800,667100,1080000,,,,
"5-Hydroxyindoleacetic acid",5-ôÇ»ùßÅßáÒÒËá,0.7181,0.8152,0.2803,0.4297,1.0627,0.0877,no,up,C05635,-,-,map01100;map04726;map00380,"Metabolic pathways;Serotonergic synapse;Tryptophan metabolism","Metabolism;Organismal Systems;Metabolism","Global and overview maps;Nervous system;Amino acid metabolism",PW_C000609;HMDB0000763,"Organoheterocyclic compounds","Indoles and derivatives","Indolyl carboxylic acids and derivatives",54-16-0,192.065226354,2.34395,M+H,C10H9NO3,79.2,0,metab_672,pos_1627,pos,133100,152100,108100,110100,144500,124900,93040,203700,109600,82610,93460,144800,,,,
"Ubiquinol 8",·º´¼8,0.6891,0.7957,0.272,0.4953,0.8141,-0.2967,no,down,-,-,-,-,-,-,-,HMDB0001060;PW_C000835,"Lipids and lipid-like molecules","Prenol lipids","Quinone and hydroquinone lipids",74075-00-6,792.586121435,7.05275,M+ACN+Na,C49H76O4,0,39.3,metab_2021,pos_2936,pos,69730,87780,1330,153800,63.76,40790,54750,126200,141100,81750,28320,2101,,,,
"Leucomycin a5",°×Ã¹ËØa5,0.6925,0.7979,0.2709,0.4629,1.1225,0.1667,no,up,C14058,-,-,-,-,-,-,HMDB0254036,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",18361-45-0,813.475600759,6.46911666667,M+ACN+H,C39H65NO14,0,71.4,metab_3749,pos_4725,pos,62170,97500,33450,69410,38510,85910,82660,32580,114900,42980,32000,39570,,,,
"PC(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))",-,0.5988,0.7228,0.2688,0.4332,0.8841,-0.1777,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004690;HMDB0008642;LMGP01012090,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,856.581151257,7.65663333333,"M+H, M+2Na-H",C50H82NO8P,0,62,metab_6149,pos_832,pos,8297000,21260000,19870000,25560000,30390000,17250000,20440000,22160000,25300000,6804000,29900000,34140000,,,,
Threonylproline,ËÕ°±õ£¸¬°±Ëá,0.6369,0.7549,0.2672,0.7416,1.1302,0.1766,no,up,-,-,-,-,-,-,-,HMDB0029069,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",46398-79-2,199.107436107,2.64931666667,M+H-H2O,C9H16N2O4,0,56.4,metab_5042,pos_5947,pos,668300,748600,1512000,403300,632700,1248000,872900,512100,1242000,520100,687800,777900,,,,
"PE(16:1(9Z)/18:3(9,11,15)-OH(13))",-,0.6381,0.7558,0.2645,0.2799,1.1025,0.1408,no,up,-,-,-,-,-,-,-,HMDB0261076,"Not Available","Not Available","Not Available",-,769.511829927,6.55018333333,M+ACN+H,C39H70NO9P,0,62.5,metab_3665,pos_4648,pos,370200,131600,344900,113400,319900,275000,261300,208600,233000,257500,289600,160600,,,,
"Pyroglutamic Acid",½¹¹È°±Ëá,0.6689,0.7791,0.2624,0.4355,0.96,-0.0589,no,down,C01879,Peptides,"Amino acids",map01100;map00480,"Metabolic pathways;Glutathione metabolism",Metabolism;Metabolism,"Global and overview maps;Metabolism of other amino acids",HMDB0000267;PW_C000182;MJDBOTE0000549,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",98-79-3,147.076213618,0.665266666667,M+NH4,C5H7NO3,65.7,0,metab_5479,pos_6364,pos,2101000,1809000,1921000,1970000,1867000,2012000,2482000,1667000,2641000,1653000,1875000,1846000,,,,
"Arachidonic acid",»¨ÉúËÄÏ©Ëá,0.725,0.7991,0.2601,0.4614,1.0474,0.0668,no,up,C00219,Lipids,"Fatty acids",map05140;map04666;map04664;map05146;map04750;map00590;map04217;map01100;map04270;map04921;map04923;map04730;map04925;map01040;map00591;map04726;map04912;map04913;map04723;map04216;map04611,"Leishmaniasis;Fc gamma R-mediated phagocytosis;Fc epsilon RI signaling pathway;Amoebiasis;Inflammatory mediator regulation of TRP channels;Arachidonic acid metabolism;Necroptosis;Metabolic pathways;Vascular smooth muscle contraction;Oxytocin signaling pathway;Regulation of lipolysis in adipocytes;Long-term depression;Aldosterone synthesis and secretion;Biosynthesis of unsaturated fatty acids;Linoleic acid metabolism;Serotonergic synapse;GnRH signaling pathway;Ovarian steroidogenesis;Retrograde endocannabinoid signaling;Ferroptosis;Platelet activation","Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Metabolism;Cellular Processes;Metabolism;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Metabolism;Metabolism;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Cellular Processes;Organismal Systems","Infectious disease: parasitic;Immune system;Immune system;Infectious disease: parasitic;Sensory system;Lipid metabolism;Cell growth and death;Global and overview maps;Circulatory system;Endocrine system;Endocrine system;Nervous system;Endocrine system;Lipid metabolism;Lipid metabolism;Nervous system;Endocrine system;Endocrine system;Nervous system;Cell growth and death;Immune system",HMDB0001043;LMFA01030001;PW_C000821,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",506-32-1,303.232591886,6.67931666667,M-H,C20H32O2,0,32.4,metab_7091,neg_1675,neg,640400,451400,571100,503100,556100,555600,318300,586800,582100,599300,694900,348200,,,,
P-Tolyl-ss-D-glucuronide,-,0.6836,0.7648,0.2448,0.6471,0.8704,-0.2002,no,down,-,-,-,-,-,-,-,HMDB0256060,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",-,283.08194884,5.00986666667,M-H,C13H16O7,0,54.4,metab_8887,neg_869,neg,945400,677300,1504000,723400,920800,1677000,957500,342100,2381000,723300,858400,2148000,,,,
Cyclopamine,»·èËÃ÷,0.7982,0.872,0.2394,0.4756,0.9409,-0.0879,no,down,C10798,-,-,-,-,-,-,HMDB0250664,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroidal alkaloids",4449-51-8,434.30457721,7.1237,M+Na,C27H41NO2,0,66.6,metab_3049,pos_4010,pos,334300,590600,913900,584600,455400,570000,689000,440500,657700,1097000,441800,339000,,,,
"Allyl 3-cyclohexylpropionate",3-»·¼º»ù±ûËáÏ©±ûõ¥,0.7595,0.8454,0.2388,0.5709,0.8962,-0.1581,no,down,C12306,-,-,-,-,-,-,LMFA07010775;HMDB0040206,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",2705-87-5,410.325840887,6.3033,2M+NH4,C12H20O2,0,73.8,metab_3956,pos_4922,pos,65500,42490,175600,39800,118700,52060,34240,158500,126200,70600,121600,40190,,,,
Ascomycin,³¤´¨Ã¹ËØ,0.7233,0.8183,0.2386,0.2043,1.1979,0.2605,no,up,C12102,-,-,-,-,-,-,HMDB0248652,"Phenylpropanoids and polyketides","Macrolide lactams","Not Available",104987-12-4,814.475715385,6.55018333333,M+Na,C43H69NO12,0,32.4,metab_3663,pos_4646,pos,49820,129100,37550,57.1,1119,73970,1367,33770,44690,62350,56020,45250,,,,
1-Hexadecanoyl-sn-Glycero-3-Phosphoethanolamine,"1-Ê®Áù[Íé]õ£-Sn-±ûÈý»ù3 -Á×ËáÒÒ´¼°·",0.762,0.8473,0.2378,0.2262,0.9634,-0.0538,no,down,-,-,-,-,-,-,-,LMGP02050002;HMDB0011503,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,53862-35-4,454.291866673,6.75818333333,M+H,C21H44NO7P,61.6,0,metab_1786,pos_2686,pos,4577000,3904000,3972000,3423000,3366000,3647000,3793000,2865000,3475000,5299000,5159000,3168000,,,,
Deoxyspergualin,ÍÑÑõ¾«ëÒ¾úËØ,0.6765,0.7852,0.2363,0.2854,0.9087,-0.1381,no,down,-,-,-,-,-,-,-,HMDB0243514,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,797.585241024,6.35915,2M+Na,C17H37N7O3,0,32.4,metab_1482,pos_2393,pos,274200,396100,159400,321000,184600,229000,489200,327200,151600,289500,281500,182500,,,,
PE(18:1(9Z)/18:1(9Z)),-,0.8009,0.8735,0.2361,0.3616,1.0622,0.0871,no,up,C00350,Lipids,Phospholipids,map01100;map00564;map00563;map04136;map05167;map04723;map04140,"Metabolic pathways;Glycerophospholipid metabolism;Glycosylphosphatidylinositol (GPI)-anchor biosynthesis;Autophagy - other;Kaposi sarcoma-associated herpesvirus infection;Retrograde endocannabinoid signaling;Autophagy - animal","Metabolism;Metabolism;Metabolism;Cellular Processes;Human Diseases;Organismal Systems;Cellular Processes","Global and overview maps;Lipid metabolism;Glycan biosynthesis and metabolism;Transport and catabolism;Infectious disease: viral;Nervous system;Transport and catabolism",PW_C005107;LMGP02010052;HMDB0009059,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,744.552505001,6.9337,M+H,C41H78NO8P,0,48.6,metab_3223,pos_4200,pos,1707000,4960000,3611000,4947000,7238000,5924000,4794000,4591000,4626000,1010000,6094000,5612000,,,,
"PC(17:2(9Z,12Z)/0:0)",-,0.6735,0.7571,0.2313,0.3213,0.9154,-0.1275,no,down,-,-,-,-,-,-,-,HMDB0256157;LMGP01050127,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,504.309504961,7.55458333333,M-H,C25H48NO7P,0,77.4,metab_6864,neg_1468,neg,193300,112200,231800,152700,159400,143700,95840,251100,175300,284900,166000,111800,,,,
"14,15-DiHETrE",-,0.7415,0.8126,0.2302,0.3029,0.9681,-0.0468,no,down,C14775,-,-,map00590;map01100;map04726,"Arachidonic acid metabolism;Metabolic pathways;Serotonergic synapse","Metabolism;Metabolism;Organismal Systems","Lipid metabolism;Global and overview maps;Nervous system",PW_C001529;HMDB0002265,"Lipids and lipid-like molecules","Fatty Acyls",Eicosanoids,77667-09-5,337.238087223,6.3013,M-H,C20H34O4,0,86.8,metab_7185,neg_1761,neg,73390,68130,60610,82440,57380,82100,55730,92050,75910,66840,65540,81900,,,,
"Hydroxyoctadecadienoic acid",-,0.6429,0.7336,0.2275,0.3004,0.9358,-0.0957,no,down,-,-,-,-,-,-,-,HMDB0253281,"Lipids and lipid-like molecules","Fatty Acyls","Lineolic acids and derivatives",-,277.216907182,6.61696666667,M-H2O-H,C18H32O3,0,56.9,metab_6465,neg_1107,neg,83040,43780,68540,52550,79480,60850,36570,68900,84810,72560,75490,76520,,,,
"PC(18:1(11Z)/18:2(9Z,12Z))",-,0.6228,0.7433,0.2246,0.4003,0.8908,-0.1668,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",LMGP01012149;HMDB0008072;PW_C004121,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,784.581758178,7.70341666667,M+H,C44H82NO8P,0,62,metab_2684,pos_3628,pos,43290000,152800000,128100000,126000000,199800000,157900000,161200000,158500000,161600000,35110000,185700000,204200000,,,,
DG(11M3/9D5/0:0),-,0.7374,0.829,0.2244,0.4267,0.8927,-0.1638,no,down,C00165,-,-,map05214;map05167;map05143;map05163;map05146;map04915;map04015;map04014;map04659;map04658;map04270;map04012;map05231;map04650;map04370;map04371;map04072;map04071;map05235;map04921;map05415;map04750;map04919;map04933;map04961;map05012;map04920;map04923;map04925;map05017;map04926;map05171;map04726;map04725;map04724;map04723;map04728;map05223;map04720;map04666;map05170;map04664;map04540;map04662;map04660;map05200;map04261;map04010;map04024;map04929;map04020;map04928;map04062;map05225;map04064;map04066;map04625;map01521;map04972;map04973;map04970;map04971;map04730;map04975;map04918;map04713;map04916;map04714;map04722;map04911;map04912;map04935;map04613;map05022;map04611;map04931,"Glioma;Kaposi sarcoma-associated herpesvirus infection;African trypanosomiasis;Human cytomegalovirus infection;Amoebiasis;Estrogen signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Th17 cell differentiation;Th1 and Th2 cell differentiation;Vascular smooth muscle contraction;ErbB signaling pathway;Choline metabolism in cancer;Natural killer cell mediated cytotoxicity;VEGF signaling pathway;Apelin signaling pathway;Phospholipase D signaling pathway;Sphingolipid signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;Oxytocin signaling pathway;Diabetic cardiomyopathy;Inflammatory mediator regulation of TRP channels;Thyroid hormone signaling pathway;AGE-RAGE signaling pathway in diabetic complications;Endocrine and other factor-regulated calcium reabsorption;Parkinson disease;Adipocytokine signaling pathway;Regulation of lipolysis in adipocytes;Aldosterone synthesis and secretion;Spinocerebellar ataxia;Relaxin signaling pathway;Coronavirus disease - COVID-19;Serotonergic synapse;Cholinergic synapse;Glutamatergic synapse;Retrograde endocannabinoid signaling;Dopaminergic synapse;Non-small cell lung cancer;Long-term potentiation;Fc gamma R-mediated phagocytosis;Human immunodeficiency virus 1 infection;Fc epsilon RI signaling pathway;Gap junction;B cell receptor signaling pathway;T cell receptor signaling pathway;Pathways in cancer;Adrenergic signaling in cardiomyocytes;MAPK signaling pathway;cAMP signaling pathway;GnRH secretion;Calcium signaling pathway;Parathyroid hormone synthesis, secretion and action;Chemokine signaling pathway;Hepatocellular carcinoma;NF-kappa B signaling pathway;HIF-1 signaling pathway;C-type lectin receptor signaling pathway;EGFR tyrosine kinase inhibitor resistance;Pancreatic secretion;Carbohydrate digestion and absorption;Salivary secretion;Gastric acid secretion;Long-term depression;Fat digestion and absorption;Thyroid hormone synthesis;Circadian entrainment;Melanogenesis;Thermogenesis;Neurotrophin signaling pathway;Insulin secretion;GnRH signaling pathway;Growth hormone synthesis, secretion and action;Neutrophil extracellular trap formation;Pathways of neurodegeneration - multiple diseases;Platelet activation;Insulin resistance","Human Diseases;Human Diseases;Human Diseases;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Organismal Systems;Organismal Systems;Environmental Information Processing;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Environmental Information Processing;Environmental Information Processing;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Cellular Processes;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Environmental Information Processing;Organismal Systems;Organismal Systems;Human Diseases;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases","Cancer: specific types;Infectious disease: viral;Infectious disease: parasitic;Infectious disease: viral;Infectious disease: parasitic;Endocrine system;Signal transduction;Signal transduction;Immune system;Immune system;Circulatory system;Signal transduction;Cancer: overview;Immune system;Signal transduction;Signal transduction;Signal transduction;Signal transduction;Cancer: overview;Endocrine system;Cardiovascular disease;Sensory system;Endocrine system;Endocrine and metabolic disease;Excretory system;Neurodegenerative disease;Endocrine system;Endocrine system;Endocrine system;Neurodegenerative disease;Endocrine system;Infectious disease: viral;Nervous system;Nervous system;Nervous system;Nervous system;Nervous system;Cancer: specific types;Nervous system;Immune system;Infectious disease: viral;Immune system;Cellular community - eukaryotes;Immune system;Immune system;Cancer: overview;Circulatory system;Signal transduction;Signal transduction;Endocrine system;Signal transduction;Endocrine system;Immune system;Cancer: specific types;Signal transduction;Signal transduction;Immune system;Drug resistance: antineoplastic;Digestive system;Digestive system;Digestive system;Digestive system;Nervous system;Digestive system;Endocrine system;Environmental adaptation;Endocrine system;Environmental adaptation;Nervous system;Endocrine system;Endocrine system;Endocrine system;Immune system;Neurodegenerative disease;Immune system;Endocrine and metabolic disease",PW_C063632;HMDB0116394,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,725.470819589,6.24016666667,M+K,C42H70O7,0,35.7,metab_1381,pos_2295,pos,152100,205900,210000,58920,20130,61300,166300,89580,56240,98720,186000,196800,,,,
"SM(d19:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))",-,0.7668,0.8499,0.2202,0.1781,0.9352,-0.0967,no,down,-,-,-,-,-,-,-,HMDB0290647,"Not Available","Not Available","Not Available",-,851.566886418,6.6864,M+2Na-H,C46H83N2O7P,0,55.2,metab_1723,pos_2620,pos,96470,346400,352500,494900,238100,211800,315700,400900,408300,262000,211000,262400,,,,
PG(TXB2/i-12:0),-,0.7075,0.8089,0.2181,0.2148,1.1998,0.2628,no,up,-,-,-,-,-,-,-,HMDB0271088,"Not Available","Not Available","Not Available",-,813.475758374,6.50936666667,M+CH3OH+H,C38H69O14P,0,36.3,metab_1577,pos_2480,pos,8479,56810,46110,13100,58010,561.1,20310,19530,58360,23820,30190,341.2,,,,
(+)-gamma-Hydroxy-L-homoarginine,£¨+£©-¦Ã-ôÇ»ù-L-¸ß¾«°±Ëá,0.6666,0.752,0.2178,0.5101,0.9346,-0.0976,no,down,C08286,-,-,-,-,-,-,HMDB0301838,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1616-99-5,239.09206211,6.05528333333,M+Cl,C7H16N4O3,0,54.7,metab_8984,neg_957,neg,36280,38920,39150,23040,32400,29270,30990,28320,56580,38930,30840,27370,,,,
"PE-NMe(16:0/22:4(7Z,10Z,13Z,16Z))",-,0.7385,0.8104,0.2166,0.3771,0.9156,-0.1272,no,down,"C01241 ",-,-,-,-,-,-,HMDB0113055;PW_C059178,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,826.561049272,6.55438333333,"M+Cl, M+FA-H",C44H80NO8P,0,79.4,metab_8164,neg_267,neg,9990000,55290000,39070000,44750000,65360000,49870000,45830000,50130000,58120000,6733000,58060000,69820000,,,,
LysoPC(0:0/16:0),-,0.7763,0.84,0.2127,0.3106,1.0587,0.0823,no,up,-,-,-,-,-,-,-,HMDB0240262,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,66757-27-5,540.330411505,6.81288333333,"M+Cl, M+FA-H, M+K-2H",C24H50NO7P,0,81.8,metab_8329,neg_35,neg,43780000,24370000,32900000,26880000,23510000,23760000,19910000,24330000,28580000,48720000,25460000,18480000,,,,
Cerulenin,Ç³À¶¾úËØ,0.775,0.8559,0.2098,0.7916,0.9556,-0.0655,no,down,C12058,-,-,-,-,-,-,LMFA08010013;HMDB0015168,"Organoheterocyclic compounds",Epoxides,"Oxirane carboxylic acids and derivatives",17397-89-6,241.154100539,1.89588333333,M+NH4,C12H17NO3,0,35.1,metab_5142,pos_6039,pos,1134000,1245000,1592000,721400,750400,1262000,1175000,825600,1639000,1170000,961100,1247000,,,,
Xi-4-Hydroxy-4-methyl-2-cyclohexen-1-one,-,0.7847,0.8626,0.2091,0.7881,1.0118,0.0169,no,up,-,-,-,-,-,-,-,HMDB0033629,"Organic oxygen compounds","Organooxygen compounds","Carbonyl compounds",-,91.05454078,3.17431666667,M+H-2H2O,C7H10O2,0,31.3,metab_777,pos_1723,pos,965700,946900,971300,917100,1020000,1037000,1040000,872500,1087000,912000,887900,989500,,,,
PE-NMe2(18:1(9Z)/14:1(9Z)),-,0.7802,0.8588,0.2063,0.3637,1.1189,0.1621,no,up,C04308,-,-,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0114039;PW_C060056,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,779.529918106,6.78978333333,M+ACN+Na,C39H74NO8P,0,56.1,metab_1814,pos_2717,pos,134600,56960,25470,84280,147900,17220,150800,57770,51910,63190,17840,75390,,,,
"Docosahexaenoic Acid",Ø¥¶þÌ¼ÁùÏ©Ëá,0.6611,0.7501,0.2058,0.5301,0.9445,-0.0824,no,down,C06429,Lipids,"Fatty acids",map01040,"Biosynthesis of unsaturated fatty acids",Metabolism,"Lipid metabolism",PW_C001472;LMFA01031176;HMDB0002183;MJDBOTE0001119,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",6217-54-5,327.232564614,6.61056666667,M-H,C22H32O2,93.1,0,metab_7102,neg_1686,neg,968900,727700,744000,649700,757400,791900,503400,871600,854900,1055000,1015000,612800,,,,
"Blasticidin S",²¼À­Ò¶Ë¹,0.7666,0.8499,0.2033,0.5735,1.1555,0.2085,no,up,C02010,-,-,-,-,-,-,HMDB0030452,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",2079-00-7,405.197178584,2.90553333333,M+H-H2O,C17H26N8O5,0,39.3,metab_740,pos_1689,pos,173900,434300,337400,165600,225600,304300,80220,775700,141600,30160,199800,192600,,,,
PC(17:0/0:0),-,0.834,0.897,0.1978,0.1277,0.9015,-0.1496,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",LMGP01050024;HMDB0012108,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,50930-23-9,532.336580376,7.617,M+Na,C25H52NO7P,80.9,0,metab_2304,pos_3236,pos,3036000,811600,1646000,693000,737200,651300,674600,1287000,905500,3904000,1062000,570800,,,,
Non-6-enedioylcarnitine,"·Ç6 -Ï©¶þõ£»ùÈâ¼î",0.8412,0.9018,0.1953,0.6523,0.9291,-0.1061,no,down,-,-,-,-,-,-,-,HMDB0241757,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,362.216514962,3.78211666667,"M+H, M+CH3OH+H",C16H27NO6,0,36.9,metab_2714,pos_366,pos,169100,253000,692400,93640,144400,195700,249400,226900,385300,291000,197400,316000,,,,
Octanedioylcarnitine,ÐÁÍé¶þõ£»ùÈâ¼î,0.8164,0.8851,0.1904,0.5699,0.9371,-0.0937,no,down,-,-,-,-,-,-,-,HMDB0241733,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,318.190446957,3.58425,M+H,C15H27NO6,0,82.6,metab_4871,pos_5788,pos,2854000,2908000,8285000,1484000,3072000,3936000,3733000,3466000,5696000,2961000,3440000,4760000,,,,
Norfuraneol,ß»à«·Ó,0.7958,0.8564,0.1863,0.2209,0.9622,-0.0556,no,down,-,-,-,-,-,-,-,HMDB0031859,"Organoheterocyclic compounds",Dihydrofurans,Furanones,19322-27-1,113.023374275,0.636666666667,M-H,C5H6O3,0,47.2,metab_7970,neg_2494,neg,63310,66950,47600,80780,97890,65590,87360,64080,73680,68530,45470,99570,,,,
"PE-NMe(18:2(9Z,12Z)/20:0)",-,0.812,0.868,0.1853,0.5498,1.0892,0.1233,no,up,"C01241 ",-,-,-,-,-,-,PW_C059299;HMDB0113176,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,830.592064735,6.18483333333,M+FA-H,C44H84NO8P,0,78.7,metab_7243,neg_1813,neg,3620000,2366000,2283000,2388000,6387000,765200,2733000,2172000,1893000,3877000,4970000,705600,,,,
Isoleucyl-thiazolidine,-,0.801,0.8735,0.1833,0.1853,0.9594,-0.0598,no,down,-,-,-,-,-,-,-,HMDB0253651,"Organoheterocyclic compounds",Azolidines,Thiazolidines,-,427.215749455,7.44245,2M+Na,C9H18N2OS,0,49.3,metab_2846,pos_3804,pos,107500,90010,63770,78210,87600,74710,56320,77930,94800,142300,76330,75450,,,,
Isoetharine,ÒìËûÁÖ,0.6867,0.7937,0.1829,0.2269,1.1513,0.2033,no,up,C07053,-,-,-,-,-,-,HMDB0014366,Benzenoids,Phenols,Benzenediols,530-08-5,542.320909457,7.62488333333,2M+ACN+Na,C13H21NO3,0,74.7,metab_2738,pos_3687,pos,7155000,2156000,4362000,3112000,3841000,2976000,1504000,3529000,2202000,8171000,3431000,1665000,,,,
"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione","1-£¨6-£¨£¨3-¼×Ñõ»ù´Æ-1,3,5£¨10£©-ÈýÏ©-17-»ù£©°±»ù£©¼º»ù£©-1H-ßÁ¿©-2,5-¶þÍª",0.819,0.8737,0.1825,0.1829,1.0952,0.1312,no,up,-,-,-,-,-,-,-,HMDB0244394,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Azasteroids and derivatives",-,485.282160289,6.81288333333,M+Na-2H,C29H40N2O3,0,47.5,metab_6532,neg_1169,neg,5064000,1189000,1497000,1637000,1750000,1637000,1119000,1271000,1675000,4374000,2174000,1053000,,,,
"Enantio-PAF C-16",-,0.8859,0.9305,0.1798,0.2701,0.9797,-0.0296,no,down,-,-,-,-,-,-,-,-,-,-,-,-,524.370208053,7.71138333333,"M+H-H2O, M+H",C26H54NO7P,59.1,0,metab_6156,pos_839,pos,613700000,451600000,611500000,455000000,397100000,426100000,450500000,466400000,460500000,785800000,452100000,401100000,,,,
"4-Piperidinone, 1-hydroxy-2,2,6,6-tetramethyl-","4 -ßßà¤Íª£¬1 -ôÇ»ù- 2£¬2£¬6£¬6 -ËÄ¼×»ù-",0.8288,0.8932,0.177,0.2949,1.0034,0.0049,no,up,-,-,-,-,-,-,-,-,-,-,-,-,172.132926132,4.56751666667,M+H,C9H17NO2,43.2,0,metab_4782,pos_5705,pos,371900,383400,375800,378000,375200,389400,383100,362700,362900,376800,390800,389700,,,,
"(7Z,9Z,12Z,15Z,18Z,21Z)-Tetracosa-7,9,12,15,18,21-hexaenoylcarnitine","£¨7Z£¬9Z£¬12Z£¬15Z£¬18Z£¬21Z£©-Tetracosa-7,9,12,15,18,21-¼ºÏ©õ£»ùÈâ¼î",0.7786,0.8572,0.1746,0.7858,0.9508,-0.0728,no,down,-,-,-,-,-,-,-,HMDB0241638,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,522.354785085,6.19298333333,"M+H-H2O, M+2Na-H, M+Na",C31H49NO4,0,32.1,metab_442,pos_141,pos,27480000,19730000,10930000,27020000,21660000,17260000,15360000,16670000,25860000,22950000,32460000,17220000,,,,
LysoPA(18:0/0:0),-,0.8946,0.9359,0.172,0.5394,0.979,-0.0306,no,down,-,-,-,-,-,-,-,HMDB0007854,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,480.307909132,6.78175,M+ACN+H,C21H43O7P,0,81.2,metab_1807,pos_2709,pos,2968000,1681000,3133000,2451000,2029000,2313000,1716000,2700000,2275000,3256000,3330000,1608000,,,,
Nitrobenzyl-6-thioinosine,"Ïõ»ùÜÐ»ù- 6 -Áò´ú¼¡ÜÕ",0.8738,0.922,0.1714,0.2412,1.0362,0.0513,no,up,-,-,-,-,-,-,-,HMDB0255642;HMDB0255484,"Nucleosides, nucleotides, and analogues","Purine nucleosides","Not Available",-,442.082950767,3.15083333333,M+Na,C17H17N5O6S,0,64.8,metab_4937,pos_5850,pos,225800,228100,43900,189900,160000,251100,244500,157400,75280,169600,228800,184700,,,,
"PE-NMe(22:4(7Z,10Z,13Z,16Z)/18:0)",-,0.7456,0.8164,0.1675,0.6473,1.1004,0.138,no,up,"C01241 ",-,-,-,-,-,-,HMDB0113597;PW_C059726,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,854.59169879,6.45871666667,M+FA-H,C46H84NO8P,0,85.9,metab_7144,neg_1723,neg,44230000,28380000,20900000,26750000,5296000,40860000,38630000,22580000,30230000,28300000,3222000,28310000,,,,
Ethyl-4-hydroxymethyl-3(2H)-Furanone,-,0.8404,0.9016,0.1635,0.7114,0.9571,-0.0633,no,down,-,-,-,-,-,-,-,-,-,-,-,-,302.159196775,2.6973,2M+NH4,C7H10O3,0,44.8,metab_715,pos_1666,pos,136100,295300,381100,255400,167300,171100,217100,168300,356900,201400,187600,337900,,,,
Caryophyllen-beta,-,0.8731,0.9216,0.1629,0.4635,0.9743,-0.0376,no,down,-,-,-,-,-,-,-,HMDB0304653,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acid esters",-,290.159129632,2.65731666667,M+H,C13H23NO6,0,73,metab_5035,pos_5940,pos,9609000,13540000,17790000,13010000,11220000,7663000,11000000,11680000,18600000,12070000,9131000,12280000,,,,
L-Coprine,-,0.7895,0.8504,0.1598,0.3014,1.15,0.2016,no,up,C08271,-,-,-,-,-,-,HMDB0034266,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",58919-61-2,403.182813963,3.48988333333,2M-H,C8H14N2O4,0,52.1,metab_8776,neg_768,neg,35300,92120,67640,27480,46450,66860,13890,166600,32180,1763,36680,40940,,,,
"PG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/18:1(9Z))",-,0.7621,0.8473,0.1595,0.1911,1.1298,0.1761,no,up,-,-,-,-,-,-,-,HMDB0268980,"Not Available","Not Available","Not Available",-,826.535028383,7.60911666667,2M+3H2O+2H,C44H77O11P,0,50.8,metab_2301,pos_3233,pos,2133000,614900,300200,1080000,978500,780800,636600,727700,408100,2111000,824000,503200,,,,
G-Glu-Val,G-¹È°±õ£-çÓ°±Ëá,0.7658,0.8493,0.159,0.693,0.9514,-0.0719,no,down,-,-,-,-,-,-,-,HMDB0011172,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",2746-34-1,247.128289448,2.47261666667,M+H,C10H18N2O5,47.9,0,metab_678,pos_1632,pos,107600,147800,84720,82040,72590,103500,84660,113400,133600,71330,145100,80700,,,,
Digimed,ÑóµØ»Æ¶¾ÜÕ,0.8088,0.879,0.1549,0.1465,0.925,-0.1125,no,down,C06955,Steroids,"23-Carbon atoms",-,-,-,-,HMDB0251273;HMDB0015468,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroid lactones",71-63-6,806.472179719,6.46911666667,M+ACN+H,C41H64O13,0,43.8,metab_1550,pos_2456,pos,31290,20850,41290,38080,45430,102000,53760,37520,77890,77360,35430,19660,,,,
"6-Hydroxypentadecanedioic acid","6 -ôÇ»ùÊ®ÎåÍé¶þËá",0.8333,0.8838,0.1538,0.2289,0.9665,-0.0492,no,down,-,-,-,-,-,-,-,HMDB0031885,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",38076-52-7,309.168110088,6.37583333333,M+Na-2H,C15H28O5,0,45.5,metab_6408,neg_1054,neg,26780,36750,49030,43940,42530,74420,42290,46930,61780,48330,41730,41910,,,,
5'-Methylthioadenosine,5¡¯-¼×ÁòÏÙÜÕ,0.832,0.8954,0.1536,0.6696,0.9489,-0.0757,no,down,C00170,-,-,map01100;map00270,"Metabolic pathways;Cysteine and methionine metabolism",Metabolism;Metabolism,"Global and overview maps;Amino acid metabolism",HMDB0001173;PW_C000910,"Nucleosides, nucleotides, and analogues",5''-deoxyribonucleosides,5''-deoxy-5''-thionucleosides,2457-80-9,298.096215519,3.033,M+H,C11H15N5O3S,97,0,metab_4958,pos_5871,pos,1809000,2186000,2168000,1384000,1436000,1820000,3560000,833700,2206000,2335000,1467000,985900,,,,
"PE-NMe2(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))",-,0.7278,0.8217,0.1508,0.4014,0.8484,-0.2372,no,down,C04308,-,-,map01100;map00564,"Metabolic pathways;Glycerophospholipid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",PW_C059998;HMDB0113981,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,855.56265035,6.44556666667,M+ACN+Na,C45H78NO8P,0,42.2,metab_3773,pos_4747,pos,42890,112500,18490,7143,23140,57330,10770,43680,52760,12790,98820,89450,,,,
"Choline Phosphate",Á×Ëáµ¨¼î,0.6984,0.8025,0.1507,0.3454,1.0233,0.0332,no,up,C00588,-,-,map01100;map00564;map05231,"Metabolic pathways;Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Metabolism;Human Diseases","Global and overview maps;Lipid metabolism;Cancer: overview",HMDB0001565,"Organic nitrogen compounds","Organonitrogen compounds","Quaternary ammonium salts",3616-04-4;107-73-3,184.072998033,6.9337,M+H,C5H14NO4P,60.3,0,metab_3225,pos_4202,pos,3768000,3156000,3721000,3307000,3232000,3342000,2858000,3470000,3349000,3917000,3542000,2923000,,,,
"Tranexamic Acid",ÄýÑªËá,0.7119,0.8104,0.1492,0.2978,0.988,-0.0174,no,down,C12535,-,-,-,-,-,-,PW_C008836;HMDB0014447;MJDBOTE0000780,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",1197-18-8,158.117314678,7.84611666667,"M+H, M+ACN+H",C8H15NO2,0,32.2,metab_6203,pos_882,pos,573900,524600,504900,519200,606500,537600,559000,549400,564900,522600,543000,567200,,,,
Monopalmitin,¸ÊÓÍ-×ØéµËáõ¥,0.8759,0.9233,0.1445,0.2108,0.9799,-0.0293,no,down,-,-,-,-,-,-,-,HMDB0011564;HMDB0245964,"Lipids and lipid-like molecules",Glycerolipids,Monoradylglycerols,32899-41-5,313.273045642,6.75018333333,M+H-H2O,C19H38O4,48.5,0,metab_1779,pos_2679,pos,388900,355600,368100,310500,297100,330700,345500,274200,251800,468500,471400,281400,,,,
"Coniferyl acetate",-,0.8009,0.8597,0.1437,0.7007,0.9686,-0.046,no,down,C20225,-,-,-,-,-,-,HMDB0304294,Benzenoids,Phenols,Methoxyphenols,-,243.061845272,0.714166666667,"M-H2O-H, M+Na-2H",C12H14O4,0,43.7,metab_8350,neg_369,neg,472900,641800,798400,538100,437100,559400,549200,532400,798700,666900,510000,501800,,,,
D-Xylulose,D-Ä¾ÍªÌÇ,0.8124,0.8681,0.1428,0.3158,1.0284,0.0404,no,up,C00310,Carbohydrates,Monosaccharides,map01100;map00040,"Metabolic pathways;Pentose and glucuronate interconversions",Metabolism;Metabolism,"Global and overview maps;Carbohydrate metabolism",HMDB0001644,"Organic oxygen compounds","Organooxygen compounds","Carbohydrates and carbohydrate conjugates",20750-28-1;551-84-8,171.026568878,0.562916666667,M+Na-2H,C5H10O5,0,32.7,metab_8378,neg_394,neg,13000,18320,13480,16590,20700,15610,15410,13160,18170,13540,13060,21640,,,,
"PC(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/14:0)",-,0.9001,0.9388,0.1413,0.4454,1.0122,0.0175,no,up,-,-,-,-,-,-,-,HMDB0285667,"Not Available","Not Available","Not Available",-,794.527385463,6.55018333333,"M+H, M+ACN+Na",C44H76NO9P,0,43.5,metab_4978,pos_589,pos,2760000,4068000,2729000,2546000,2597000,3261000,3155000,2487000,2748000,2766000,3050000,3535000,,,,
PC(16:0/16:1(9Z)),-,0.8983,0.9379,0.1326,0.4969,1.0165,0.0236,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",LMGP01010566;HMDB0007969;PW_C004018,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,53595-24-7,732.552425003,7.66461666667,"M+Na, M+CH3OH+H, M+H",C40H78NO8P,0,60.3,metab_24,pos_102,pos,6959000,9245000,8255000,8996000,10530000,9660000,7239000,7586000,9026000,6015000,12640000,10260000,,,,
PE(20:1/0:0),-,0.7869,0.8486,0.1283,0.2455,0.9335,-0.0993,no,down,-,-,-,-,-,-,-,-,-,-,-,-,506.32470094,6.81288333333,M-H,C25H50NO7P,31.6,0,metab_7027,neg_1616,neg,3724000,1503000,2937000,2294000,2061000,2058000,1470000,2664000,2374000,4996000,2656000,1452000,,,,
(+/-)-Tryptophan,-,0.8738,0.9136,0.1227,0.2902,1.0163,0.0233,no,up,C00806,-,-,-,-,-,-,HMDB0030396,"Organoheterocyclic compounds","Indoles and derivatives","Indolyl carboxylic acids and derivatives",54-12-6,203.081830527,3.69151666667,M-H,C11H12N2O2,0,48.4,metab_7516,neg_2061,neg,63560,74570,39400,50070,66190,64950,68690,50790,54160,64830,56680,57800,,,,
LysoPC(16:0/0:0),-,0.7596,0.8454,0.1223,0.1921,1.0712,0.0992,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010382,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,17364-16-8,518.320948448,7.64878333333,M+Na,C24H50NO7P,0,88,metab_2319,pos_3255,pos,53210000,26650000,35970000,28660000,30810000,28810000,22480000,26320000,28200000,60210000,31790000,21580000,,,,
PC(18:2/0:0),-,0.7398,0.8313,0.1215,0.4538,1.062,0.0868,no,up,-,-,-,-,-,-,-,LMGP01050034,-,-,-,-,520.339029198,6.75818333333,"M+H-H2O, M+H",C26H50NO7P,77.4,0,metab_5571,pos_645,pos,448200000,231200000,393400000,329300000,308900000,271800000,193600000,369400000,261100000,467100000,383200000,192600000,,,,
"5,7-Megastigmadien-9-ol glucoside",-,0.8498,0.9068,0.1204,0.7961,1.0335,0.0475,no,up,-,-,-,-,-,-,-,HMDB0041044,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acyl glycosides",146610-77-7,374.25300968,5.83281666667,M+NH4,C19H32O6,0,35.7,metab_1014,pos_1937,pos,255000,289400,225500,127500,103700,203300,207800,156500,220500,187300,151500,242200,,,,
Glutamylisoleucine,¹È°±õ£ÒìÁÁ°±Ëá,0.8784,0.9253,0.1199,0.6239,1.0314,0.0446,no,up,-,-,-,-,-,-,-,HMDB0028822,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",5879-22-1,261.143955497,3.26821666667,M+H,C11H20N2O5,0,72,metab_796,pos_1740,pos,304100,514200,188200,436000,275100,231800,293400,319900,367900,203100,456000,249900,,,,
"Parasorbic acid",-,0.8022,0.86,0.1198,0.5303,0.9683,-0.0465,no,down,C08502,-,-,-,-,-,-,HMDB0301801,"Organoheterocyclic compounds",Pyrans,"Pyranones and derivatives",10048-32-5,223.096158786,6.08663333333,2M-H,C6H8O2,0,36.7,metab_9001,neg_972,neg,86160,89500,106300,74550,92140,75270,67870,74230,109600,80880,78450,130100,,,,
Pantolactone,DL-·ºõ£ÄÚõ¥,0.9648,0.9773,0.1164,0.4592,0.9917,-0.012,no,down,C01012,-,-,-,-,-,-,HMDB0303902;HMDB0059876,"Organoheterocyclic compounds",Lactones,"Gamma butyrolactones",599-04-2,274.200648618,5.17095,2M+NH4,C7H12O2,0,48.9,metab_927,pos_1859,pos,48740,41790,78900,27730,40100,36540,39590,42880,53980,63190,39440,37020,,,,
"PC(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))",-,0.8005,0.8735,0.1159,0.2607,1.1311,0.1777,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004303;LMGP01011730;HMDB0008255,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,826.538917101,7.37853333333,M+H,C48H76NO8P,0,87.3,metab_2878,pos_3836,pos,994800,215100,286100,259800,286900,225000,111500,228000,187100,881200,222300,374300,,,,
"LysoPC(18:3(6Z,9Z,12Z)/0:0)",-,0.8086,0.8655,0.1121,0.2756,0.9613,-0.0569,no,down,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010387,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,562.314704163,6.43408333333,M+FA-H,C26H48NO7P,0,57,metab_7154,neg_1732,neg,569500,231700,537400,408800,510000,411600,378100,423100,397100,648700,587100,341700,,,,
"DG(20:4(8Z,11Z,14Z,17Z)/18:0/0:0)",-,0.9533,0.9708,0.1012,0.226,1.0078,0.0112,no,up,C00165,-,-,map05214;map05167;map05143;map05163;map05146;map04915;map04015;map04014;map04659;map04658;map04270;map04012;map05231;map04650;map04370;map04371;map04072;map04071;map05235;map04921;map05415;map04750;map04919;map04933;map04961;map05012;map04920;map04923;map04925;map05017;map04926;map05171;map04726;map04725;map04724;map04723;map04728;map05223;map04720;map04666;map05170;map04664;map04540;map04662;map04660;map05200;map04261;map04010;map04024;map04929;map04020;map04928;map04062;map05225;map04064;map04066;map04625;map01521;map04972;map04973;map04970;map04971;map04730;map04975;map04918;map04713;map04916;map04714;map04722;map04911;map04912;map04935;map04613;map05022;map04611;map04931,"Glioma;Kaposi sarcoma-associated herpesvirus infection;African trypanosomiasis;Human cytomegalovirus infection;Amoebiasis;Estrogen signaling pathway;Rap1 signaling pathway;Ras signaling pathway;Th17 cell differentiation;Th1 and Th2 cell differentiation;Vascular smooth muscle contraction;ErbB signaling pathway;Choline metabolism in cancer;Natural killer cell mediated cytotoxicity;VEGF signaling pathway;Apelin signaling pathway;Phospholipase D signaling pathway;Sphingolipid signaling pathway;PD-L1 expression and PD-1 checkpoint pathway in cancer;Oxytocin signaling pathway;Diabetic cardiomyopathy;Inflammatory mediator regulation of TRP channels;Thyroid hormone signaling pathway;AGE-RAGE signaling pathway in diabetic complications;Endocrine and other factor-regulated calcium reabsorption;Parkinson disease;Adipocytokine signaling pathway;Regulation of lipolysis in adipocytes;Aldosterone synthesis and secretion;Spinocerebellar ataxia;Relaxin signaling pathway;Coronavirus disease - COVID-19;Serotonergic synapse;Cholinergic synapse;Glutamatergic synapse;Retrograde endocannabinoid signaling;Dopaminergic synapse;Non-small cell lung cancer;Long-term potentiation;Fc gamma R-mediated phagocytosis;Human immunodeficiency virus 1 infection;Fc epsilon RI signaling pathway;Gap junction;B cell receptor signaling pathway;T cell receptor signaling pathway;Pathways in cancer;Adrenergic signaling in cardiomyocytes;MAPK signaling pathway;cAMP signaling pathway;GnRH secretion;Calcium signaling pathway;Parathyroid hormone synthesis, secretion and action;Chemokine signaling pathway;Hepatocellular carcinoma;NF-kappa B signaling pathway;HIF-1 signaling pathway;C-type lectin receptor signaling pathway;EGFR tyrosine kinase inhibitor resistance;Pancreatic secretion;Carbohydrate digestion and absorption;Salivary secretion;Gastric acid secretion;Long-term depression;Fat digestion and absorption;Thyroid hormone synthesis;Circadian entrainment;Melanogenesis;Thermogenesis;Neurotrophin signaling pathway;Insulin secretion;GnRH signaling pathway;Growth hormone synthesis, secretion and action;Neutrophil extracellular trap formation;Pathways of neurodegeneration - multiple diseases;Platelet activation;Insulin resistance","Human Diseases;Human Diseases;Human Diseases;Human Diseases;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Organismal Systems;Organismal Systems;Environmental Information Processing;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Environmental Information Processing;Environmental Information Processing;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Cellular Processes;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Environmental Information Processing;Organismal Systems;Organismal Systems;Human Diseases;Environmental Information Processing;Environmental Information Processing;Organismal Systems;Human Diseases;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Organismal Systems;Human Diseases;Organismal Systems;Human Diseases","Cancer: specific types;Infectious disease: viral;Infectious disease: parasitic;Infectious disease: viral;Infectious disease: parasitic;Endocrine system;Signal transduction;Signal transduction;Immune system;Immune system;Circulatory system;Signal transduction;Cancer: overview;Immune system;Signal transduction;Signal transduction;Signal transduction;Signal transduction;Cancer: overview;Endocrine system;Cardiovascular disease;Sensory system;Endocrine system;Endocrine and metabolic disease;Excretory system;Neurodegenerative disease;Endocrine system;Endocrine system;Endocrine system;Neurodegenerative disease;Endocrine system;Infectious disease: viral;Nervous system;Nervous system;Nervous system;Nervous system;Nervous system;Cancer: specific types;Nervous system;Immune system;Infectious disease: viral;Immune system;Cellular community - eukaryotes;Immune system;Immune system;Cancer: overview;Circulatory system;Signal transduction;Signal transduction;Endocrine system;Signal transduction;Endocrine system;Immune system;Cancer: specific types;Signal transduction;Signal transduction;Immune system;Drug resistance: antineoplastic;Digestive system;Digestive system;Digestive system;Digestive system;Nervous system;Digestive system;Endocrine system;Environmental adaptation;Endocrine system;Environmental adaptation;Nervous system;Endocrine system;Endocrine system;Endocrine system;Immune system;Neurodegenerative disease;Immune system;Endocrine and metabolic disease",PW_C003586;HMDB0007535,"Lipids and lipid-like molecules",Glycerolipids,Diradylglycerols,-,627.533409254,7.5536,M+H-H2O,C41H72O5,0,80.8,metab_2780,pos_3739,pos,1104000,850500,771500,838200,1035000,840700,804000,1169000,787000,561700,848600,1228000,,,,
"Linoleic Acid",ÑÇÓÍËá,0.802,0.86,0.101,0.4998,0.9775,-0.0328,no,down,C01595,Lipids,"Fatty acids",map01100;map00591;map01040,"Metabolic pathways;Linoleic acid metabolism;Biosynthesis of unsaturated fatty acids",Metabolism;Metabolism;Metabolism,"Global and overview maps;Lipid metabolism;Lipid metabolism",HMDB0006270;LMFA01030120;PW_C000530;HMDB0247706;HMDB0000673;MJDBOTE0000548,"Lipids and lipid-like molecules","Fatty Acyls","Lineolic acids and derivatives",506-21-8;60-33-3,279.232565201,6.71068333333,"M-H, M+FA-H, 2M-H",C18H32O2,84.3,0,metab_8318,neg_34,neg,3494000,2481000,2904000,2740000,3154000,2670000,2084000,3325000,3051000,3356000,3369000,2658000,,,,
N-Acetyl-D-cysteine,N-ÒÒõ£-D-°ëë×°±Ëá,0.9196,0.9507,0.0934,0.6998,1.0255,0.0363,no,up,C06809,-,-,-,-,-,-,HMDB0255048,"Organic acids and derivatives","Carboxylic acids and derivatives","Amino acids, peptides, and analogues",-,146.026832334,0.77475,M+H-H2O,C5H9NO3S,0,51.3,metab_5330,pos_6219,pos,211900,101500,61160,69590,120700,136200,97010,141400,143000,73780,165600,62710,,,,
LysoPA(19:0/0:0),-,0.9862,0.9915,0.09,0.5179,0.9973,-0.0039,no,down,-,-,-,-,-,-,-,HMDB0114746,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphates,-,494.323278195,6.6864,"M+ACN+Na, 2M+ACN+H, M+ACN+H",C22H45O7P,0,33.8,metab_686,pos_164,pos,14250000,8428000,11700000,11790000,9717000,10480000,7876000,13450000,12230000,14840000,11450000,6682000,,,,
9-Nonylpurine,"9 -ÈÉ»ùàÑßÊ",0.7931,0.8677,0.0885,0.4873,1.0874,0.1209,no,up,-,-,-,-,-,-,-,HMDB0260401,"Organoheterocyclic compounds",Imidazopyrimidines,"Purines and purine derivatives",-,515.362555235,6.88568333333,2M+Na,C14H22N4,0,42.6,metab_3269,pos_4247,pos,334600,464600,598800,583200,349300,467900,381700,242300,459600,1043000,224100,222300,,,,
"PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/19:0)",-,0.8395,0.9012,0.0829,0.7595,0.9378,-0.0926,no,down,-,-,-,-,-,-,-,HMDB0256888;LMGP03010833,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoserines,-,872.536987015,7.64091666667,"M+H-2H2O, M+Na",C47H80NO10P,0,61.1,metab_6140,pos_824,pos,371400,635000,579500,767500,1614000,539500,528100,711000,901500,389900,1495000,780600,,,,
"Phenol sulphate",-,0.8793,0.9167,0.0824,0.7479,0.9183,-0.123,no,down,C02180;C00850,-,-,-,-,-,-,HMDB0060015;PW_C040399,"Organic acids and derivatives","Organic sulfuric acids and derivatives",Arylsulfates,937-34-8,172.990497393,3.52571666667,M-H,C6H6O4S,0,39.5,metab_9045,neg_2078,neg,9921000,3744000,27190000,694900,2681000,5067000,7429000,10800000,19590000,7871000,2631000,5361000,,,,
LysoPC(16:1(9Z)/0:0),-,0.9122,0.9415,0.0821,0.251,1.0154,0.022,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010383,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,76790-27-7,538.314738324,6.52625,M+FA-H,C24H48NO7P,0,69.8,metab_6441,neg_1085,neg,965300,656300,793900,869400,718600,852800,612900,799000,1008000,1131000,738900,492100,,,,
"5-((6-((Aminomethyl)amino)-1-oxohexyl)amino)pentanoic acid",5-£¨£¨6-£¨£¨°±»ù¼×»ù£©°±»ù£©-1-Ñõ´ú¼º»ù£©°±»ù£©ÎìËá,0.8717,0.9126,0.0811,0.4031,0.9726,-0.0401,no,down,-,-,-,-,-,-,-,HMDB0258266,"Lipids and lipid-like molecules","Fatty Acyls","Fatty amides",-,307.152371308,6.32371666667,M+Cl,C12H24N4O3,0,49.2,metab_6398,neg_1045,neg,185500,205600,206600,166400,160900,290700,127500,280100,244700,202100,268500,126800,,,,
"DG(i-21:0/0:0/20:3(8Z,11Z,14Z)-2OH(5,6))",-,0.9618,0.9763,0.077,0.1361,1.0205,0.0293,no,up,-,-,-,-,-,-,-,HMDB0300264,"Not Available","Not Available","Not Available",-,762.625890886,6.48175,M+ACN+H,C44H80O7,0,34,metab_1560,pos_2465,pos,105200,84810,18100,49340,33620,234900,20680,74260,119200,88180,99520,113500,,,,
"Terephthalic Acid",¶Ô±½¶þ¼×Ëá,0.9602,0.9752,0.077,0.4429,1.0203,0.029,no,up,C06337,-,-,map01100,"Metabolic pathways",Metabolism,"Global and overview maps",HMDB0002428;MJDBOTE0000641,Benzenoids,"Benzene and substituted derivatives","Benzoic acids and derivatives",100-21-0,165.018403718,6.70285,M-H,C8H6O4,51.2,0,metab_6498,neg_1138,neg,800600,205900,205700,194900,312600,239900,224600,233000,199100,274700,724200,265200,,,,
"(3b,4b,11b,14b)-11-Ethoxy-3,4-epoxy-14-hydroxy-12-cyathen-15-al 14-xyloside","£¨3b£¬4b£¬11b£¬14b£©-11-ÒÒÑõ»ù-3,4-»·Ñõ-14-ôÇ»ù-12-Çè»ù-15-al 14-Ä¾ÌÇÜÕ",0.9203,0.9476,0.0758,0.4197,0.9304,-0.1041,no,down,-,-,-,-,-,-,-,HMDB0034617,"Lipids and lipid-like molecules","Prenol lipids",Diterpenoids,178120-49-5,539.289195616,6.45136666667,M+FA-H,C27H42O8,0,68.1,metab_7148,neg_1727,neg,1.54,95610,582100,104400,176800,84340,173600,339300,1.666,36340,1.512,571900,,,,
DG(17:0/0:0/LTE4),-,0.9867,0.9918,0.0733,0.4483,1.005,0.0072,no,up,-,-,-,-,-,-,-,HMDB0295677,"Not Available","Not Available","Not Available",-,779.526157944,6.71823333333,2M+3H2O+2H,C43H75NO8S,0,49.9,metab_1747,pos_2647,pos,112300,100500,48530,179200,124800,156300,217300,116600,62530,75840,47950,197700,,,,
LysoPC(15:0/0:0),-,0.9636,0.9777,0.0731,0.1619,1.009,0.0129,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",HMDB0010381;HMDB0010375,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,480.309105983,6.74991666667,M-H,C23H48NO7P,0,38.5,metab_7037,neg_1626,neg,43600000,22270000,31180000,25210000,23310000,23110000,21300000,23600000,24710000,47060000,32430000,18050000,,,,
LysoPE(18:0/0:0),-,0.9989,0.9989,0.0612,0.166,1.0002,0.0003,no,up,-,-,-,-,-,-,-,HMDB0011130,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,69747-55-3,482.323385122,6.9737,"M+H, M+Na",C23H48NO7P,0,47.4,metab_6007,pos_701,pos,7148000,4616000,5097000,4168000,4053000,4481000,4248000,4307000,4360000,7352000,5950000,3338000,,,,
"PC(18:0/20:4(8Z,11Z,14Z,17Z))",-,0.8936,0.9355,0.0599,0.6236,1.0392,0.0555,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008049;LMGP01012144;PW_C004098,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,810.598862065,6.92566666667,M+H,C46H84NO8P,0,69.4,metab_1911,pos_2821,pos,606900000,296100000,248400000,278800000,103300000,373700000,401500000,269200000,326900000,467900000,79500000,290400000,,,,
"Spirolide F",-,0.9105,0.9452,0.0576,0.4801,0.9774,-0.033,no,down,-,-,-,-,-,-,-,HMDB0030501,"Lipids and lipid-like molecules","Prenol lipids","Terpene lactones",183159-73-1,750.493350289,6.34308333333,"M+Na, M+ACN+H",C43H69NO8,0,36,metab_6163,pos_846,pos,316200,136500,145200,130500,215100,172400,256400,118000,145000,251800,158700,212100,,,,
Narasin,¼×»ùÑÎÃ¹ËØ,0.9121,0.9464,0.0534,0.5028,1.0399,0.0564,no,up,-,-,-,-,-,-,-,HMDB0030448,"Lipids and lipid-like molecules","Prenol lipids","Terpene glycosides",55134-13-9,809.472620282,6.54216666667,M+2Na-H,C43H72O11,0,36.9,metab_3670,pos_4652,pos,53140,73790,95800,12350,47000,19570,62980,78750,13570,48470,17690,68580,,,,
"PE-NMe(18:0/22:5(7Z,10Z,13Z,16Z,19Z))",-,0.911,0.9407,0.0518,0.2968,1.035,0.0496,no,up,"C01241 ",-,-,-,-,-,-,PW_C059229;HMDB0113106,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,852.573852929,6.47103333333,M+FA-H,C46H82NO8P,0,91,metab_7141,neg_1720,neg,351800,7786000,5621000,5615000,10320000,6676000,6882000,6309000,6833000,96440,7287000,7737000,,,,
"PC(18:0/18:1(9Z)-O(12,13))",-,0.8862,0.9307,0.0506,0.6888,0.9601,-0.0587,no,down,-,-,-,-,-,-,-,HMDB0286265,"Not Available","Not Available","Not Available",-,766.572064026,7.3548,"M+H-2H2O, M+Na",C44H84NO9P,0,40.1,metab_6097,pos_784,pos,231400,470400,499300,896500,1078000,558900,339000,731000,813400,216000,989100,801800,,,,
DG(PGF1alpha/0:0/a-21:0),-,0.9275,0.9557,0.05,0.0508,1.0373,0.0528,no,up,-,-,-,-,-,-,-,HMDB0298089,"Not Available","Not Available","Not Available",-,780.637021355,6.49781666667,M+ACN+H,C44H82O8,0,35.6,metab_1568,pos_2472,pos,68140,41740,53680,3614,87620,45920,46450,36930,114400,57300,34800,8.057,,,,
"Phthalic Acid",ÌªËá,0.9935,0.9956,0.0473,0.4776,1.0024,0.0035,no,up,C01606,-,-,map01100;map02010,"Metabolic pathways;ABC transporters","Metabolism;Environmental Information Processing","Global and overview maps;Membrane transport",HMDB0002107;MJDBOTE0000627,Benzenoids,"Benzene and substituted derivatives","Benzoic acids and derivatives",88-99-3,165.018400815,6.84488333333,M-H,C8H6O4,61.4,0,metab_6554,neg_1189,neg,876700,285000,276100,294900,414000,348900,327700,338900,271300,323700,821800,405900,,,,
"9,10-Epoxyoctadecenoic acid","9£¬10 -»·ÑõÊ®°ËÌ¼Ï©Ëá",0.902,0.934,0.0432,0.1859,0.9429,-0.0848,no,down,C14825,-,-,map01100;map00591,"Metabolic pathways;Linoleic acid metabolism",Metabolism;Metabolism,"Global and overview maps;Lipid metabolism",HMDB0004701,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",-,591.462947242,6.84488333333,2M-H,C18H32O3,0,95.9,metab_6992,neg_1584,neg,51130,276900,118900,48910,37630,65630,44210,207800,65480,186300,89980,41540,,,,
PC(18:0/0:0),-,0.8406,0.9016,0.0426,0.277,1.0361,0.0512,no,up,C04230,Lipids,Phospholipids,map00564;map05231,"Glycerophospholipid metabolism;Choline metabolism in cancer","Metabolism;Human Diseases","Lipid metabolism;Cancer: overview",LMGP01050026;HMDB0010384,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,19420-57-6,546.352057698,7.66461666667,M+Na,C26H54NO7P,95.6,0,metab_2331,pos_3268,pos,229100000,148700000,194400000,153500000,133500000,140400000,137400000,139500000,140000000,276900000,148600000,122400000,,,,
PA(15:0/PGF1alpha),-,0.9632,0.9764,0.0391,0.8921,1.0037,0.0053,no,up,-,-,-,-,-,-,-,HMDB0263258,"Not Available","Not Available","Not Available",-,767.504744832,6.32713333333,"M+CH3OH+H, M+ACN+Na, M+2Na-H, M+Na",C38H71O11P,0,51.5,metab_534,pos_15,pos,2530000,3049000,3164000,3136000,2575000,3509000,3292000,2382000,3006000,2939000,2794000,3488000,,,,
Cyclopentolate,»·ÅçÍÐõ¥,0.9628,0.9764,0.0384,0.2525,0.9893,-0.0155,no,down,C06932,-,-,-,-,-,-,HMDB0015114,Benzenoids,"Benzene and substituted derivatives","Not Available",512-15-2,324.21618048,6.0081,M+CH3OH+H,C17H25NO3,0,36.6,metab_4331,pos_5295,pos,197500,397100,229600,112400,205000,134900,194200,157900,213200,337200,202600,185500,,,,
Favipiravir,·¨Æ¥À­Î¤,0.9162,0.9477,0.0384,0.5154,1.0296,0.0421,no,up,-,-,-,-,-,-,-,HMDB0252176,"Organoheterocyclic compounds",Diazines,Pyrazines,-,190.060815976,2.8334,M+CH3OH+H,C5H4FN3O2,0,55.6,metab_4987,pos_5898,pos,49320,47930,80720,9269,34770,65590,41420,27700,84470,43000,43100,39580,,,,
5-Methoxyindoleacetate,"5 -¼×Ñõ»ùßÅßáÒÒËáõ¥",0.9554,0.9719,0.0377,0.188,0.9904,-0.0139,no,down,C05660,-,-,map00380,"Tryptophan metabolism",Metabolism,"Amino acid metabolism",HMDB0004096;PW_C002060,"Organoheterocyclic compounds","Indoles and derivatives","Indolyl carboxylic acids and derivatives",3471-31-6,247.107237085,5.01265,"M+ACN+H, M+2Na-H, M+H-H2O",C11H11NO3,0,50.9,metab_6125,pos_81,pos,387400,233000,339500,119600,272600,326900,260700,209800,386800,241800,328600,267600,,,,
Lipofectin,Àû°û·¢¶¡,0.9908,0.9942,0.0372,0.0778,1.0025,0.0036,no,up,-,-,-,-,-,-,-,HMDB0244088;HMDB0254118;HMDB0009059,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoethanolamines,-,767.517984101,6.69436666667,M+Na,C41H77O9P,0,30.4,metab_1728,pos_2626,pos,162500,93090,104500,109400,114500,123800,159300,81210,29070,97690,175500,163200,,,,
Apigenidin,ÇÛ²Ë¶¨,0.9499,0.9687,0.0251,0.5289,1.017,0.0243,no,up,C08574,-,-,-,-,-,-,HMDB0303074,"Phenylpropanoids and polyketides",Flavonoids,Hydroxyflavonoids,-,278.056463933,0.618083333333,M+Na,C15H11O4+,0,79.8,metab_351,pos_1318,pos,205500,237800,358400,52290,192800,313700,205100,125800,420700,196100,190000,199600,,,,
"Metronidazole phosphate",Á×Ëá¼×Ïõßò,0.9525,0.9717,0.021,0.4323,0.9608,-0.0577,no,down,C07203,-,-,-,-,-,-,HMDB0254689;HMDB0015052,"Organoheterocyclic compounds",Azoles,Imidazoles,443-48-1,286.002297728,3.67583333333,M+Cl,C6H10N3O6P,0,40.7,metab_8795,neg_785,neg,37620,714.1,42520,3999,748.5,67140,18940,3487,10810,84430,3391,37940,,,,
"Xanthylic acid",»ÆÜÕËá,0.9779,0.9875,0.0168,0.6591,0.991,-0.013,no,down,C00655,-,-,map01100;map00230,"Metabolic pathways;Purine metabolism",Metabolism;Metabolism,"Global and overview maps;Nucleotide metabolism",PW_C001196;HMDB0001554,"Nucleosides, nucleotides, and analogues","Purine nucleotides","Purine ribonucleotides",523-98-8,382.076000319,2.81736666667,M+NH4,C10H13N4O9P,0,51.3,metab_731,pos_1680,pos,386500,283000,188600,49660,203600,348100,184400,112200,444500,257900,85470,388400,,,,
"Norcholic acid",È¥¼×µ¨Ëá,0.9572,0.9729,0.014,0.2293,1.0121,0.0174,no,up,-,-,-,-,-,-,-,HMDB0255727;LMST04060019,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Bile acids, alcohols and derivatives",-,852.567474324,6.67033333333,2M+ACN+Na,C23H38O5,0,34.5,metab_1711,pos_2608,pos,240500,212900,215200,89390,271700,126700,151000,118800,168800,279600,292500,131700,,,,
"PC(18:2(9Z,12Z)/18:0)",-,0.98,0.9886,0.0128,0.6667,0.9973,-0.0039,no,down,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",PW_C004183;HMDB0008135;LMGP01010935,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,786.599030586,7.70341666667,M+H,C44H84NO8P,0,71,metab_2351,pos_3293,pos,348800000,401400000,316600000,322400000,250700000,319400000,468700000,325800000,320700000,332700000,222700000,294700000,,,,
"Valeric acid",ÎìËá,0.9578,0.9731,0.0126,0.1998,1.0075,0.0108,no,up,C00803,"Organic acids","Carboxylic acids",-,-,-,-,LMFA01010005;HMDB0000892,"Lipids and lipid-like molecules","Fatty Acyls","Fatty acids and conjugates",109-52-4,144.101726692,0.704516666667,M+ACN+H,C5H10O2,0,43.1,metab_423,pos_1390,pos,510100,421600,728500,331200,360800,564900,450500,582600,530000,402200,470800,459400,,,,
GPCho(20:4/20:4),-,0.9439,0.9653,0.0126,0.0561,1.0504,0.0709,no,up,C00157,Lipids,Phospholipids,map01100;map00564;map00590;map00591;map00592;map05231;map04723,"Metabolic pathways;Glycerophospholipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;Choline metabolism in cancer;Retrograde endocannabinoid signaling","Metabolism;Metabolism;Metabolism;Metabolism;Metabolism;Human Diseases;Organismal Systems","Global and overview maps;Lipid metabolism;Lipid metabolism;Lipid metabolism;Lipid metabolism;Cancer: overview;Nervous system",HMDB0008443;HMDB0008477;HMDB0008476;HMDB0008444,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphocholines,-,852.552269383,7.56956666667,M+Na,C48H80NO8P,74.2,0,metab_2282,pos_3209,pos,929600,88640,131300,309900,14.47,117600,119400,176500,155200,748800,265600,35940,,,,
"Chikusetsu saponin iva",Öñ½Ú²ÎÔíÜÕ,0.9251,0.9546,0.0118,0.0631,1.0314,0.0446,no,up,C10246,-,-,-,-,-,-,HMDB0250078;HMDB0038778,"Lipids and lipid-like molecules","Prenol lipids","Terpene glycosides",51415-00-0,812.474438661,6.59031666667,M+NH4,C42H66O14,0,33.1,metab_3612,pos_4598,pos,48180,110000,146200,130100,87700,20050,28030,56430,156800,51470,128600,104300,,,,
"SM(d20:1/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))",-,0.9797,0.9886,0.0051,0.0368,1.0045,0.0065,no,up,-,-,-,-,-,-,-,HMDB0290755,"Not Available","Not Available","Not Available",-,819.606717469,7.22688333333,M+H,C47H83N2O7P,0,57.2,metab_2960,pos_3923,pos,105000,67950,154600,148500,186900,134300,110000,121400,184900,112400,122200,143100,,,,
"Corchoroside B",»ÆÂéÜÕB,0.9743,0.9835,0.0027,0.3506,1.0203,0.029,no,up,-,-,-,-,-,-,-,HMDB0030343,"Lipids and lipid-like molecules","Steroids and steroid derivatives","Steroidal glycosides",35536-76-6,563.289426878,6.41933333333,M+FA-H,C29H42O8,0,66.6,metab_7155,neg_1733,neg,2803,223000,667700,257600,383200,123800,316900,450100,293.3,36760,2469,819200,,,,
PS(16:0/16:1(9Z)),-,0.9691,0.9808,0.0005,0.2186,1.0122,0.0175,no,up,C02737,Lipids,Phospholipids,map01100;map00564;map05146;map05322;map00260;map05140,"Metabolic pathways;Glycerophospholipid metabolism;Amoebiasis;Systemic lupus erythematosus;Glycine, serine and threonine metabolism;Leishmaniasis","Metabolism;Metabolism;Human Diseases;Human Diseases;Metabolism;Human Diseases","Global and overview maps;Lipid metabolism;Infectious disease: parasitic;Immune disease;Amino acid metabolism;Infectious disease: parasitic",HMDB0012355;PW_C007884;LMGP03010909,"Lipids and lipid-like molecules",Glycerophospholipids,Glycerophosphoserines,-,778.453774205,6.7342,M+2Na-H,C38H72NO10P,0,53.5,metab_3434,pos_4415,pos,59630,52510,124700,17630,64180,30880,62220,64940,38680,25010,77930,76600,,,,
